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Synopsis 
 
Enterohaemorrhagic Escherichia coli (EHEC) O157:H7 Sakai is an emerging human 
pathogen. The genes responsible for EHEC virulence are contained in a pathogenicity island 
named the locus of enterocyte effacement (LEE). The LEE consists of five major 
polycistronic operons (LEE1-5), which co-ordinately encode a type three secretion apparatus 
and effector molecules that are associated with the attaching and effacing lesions in the 
intestine.  
 
Expression of the genes in LEE is primarily coordinated by expression of the LEE1 operon. 
GrlA is a LEE-encoded transcription regulator that has been proposed to be involved in the 
regulation of expression of the LEE1 operon. To study GrlA-dependent effects at the LEE1 
operon regulatory region further, a simple plasmid-based system is described in this work. 
The work reveals that GrlA can activate transcription initiation at the LEE1 P1 promoter by 
binding to a target located within the 18 base pair spacer between the promoter -10 and -35 
elements, which were defined by mutational analysis. Shortening this spacer to 17 base pairs 
increases P1 promoter activity and short-circuits GrlA-dependent activation. Hence, at the P1 
promoter, the action of GrlA resembles that of many MerR family transcription activators at 
their target promoters.  
 
A cryptic promoter, designated P1A, was found that can initiate transcription within the LEE1 
operon regulatory region. Mutational- and biochemical analyses revealed that the P1A 
promoter overlaps the principal P1 promoter and transcription from the P1A starts at a site 
located 10 base pairs upstream of the P1 promoter. P1A is likely to compete with the P1 since 
it can only be active when the P1 promoter is mutated. A single base substitution in the P1 
consensus -35 element unmasks P1A promoter activity. In contrast, P1A activity is much less 
when P1 is inactivated by a mutation in its -10 hexamer element. This suggests that, even 
when P1 is inactive, a consensus -35 element can sequester RNA polymerase and prevent its 
access to the P1A promoter. 
 
The LEE1 operon regulatory region has ~170 bases-long leader sequence. Deletion and 
mutational analyses revealed that the LEE1 operon leader sequence contains a short translated 
 
 
iii 
open reading frame, which has a strong ribosome binding site in front of two adjacent 
alternative translation start sites, followed by a lysine codon and a nonsense codon. 
Inactivation of this mini-gene significantly reduced the expression of the downstream ler gene, 
suggesting that optimal expression of the ler gene needs prior translation of the upstream 
mini-gene.  
 
Deletion and subsequent reporter gene assays revealed that overexpressed Ler represses 
expression from the LEE1 promoter regulatory region i.e., autoregulates its own transcription.  
In contrast, it activates expression from the LEE2 promoter by negating H-NS-mediated 
repression. This suggests that both the GrlA and the mini-gene play positive roles in the 
expression of the ler gene whilst overexpressed Ler exhibits a negative role on its own 
expression and activates the expression from the LEE2 promoter. 
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Introduction 
 
  
 
2 
1.1 Escherichia coli  
Escherichia coli belongs to the large family of enteric bacteria, the Enterobacteriaceae. These 
are facultatively-anaerobic Gram-negative rods, which are found in different environments 
including gastrointestinal tracts of humans and other warm-blooded animals. E. coli can be 
differentiated from other members of the Enterobacteriaceae family by either a lactose-
positive or an indole-positive test (Nataro and Kaper, 1998; Murray et al., 2009).  
 
E. coli cells are about 2 μm long, 0.5 μm in diameter with a cell volume of 0.6-0.7 μm3 
(Murray et al., 2009). An E. coli cell consists of cell envelope and cytoplasm. Like other 
bacteria, the E. coli cytoplasm is encased by the cell envelope and is the place where the 
functions of metabolism, protein production and DNA replication occur (Murray et al., 2009). 
Many essential macromolecular assemblies are distributed in the cytoplasm. For example, the 
E. coli chromosome is a single, double-stranded circle of DNA that is located in a discrete 
area of the cytoplasm known as the nucleoid. Unlike in eukaryotic cells, bacterial 
chromosomes are not confined in a separate membrane-enclosed nuclear compartment.  
 
For E. coli, the cell envelope consists of an interior cytoplasmic membrane, a periplasmic 
space containing peptidoglycan, an outer membrane and sometimes a capsule. The 
cytoplasmic membrane is a phospholipid bilayer that shares many of the properties and 
functions of the eukaryotic cytoplasmic membrane. Located immediately outside of the 
cytoplasmic membrane is the periplasmic space. This can comprise up to 40% of the total cell 
volume and can contain at least 20% of the total cell water (Stock et al., 1977; Murray et al., 
2009). The periplasmic space helps in osmoregulation and thus protects the cytoplasm. It 
houses numerous proteins including those necessary for nutrient binding, chemosensing, 
peptidoglycan synthesis and electron transport. It also contains degradative proteins including 
proteases, nucleases or phosphatases necessary for degradation of large nucleic acid or protein 
molecules to small transportable sizes. Moreover, it contains a detoxifying enzyme, beta-
lactamase, which degrades incoming antibiotics before being penetrated into the cytoplasm or 
target sites. The peptidoglycan polysaccharide layer located within this space provides the 
rigidity to the cell and determines the shape to the cell. Peptidoglycan is absent in eukaryotic 
cells but is essential for bacterial survival. In E. coli, the peptydoglycan layer is thin compared 
with that of Gram-positive bacteria and thus, the E. coli cannot retain the crystal violet dye 
  
 
3 
when washed in a decolorizing solution in the Gram staining protocol and hence it is referred 
to as Gram-negative. Linked to the peptidoglycan layer is the outer membrane. E. coli cells, 
like all other Gram-negative organisms, have unique outer membranes that are essential for 
survival; these structures are lacking in Gram-positive bacteria. This outer membrane contains 
lipopolysaccharides (consisting of lipid A, core polysaccharides and „O‟ antigen) and integral 
membrane proteins, as well as proteins located on the periphery; both on the surface of the 
organisms and within the periplasmic space (Schilling et al., 2001). For Gram-negative 
bacteria, the outer membrane provides the interface with the environment and acts as a 
molecular sieve, excluding noxious compounds while allowing the uptake of essential 
nutrients. The capsule is usually made up of complex polysaccharides that protect the cell 
from desiccation and phagocytosis (Burns and Hull, 1999). It can also promote adherence to 
other bacteria and to the host cell surfaces and acts as a major virulence determinant in some 
disease producing E. coli (Hérias et al., 1997; Bahrani-Mougeot et al., 2002). 
 
Many E. coli possess flagella that protrude from the cell envelope and help in bacterial 
motility and initial colonization during pathogenesis (Darnton et al., 2007; Mahajan, et al., 
2009). Flagella and the other surface structures mentioned above form the basis for serotyping 
of E. coli such that they are differentiated based on their O (lipopolysaccharide), H (flagellar), 
and K (capsular) surface antigen profiles (Edwards and Ewing, 1972). Fimbriae or pili are 
other bacterial surface appendages. They extend out from the outside of the cell surface and 
play an important role in attachment of bacterial cells to surfaces to start biofilm formation, 
and to host cells during pathogenesis (Hicks et al., 1998; Pawar et al., 2005). Specialized pili 
help in the bacterial conjugation process during which plasmid DNA is passed from one 
bacterium to another (Ou and Anderson, 1970). 
 
Non-pathogenic E. coli, particularly E. coli K-12 strains, are often considered model 
organisms for studying the molecular bases of life, and it has been said that "what's true for E. 
coli is true for an elephant." This widely quoted phrase was expressed in 1954 by Nobel 
Laureate Jacques Monod who won the prize for his operon model, which was derived from 
research on E. coli K-12 (Friedmann, 2004; Hobman et al., 2007). The great advantage of 
using the E. coli K-12 strain lies in its rapid growth rate and simple nutritional requirements 
in laboratory conditions. In 1922, the original laboratory E. coli K-12 strain was isolated from 
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human faeces at Stanford University. During many years of use in laboratory conditions, the 
strain lost its „O‟ surface antigens and this increased its acceptance as it was harmless to the 
researchers. Hence E. coli K-12 is currently the best characterized organism at the molecular 
level, and it has played pioneering roles in studies of various key aspects of life including 
DNA replication, transcription, translation, gene regulation, the operon concept, restriction 
enzymes and horizontal gene transfer (Hobman et al., 2007). Also the molecular study of 
higher organisms largely depends on the use of E. coli as a vector. It is thus, true that “all cell 
biologists have two cells of interest, the one they are studying and Escherichia coli” 
(Neidhardt and Curtiss, 1996) and E. coli K-12 is still unchallenged as a model organism 
playing unparalleled roles in different fields of study including genetic engineering and 
modern biotechnology, synthetic biology, and systems biology (Baba et al., 2006).  
 
Sequence analysis of the E. coli K-12 genome revealed a total of 4,639,221 base pairs in 
which its genes are embedded (Blattner et al., 1997). The total G+C content is 50.8%, and 
genes that encode proteins account for >87 % of the genome. The genome also contains many 
horizontally acquired insertion sequence elements and phage sequences. Comparison of 
sequence data from different E. coli strains revealed that E. coli is a diverse bacterial species 
where ca. 50% of a genome is common to all strains but where this 50% represents a 
significantly smaller portion (ca. 20%) of the total gene repertoire identified among more than 
100 E. coli strains to date (Lukjancenko et al., 2010). This diversification is due to acquisition 
and loss of pathogenic islands and other mobile genetic elements; pathogenic bacteria often 
have genomes ca. 1Mbp larger than their non-pathogenic counterparts (Croxen and Finlay, 
2010). 
 
1.2 Pathogenic E. coli  
In 1885, Theodor Escherich, a German paediatrician and bacteriologist, dicovered E. coli in 
the faeces of healthy infants (Friedmann, 2006; Shulman et al, 2007). The species name is 
„coli‟ as it can be found universally in the large intestine or colon. Human intestines are 
usually colonized by E. coli a few hours after birth and thereafter, E. coli remain as harmless 
commensals, and even provide benefits to the host. For instance, E. coli can benefit its host by 
providing important metabolic contributions, including vitamin K2 synthesis, as well as 
preventing colonization by harmful bacteria (Reid et al., 2001; Canny and McCormick, 2008).  
  
 
5 
However, a large number of E. coli strains can cause a wide range of diseases in humans as 
well as in mammals and birds worldwide (Kaper et al., 2004). Pathogenic E. coli are broadly 
classified into two groups. One group causes intestinal pathologies, whilst the second group 
cause extra-intestinal disease. Intestinal pathologies mostly consist of more or less severe 
diarrhoea and are caused by several pathovars, hence the group is also known as 
diarrhoeagenic E. coli. Six well studied pathovars in this group are: enteropathogenic E. coli 
(EPEC), enterohaemorrhagic E. coli (EHEC), enterotoxigenic E. coli (ETEC), 
enteroaggregative E. coli (EAEC), enteroinvasive E. coli (EIEC) and diffusely adherent E. 
coli (DAEC) (Kaper et al., 2004; Croxen and Finlay, 2010). The most common extra-
intestinal infections (due to ExPEC; Russo and Johnson, 2003) are urinary tract infections 
caused by uropathogenic E. coli (UPEC) and meningitis caused by neonatal meningitis E. coli 
(NMEC) (Croxen and Finlay, 2010). Recent genome comparisons have demonstrated that the 
four Shigella spp. are in fact E. coli and are most similar to the EIEC. Shigella spp. causes 
bacillary dysentery and bloody diarrhoea (Levine et al., 1973). S. dysenteriae arose 
independently of the other three Shigella strains and is closely related to EHEC (Chaudhuri et 
al., 2010). 
 
Different pathovars can be identified on the basis of their clinical manifestations and 
repertoire of virulence factors (Nataro and Kaper, 1998). The EAEC, EPEC or DAEC 
pathovars can be differentiated phenotypically by performing a HEp-2 adherence assay (Vial 
et al., 1990). Furthermore, numerous immunological assays can be used to detect antigens e.g. 
Shiga-like exotoxin, which is specific to certain pathovars (Sowers et al., 1996). Nucleic acid 
probes can be used to detect enterotoxins or target genes (Moseley et al., 1982). Additionally, 
polymerase chain reaction (PCR) using oligonucleotide primers specific for target genes can 
be used to differentiate pathovars (Stacy-Phipps et al., 1995). 
 
In addition to pathogenic E. coli, there are a number of clinically significant bacteria in the 
Enterobacteriaceae family that also cause intestinal infections including Salmonella enterica 
and Citrobacter rodentium. S. enterica causes gastroenteritis associated with diarrhoera 
though S. enterica serovar Typhi causes a severe desseminated invasive infection called 
typhoid (Zhang et al., 2003). C. rodentium is a natural mouse pathogen that colonizes the 
intestine and causes colitis and transmissible colonic hyperplasia (Schauer et al., 1993; Deng 
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et al., 2001). C. rodentium infection in the mouse is also used as a model for EPEC mediated 
disease in humans due to the similarity of the infectious process. 
 
1.3 E. coli pathovars EPEC and EHEC 
Among different pathovars of E. coli, EPEC is a leading cause of infantile diarrhoea 
worldwide, particularly in developing countries (reviewed by Nataro and Kaper, 1998; 
Schmidt, 2010). EPEC was first reported to be a cause of epidemic and sporadic diarrhoea in 
the 1940‟s (Frankel et al., 1998). The disease can be associated with high rates of mortality 
(Chen and Frankel, 2005). To promote an infectious cycle, a bacterium needs to be able to 
exploit its host cell for colonization, multiplication and dissemination by using numerous 
virulence factors. The 2nd International Symposium on EPEC (Kaper, 1996) defined typical 
EPEC as those E. coli strains possessing specific virulence factors namely bundle-forming pili 
encoded on the EPEC adherence factor plasmid (EAF) and carry the locus of enterocyte 
effacement (LEE) pathogenicity island encoding a type III secretion system (T3SS). Bundle-
forming pili promote initial adherence, primarily in the small intestine, and interaction with 
other EPEC bacteria to form microcolonies, a characteristic of localized adherence. The LEE-
encoded T3SS promotes the formation of attaching and effacing (A/E) lesions, which is a 
defining feature of EPEC. Atypical EPEC (aEPEC) that lack the EAF plasmid but possess the 
LEE pathogenicity island (Nataro, 2006), show diffuse adherence instead of localized 
adherence (Schmidt, 2010) and can cause prolonged diarrhoea in children (Spano et al., 
2008). 
 
Like atypical EPEC, EHEC strains lack the EAF plasmid and contain the LEE pathogenicity 
island. However, in contrast to both typical and atypical EPEC strains, EHEC possess 
enterotoxins and a ca. 60 MDa plasmid pO157. The toxins are called Shiga-like toxins (Stxs) 
because of their close resemblance to the Shiga toxins of S. dysenteriae (O‟Brien et al., 1982). 
The E. coli version of Stxs are also called Verotoxins (VTs) since they cause irreversible 
pathotypic effects on Vero cell cultures (kidney cells of African green monkey) 
(Konowalchuk et al., 1977). It is believed that the EHEC strains have evolved from the 
prototype EPEC via acquisition of bacteriophage encoding VTs (Whittam et al., 1993; Wick 
et al., 2005). The pO157 plasmids encode several virulence factors including cytotoxin 
haemolysin. The virulence properties of EHEC strains cause A/E lesions on epithelial cells in 
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the large bowel, and cause haemorrhagic colitis and haemolytic uremic syndrome (HUS) in 
humans (Karmali, 1989; Bettelheim, 2003; Kaper et al., 2004; Orth et al., 2006; Spears et al., 
2006). The E. coli O157:H7 is the predominant and most virulent serotype in EHEC. 
However, other serotypes including O26 and O111, which have the same clinical, 
epidemiological and pathogenic properties associated with the O157:H7 are also referred to 
EHEC (Levine, 1987; Karmali, 1989; Sharma, 2002). 
 
Generally, all E. coli strains that produce VTs are collectively called verotoxigenic E. coli 
(VTEC). In this respect, EHEC strains are referred to as VTEC strains. There are over 100 
VTEC serotypes. Many of them have been associated with human illness (Johnson et al., 
1996; Bettelheim, 2003). However, it appears that the VTs alone are not enough to cause 
virulence. To exert virulent effects, VTEC strains need to have other virulence determinants 
such as the LEE pathogenicity island and pO157 virulence plasmids (Stephan et al., 2000; 
Morabito et al., 2001). Therefore, the VTEC is a general term used for all E. coli strains that 
produce VTs, whereas the EHEC is a subset of  the VTEC that also contain other virulence 
factors including the LEE pathogenicity island.  
 
The topic of this thesis is the regulation of the LEE virulence determinant of the EHEC strain 
O157:H7. Therefore, different aspects of the O157:H7 pathogenicity such as epidemiology, 
clinical features and virulence factors are described in next few sections.  
 
1.3.1 Epidemiology and outbreak of E. coli O157:H7 serotype 
Ruminants, predominantly cattle, are the main natural reservoirs of EHEC and are usually 
considered as healthy carriers (Naylor et al., 2005; Spears et al., 2006; Karmali et al., 2010). 
EHEC strains are rarely harboured by pigs, dogs, cats, birds, amphibians, and fish (Beutin et 
al., 1993; Ferens and Hovde, 2011). The presence of EHEC in cattle faeces provides the 
potential for the pathogens to enter the food chain through contamination of milk, 
contamination of meat with intestinal contents during slaughter, or contamination of fruits and 
vegetables by contact with faeces or contaminated manure. Consumption of such 
contaminated foods can trigger EHEC infection and can lead to severe outbreaks (Naylor et 
al., 2005). EHEC O157:H7 serotype was first recognised as the causative agent of outbreaks 
of HUS in the early 1980‟s (Riley et al., 1983). Since then, it has been emerged as an 
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important cause of diarrhoea in industrialized countries. Outbreaks are mainly associated with 
hamburgers, unpasteurized milk or fruit juices and fresh vegetables. A number of major 
outbreaks including a massive-outbreak in the Japanese city of Sakai that affected 
approximately 10000 people including nearly 5000 schoolchildren are listed in Table 1.1.  
 
1.3.2 Clinical features of E. coli O157:H7 pathogenesis 
Studies of EHEC O157:H7 outbreaks provide evidence that EHEC virulence is associated 
with two distinctive clinical features: haemorrhagic colitis (Riley, 1987) and HUS (Gasser et 
al., 1955; Karmali et al., 1983). Haemorrhagic colitis is an illness characterized by sudden 
onset of severe abdominal cramps followed by diarrhoea, which is initially watery but 
becomes grossly bloody. The incubation period is usually three to four days. In some cases, it 
can be prolonged and can be fatal, especially in very young or very old patients. The HUS, on 
the other hand, is a serious complication that may be preceded by haemorrhagic colitis or 
diarrhoea, and is defined by the triad: acute renal failure (uremia), thrombocytopenia (low 
platelet count) and microangiopathic
 
haemolytic anemia. The disease predominantly affects 
children and may cause 5-10% mortality and recovered patient may face chronic kidney 
disease and may rely on renal replacement therapy (Corrigan and Boineau, 2001). 
 
1.3.3 Major pathogenic determinants of E. coli O157:H7 serotype: toxins 
As mentioned earlier, the EHEC chromosome contains phage encoded Stx1 and/or Stx2, and 
these are the major virulence determinant and the defining characteristic of EHEC. Usually, 
lambdoid phage-mediated lysis of bacterial cells in response to DNA damage and the SOS 
response causes release of Stx (Toshima et al., 2007). Both Stx1 and Stx2 are ~70 kDa 
holotoxins consisting of a single A subunit of 32 kDa and five 7.7 kDa B subunits (AB5) 
(Middlebrook and Dorland, 1984; O'Brien and Holmes, 1987). The A subunit is composed of 
a 28 kDa peptide (A1) and a 4 kDa peptide
 
(A2), which remain attached by a disulfide bond 
(Takao et al., 1988). The A1
 
peptide is enzymatically active whereas the A2 peptide helps
 
to 
bind the A subunit to B subunits. The B subunits help in binding the holotoxin to a specific 
glycolipid
 
receptor known as globotriaosylceramides (Gb3), which are found on the
 
surface of 
Paneth cells in the human intestinal mucosa and surface of the kidney epithelial cells (Nataro 
and Kaper, 1998; Schüller et al., 2007). The interaction of Stx B with Gb3 induces membrane 
invaginations that help the holotoxin to be internalised. The internalised holotoxin is then 
transported
 
to the Golgi apparatus and then to the endoplasmic reticulum. Stx A is
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Table 1.1: Major worldwide outbreaks of EHEC 0157: H7 infection 
 
Location No. of 
cases 
No. of 
HUS 
No. of 
deaths 
Setting Source Date Reference 
Ontario 73 12 19 Nursing home Sandwich meal  Sept 1985 Carter et al., 1987 
Alberta 15  2 Nursing home Ground beef June 1987 Hockin and Lior, 1987 
Saitama, Japan 174 14 2 Nursery School Tap water 1990 Akashi et al., 1994 
Western USA 700 45 4 Community Hamburgers  Nov 1992 -Feb 1993 Bell et al., 1994; Tuttle 
et al., 1999 
Oregon, Canada 14   Community Dairy milk Dec 1992- Apr 1993 Keene et al., 1997 
Western United 
States and British 
Colombia 
70 14 1  Apple juice Fall 1996 Cody et al., 1999 
New haven  
county, USA 
14 2  Connecticut 
residents 
Apple cider Oct 1996 Hilborn et al., 2000 
United Kingdom 345 34 16 Central Scotland Meat 1996 Dundas et al., 2001 
 
Sakai,  Japan 9451 122 12 Mostly schoolchildren White radish 
sprouts 
May-Dec 1996 Higami et al., 1998; 
Michino et al., 1999  
Montgomery, 
Pennsylvania  
51 8  Dairy farm visitors Calves  Sept 2000 Crump et al., 2002 
26 States, USA 199 31 3  Fresh spinach Sept 2006 Wendel et al., 2009 
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translocated to the cytoplasm,
 
where it acts on the 60S ribosomal subunit. Specifically the
 
A1 
peptide is an N-glycosidase that cleaves 28S rRNA of host cells, thereby causing protein 
synthesis to be ceased. The resulting disruption of protein synthesis
 
leads to the cell death 
(Melton-Celsa and O‟Brien, 1998; Johannes and Römer, 2010). 
 
1.3.4 Major pathogenic determinants of E. coli O157:H7 serotype: T3SS  
Bacterial pathogens exploit host cell for their own benefit such as seeking out essential 
nutrients for survival. However, protective responses of host cell cause hostile environment 
for bacterial pathogens. Thus, bacterial pathogens use a large number of virulence proteins to 
manipulate host cell responses in the course of an infection. In order to release proteins to the 
host cytosol or to the external milieu, bacterial pathogens have evolved a number of different 
complex secretion systems. These are classified as Type I, Type II etc (Pugsley, 1993; Hueck, 
1998; Aizawa, 2001). In addition to transport virulence proteins to the host cell cytoplasm, 
bacteria use protein secretion systems to export proteins necessary for biogenesis of external 
appendages such as pili or flagella. To date, six different secretion systems (T1SS to T6SS) 
have been described in many Gram-negative bacteria (Bleves et al., 2010). The T2SS and 
T5SS-mediated protein exportation occurs in two steps. Type I and type V exoproteins are 
exported to periplasm by the Sec or Tat system first. Then they are exported to the external 
environment by their dedicated systems. In contrast, T1SS, T3SS, T4SS and T6SS  use one 
step mechanisms in such that the type I, type III, type IV and type VI exoproteins are 
delivered directly to extracellular medium or host cell cytoplasm by their cognate secretion 
apparatus (Figure 1.1).  
 
In EHEC and related bacterial pathogens, the T3S apparatus play crucial roles in exportation 
of bacterial effector proteins to the host cytosol. These nanomachines are bacterial surface 
appendages shaped like microneedles. Remarkably, the T3SS export apparatus is believed to 
have a common origin with the bacterial flagellum (Pallen et al., 2005b; Troisfontaines and 
Cornelis, 2005; Pallen and Gophna, 2007). The bacterial flagellum possesses a built-in 
secretion apparatus like the T3S apparatus and there is a substantial level of similarity both in 
sequence and physico-chemical properties in core components of these two nanomachines 
(Aizawa, 2001; Blocker et al., 2003, Pallen et al., 2005b). Moreover, in both cases, there are 
many functional similarities including specific chaperones necessary in both systems (Parsot
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Figure 1.1. Bacterial secretion systems. 
The figure shows the schematic diagram of six distinct secretion systems in Gram-negative bacteria. In case of Type II and Type V 
secretion systems, exoproteins are first exported from bacterial cytoplasm through the inner membrane to the periplasmic space by the Sec 
or the two arginine (Tat) pathways. After that, proteins are transported through the outer membrane from periplasm to external medium by 
the dedicated systems. On the other hand, Type 1, Type 3, Type 4 and Type 6 secretion systems directly mediate protein export through 
inner and outer membranes to the extracellular medium or to the host cytoplasm. The figure adapted from Beleves et al. (2010) and KEGG 
http://www.genome.jp/kegg/pathway/map/map03070.html
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et al., 2003), molecular systems used to control the size of the apparatus (Minamino and 
Pugsley, 2005), exporting distal components (needle subunits) before substrates to be secreted 
(Blocker et al. 2003). Additionally, many reports show that the bacterial flagellum can secret 
non-flagellar proteins, supporting that it can act as a pure secretory apparatus (Young and 
Young, 2002; Konkel et al., 2004; Lee and Galan, 2004). Taking all into consideration, T3S 
systems are broadly grouped into two: flagellar- and non-flagellar T3SSs.  
 
Non-flagellar T3S systems are present in EHEC and related bacteria as well as in many other 
Gram-negative bacteria (reviewed by Pallen et al., 2005b; Troisfontaines and Cornelis, 2005). 
Examples are the plasmid-encoded Ysc T3S from Yersinia spp. (Cornelis, 2002), the Psc 
system of Pseudomonas aeruginosa, a pathogen for nematodes, plants, insects, and mammals 
(Bodey et al., 1983), the Asc system of Aeromonas salmonicida, a pathogen of fish causing 
fatal disease in Salmonids (Burr et al., 2003) and the Vsc system of Vibrio spp., found in 
association with plankton and juvenile shrimps, prawns, lobsters, and fish causing serous 
human gastroenteritis (Park et al., 2004). T3S systems from intracellular pathogens S. 
enterica and Shigella spp., which are known as Inv-Spa and Inv-Mxi T3S systems 
respectively make the Inv-Mxi-Spa family of T3S system. Members of this T3S family help 
in invasion of bacterial cells to host cells and trigger actin polymerization and the family 
includes T3S systems of Chromobacterium violaceum and Burkholderia spp. that are 
associated with human diseases (Duran et al., 2001; Stevens et al., 2002). 
 
In EHEC and related bacteria, the LEE encodes a T3SS that consists of a T3S apparatus, 
regulators, chaperones, translocators and effectors that co-ordinately cause A/E lesions in host 
epithelial cells. EHEC and related bacteria have acquired this pathogenic determinant via 
horizontally gene transfer (Hacker and Kaper, 2000; Deng et al., 2001; Pallen and Wren, 
2007). Sequence analysis of the entire LEE region from different strains reveals that the 
EPEC prototype strain E2348/69 contains the core LEE region, which is approximately 35.4 
kb in size. The average G+C content of nearly 38% is far below that of the E. coli 
chromosome (50.8% in E. coli chromosome; Blattner et al., 1997). Like many other 
pathogenicity islands, the LEE is found to be inserted near tRNA genes, at targets known as 
recombination hot spots (McDaniel et al. 1995; Perna et al., 1998; Deng et al., 2001; Schmidt, 
2010). The size of the LEE differs due to flanking sequence variation in different isolates. In 
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EHEC and C. rodentium isolates, the region is flanked by bacteriophage and insertion 
sequences, respectively (Perna et al., 1998; Müller et al., 2009). 
 
The LEE region contains 41 predicted genes encoding proteins with more than 50 amino acids 
(Elliott et al., 1998; Perna et al., 1998; Deng et al., 2001). Reverse transcriptase-polymerase 
chain reaction (RT-PCR) analysis of RNAs revealed that the LEE genes are organized into 
five major polycistronic operons: LEE1, LEE2, LEE3, LEE4, LEE5 (or TIR) and several 
smaller transcriptional units (Mellies et al., 1999; Sanchez-SanMartin et al., 2001; Deng et al., 
2004; Lodato and Kaper, 2009; Bhatt et al., 2011). Genes from LEE1-3 encode proteins that 
are necessary for the formation of the T3S apparatus. The LEE4 operon encodes proteins 
necessary for the formation of a translocon for delivering effector molecules to the host cell 
and disruption of the host cytoskeleton (Nougayrede and Donnenberg, 2004; Dean et al., 
2010). Finally, the LEE5 operon encodes proteins necessary for intimate attachment of the 
bacterial cell to the host cell (Jerse et al., 1990; Elliott et al., 1999).  
 
The nomenclature of the LEE genes is now well-established (Elliott et al., 1998; Pallen et al., 
2005a). Generally, the names of LEE genes have been adopted following the homology with 
the most intensively studied T3S system from Yersinia spp. The genes that encode E. coli 
secretion proteins were given the generic name esp (E. coli secreted proteins) (McDaniel et al., 
1995). Those homologous to the genes of the Yersinia T3S (ysc) were named as esc (E. coli 
secretion) genes with the same suffix as Yersinia homologues. The genes that are not 
homologous to ysc but related to T3S were refered to sep (secretion of E. coli proteins). The 
genes that function as chaperones for secretion of other proteins were refered to ces 
(chaperone of E. coli secretion) (Wainwright and Kaper, 1998). The gene that encode intimin 
was named eae (E. coli attaching and effacing) and the intimin receptor gene was named tir 
(translocated intimin receptor) (Jerse et al., 1990; Kenny et al.,1997b). Apart from these, 
some genes including ler, grlR, and grlA were named on the basis of their regulatory roles in 
the expression of other genes (Mellies et al., 1999; Deng et al., 2004). In Figure 1.2, the 
organisation of LEE genes is shown and different genes are marked according to their 
functional properties.  
 
The assembly of a typical T3S apparatus is shown in Figure 1.3 using E. coli nomenclature
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Figure 1.2. Organization of genes in the locus of enterocyte effacement. 
The figure shows the arrangement of 41 genes in the LEE region. Genes shown are organised in five major polycistronic operons: LEE1, 9 
genes; LEE2, 6 genes; LEE3, 7 genes; LEE4, 8 genes and LEE5 or TIR, 3 genes. orf, open reading frames with unknown functions; ler, 
encodes LEE-encoded regulator; esc, encodes E. coli secretion component (homologous to Yersinia type III secretion, ysc); grlR, encodes 
global regulator of LEE repressor; grlA, encodes global regulator of LEE activator; ces, encodes chaperone of E. coli secretion; sep, encode 
secretion of E. coli proteins (not ysc homolog but involved in type III secretion); esp, encode E. coli  secreted proteins; map, encodes 
mitochondrial associated protein; tir, encodes translocated intimin receptor protein; eae (E. coli attaching and effacing) encodes intimin; 
etgA, encodes a lytic transglycosylase. This figure has been adapted from Castillo et al. (2005). Nomenclature of the genes has been given 
mainly following Pallen et al. (2005a). 
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Figure 1.3. Organisation of a type three secretion system. 
The left side of the figure illustrates the structure of a type three secretion apparatus encoded 
by the LEE genes (details in the text). The right side of the figure shows a non-LEE-encoded 
T3S apparatus that usually lacks a filamentous EspA pilus and uses the short needle complex 
in protein delivery. HM, host cell membrane; OM, outer membrane; IM, inner membrane; PG, 
peptidoglycan layer. This figure has been adapted from Pallen et al. (2005a,b). 
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for the different proteins. The basement of the T3S apparatus in the bacteial inner membraneis 
made up of a number of proteins including EscD, EscQ, EscR, EscS, EscT, EscU, EscV that 
are mainly encoded by the genes from LEE1-3 operons (Ogino et al., 2006). Moreover,   the 
putative ATPase component, EscN, that supplies energy for transport, is involved in the inner 
membrane basal structure (Gauthier et al., 2003). EscC on the other hand, is associated with 
the formation of the outer-membrane ring of the structure (Gauthier et al., 2003; Ogino et al., 
2006). EscJ forms a large 24-subunit 'ring' that might connect membrane-bound rings of the 
structure (Yip et al., 2005). EscF form a needle-like structure onto which EspA molecules 
polymerize to form a filament or translocon, also known as the EspA pilus (Knutton et 
al.,1998; Daniell et al., 2003). This EspA filamentous pilus is the characteristic feature of the 
LEE-encoded T3S system (Daniell et al., 2001). The pilus that extends to the host cell, is 
usually absent in other T3S systems that have only a short needle complex for delivering 
proteins (Figure 1.3). The EspA pilus is capped by the EspD and EspB molecules, which form 
a translocation pore in the host cell plasma membrane through which the effector proteins are 
delivered (Daniell et al., 2001). 
 
The LEE encodes several effector proteins including Tir, Map, EspF, EspH, EspZ and EspG 
(Schmidt, 2010). These proteins are delivered from bacterial cells to the host cell through the 
T3S apparatus and manipulate host cellular functions (reviewed by Spears et al., 2006). EspG 
encoded in the espG-rorf1 bicistronic operon modulates the host cytoskeleton and promote 
colonisation during pathogenicity (Shaw et al., 2005). EspH encoded in the LEE3 causes 
cytoskeleton disruption (Tu et al., 2003). EspF encoded in the LEE4 operon is injected into 
the host cell and targeted to the nucleolus and mitochondria playing a role in the cell death 
pathway (Nougayrede and Donnenberg, 2004; Dean et al., 2010; Holmes et al., 2010). EspF 
also disrupts transepithelial cell resistance causing disruption of tight junctions, apoptosis 
(McNamara et al., 2001). Tir encoded in the LEE5 operon helps in attachment of bacterial 
cells to the host cells, actin polymerization, and A/E lesion formation (Jerse et al., 1990; 
Elliott et al., 1999). Map encoded by the map gene causes disruption of tight junctions, 
mitochondrial membrane potential and filopodium formation (Kenny and Jepson, 2000; 
Kenny et al., 2002). 
 
Apart from the LEE-encoded effector molecules, a number of non-LEE-encoded effectors are 
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translocated by the T3S apparatus. Some of these are associated with pathogenicity. These 
effectors are mostly encoded from the genes located at the lambdoid-like prophages that are 
scattered throughout the chromosome (Garmendia et al., 2005; Spears et al., 2006; Tobe et al., 
2006). Effector molecules TccP/EspFu and EspJ are encoded by a bicistronic operon located 
on prophage CP-933U. TccP/EspFu is required for actin polymerization at the cytoplasmic 
domain of Tir in EHEC, (Campellone et al., 2004; Garmendia et al., 2004) whilst EspJ is 
believed to have „antivirulence‟ properties (Dahan et al., 2005). NleA/EspI effector molecule 
is encoded by a cistron located on prophage Sp9 and is required for C. rodentium to colonise 
the mouse colon (Deng et al., 2004; Mundy et al., 2004) and this protein is conserved in E. 
coli pathogens containing the LEE genes (Gruenheid et al., 2004; Roe et al., 2007). 
 
The cellular target of many bacterial pathogens is the host cytoskeleton. The cytoskeleton of 
eukaryotic cells consists of actin filaments, microtubules and intermediate filaments, which 
direct numerous cellular functions from cell shape and structure to programmed cell death. 
Therefore, alteration of the cytoskeleton is crucial for bacterial pathogenesis. Bacterial 
pathogens often subvert and control the polymerization of host actin filaments in order to 
modulate cellular processes, and they do this through the action of delivered effector proteins. 
During infection, the Tir protein translocates into the host cell and inserts itself into the host 
cell plasma membrane, a process that requires a cognate chaperone, CesT, for maximum 
efficiency (Kenny et al., 1997b; Abe et al., 1999; Sal-Man et al., 2009). The receptor protein, 
Tir interacts with intimin on the bacterial surface, thus firmly attaching the bacterium to the 
host cell. Then the T3SS serves as a molecular syringe for delivery of effector Esp molecules 
to the host cell (Figure 1.3) to facilitate the disruption of the cytoskeleton in the formation of 
AE lesions and subvert the host immune response. During the EPEC infection period, Tir 
becomes phosphorylated by host protein kinases resulting in binding directly to host adaptor 
protein, Nck, which activates neural Wiskott-Aldrich syndrome protein (N-WASP) and the 
actin related protein 2/3 (ARP 2/3) complex to direct actin rearrangements and pedestal 
formation. In EHEC, Tir is not phosphorylated and actin rearrangement is Nck independent. 
However, in this case (Figure 1.4), actin rearrangement is mediated by Tir cytoskeleton 
-coupling protein (TccP or EspFu), which is encoded by prophage CP-933U and delivered by 
T3S to the host cell (Campellone et al., 2004; Garmendia et al., 2004). This TccP is linked 
with the Tir to the host protein insulin receptor tyrosine kinase substrate (IRTKS) and 
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Figure 1.4. Generation of pedestals by an enterohaemorrhagic E. coli. 
The figure illustrates the mechanism by which A/E bacteria rearrange host cell cytoskeleton 
resulting in formation of a pedestal like structure beneath the attached bacteria. Tir, 
translocated intimin receptor protein; IRTKS, host protein insulin receptor tyrosine kinase 
substrate; TccP, Tir cytoskeleton-coupling protein also known as EspFu; N-WASP, neural 
Wiskott-Aldrich syndrome protein; ARP2/3, actin related protein 2/3.  The figure has been 
adapted from Croxen and Finlay (2010). 
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interacts with N-WASP to activate ARP 2/3 complex. This leads to the polymerization of 
actin filaments beneath the adherent bacterium and this produces pedestal-like structure on the 
host cell surface (reviewed by Bhavsar et al., 2007; Croxen and Finlay, 2010; Schmidt, 2010). 
Moreover, in response to stress or SOS induction of bacterial prophages, a subset of bacteria 
lyses and the released Stxs on epithelial cells triggers redistribution of nucleolin to the cell 
surface. This nucleolin can bind to the bacterial surface protein intimin and can strengthen the 
attachment (Figure 1.4) (Toshima et al., 2007; Tree et al., 2009; Croxen and Finlay, 2010). 
 
1.3.5 Coordination of LEE gene activity 
The LEE-encoded T3S system must be assembled in a coordinated manner such that the T3S 
apparatus is first formed and then effector molecules are exported through the apparatus into 
the host cell (reviewed by Tree et al., 2009; Deane et al., 2010). Most of the basal apparatus 
proteins are encoded by the LEE1-3 operons. These proteins are related to the flagellar 
proteins. These proteins are exported in a Sec-dependent manner and form basal apparatus, 
which has a close association with inner and outer membranes through the peptydoglycan 
layer. Once the basal apparatus has formed, proteins associated with the formation of the 
needle and filamentous apparatus are assembled. In EPEC and EHEC, basal apparatus protein 
EscU, which is a functional homologue to Salmonella flagella, is likely to be involved in the 
switch to needle complex assembly (Edqvist, et al., 2003). With the completion of needle 
formation, translocon components EspA, EspD and EspB are assembled and form filamentous 
translocon. The opening of this filamentous conduit in the host cell leads to changes such as 
lowering calcium levels that switch to effector protein secretions (Deng et al., 2005). It is 
likely that sequential activities of effector proteins are important for the Esc T3S system. 
Based on the translocation efficiency, the system has a secretion hierarchy of 
Tir>EspZ>EspF>EspH>EspG>Map (Mills et al., 2008). 
 
From the above discussion, it is clear that, to execute the function of T3S system leading to 
pathogenesis, the expression of the associated LEE genes need to be orchestrated 
appropriately in time and space. This is likely to account for the control of the LEE gene 
expression at transcriptional, post-transcriptional and post-translational levels (Tree et al., 
2009; Bhatt et al., 2011). Since a major part of this thesis concerns the regulation of the LEE 
genes at the transcriptional level, an overview of transcription initiation and regulation in E. 
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coli K-12 system is discussed in the next section, together with a discussion of relevant 
aspects of post-transcriptional regulation. 
 
1.4 Regulation of bacterial transcription: an overview 
1.4.1 The importance of regulation 
Bacteria are highly versatile and responsive organisms. They can rapidly sense environmental 
changes and adapt themselves to changing environments by controlling metabolic patterns 
with a wide variety of mechanisms. Their genomes provide the template for the production of 
proteins necessary for the correct functioning of the cell. Under specific environmental 
conditions, each gene product is necessary at a certain concentration. Therefore, bacteria have 
to modulate the level of gene expression in response to environmental changes for survival. 
The expression of genes can be regulated at many steps, from the initiation of transcription, 
through to the stability of transcripts, translation initiation and the stability of protein. 
However, from the point of view of economy, the key step of regulation of a gene is the   
initiation of RNA-transcript formation. The components of transcriptional regulation include 
RNA polymerase, σ factors, promoter DNA sequences, small ligands, components of the 
folded chromosome and transcription factors (Browning and Busby, 2004). 
 
1.4.2 RNA polymerase 
RNA polymerase (RNAP) is a multi subunit enzyme that catalyzes DNA-dependent RNA 
synthesis. RNAP plays a major role in controlling gene expression. In a single E. coli cell, 
transcription of over 4000 genes are catalyzed by a limiting number of RNAP molecules, the 
majority of which are occupied with transcription of stable RNA genes such as rRNA and 
tRNA genes. Therefore, only a very little amount of RNAP is available for transcription of the 
remaining genes (Ishihama, 2000). Since RNAP is in such short supply, it is crucial that 
transcription initiation is regulated, such that genes are expressed at the required time and 
under the appropriate environmental conditions. Prudent distribution of RNAP is mediated by 
the combination and sequence of promoter elements, the availability and activity of 
alternative sigma factors, and transcription factors (Browning and Busby, 2004; Browning et 
al., 2010).  
 
The form of RNAP, which transcribes genes, is known as the core enzyme that has a subunit 
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composition of α2ββ΄ω with a molecular mass of ~400 kDa, where α, β, β΄ and ω denote 
different subunits. Each of the subunits has different size: β' subunit, ~155 kDa; β subunit, 
~151 kDa; α subunit, ~37 kDa and ω subunit, ~6 kDa. These core RNAP subunits share 
considerable sequence, and even more structural homology, with their archaeal and eukaryotic 
counterparts (Ebright, 2000). Structural studies revealed that core RNAP adopts a structure 
reminiscent of a crab claw (Zhang et al., 1999; Murakami et al., 2002b; Browning and Busby, 
2004) (Figure 1.5). The two „pincers‟ of the „claw‟ are made up of the two large subunits β' 
and β and define a cleft. The cleft has active centre at the base of the two pincers that can bind 
two Mg
2+
 ions and can accommodate a double-stranded nucleic acid. Thus, the cleft serves as 
the active center cleft and carries at least part of the binding site for double-stranded nucleic 
acid. The two identical α subunits are located distal to the cleft. One α subunit interacts with 
the β; this subunit is designated αI. The other α subunit interacts with β'; this α subunit is 
designated αII. Each α subunit consists of two domains: an N-terminal domain (αNTD) 
responsible for interaction with β' and β, and a C-terminal domain (αCTD) responsible for 
sequence-specific protein-DNA interactions with upstream-bound activators and repressors 
(Busby and Ebright, 1994; Browning and Busby, 2004). αCTD is connected to αNTD, and 
thus to the remainder of RNAP, through a long, flexible linker. The linker allows αCTD to 
occupy different positions relative to the remainder of RNAP in different promoter contexts 
(Blatter et al., 1994; Busby and Ebright, 1994; Ebright and Busby, 1995). The ω subunit also 
is located distal to the cleft, near the base of pincer consisting of β' and exclusively interacts 
with β'. The small ω subunit has no direct role in transcription but seems to function as a 
chaperone by which it helps to maintain β' in a correct conformation and recruit it to the α2β 
subassembly to form a functional core enzyme (α2ββ'ω) (Ghosh et al., 2001, 2003; Mathew 
and Chattergi, 2006). 
 
The core form of RNAP enzyme is capable of carrying out transcript elongation. Specific 
initiation of transcription, however, requires the holoenzyme which, in addition to the core 
subunits contains the transcription initiation specific sigma subunit or specificity factor (σ: 70 
kDa) (Murakami et al., 2002a,b). The σ subunit has multiple functions: to ensure the 
recognition of specific promoter sequences; to position the RNAP holoenzyme at a target 
promoter and to facilitate unwinding of the DNA double helix to form a transcription bubble 
near the transcript start site. 
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Figure 1.5. RNA polymerase interactions at a promoter. 
A. The DNA strands are shown in green, with the –10 and –35 elements highlighted in yellow 
and the TGn extended –10 and the UP elements highlighted in red. RNA polymerase is shown 
with the β and β′ subunits coloured light blue and pink, respectively, αNTDs are coloured 
grey and the different domains of σ are coloured red. Grey spheres labelled I and II, represent 
the domains of αCTD that bind to the promoter. The RNA polymerase active site is denoted 
by the Mg
2+
 ion (magenta).  
B. Schematic diagram of the different interactions between RNA polymerase holoenzyme and 
promoter elements shown in part A: αCTDs and the UP element; σ70 region 4.2 and the -35 
hexamer (consensus TTGACA); σ70 region 3.0 and the extended -10 (TGn) element; σ70 
region 2.4 and the -10 hexamer (consensus TATAAT) and σ70 region 1.2 and discriminator 
(Dis) sequence (not resolved in crystal structure) (adapted from Browning and Busby, 2004). 
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1.4.3 Promoters 
RNAP initiates transcription at segments of DNA known as promoters. A standard promoter 
has two or more core elements. The two principal conserved core elements are the -10  
hexamer (consensus 5΄-12TATAAT7-3΄) and -35 hexamer (consensus 5΄-35TTGACA30-3΄) 
sequences that are located 10 and 35 base pairs upstream from the transcript start site, 
respectively (Rosenberg and Court, 1979; McClure 1985; Lisser and Margalit, 1993). These 
two core elements are separated from each other by a spacer having a characteristic length of 
17±1 base pairs. Sequence changes in the spacer region have little influence on the promoter 
activity, while differences in spacer length drastically affect the performance of a promoter 
(Wagner, 1984; deHaseth and Helmann, 1995). The sequences outside of the core elements 
can contribute much to the activity of a given promoter. For instance, an extended -10 element 
that is a 3-4 base pair motif, located one base upstream of the -10 hexamer can increase 
promoter activity significantly. The major determinant of the extended -10 element is 5′-TG-
3′, which is located at positions –15/–14 with respect to the transcription start point (Barne et 
al., 1997; Mitchell et al., 2003). At many but not all promoters, upstream or UP elements, 
which are ~ 20 base pairs sequence located upstream of the promoter -35 element can increase 
promoter efficiency by as much as 30-fold (Ross et al., 1993). In addition, the downstream 
sequence region, ranging from positions +1 to  +20 can also contribute to promoter activity by 
providing stability to the open complex and influencing the facility with which RNAP escapes 
from the open complex as the nascent RNA chain is elongated (Wagner, 1984). 
 
Transcription initiation requires recognition of promoter elements by RNAP holoenzyme. The 
four core promoter elements, i.e., the UP, -35, -10, and extended -10 elements, specify the 
initial binding of RNAP to a promoter (Figure 1.5). Promoters with core elements closer to 
the consensus are generally stronger than those that match less well (McClure, 1985; 
Miroslavova and Busby, 2006). The strength of a promoter can be defined by the number of 
transcripts it can initiate in a given time. This measure is influenced by how well the promoter 
binds polymerase initially, how efficiently it supports isomerization and how rapidly the 
polymerase can then escape. It is important to mention that there is no known naturally 
occurring promoter in which all the core elements are consensus (Browning and Busby, 2004; 
Mitchell et al., 2003). An artificial promoter with perfect match of all core components could 
bind RNAP too tightly resulting in reduced level of activity (Miroslavova and Busby, 2006). 
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Many promoters particularly tRNA and rRNA promoters contain ~20 base pairs A/T rich, 
factor-independent activation sequence, located upstream of the promoter - 35 element. These 
are known as UP elements (Ross et al., 1993; Estrem et al., 1998). Genetic and biochemical 
analyses revealed that the α subunit C-terminal domain (αCTD) of RNAP holoenzyme is 
responsible for recognition of UP elements (Ross et al., 1993; Busby and Ebright, 1999). UP 
element sequences consist of two subsites, each of which binds one αCTD (Estrem et al., 
1999). Transcription from promoters containing only a consensus proximal UP element 
subsite require only one αCTD, and this subsite is preferred by αCTD in UP elements 
containing good matches to consensus in both subsites. Each UP element subsite interacts 
with a single αCTD and as a result, UP elements containing two good subsites require both 
αCTDs for maximal stimulation of transcription. The two αCTDs of RNAP are functionally 
interchangeable with respect to recognition of an UP element consisting of only a consensus 
proximal subsite. Promoters containing only a consensus distal subsite require both αCTDs 
for efficient transcription, perhaps because of sequence-non-specific interactions between the 
proximal subsite region and the second αCTD or because the second αCTD in some other way 
affects the overall stability of the complex (Gourse et al., 2000). 
 
Apart from interaction between promoter UP elements and the RNAP α subunit, other core 
elements of a promoter are recognized by the RNAP specificity factor or σ factor. Sequence 
analysis of different σ factors together with structural analysis revealed that members of the 
σ70 family typically share four conserved domains named σ1, σ2, σ3 and σ4 (Helmann and 
Chamberlin, 1988; Browning and Busby, 2004) (Figure 1.5). These domains are linked to 
each other by flexible linkers and consist of conserved region 1.1-1.2, 2.1-2.4,  
3.0-3.2, and 4.1-4.2, respectively  (Lonetto et al., 1992; Campbell et al., 2002; Murakami et 
al., 2002b).  Region 2 is the most highly conserved region playing critical functions including 
core RNAP binding, promoter -10 element (consensus sequence TATAAT) recognition, 
melting and interaction with the -10 region nontemplate strand DNA to stabilise the melted 
state (Siegele et al., 1989, Fenton et al., 2000; Feklistov and Darst, 2009). Region 3.0 
interacts with the „extended -10‟ promoter motif (Barne et al., 1997; Campbell et al., 2002). 
Region 4 is the most conserved domain of σ70 after Region 2. Residues in region 4.2 
determine sequence-specific interactions with the -35 element (consensus sequence TTGACA) 
(Siegele et al., 1989; Feklistov and Darst, 2009). Genetic studies revealed that σ region 4 is 
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dispensable at promoters containing an „extended -10‟ element (TGnTATAAT) 
(Ponnambalam et al., 1986; Keilty and Rosenberg, 1987; Barne et al., 1997; Mitchell et al., 
2003). This is because interactions between residues in region 3.0 and the upstream „TG‟ 
motif can substitute for region 4 interactions with the -35 element.  
 
Domain 1.1 is present mainly in the primary σ factors, including σ70 (Lonetto et al., 1992). 
Structural analysis cannot resolve this protease sensitive domain and the function of this 
domain is not clear. One possibility is that this domain is involved in inhibition of promoter 
recognition by free σ (Dombroski et al., 1993) and the inhibition is presumed to be relieved 
upon σ binding to core RNAP. Moreover, it can accelerate open complex formation at some 
promoters (Vuthoori et al., 2001). Additionally, many promoters share an element located 
immediately downstream of the -10 element, within the discriminator region. The 
discriminator region includes G+C rich sequence motif that binds to σ region 1.2 (Figure 1.5). 
High G+C content interferes with strand separation, leading to promoter regulation. Genetic 
analysis revealed that a base substitution C to G, two nucleotides downstream from the -10 
hexamer in the rRNA promoter rrnB P1 eliminated its regulation implying that the 
discriminator region is related to the stability of transcription initiation complex (Haugen et 
al., 2006). 
 
1.4.4 Transcription initiation 
Transcription initiation takes place in a number of steps (Murakami and Darst, 2003) (Figure 
1.6). Specific recognition of promoter DNA by holo RNAP results in closed complex 
formation (RPC) in which double stranded -35 and -10 elements interact with σ4 and σ2, 
respectively (Borukhov and Nudler, 2008). In this form, the DNA remains double stranded, 
hence the name „closed complex‟ and is partially protected by RNAP from about -50 to +5 
position (Li and McClure, 1998). In the second step of initiation, the RPC undergoes a 
transition to the open complex (RPO) in which the DNA strands around the transcription start 
site unwind and melt and the template strand moves into the RNAP active site to form the 
transcription bubble. During open complex formation, conserved aromatic residues within σ2.3 
function to trigger the destabilization of the DNA duplex at the conserved -11 position (A/T 
bp) (deHaseth and Helmann, 1995; Murakami et al., 2002b). The bending of DNA resulting 
from duplex unwinding at positions -11 to -7 allows the downstream DNA to bend or kink 
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Figure 1.6. Transcription initiation by bacterial RNA polymerase. 
The figure shows schematic diagrams depicting structural transitions during the steps of 
transcription initiation. Cross-sectional views of the RNA polymerase-promoter DNA 
complexes at different stages are shown: (a) RNA polymerase-promoter closed complex (RPC) 
(b) intermediate complex (I), (c) RNA polymerase-promoter open complex (RPO) and 
abortive initiation, (d) end of abortive initiation, after displacement of the σ 3.2 loop (e) 
promoter clearance and (f) elongation complex (TEC). RNA polymerase β flap, blue; σ, 
orange; rest of RNAP, grey; catalytic Mg
2+
, yellow sphere; promoter DNA-template strand, 
dark green; nontemplate strand, light green; and the RNA transcript, red. The figure has been 
adapted from Murakami and Darst (2003).   
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across the entrance of the active-site channel leading to the entrance of the ~20 bp 
downstream DNA duplex (ahead of the +1 start site) into the DNA-binding clamp. At this 
point, the fully unwound duplex and transcription bubble stretches from -11 to +2, thus 
occupying the major channel. This sequence of events allow the correct placement of the +1 
base of the template strand in the catalytic centre, which enables the initiation phase of 
transcription (Naryshkin et al., 2000; Murakami et al., 2002b; Murakami and Darst, 2003). 
However, the process of DNA entry to RNAP channel is accompanied by simultaneous exit 
of σ1.1, which occupies the main RNAP channel in the RPC (Mekler et al., 2002). On 
formation of RPO, the RNAP active site provided with NTP substrates through the secondary 
channel, starts catalyzing the synthesis of the RNA chain. The initial short transcript 
encounters the σ3.2 loop that blocks the RNA exit channel, resulting in multiple rounds of 
abortive initiation. To be retained in elongating RNAP, nascent RNAs must successfully 
compete with region of σ3.2 (Young et al., 2002). If RNA transcripts lose the competition, they 
are ejected as abortive transcripts; if they win, region σ3.2 is ejected and the transcript is 
successfully elongated. Eventually, the RNA chain elongates to a length of about 12 
nucleotides, which is sufficient to fill the RNA-DNA hybrid and upstream RNA exit channel 
completely under the β flap, thereby displacing the σ3.2 and marking the end of abortive 
initiation as well as allowing the transcription to proceed into the elongation phase (Murakami 
and Darst, 2003) (Figure 1.6). 
 
1.4.5 Small ligands 
Small ligands like guanosine 3', 5'-biphosphate (ppGpp) or ATP (adenosine triphosphate) 
provide alternative mechanisms by which bacteria can respond quickly and efficiently to 
environmental changes and thus act as transcriptional regulators. For example, increased 
levels of ATP in a bacterial cell helps the promoters of housekeeping genes to capture more 
RNAP at exponential growth phage (Gaal et al., 1997) whereas the availability of intracellular 
levels of ppGpp shut down the transcription process rapidly by destabilizing open complexes 
if protein synthesis slows down due to amino acid limitation (Chatterji and Ojha, 2001). It 
seems that ppGpp controls expression of the translational machinery in response to sudden 
starvation, while ATP availability controls expression in response to growth rate. Apart from 
inhibition of transcription of rRNA and tRNA genes, ppGpp stimulates expression of proteins 
required for amino acid biosynthesis and transport (Paul et al., 2005). The overall effect of 
ppGpp action is thus to increase amino acid pools in the cell. 
  
 
28 
The activity of ppGpp upon RNAP is modulated by DksA. DksA is a small α-helical protein 
that consists of 151-amino-acids (Perederina et al., 2004). This protein has three distinct 
structural parts. The globular portion or G domain is composed of N- and C- terminal regions 
(residues 7-33 and 110-134). The central domain, a 75 residue coiled coil (CC), consists of 
two long N- and C-terminal α helices (residues 35-68 and 75-109) connected by a linker at the 
tip of the CC that comprises two residues (69 and 70) in an extended conformation and an α- 
helical turn (α turn, residues 71 and 75). The third part is a C terminal α helix (residues 135-
151) that is loosely bound with rest of the protein. Unlike conventional transcription factors, 
DksA binds directly to RNAP and modifies the kinetic properties of the promoter complex, 
sensitizing it to changes in the concentrations of ppGpp and the initial NTP in the transcript. 
Hence, it can enhance direct effects of ppGpp on the negative control of rRNA promoters 
(Paul et al., 2004). Structural analysis of the RNAP-ppGpp complex revealed that ppGpp 
binds in the secondary channel close to the RNAP active site, where they likely coordinate the 
catalytic Mg
+2
 ion (Artsimovitch et al., 2004). Upon binding to RNAP, the DksA CC extends 
into the secondary channel toward the ppGpp binding site and coordinates one of the ppGpp 
bound Mg
2+
 ion through the invariant acidic side chains at the CC tip, thereby stabilizing the 
RNAP-ppGpp complex (Perederina et al., 2004). 
 
1.4.6 Transcription factors 
The concept of transcriptional regulation by transcription factors started from the early 
paradigm of the operon model, which was ingeniously proposed by Jacob and Monod (1961). 
An operon has three parts: promoter, operator and structural gene(s). In addition, there are 
associated regulatory genes that are located at some distance from the operon on the DNA. 
Regulatory genes produce repressor or activator proteins that function as the on-off switch for 
a gene. The operon model explained gene regulation by direct repression, which today is 
known to be only one kind of the many regulatory concepts. More than 300 hundred genes in 
E. coli genome encode proteins that act as transcription factors and are supposed to be bound 
to promoters to scale up or down the expression of a large number of genes in response to 
environmental signals (Perez-Rueda and Collado-Vides, 2000). Most of these proteins have 
sequence specific DNA binding sites and are therefore, directed to specific promoters. Some 
proteins act as global regulators and interact at scores of promoters, whereas others relate to 
just one or two promoters. For example, the E. coli cyclic adenosine monophosphate (AMP) 
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receptor protein, CRP, interacts at nearly 200 different promoters and regulates their 
efficiency in response to certain stress conditions. It has been estimated that seven 
transcription factors (CRP, FNR, IHF, Fis, ArcA, Narl and Lrp) have a role in regulation 
of >50% promoters, whereas ~60 transcription factors regulate single promoters  
(Martinez-Antonio and Collado-Vides, 2003). 
 
Transcription factors control the expression of genes in response to environmental signals. 
Thus, the action of transcription factors must be regulated. This can be done by small ligands 
that can alter the DNA binding affinity of a transcription regulator or by covalent 
modification, which can also alter the affinity of a transcription regulator to its DNA target. 
Moreover, in some cases, the activity of a transcription factor is solely controlled by its 
cellular concentration. In other cases, the activity of a transcription regulator is controlled by 
binding to other regulatory proteins (Browning and Busby, 2004). 
 
A transcription factor can act as an activator or repressor upon binding to a promoter. Some 
transcription factors function purely as activators or repressors, whereas others can act as 
either according to the architecture of the target promoter (Perez-Rueda and Collado-Vides, 
2000). For instance, CRP functions as an activator in the case of the gal P1 promoter and 
simultaneously as a repressor in the case of the gal P2 promoter (Musso et al., 1977). 
Activators improve the performance of a promoter by improving its receptivity to RNAP. On 
the other hand, repressor proteins reduce transcription initiation at target promoters. Most 
activators function by binding to target promoters before acting on RNAP. However, several 
transcription regulators, for example MarA and SoxS, provide alternative mechanisms in 
which they interact with free RNAP before binding to promoter DNA (Martin et al., 2002).  
 
At many promoters, regulation of transcription is simple, mediated just by a single factor. 
However, in other cases, more than one transcription factors are involved in influencing the 
activity of a single promoter with each factor relying on an environmental signal. In the case 
of simple activation, most activators function by binding to a target that is located upstream or 
overlapped with the -35 element and recruit RNAP to the promoter by interacting with the 
RNAP subunits. The first mode is known as Class I activation whilst the latter is referred to as 
Class II activation (Browning and Busby, 2004). In the case of Class I activation, the activator 
recruits the RNAP to the promoter by directly interacting with the RNAP αCTD 
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(Ebright, 1993) (Figure 1.7A). In case of Class II activation, RNAP recruitment to the 
promoter is facilitated by the interaction between the activator and domain 4 of RNAP σ 
subunit (Dove et al., 2003) (Figure 1.7B).  
 
Though most transcription activators bind sites that are upstream of or overlapping the -35 
elements of the promoters, a number of transcription factors bind to sites that are located 
between promoter -10 and -35 elements and activate the promoters. In these cases, the spacer 
DNA sequences between the promoter -35 and -10 elements recognised by the RNAP σ factor 
are greater than the optimal 17 base pairs. For instance, members of the MerR family of 
transcription factors bind to the suboptimal spacing sequence of the target promoters and twist 
and/or bend the spacer DNA to reorientate the -35 and -10 elements so that they can be bound 
by the RNAP σ subunit (Brown et al., 2003; Hobman, 2007) (Figure 1.7C). MerR family 
regulators include metal-responsive regulators MerR, PbrR, CueR, CadR; dye-responsive 
regulators BmrR, BltR; and stress-responsive regulator SoxR (Ahmed et al., 1995; Markham 
et al., 1996; Caslake et al., 1997; Hidalgo and Demple 1997; Borremans et al., 2001; Lee et 
al., 2001; Adaikkalam and Swarup, 2002). A MerR family transcription activator has an N-
terminal helix-turn-helix DNA binding region and a C-terminal effector-binding region. The 
signature of the family is amino acid similarity in the first 100 amino acids, including a helix- 
turn-helix motif followed by a coiled-coil region (Brown et al., 2003; Newberry and Brennan, 
2004). 
 
The MerR transcriptional activator is the best-studied member of MerR family regulators. It is 
a regulator of Gram-negative mercury resistance (mer) operons found on transposable 
elements Tn21 and Tn501 (Brown et al., 1983; 2003; Barrineau et al., 1985). This regulator 
acts as an activator of the mer genes in the presence of Hg (II) salts and as a weak repressor in 
the absence of Hg (II). Genetic studies revealed that the 19 base pairs suboptimal spacer 
region between mer promoter -10 and -35 elements is essential for normal induction of the 
promoter by the MerR (Parkhill and Brown, 1990). A model for the mechanism of action of 
MerR at the mer operator is now well understood. In the absence of Hg (II) and MerR, RNAP 
transcribes from the merR promoter, which results in an increased concentration of MerR. The 
MerR then binds to the mer operator and represses the merR promoter by bending the DNA 
and unwinding the operator sequence. In the absence of Hg (II), the MerR is thus bound to 
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Figure 1.7. Activation at simple promoters.  
A. The activator binds to an upstream site and contacts the αCTD of RNA polymerase, 
thereby recruiting the polymerase to the promoter.  
B. The activator binds to a target that is adjacent to the promoter -35 element, and interacts 
with domain 4 of σ70.   
C. The activator binds in abnormal spacer sequence between promoter -10 and -35 elements 
elements and realigns promoter elements so that the RNA polymerase holoenzyme can bind to 
the promoter efficiently. The figure has been adapted from Browning and Busby (2004). 
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DNA in the repressor confirmation, maintaining repression of the promoter. Binding of Hg 
(II) to one of two binding sites on the MerR causes a conformational change to put MerR in 
an activating conformation. Due to the tight binding at the centre of the operator, this causes 
DNA distortion at the centre of the operator, giving ~33° unwinding of DNA and 
straightening of helix backbone. This results in reorientation of the -35 and -10 sequences and 
allows them to interact productively with the RNAP σ70 subunit to form an open 
transcriptional complex and transcription is initiated (Ansari et al., 1992, 1995). 
 
Repressor proteins reduce transcription initiation at target promoters. Like activators, they can 
convey their regulatory role either in simple or complex ways (Browning and Busby, 2004). 
In case of simple repression, the repressor can use three mechanisms (Figure 1.8). Steric 
hindrance of RNAP binding to the promoter is the simplest mechanism of repression. In this 
case, the repressor binds in or close to, the core elements and may prevent RNAP recruitment 
or may interfere post-recruitment steps in transcription initiation. For instance, binding of 
Lac-repressor at lac promoter interferes with the recruitment of the RNAP to the promoter 
(Muller-Hill, 1998). In some cases, multiple repressor molecules may bind to promoter-distal 
sites that cause looping, which shuts off transcription in the looped domain. Repression of the 
gal promoter by the GalR repressor follows this mechanism (Choy and Adhya, 1996). Simple 
repression can also occur indirectly. In this case, a repressor can act as an anti-activator. The 
best example is the repression by CytR of CRP-dependent promoter, where repressor, CytR 
interacts with the activator, CRP and thus modulates the transcription of the CRP-dependent 
promoter (Shin et al., 2001). 
 
1.4.7 Nucleoid-associated proteins 
Bacterial chromosomes are highly compacted by supercoiling and interactions with proteins 
and RNAs. Folding of bacterial chromosomes by nucleoid-associated proteins affects the 
distribution of RNAP between promoters and thus controls its transcription. In E. coli, a 
number of nucleoid-associated proteins like Fis (factor for inversion stimulation), IHF 
(integration host factor), H-NS and HU (histone-like nucleoid-structuring proteins), StpA (a 
H-NS homologue), Dps (DNA-protein from starved cells), modulate gene expression either 
positively or negatively (Azam and Ishihama, 1999; Browning et al., 2010). In addition to a 
role in genome compaction, these proteins can act solely as transcription regulators. 
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Figure 1.8. Mechanisms of repression.  
A. The repressor-binding site overlaps core promoter elements and blocks recognition of the 
promoter by the RNA polymerase holoenzyme.  
B. Repressors bind to distal sites and interact by looping, repressing the intervening promoter. 
C. The repressor binds to an activator and prevents the activator from functioning by blocking 
promoter recognition by the RNA polymerase holoenzyme. The figure has been adapted from 
Browning and Busby (2004). 
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H-NS, encoded by hns, belongs to a family of small abundant (20,000 molecules per cell) 
proteins in Gram-negative bacteria (Grainger et al., 2006; Dorman, 2007). This protein acts as 
a global repressor in bacterial gene expression (Stoebel et al., 2008; Browning et al., 2010). 
Genome-wide analysis using whole-genome transcriptomic methods including DNA 
microarray technique and chromatin immunoprecipitation on chip (ChIP-on-chip) reveals an 
extensive regulon of H-NS in enteric bacteria (Grainger et
 
al., 2006; Navarre et al., 2006; 
Oshima et al., 2006; Wade et al., 2007). H-NS or H-NS like proteins consist of a C-terminal 
DNA binding domain and an N-terminal oligomerization domain that are separated by a  
flexible linker sequence (Bertin et al., 1999; Dorman et al., 1999; Bloch et al., 2003; Stoebel 
et al., 2008; Arold et al., 2010). H-NS acts as a transcription silencer and preferentially binds 
A+T rich DNA sequences irrespective of chromosome location (Navarre et al., 2006). 
Horizontally acquired foreign DNAs, particularly various pathogenic islands in Gram-
negative bacteria contain a substantially increased level of A+T content compared with that of 
the resident genome and are found to be silenced by H-NS (Hacker et al., 1997; Elliott et al., 
1998; McClelland et al., 2001; Dorman and Kane, 2009). H-NS mediated silencing of the 
foreign genes prevents inappropirte expression and thus, protect the cell from detrimental 
consequences of invading DNA.  
 
Unlike classical regulators, H-NS does not recognise a particular DNA sequence (Lucchini et 
al., 2006). However, different in vitro experiments suggest that H-NS interacts with a A+T 
rich DNA region that is prone to intrinsic curvature (Yamada et al., 1991; Rimsky et al., 
2001). Moreover, oligomerization properties of H-NS molecules suggest that it can interact 
with an extended region of curved DNA and may develop DNA-protein-DNA
 
bridges both 
between separate DNA molecules and between different
 
portions of the same DNA molecule 
(Stoebel et al., 2008). However, Lang et al. (2007) proposed that H-NS preferentially binds to 
a sequence of 5'-TCGATATATT-3' located in A+T rich DNA region of a target gene. It is 
likely that H-NS nucleates at the proposed or related sites, then spreads along the DNA 
sequences laterally and forms H-NS filaments that possibly lead to formation of DNA-H-NS-
DNA bridges. 
 
Many regulators including SlyA, RovA, ToxT and Ler have been shown to act as antisilencers 
by displacing H-NS from the target site(s) of respective genes (reviewed by Stoebel et al., 
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2008) and thus, provide bacteia selective advantages. SlyA protein is usually an activator that 
regulates many genes in both E. coli and Salmonella and is related with the MarR protein in E. 
coli (Ellison and Miller, 2006). This protein acts as an anti-repressor in the expression from 
hlyE, the haemolysin gene by counteracting H-NS- mediated repression. Usually H-NS 
prevents RNAP to direct transcription from the hlyE promoter, whereas SlyA permits RNAP 
to bind and prevents H-NS binding (Lithgow et al., 2007). Moreover, based on the relative 
abundance, both H-NS and SlyA proteins can show mutual antagonism at the target promoter 
site of the hlyE gene in such a way that H-NS can displace SlyA protein if the concentration 
of H-NS is higher than that of the SlyA protein and vice versa (Lithgow et al., 2007). H-NS 
also represses horizontally acquired genes that encodes major toxins, CTX and Tcp in Vibrio 
cholerae responsible for human cholera disease (Skorupski and Taylor, 1997). H-NS binds 
A+T rich promoter sequences and represses the expression from the promoters (Nye et al., 
2000). However, the ToxT regulatory protein, an AraC like DNA binding protein, negates the 
repression (Yu and DiRita, 2002). It is likely that ToxT plays dual roles: displacing the H-NS 
from the promoters and activates the promoters, possibly by directly interacting with RNAP 
(Yu and DiRita,
 
2002).  
 
1.5 Post-transcriptional regulation 
from a gene to its protein product. Though the regulation at transcription level is pivotal for 
any gene expression, various forms of post-transcriptional control can also affect bacterial 
gene expression. These forms of regulation are independent of changes in transcription. In 
post-transcriptional regulation, messenger RNA (mRNA) and proteins are the regulatory 
targets. Examples are regulation of translation initiation, changes in mRNA or protein 
stability or availability, or programmed frameshifting.   
 
1.5.1 Regulation of translation initiation 
mRNAs are used as templates to form proteins during translation when the templates are read 
according to the genetic code that relates base sequences to amino acid sequences. In fact, the 
process mediates through interplay of many macromolecules including mRNAs, transfer 
RNAs (tRNA) and a number of proteins. Most importantly, molecular machines (known as 
ribosomes) coordinate this interplay and catalyze the process. Usually, an E. coli cell in 
exponential growth contains ~20000 ribosomes (Forsman et al., 1990; Stryer, 1995). Each 
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ribosome consists of RNAs and proteins and has a size of ~2700 kDa with a sedimentation 
coefficient of 70S. This 70S ribonucleoprotein can be disassembled to a large 50S subunit and 
a small 30S subunit. The 50S subunit is made up of 34 different proteins (L1-L34) and 2 
species of RNA molecules (23S and 5S). The 30S subunit possesses 21 different proteins (S1-
S21) and a single RNA species named 16S (Wittmann, 1982; Wittmann et al., 1982; 
Wittmann, 1983).  
 
The translation process starts at the 5' end segment of bacterial mRNA with recognition of a 
translation initiation region (TIR) by the 30S ribosomal subunit together with initiation factors 
and initiator tRNA. This event is then followed by the attachment of the large 50S subunit and 
release of initiation factors. In most bacteria, the TIR contains two key sequences, a 
translation initiation codon and a ribosomal-binding sequence termed the Shine-Dalgarno (SD) 
sequence (Shine and Dalgarno, 1974; 1975). The SD sequence is a purine-rich nucleotide 
sequence (typically GGAGG), that is usually located ~10 nucleotides upstream of the 
initiation codon. The SD sequence base pairs directly to a complementary sequence (CCUCC) 
near the 3‟ end of the 16S ribosomal RNA. The initiation codon, on the other hand, base pairs 
to the anti-codon of the initiator tRNA. The most common translation initiator codon in 
mRNA is AUG. However, translation can also initiate less frequently at GUG, and rarely at 
TTG, AUU, CUG, AUA or AUC (Kozak, 1983; Schneider et al., 1986; Romero and García, 
1991; Chalut and Egly, 1995; Van Etten and Janssen, 1998; O'Donnell and Janssen, 2001). 
Alterations of either the SD sequence or the initiation codon affect the translation process. 
Even, the distance between these two elements is crucial, can markedly affect the translation 
efficiency (Chen et al., 1994). Moreover, bases upstream of the SD sequence and downstream 
of the initiator codon can function as translation enhancers (Qing et al., 2003; Vimberg et al., 
2007).  
 
Secondary structures of the 5' untranslated region of mRNA molecules nearer to the 
translation initiation region often provide mechanisms for regulation of translation. This cis-
acting structured segment can down-regulate the translation efficiency by competing with the 
30S ribosome for the SD sequence (de Smit and van Duin, 1994a,b). Moreover,  
down-regulation can also arise when a trans-acting repressor prevents the 30S ribosomal 
subunits from binding to the SD sequence (Moine et al., 1988; Draper et al., 1998). In many 
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cases, secondary structures near the initiation codon, in conjunction with repressor proteins, 
can stall or entrap ribosomes resulting in unproductive translation preinitiation complexes. 
For instance, translation of rpsO mRNA is repressed by the S15 ribosomal protein by an 
entrapment mechanism. The model for this regulation suggests that, though the SD sequence 
can base pair to the ribosome, the ribosome is still stalled because the translation initiator 
codon is hindered by the pseudoknot structure of the mRNA that makes the initiation codon 
inaccessible for binding to the initiator tRNA (Marzi et al., 2007). 
 
In many cases, 5' untranslated regions of mRNA molecules contain characteristic genetic 
elements known as riboswitches that can directly sense various metabolites without involving 
proteins (Mandal et al., 2003; Breaker, 2010). Riboswitches usually contain two functional 
components: a metabolic binding aptamer domain and an expression platform. The size of an 
aptamer can range from 35 to 200 nucleotides. The binding of metabolites to the aptamer 
induces allosteric changes in riboswitches causing downstream structural changes and affects 
expression of adjacent genes. In contrast to the conserved aptamer, the expression platform 
varies widely in size, sequences and structures allowing regulation at different levels from 
transcriptional elongation to translation initiation. This form of post-transcriptional regulation 
has been reported to control the genes of many essential metabolic pathways including 
biosynthesis of cobalamin transport protein, thiamine, riboflavin or riboflavin transport 
protien, lysine, adenine and glycine (Mironov et al., 2002; Nahvi et al., 2002; Winkler et al.,  
2002a,b; Sudarsan et al., 2003; Mandal and Breaker., 2004; Lemay and Lafontaine, 2007). 
 
In addition to secondary structure, many bacterial mRNA molecules may contain short ORFs 
in the 5' untranslated long leader region. Translation of these leader ORFs can cause changes 
in the structure of the downstream region and subsequently can modulate the translation of 
downstream genes. These leader ORF-dependent regulatory mechanisms depend on the 
coupling between transcription and translation and examples can be found in regulation of 
many amino acid biosynthesis operons including those for tryptophan, leucine, isoleucine, and 
histidine (reviewed by Yanofsky, 1981; Vitreschak et al., 2004). Leader peptide-mediated 
post-transcriptional regulation was first found in tryptophan biosynthesis and it has been 
intensively studied (Yanofsky, 1981; 2000). The tryptophan operon, consisting of five 
contiguous trp genes, contains a 161 nucleotide leader sequence. The genes of the trp operon 
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are transcribed when tryptophan is limiting. However, once RNAP initiates a trp mRNA 
molecule, it does not always complete the full transcript as the trp leader sequence contains an 
attenuator. In the presence of high levels of tryptophan, trp transcription stops at the 
attenuator and yields an immature 139 nucleotides long RNA product. However, certain 
features in the leader sequence allow the attenuator to be passed by RNAP when tryptophan is 
limiting. This feature is an ORF encoding a short leader peptide of 14 amino acids and this 
ORF is preceded by a strong-ribosome binding site. The important feature of this leader 
peptide is to have two adjacent tryptophan codons. The function of these two codons is to stop 
a ribosome attempting to translate the leader peptide. Therefore when tryptophan is limiting, 
translation is stalled at the tryptophan codons long enough for the succeeding segment of the 
transcript to form a secondary structure that allows the transcribing RNAP molecule to 
proceed through the attenuator ensuring the full length transcription of the trp genes. 
 
1.5.2 Messenger RNA turnover 
mRNA stability is co-related with the level of expression of a particular gene. In a bacterial 
cell, activities of various exo- and endoribonucleases can limit the lifetime of mRNA 
molecules or impede
 
the ability of an mRNA molecule to participate in the initiation
 
of 
synthesis to generate the normal functional protein product and thus, allows timely changes in 
gene expression within a cell (Kennell, 2002). Exonucleases catalyse sequential cleavage of 
mononucleotides from either a free 5′ or 3′ terminus, or both. Generally, exonucleases in E. 
coli digest RNA in a 3' to 5' direction (Deutscher, 1993), though 5' to 3' exonuclease activity 
has also been reported to play a role in rRNA maturation and mRNA stability (Mathy et al., 
2007). Endoribonucleases cleave the polynucleotide internally and can increase the decay rate 
by the removal of stabilization elements (stem-loop structures) that impede processive 
degradation by exoribonucleases (Higgins et al., 1992).  
 
Endoribonuclease E (RNase E) is a key enzyme involved in RNA metabolism participating in 
the degradation, processing and maturation of variety of RNAs in bacteria. This enzyme is 
found to be involved in the post-transcriptional processing of EHEC LEE4 operon in the LEE 
pathogenicity island (Roe et al., 2003; Lodato and Kaper, 2009). Transcription of the LEE4 
operon initiates upstream of the first gene sepL and terminates at the last gene, espF. However, 
RNase E is involved in processing the transcript to produce a partial transcript corresponds to 
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espADB transcript. Ribonuclease protection assays showed that the processing event occurs in 
the A+T-rich intergenic region between sepL and espA. 3' RACE mapped the 3' end of the 
espADB transcript that is located inside the coding region of cesD2 and followed by  
stem-loop structure, predicted to be a Rho-independent transcription terminator (Lodato and 
Kaper, 2009). Interestingly, translation itself stabilizes mRNA. During translation, translating 
ribosomes can protect mRNA decay by shielding potential endoribonuclease sensitive sites in 
the mRNA (Arraiano et al., 2010) or a translational event can remove secondary structures, 
which may be necessary for initiation of the endoribonucleatic activity (Cole and Nomura, 
1986; Nilsson et al., 1987). 
 
1.5.3 Regulation by small RNAs 
Small regulatory RNAs play many important roles in modifying mRNA stability and 
translatability (Waters and Storz, 2009). Usually, regulatory RNAs base pair with target 
mRNAs and directly modulate mRNA stability and translation. The best example is the DsrA 
small RNA that can regulate mRNA translation either positively or negatively. It binds the 5'-
untranslated leader region of rpoS, removing a hairpin-like secondary structure, associated 
with the sequesteration of the SD sequence of rpoS. This permits access of ribosomes and 
enhances the mRNA stability and translation (Brown and Elliott, 1997; Majdalani et al., 
1998). In case of hns mRNA, DsrA pairs just beyond the translation initiation codon and 
reduces the half-life of hns possibly by exposing or creating a RNase sensitive site within hns 
or by blocking translation (Lease and Belfort, 2000). In either case, a role for Hfq is crucial. 
Hfq is considered to be an RNA chaperone that can bind, stabilize and bring small RNAs to 
their targets (Zhang et al., 2003; Geissmann and Touati, 2004; Brennan and Link, 2007; Sittka 
et al., 2008).  
 
The Hfq protein has two RNA binding sites. The proximal site binds small RNAs and 
mRNAs, whereas the distal site binds the poly (A) tail. Apart from a role in stabilizing small 
RNAs and helping them to bind preferentially to single-stranded A+ U-rich regions of target 
mRNAs, it interacts with ribonucleases that are involved in mRNA decay (Brennan and Link, 
2007). Hfq in conjunction with small RNAs play important roles in post-transcriptional 
regulation of virulence genes in different pathogens including S. enterica serovar 
Typhimurium (Sittka et al., 2007; Wilson et al., 2007), S. sonnei (Mitobe et al., 2008), Y. 
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enterocolitica (Nakao et al., 1995) and uropathogenic E. coli (Kulesus et al., 2008). Recently, 
Hansen and Kaper (2009) reported that Hfq is involved in post-transcriptional regulation of 
genes in the LEE pathogenicity island in EHEC, though the small RNA involved in the 
system remains to be determined. The regulation is indirect, mediating through destabilizing 
mRNA of the grlRA operon that encodes regulators, GrlA and GrlR.  Since GrlA positively 
regulates expression of Ler, which functions as an activator in most of the LEE gene 
expression, Hfq-mediated post-transcriptional control of GrlRA thus affects the LEE genes.  
 
1.6 An overview of regulation of the LEE genes 
As for other pathogenesis-related genes, the expression of the LEE genes is co-ordinately 
controlled by a complex network of signals and transcription factors in response to external 
stimuli (reviewed by Mellies et al., 2007; Tree et al., 2009). The promoters of the LEE region 
are not simple and their activities are influenced by many different transcription factors. The 
LEE1 operon in EHEC has two promoters, one of which is a proximal promoter whose 
transcription start site is located 32 base pairs upstream from the predicted ler translation start 
site (Sperandio et al., 1999). This promoter is present in EHEC and absent in EPEC 
(Sperandio et al., 1999; Elliott et al., 2000). The second one is a distal promoter whose 
transcription start site is located 163 base pairs upstream from the predicted ler translation 
start site and is present in both EHEC and EPEC (Mellies et al., 1999; Sperandio et al., 2002). 
Both LEE2 and LEE3 seem to have two overlapping promoters. The transcription start point 
of the LEE2 operon is located 110 base pairs 5' to the translation start site of the espZ whereas 
transcription start point of the LEE3 is located 60 base pairs upstream of the translation start 
site of the cesL (Mellies et al., 1999) in EPEC. The LEE4 and LEE5 operons are predicted to 
have simple promoters. The transcription start point of the LEE4 is located upstream from the 
translation start site of the sepL (Roe et al., 2003). Transcription of the LEE5 operon starts 86 
nucleotides upstream of the tir start codon in EPEC (Sanchez-SanMartin et al., 2001).  
 
Expression of the LEE genes is under the control of multiple environmental signals and host 
regulators. The first gene of the LEE1 operon encodes a protein known as Ler (LEE encoded 
regulator) (Mellies et al., 1999) that functions as an activator of expression of most of the 
LEE genes (reviewed by Spears et al., 2006; Mellies et al., 2007; Tree et al., 2009). Ler is 
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often regarded as the master regulator of LEE gene expression and thus, the regulatory region 
of the LEE1 operon is the main target for many of the regulatory inputs (Figure 1.9).  
 
Various environmental signals appear to be necessary for the expression of the LEE genes. 
For instance, LEE genes are thermoregulated (Kenny and Finlay, 1995; Rosenshine et al., 
1996). Cells, growing at 27-30°C show reduced level of LEE gene expression, whereas 
growth at 37°C stimulates LEE gene expression. LEE gene expression is regulated in 
response to signals such as calcium, iron, osmolarity, bicarbonate or pH, and starvation or 
growth arrest (in the SOS response) (Kenny et al., 1997a; Abe et al., 2002; Nakanishi et al., 
2006). Quorum sensing, a cell-to-cell communication mechanism through which a bacterium 
can sense other bacteria in a given environment by the production of autoinducer (AI-3), also 
plays an important role in LEE gene expression (Sperandio et al., 1999; Kendall et al., 2010). 
Regulation depends on a wide range of both LEE and non-LEE encoded regulatory factors. 
Hence, the coordinate transcription of genes in the LEE operons is blocked by repressor 
proteins and activated by stimulatory proteins.  
 
Global transcriptional regulators including H-NS and its homologue Hha, IHF, and Fis that 
affect bacterial chromosomal structure, appear to control the LEE gene expression. The 15.6 
kDa nucleoid-associated protein, H-NS represses transcription of the LEE genes (reviewed by 
Clarke et al., 2003; Mellies et al., 2007). Umanski et al. (2002) reported that H-NS represses 
ler expression at 27°C, but not at 37°C, whereas it can repress LEE2-5 operons at both 27°C 
and 37°C. This suggested that H-NS plays a role in the thermoregulated expression of the 
LEE operons. After induction at 37°C, Ler activates other LEE operons. In vitro experiments 
including electro mobility shift assays and footprinting analyses using purified H-NS, 
revealed that H-NS can bind and protect extended regions of LEE2, LEE3 and LEE5 
regulatory sequences and thus directly controls transcription (Bustamante et al., 2001; Haack 
et al., 2003). However, the precise mechanism of H-NS mediated silencing of LEE genes 
remains to be determined, though several studies reported that H-NS silences expression from 
promoters by binding over extended AT-rich regions and is capable of bridging or looping 
DNA (Dorman, 2004; Dame et al., 2005; Browning et al., 2010) (see details in section 1.4.7). 
 
Another nucleoid-associated protein, Hha directly binds to the LEE1 regulatory region and
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Figure 1.9. Schematic representation of the regulation of LEE genes. 
The figure summarizes regulation of locus of enterocyte effacement (LEE) genes in enterohaemorrhagic E. coli O157:H7. Transcriptional 
activators and repressors are shown by pointed and blunt arrows, respectively. Black lines show regulators that interact directly with their 
target promoters, whereas green lines show regulators that interact indirectly with their targets or those that have not been shown to bind 
their targets in vitro. This figure has been adapted from Kendall et al. (2010). 
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exerts a negative role in the ler gene expression (Sharma and Zuerner, 2004). It represses E. 
coli haemolysin gene expression, where it oligomerizes with H-NS protein before binding to a 
specific regulatory sequence in the target gene (Madrid et al., 2002). Nucleoid associated IHF 
protein is reported to bind DNA sequence located upstream of the LEE1 functional promoter 
region, and positively regulates the ler expression. It is predicted that IHF-mediated activation 
of the ler expression involves direct interaction between IHF and RNAP (Friedberg et al., 
1999). However, in many cases, IHF is reported to bend the DNA to facilitate interaction of 
RNAP with another activator bound upstream (Santero et al., 1992; Engelhorn and 
Geiselmann, 1998). In the case of EHEC or EPEC flagellar biosynthesis, IHF plays the 
opposite role functioning as a repressor (Yona-Nadler et al., 2003). Additionally, nucleoid 
associated Fis protein has been shown to activate expression of many LEE genes via 
upregulation of ler gene expression in EPEC (Goldberg et al., 2001), but its role in EHEC 
remains to be determined.  
 
As mentioned earlier, quorum sensing plays an important role in LEE gene expression in both 
EPEC and EHEC. Quorum sensing-activated QseA protein acts as a positive regulator for ler 
expression and thus for other LEE genes (Sperandio et al., 1999; Sperandio et al., 2001; 
Sperandio et al., 2002; Sharp and Sperandio, 2007; Habdas et al., 2010). Moreover, it can also 
upregulate expression of the grlRA and many non-LEE encoded virulence factors in EHEC 
(Russell et al., 2007; Kendall et al., 2010). Usually, QseA responds to quorum sensing signals 
through the two-component system, QseC and QseB, which has been shown to regulate 
flagellar biosynthesis (Clarke and Sperandio, 2005). Moreover, another two-component 
system, QseEF, encoded by the qseE and qseF genes, is reported to activate the gene 
encoding EspFu, a non-LEE encoded T3S effector that plays a crucial role in the 
rearrangement of host cell cytoskeleton in EHEC. However, QseEF do not have any 
regulatory role in LEE gene expression (Reading et al., 2007). 
 
A number of host specific regulators influence expression of the LEE genes. In the EPEC 
2348/69 strain, the EAF plasmid encodes a protein PerC that positively regulates ler 
expression (Porter et al., 2004). However, expression of the per genes, including perC, is 
downregulated by GadX, an activator of the glutamate decarboxylase genes
 
involved in acid 
tolerance (Shin et al., 2001). EHEC lacks the EAF plasmid but possesses a number of perC 
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homologues (pch), encoded on horizontally acquired prophage sequences in the EHEC 
chromosome. Some of these proteins (PchA, PchB and PchC) positively regulate ler 
expression (Iyoda and Watanabe, 2004), though the precise mechanisms remain unclear. 
Genome wide analysis reveals that PchA acts as a global regulator, modulating expression of 
a number of genes including non-LEE genes associated with EHEC virulence (Abe et al., 
2008). Another two regulatory factors, EtrA and EivF, encoded by a second cryptic T3S 
system, have been shown to be involved in negative regulation of the EHEC LEE genes 
(Zhang et al., 2004). Moreover, the RcsD–RcsC–RcsB His–Asp phosphorelay system affects 
the LEE gene expression in both positive and negative manners indirectly through controlling 
ler expression. RcsB-mediated indirect activation of ler expression needs the EHEC specific 
regulator, GrvA, which has been thought to activate the ler expression independently. 
However, expression of the grvA is positively regulated by RcsB. RcsB has been shown to 
downregulate expression of the EHEC specific pch genes and thus thought to exert a negative 
role in LEE gene expression by influencing ler expression (Tobe et al., 2005).  
 
The ClpX protease, which degrades damaged and incomplete proteins, has also been found to 
increase expression of the LEE genes by downregulating expression of GrlR and interacting 
with a stationary-phase sigma factor (RpoS) (Iyoda and Watanabe, 2005). In contrast, ClpXP 
negatively regulates flagellar biosynthesis in both EHEC and S. enterica serovar 
Typhimurium (Tomoyasu et al., 2003; Iyoda and Watanabe, 2005). Also, the small non-
coding RNA, DsrA, in conjunction with stress sigma factor (RpoS) activates ler expression in 
EHEC (Laaberki et al., 2006). RpoS has also been shown to activate the LEE3 operon in  
the E. coli K-12 background (Sperandio et al., 1999).  
 
The small signalling-molecule ppGpp, in conjunction with DksA, can modulate bacterial gene 
expression (see details in section 1.4.5). The stringent response system, triggered by 
starvation of nutrients or growth arrest, causes an increase in the ppGpp concentration in 
EHEC, which in association with DksA, upregulates the expression of LEE genes via direct 
activation of the virulence regulatory genes, ler and pch (Nakanishi et al., 2006). The YhiE 
and YhiF regulatory proteins, that belong to the of LuxR family, have been shown to act as 
negative
 
regulators for LEE-encoded espA, espB, and espD expression at the RNA level. 
However, this regulation is not mediated through the ler gene (Tatsuno et al., 2003). 
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Moreover, overproduced SdiA, an E. coli homologue of quorum sensing regulator LuxR, 
interacts with homoserine lactone or HSL type molecules and downregulates expression of 
EspD and Tir in EHEC. However, EPEC does not have the same repression (Kanamaru et al., 
2000). 
 
In addition to Ler, two other regulators encoded within the LEE are GrlR (global regulator of 
LEE repressor) and GrlA (global regulator of LEE activator) (Deng et al., 2004). These two 
proteins appear to influence the expression of the LEE genes (Deng et al., 2004; Lio and Syu, 
2004; Barba et al., 2005; Jimenez et al., 2010).  
 
1.6.1 Activities of GrlR/GrlA as transcription regulators 
GrlR and GrlA consist of 123- and 137-amino acids respectively and are encoded by a 
putative bicistronic operon grlRA that is located between the etgA gene and the LEE2 operon 
(Figure 1.2). Yeast two-hybrid experiments revealed that the GrlR interacts with itself and 
with its bicistronic partner GrlA (Creasey et al., 2003). Both grlR and grlA are transcribed as 
a single unit and the transcription start site is located upstream of grlR gene (Mellies et al., 
1999; Barba et al., 2005). Recently, Tauschek et al. (2010) reported that transcription of grlA 
gene is controlled by a σ70-dependent promoter located in the intergenic region between grlR 
and grlA in C. rodentium. However, the intergenic DNA sequence between grlR and grlA 
genes is poorly conserved between C. rodentium, EHEC and EPEC. 
 
Both GrlR and GrlA proteins are highly conserved among all AE pathogens (Elliott et al., 
1998; Perna et al., 1998; Deng et al., 2001; Barba et al., 2005) but are not clearly related to 
any known protein. GrlA has 37% identity to Salmonella GrlA homologue (Sgh) and 23% 
identity to CaiF of Enterobacteriaceae (Deng et al., 2004). Moreover, it has similarity to 
several other putative transcriptional regulators including YheC, a putative regulator, encoded 
by R721 plasmid in E. coli K-12 (Pallen et al., 2005a). GrlR, on the other hand, has been 
reported to have only one homologue that is located next to the GrlA homologue in S. bongori 
(Pallen et al., 2005a). CaiF protein, which has a higher sequence similarity with GrlA, is 
encoded by the caiF gene, which lies downstream of the cai operon and in the opposite 
orientation and acts as a specific DNA binding regulatory protein for the activation of 
carnitine metabolism (Eichler et al., 1996; Buchet et al., 1999). Deng et al. (2004) predicted 
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that GrlA has a helix-turn-helix DNA binding motif at the N-terminal domain where most of 
the similarity with the CaiF and the Salmonella GrlA homologue (Sgh) is found. The C-
terminal region, on the other hand, is rich in basic side chains (nine arginines, seven lysines) 
and supposed to interact with its bicistronic partner, GrlR (Jobichen et al., 2007) (Figure 1.10). 
 
Structural-based mutational analysis identified a surface exposed EDED motif in GrlR 
containing negatively charged residues Glu
46
, Asp
47
, Glu
48
 and Asp
49
 (
46
EDED
49
) that is 
important for the recognition of the positively charged segment of GrlA by GrlR. To confirm 
whether motif 
46
EDED
49 
is crucial for the interaction between GrlR and GrlA, Jobichen et al. 
(2007) performed pull down assays. The experiment revealed that wild type GrlR bound to 
GrlA whilst GrlR derivatives containing alanine substitutions in the 
46
EDED
49 
motif did not 
bind to GrlA. This suggested that negatively charged residues Glu
46
, Asp
47
, Glu
48
 and Asp
49
 
are important for GrlR-GrlA interaction. 
 
GrlR and GrlA act as negative and positive regulators, respectively for ler transcription (Deng 
et al., 2004; Lio and Syu, 2004; Barba et al., 2005; Iyoda et al., 2006; Huang and Syu, 2008; 
Saitoh et al., 2008; Jimenez et al., 2010). The expression of ler is strongly activated by a 
positive regulatory loop formed by Ler and GrlA. GrlR apparently conveys its negative 
regulatory role through its interaction with GrlA and prevents the accumulation of Ler 
(Creasey et al., 2003; Iyoda and Watanabe, 2005; Jobichen et al., 2007). 
 
Besides the regulation of the LEE genes, it is reported that GrlR/GrlA regulates transcription 
of at least six non-LEE-encoded effectors (Deng et al., 2004). GrlA activates the expression 
of the Ehx enterohaemolysin (Saitoh et al., 2008). Ehx is encoded by the ehxCABD genes, 
which are carried on the large plasmid, pO17 of EHEC O157: Sakai. The expression of 
enterohaemolysin (Ehx) protein of EHEC O157 was examined by characterizing the grlR 
mutant phenotype. The GrlR deletion significantly induced Ehx activity of EHEC O157 on 
plates containing defibrinated sheep erythrocytes. Moreover, ehx expression was not induced 
by the grlR grlA double mutants but strikingly increased by over expression of grlA. These 
results suggested that GrlA acts as a positive regulator for ehx transcription in EHEC. GrlA 
plays a negative role in the expression of flagellar-genes in EHEC. Flagellar operon, flhD 
contains genes that are responsible for formation of flagella. In an effort to know whether  
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Figure 1.10. Schematic representation of regions of GrlA important for regulatory 
function. 
The figure showing different regions of GrlA, has been drawn on the basis of the prediction of 
helix-turn-helix DNA binding motif in N-terminal region (Deng et al., 2004), and GrlR 
interacting region located in the C-terminal region (Jobichen et al., 2007). In GrlA that 
consists of 137 amino acids (aa), predicted DNA binding motif is located between amino acid 
residues (aa) 39 and 60 in N-terminal region whilst acidic GrlR is thought to interact with 
basic residues (9 arginines and 7 lysines)  of C-terminal region ranging from 64-137 aa .  
 
 
 
 
 
 
 
 
 
N'- -C' 
Helix-turn-helix  
DNA-binding motif 
 (39-60 aa) 
Interacting site for GrlR  (9 arginine and 
7 lysine resdues from 64 to 137 aa) ? 
N-terminal region C-terminal region 
1 137 aa 
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regulatory genes for T3SS can regulate the expression of flagellar-genes in EHEC, Iyoda et al. 
(2006) assayed the transcription level of master flagellar-operon, flhD in the grlR mutant 
background and found reduced level of transcription of the operon. This suggested that GrlA 
functions as a repressor in the expression of flagellar-genes.   
 
Though it is obvious that GrlA has a positive role in the expression of the LEE genes through 
inducing the ler expression, it is a matter of dispute whether GrlA activates LEE1 by binding 
to the regulatory region independently or it needs a co-factor to bind the DNA or it activates 
indirectly by counteracting any repressor. Barba et al (2005) showed that GrlA activates 
transcription of the C. rodentium LEE1 operon in both C. rodentium and E. coli K-12 
backgrounds. This suggested that GrlA-dependent activation of C. rodentium LEE1 
transcription does not require any additional C. rodentium-specific genes. However, 
transcription of the EHEC LEE1, although activated by GrlA in an EHEC background (Iyoda 
et al., 2006) is not activated by GrlA in an E. coli K-12 background (Russell et al., 2007). 
These data suggested that EHEC LEE1 activation by GrlA is indirect and requires an 
additional transcription factor, which is absent in E. coli K-12. In contrast to Russell et al. 
(2007), Huang and Syu (2008) showed that purified GrlA-Gst fusion protein binds the EHEC 
LEE1 regulatory region. This result first suggested that GrlA could activate expression from 
the EHEC LEE1 regulatory region independently.  However, the study failed to identify the 
GrlA target in the LEE1 regulatory region. 
 
Previous studies, concerning the regulatory role of GrlA failed to find any obvious binding  
site in the regulatory region of putative target genes of GrlA. Moreover, alignment of the 
upstream regulatory regions of the putative target genes viz., ler, ehxC and flhD of GrlA 
failed to identify any clear common regulatory sequences. Together, this suggests that GrlA 
may activate putative target genes indirectly. It is important to note that expression of target 
genes of GrlA is negatively controlled by several regulators. For instance, under repressive 
conditions, both ler and ehxC are silenced by H-NS (Godessart et al., 1988; Nieto et al., 1997; 
Umanski et al., 2002; Saitoh et al., 2008).  
 
In order to determine the mechanism of GrlA-dependent activation of LEE1 promoter, both 
Barba et al. (2005) and Jimenez et al. (2010) performed a deletion analysis of LEE1 promoter 
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analysis and found that GrlA activates the expression from  a  LEE1 promoter fragment that 
lacks the upstream sequence of the promoter -35 element and carries promoter elements with 
the downstream sequence. The basal activity of this fragment was found to be slightly higher 
in the Δhns E. coli K-12 background than wild type background but did not reach the levels in 
wild type E. coli K-12 carrying plasmid encoding GrlA. These data suggested that GrlA, in 
part, counteracts H-NS repression but it is also essential
 
for the efficient activation of the ler 
promoter, even in the
 
absence of H-NS. To test this further, they measured the promoter 
activity in Δhns E. coli K-12 background containing plasmid-expressing GrlA, and found that 
GrlA induces the promoter activity significantly compared to the activity observed in
 
the E. 
coli K-12 hns mutant strain carrying only the vector. From these results, it was suggested that, 
in addition to H-NS, another factor
 
could also partially repress ler expression, and thus GrlA 
could
 
counteract the total repression exerted by more than one negative
 
regulator. 
Alternatively, GrlA could counteract the H-NS-mediated
 
repression but also promote the 
interaction of the RNAP
 
with the ler promoter.  
 
To nail this down further, Jimenez et al. (2010) performed in vitro binding assays with 
purified MBP-GrlA fusion protein and LEE1 promoter fragment. Like Huang and Syu (2008), 
they reported that GrlA binds to the LEE1 regulatory region. They also explored their in vitro 
binding system to check whether the predicted helix-turn-helix DNA binding motif located in 
the N-terminal region (Deng et al., 2004) is functional. They substituted the residues in the 
predicted DNA binding motif with alanine and found that some substitutions reduce the 
ability of GrlA to activate LEE1 promoter in vivo, and subsequently the binding ability of 
GrlA to the LEE1 promoter in vitro. However, like Huang and Syu (2008), this study failed to 
define GrlA binding target at the LEE1 promoter. 
 
Both the GrlA and GrlR regulatory proteins are required to optimize LEE1 promoter activity 
(Jobichen et al., 2007). Generally, free GrlA increases LEE1 promoter efficiency and thus 
induces ler transcription, which in turn activates the expression of all LEE genes, including 
the grlRA operon. On the other hand, to prevent the detrimental concentrations of Ler, GrlR 
interacts with GrlA and inhibits GrlA function, suggesting that GrlR acts as an anti-GrlA 
factor. However, an important question is open to all that whether one ore more additional 
factors are involved in modulating the anti-GrlA activity of GrlR in response to 
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environmental signals. Structural studies revealed that GrlR consists of a typical β-barrel fold 
with eight β-strands containing an internal hydrophobic cavity and a plug-like loop on one 
side of the barrel (Jobichen et al., 2007). This highly hydrophobic β-barrel cavity is supposed 
to be involved in recognizing a small hydrophobic ligand. Jobichen et al. (2009) further 
explored the structure of GrlR, and determined that GrlR shares lipid-binding properties 
similar to that of lipocalin structural homologue, beta-lactoglobulin. Lipocalins are a broad 
family of lipid-binding proteins identified in both eukaryotes and Gram-negative bacteria. 
 
1.6.2 Ler and its regulation 
As mentioned earlier, the LEE genes are silenced by H-NS. After being expressed from the 
first gene of the LEE1 operon under appropriate conditions, Ler negates the H-NS-mediated 
repression and thus activates expression of genes of LEE2-5 operons (Mellies et al., 1999; 
Elliott et al., 2000; Sperandio et al., 2000; Bustamante et al., 2001; Umanski et al., 2002; 
Haack et al., 2003). Moreover, it has been shown that Ler auto-regulates its own transcription 
(Berdichevsky et al., 2005; Yerushalmi et al., 2008). However, the precise mechanism of Ler 
function remains to be determined. 
 
Ler is predicted to have a molecular weight of 15.1 kDa (Mellies et al., 2007). This protein 
shares 24% identity and 44% similarity to 15.5 kDa H-NS protein of S. enterica Typhimurium 
(Sperandio et al., 2000). Like H-NS as described in section 1.5.7, Ler consists of a C-terminal 
DNA-binding domain and an N-terminal coiled-coil oligomerization domain, which are 
connected by a linker region (Yerushalmi et al., 2008; Mellies et al., 2011) (Figure 1.11). 
Taken all together, it is believed that Ler is a member of H-NS family nucleoid-associated 
proteins. However, despite the similarity in domain structure, Ler protein differs from H-NS 
family members because all other members of H-NS protein family silence transcription of 
target genes, whereas Ler usually acts as a transcription activator. Recently, Mellies et al. 
(2011) revealed some distinct differences in domain structures between these two regulators. 
They found that length of the N-terminal coiled-coil domain of Ler is shorter than that of  
H-NS. The N-terminal region of the Ler contains two α-helices, whereas region of the H-NS 
has three α-helices. These structural differences lead to differences in biochemistry. For 
instance, in solution, Ler oligomerizes more readily than H-NS. It shows higher binding 
affinity to target promoters than H-NS. Moreover, the Ler-H-NS-DNA complex migrates to a 
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Figure 1.11. Schematic representation of different domains of Ler. 
The figure shows three predicted domains of 129-peptides long Ler protein: N-terminal 
domain that functions either as a higher-order oligomerization domain or as a domain that 
interacts with other proteins, a central domain that functions as a homo-oligomerization 
domain and a C-terminal DNA binding domain. The three domains are essential for DNA 
binding and transcriptional regulation. Figure adapted from Yerushalmi et al. (2008). 
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distinct position in a band-shift assay suggesting that the Ler and H-NS get different shapes 
when they bind to the DNAs. Finally, a toroidal Ler-DNA structure that is distinct from the 
H-NS-DNA structure was found. This toroidal structure is believed to be associated with Ler-
mediated activation of gene expression. Therefore, though the Ler belongs to the H-NS family, 
it functions differently (Mellies et al., 2011). 
 
Base substitution in the putative oligomerization domain in
 
the N-terminus of Ler eliminated 
the ability of the protein
 
to bind to DNA and the ability to activate expression of a LEE2-lacZ
 
fusion, suggesting that Ler forms oligomers in
 
order to activate transcription (Sperandio et al., 
2000). Moreover, biochemical assays revealed that Ler protects extended regions of LEE1, 
LEE2 and LEE5 operon regulatory sequences supporting that Ler binds DNA in multimerized 
form (Sperandio et al., 2000; Haack et al., 2003; Berdichevsky et al., 2005). 
 
The mechanism of Ler-mediated activation of different LEE genes is still open to question. To 
date, there is no report of identification of the determinants at target promoters for Ler. In all 
cases both genetic and biochemical assays revealed that Ler interacts with an extended region 
of highly A/T rich regulatory sequences of the LEE operons which are also targets for H-NS 
(Sperandio et al., 2000; Haack et al., 2003; Berdichevsky et al., 2005; Mellies et al., 2011). 
Ler-dependent hypersensitive sites
 
in DNase I footprinting assays appear in regions known to 
be protected
 
by H-NS. Therefore, the mechanism of Ler-mediated regulation is thought to 
involve the displacement of H-NS by Ler like antagonism of H-NS repression by SlyA of 
haemolysin, hlyE in E. coli (Stoebel et al., 2008) (Figure 1.12). 
 
Ler acts as a global regulator since it can regulate genes outside of the LEE pathogenicity 
island (Elliott et al., 2000; Deng et al., 2004; Abe et al., 2008). Most of the non-LEE-encoded 
genes, reported to be controlled by the Ler, are associated with the attaching and effacing 
phenotype. For instance, the Ler regulon includes EspFu/TccP, which is required for actin 
polymerization at the cytoplasmic domain of Tir in EHEC (Campellone et al., 2004) and 
NleA/EspI, which is necessary for C. rodentium to colonise the mouse colon (Mundy et al., 
2004). Moreover, Ler is believed to control some genes found in non-pathogenic E. coli strain  
K-12 (Abe et al., 2008). However, they reported that the Ler has limited number of target 
genes outside of the LEE region compared with another activator of the LEE genes, PchA in 
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Figure 1.12. Schematic representation of action of Ler on a promoter that is repressed 
by H-NS. 
A. H-NS binds DNA sequences both upstream and downstream of the target promoter and 
forms a bridge, which prevents transcription from the promoter.  
B. Ler overcomes the H-NS mediated repression by displacing or antagonising the H-NS and 
permits transcription from the promoter. The figure has been adapted from Stoebel et al. 
(2008). 
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EHEC. Therefore, the action of Ler is confined mainly on the LEE genes. This can be 
explained by the closed proximity of the ler and its interacting counterparts in the LEE region. 
Recently, it has been reported that interacting proteins synthesized in the same vicinity, can 
facilitate interaction (Montero Llopis et al., 2010). 
 
It is clear that a number of regulatory inputs control the expression of the Ler, which in turn 
enhances expression of genes associated with the T3S apparatus, translocation secretors and 
effector molecules. However, when assembly of T3SSs is complete, Ler is no longer 
necessary and hence, it needs to be controlled. The action of Ler is found to be controlled in 
two ways. As mentioned earlier, Ler represses its own transcription (Berdichevsky et al., 
2005; Yerushalmi et al., 2008). Moreover, the action of Ler appears to be regulated post-
transcriptionally by a T3S secretion chaperone (Tsai et al., 2006; Younis et al., 2010). 
 
It has been shown that SepL and its binding partner SepD control the secretion of EspADB 
molecules that form a translocon through which effectors are delivered to host cell (O‟Connell 
et al., 2004; Deng et al., 2005). Therefore, these two proteins largely determine the secretion 
specificity in the system (reviewed by Tree et al., 2009; Bhatt et al., 2011). Recently, Younis 
et al. (2010) reported that the LEE-encoded protein, CesL functions as a class 1 chaperone 
(chaperons for effectors) for the SepL protein. Additionally, as a T3S effector, SepL is 
reported to have a secretion signal at its N-terminus. Tsai et al. (2006) showed that the CesL 
(L0036 or Mpc in their report) binds the Ler protein and down-regulates its activation 
capability. Therefore, it is believed that at post-transcriptional level, secretion of SepL 
releases its chaperone CesL, which in turn binds the Ler and restricts its activity. However, 
this partner switching approach that couples protein secretion to gene expression has been 
reported for flagellar and many other non-flagellar T3S systems (Hughes et al., 1993; Darwin 
and Miller, 2001; Francis et al., 2001; Parsot et al., 2005; Urbanowski et al., 2005; Brutinel 
and Yahr, 2008).  
 
1.7 Aims and an outline of the project 
The overarching aim of this work was to understand how the expression of the LEE genes is 
triggered. Since LEE expression is coordinated by the Ler protein, most of the work has 
focussed on the regulatory region of the LEE1 transcription unit. The approach that was taken 
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was to study this region in an E. coli K-12 genetic background with a view to building up a 
step-by-step picture of its regulation. 
 
The first aim was to define the key functional promoter elements of the LEE1 regulatory 
region and to do this, both genetic and biochemistry methods were exploited. Having done 
this, as described in the first part of Chapter 3, it was noticed that the LEE1 leader region is 
unusually long. This led to further aim that was to investigate the consequence of the long 
LEE1 leader sequence. Genetic analyses revealed a mini-gene in the leader region and its 
function. This part of the work is described in Chapter 5. 
 
During the investigation of the key functional  LEE1 promoter elements, a secondary cryptic 
promoter, which overlapped with the main promoter, was discovered. Having observed this, 
the aim was set to identify the functional elements of this secondary promoter and to 
determine its role. This part of the work is described in Chapter 4 and has been published 
(Appendix II). 
 
Although many transcriptional regulators are known to affect expression of the LEE1 operon, 
their effects at the LEE1 promoter have not been studied in detail and binding sites have not 
been identified. Hence, a further aim of my work, having defined the LEE1 promoter elements, 
was to identify binding targets for different transcription factors. The last part of Chapter 3 
describes an experimental work to investigate the action of GrlA. To do this, the reported 
GrlA-mediated activation of the promoter was reconstituted in the E. coli K-12 system. 
Different genetic analyses revealed that GrlA binds to the LEE1 promoter between its -35 and 
-10 elements and compensate non-optimal spacer length. This part of the work has been 
published (Appendix I).  
 
A final aim was to further understanding of how Ler activity is regulated and thus, the work, 
described in Chapter 6, focuses on transcriptional autoregulation of ler expression by Ler 
protein. In parallel, effects of Ler at the LEE2 regulatory region were measured.  
 
Taken together, the results in this thesis advance our understanding of promoter architecture 
and regulation in EHEC. 
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Chapter 2 
 
Materials and Methods 
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2.1 Suppliers 
Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich, BDH or Fisher 
Scientific. All radionucleotides were purchased from Perkin Elmer. Oligodeoxyribo 
-nucleotides were supplied by Alta Bioscience, University of Birmingham. Restriction 
endonucleases, Calf alkaline phosphatase, T4 DNA ligase and T4 polynucleotide kinase were 
purchased from New England Biolabs. Biotaq DNA polymerases and dNTP mix were 
supplied by Bioline. All enzymes were used according to the manufacturer‟s instructions, and 
in the buffers provided by the suppliers. Glycogen was purchased from Invitrogen. Holo 
RNAP-σ70 was purchased from Epicentre Biotechnologies (Madison, Wisconsin). 
 
2.2 Buffers, solutions and reagents 
Solutions for use in bacterial growth or DNA manipulations were autoclaved for 20 mins at 
120°C and 15 psi, or filter-sterilised using 0.2 µm filters.   
 
2.2.1 Gel electrophoresis of DNA and proteins 
General 
DNA loading dye: 0.025% Bromophenol blue; 0.025% Xylene cyanol FF; 20% Glycerol; 10 
mM Tris, pH 7.5; 1mM EDTA 
Ethidium bromide:  10 mg/ml (Bio-Rad) 
DNA markers: 100 bp and 1 kb DNA ladders were purchased from New England Biolabs, 
and were diluted 6 fold in DNA loading dye 
Protein molecular weight markers: SeeBlue® Plus2 Protein pre-stained standard consisting 
of 10 protein bands in the range of 4-250 kDa was purchased from Invitrogen 
 
Agarose gel electrophoresis 
50 x TAE Buffer: 2 M Tris acetate, 100 mM Na2EDTA (National Diagnostics). Diluted to  
1 x for use as running buffer 
Agarose solutions: 0.8% and 1.3% in 1 x TAE buffer. Heated to 100°C for 2-3 mins in a 
microwave to dissolve agarose  
 
Polyacrylamide gel electrophoresis 
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5 x TBE buffer: 0.445 M Tris borate pH 8.3, 10 mM Na2EDTA (National Diagnostics). 
Diluted to 1 x or 0.5 x for use as running buffer 
Stock acrylamide solution: 30% (w/v) acrylamide, 0.8% bisacrylamide stock solution 
(ProtoGel) (National Diagnostics) 
TEMED: N, N, N', N'-Tetramethylethylenediamine 
7.5% Acrylamide working solution: 125 ml 30% (w/v) acrylamide, 0.8% bisacrylamide 
stock solution; 100 ml 5 x TBE; 20 ml glycerol; made up to 500 ml with distilled water 
Sequencing acrylamide gel solution: SequaGel Sequencing System was prepared according 
to the manufacturer‟s (National Diagnostics) instructions 
Fixing solution: 10% (v/v) methanol, 10% (v/v) acetic acid       
 
Denaturing gel electrophoresis of proteins 
Gels:  NuPAGE Novex 4-12 % Bis-Tris gels (Invitrogen) 
SDS PAGE loading buffer:  2 g SDS, 20 ml glycerol, 5 mg bromophenol blue, made up to 
92 ml using 0.1 x stacking gel buffer.  Prior to use, 87 µl β-mercaptoethanol was added to a  
1 ml aliquot 
Stacking gel buffer:  15.15 g Tris, 10 ml 10 % SDS, 500 µl TEMED, pH 6.8.  Made up to 
100 ml in distilled water 
Coomassie blue stain solution:  50 % (v/v) methanol, 10 % (v/v) acetic acid, 2g/l
 
Coomassie 
brilliant blue 
Fast destain solution:  40 % (v/v) methanol, 10 % (v/v) acetic acid  
Shrink solution: 48 % (v/v) methanol, 2% (v/v) glycerol 
 
2.2.2 Extraction and purification of DNA fragments 
Phenol/Chloroform/Isoamyl alcohol: phenol/chloroform/isoamyl alcohol (composition 
25/24/1 v/v), pH 8.0 purchased from Fisher scientific 
TEN buffer: 60 mM Tris (pH 8.0), 5 mM EDTA, 50 mM NaCl 
TE buffer: 10 mM Tris (pH 8.0), 0.5 mM EDTA 
 
2.2.3 DNA transformation in E. coli 
Calcium chloride treated competent cells 
Calcium chloride: 100 mM CaCl2, 10 mM Tris-HCl, pH 7.5 (autoclaved) 
Freeze-thaw buffer: 100 mM CaCl2, 10 mM Tris-HCl, pH 7.5, 15% glycerol (autoclaved) 
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Rubidium chloride treated competent cells 
TFB1 buffer: 30 mM potassium acetate, 10 mM CaCl2, 50 mM MnCl2, 100mM RbCl, 15% 
glycerol,  pH  5.8 with 1 M acetic acid, filter-sterilized (0.2µM) and stored at room 
temperature 
TFB2 buffer: 10 mM PIPES, pH 6.5, 75 mM CaCl2, 10 mM RbCl, 15% glycerol,  pH  6.5 
with 1 M KOH, filter-sterilized (0.2µM) and stored at room temperature 
 
2.2.4 DNA sampling 
Extraction buffer: 50 mM Tris–HCl pH 7.5, 100 mM NaCl, 10% sucrose, 2 mM MgCl2, 
0.1% (v/v) Triton X-100, 200 μg/ml phenylmethylsulfonyl fluoride, 4 μg/ml pepstatin 
Protease inhibitor cocktail tablet (Roche diagnostics) 
RNase A (300 μg/ml) 
Lysozyme (400 μg/ml) 
Wash buffer: 20 mM HEPES pH 7.4, 100 mM NaCl, and 0.1% (v/v) Tween 20 
Elution buffer: 0.3 M NH4OH, 0.5 M EDTA, pH 8.0 
 
2.2.5 Pull down assays 
Extraction buffer: 20 mM HEPES [pH 7.4], 150 mM NaCl, 2 mM MgCl2, 0.1% Tween 20, 
200 μg/ml phenylmethylsulfonyl fluoride, 4 μg/ml pepstatin, protease inhibitor cocktail  
(1 tablet; Roche Diagnostics) 
DNase I (20 μg/ml)  
RNase A (300 μg/ml)  
Lysozyme (200 μg/ml) 
Dynabeads (M270-epoxy; Dynal) coated with rabbit immunoglobulin G 
Wash buffer: 20 mM HEPES pH 7.4, 150 mM NaCl, 0.1% Tween 20 
Elution buffer: 0.5 M NH4OH, 0.5 M EDTA pH 8.0 
 
2.2.6 KMnO4 footprinting 
[γ32P]-ATP: 7000 Ci/mmol, 100 mCi/ml (Perkin Elmer) 
Sephadex G-50 suspension: 5 g Sephadex G-50 (Pharmacia Biotech) autoclaved in 100 ml 
TE buffer. Washed three times in 150 ml TE buffer and finally suspended in 50 ml TE buffer. 
Stored at 4ºC 
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Denaturing gel loading buffer: 40% deionised formamide, 5 M urea, 5 mM sodium 
hydroxide, 1 mM EDTA, 0.025% bromophenol blue, 0.025% xylene cyanole FF 
10x HEPES/glutamate buffer: 200 mM HEPES pH 8.0, 50 mM MgCl2, 500 mM potassium 
glutamate, 10 mM DTT 
KMnO4 solution: 31 mg KMnO4 per 1 ml solution with distilled water 
Stop solution: 3 M ammonium acetate, 0.1 mM EDTA, 1.5 M β-mercaptoethanol  
 
2.2.7 In vitro transcription assays 
[α32 P]-UTP: 300 Ci/mmol, 10 mCi/ml (Perkin Elmer) 
10 x transcription buffer: 400 mM Tris Acetate pH 7.9, 100 mM MgCl2, 10 mM DTT, 1 M 
KCl 
10 mg/ml BSA 
Transcription stop solution/loading buffer: 95% (v/v) deionised formamide, 10 mM EDTA, 
0.05% bromophenol blue, 0.05% xylene cyanol FF 
 
2.2.8  β-galactosidase assays 
Z-buffer: 0.75 g KCl, 0.25 g MgSO4.7H2O, 8.53 g Na2HPO4, 4.87 g NaH2PO4.2H2O and 2.70 
ml β-mercaptoethanol, made up to 1.0 l with distilled water and autoclaved 
Note that β-mercaptoethanol was added after autoclaving, immediately prior to use  
ONPG: ortho-nitrophenol-β-D-galactopyranoside dissolved in Z-buffer (0.8 g/l), prepared 
fresh prior to use 
Sodium carbonate: 1 M Na2CO3 
Toluene 
Sodium deoxycholate: 1% (w/v) solution in distilled water 
 
2.3 Bacterial growth media 
2.3.1 Liquid media 
All liquid media were made up in distilled water, sterilised by autoclaving for 20 mins at 
120°C and 15 psi, and stored at room temperature. 
 
LB medium: 20 g/l
 
tryptone, 10 g/l
 
yeast extract, 10 g/l
 
NaCl, made up in distilled water. 
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10 x M9 salts: 60 g/l Na2HPO4, 30 g/l KH2PO4,  5 g/l
 
NaCl,  10 g/l NH4Cl,  10 mg/l Biotin,  
10 mg/l thiamine, pH 7.4 
 
M9 salts or minimal medium: The constituents of M9 salts medium were made up 
individually, autoclaved, and fresh medium was prepared aseptically when required.  
For 100 ml medium: 10 ml 10 x M9 salts, 200 µl 1 M MgSO4, 100 µl 0.1 M CaCl2,  90 ml 
sterile distilled water. Supplemented where required with 10 mM or 50 mM L-lysine. 
 
DMEM medium: Dulbecco‟s modified Eagle‟s medium, pH 7.4, adjusted with HEPES 
buffer, purchased from Sigma-Aldrich 
 
SOC medium: A rich media used in the recovery step of E. coli competent cell 
transformations. Use of SOC maximizes the transformation efficiency of competent cells. 
Ready-made solution was purchased from Sigma-Aldrich. 
 
2.3.2 Solid media 
All solid media were made up in distilled water and sterilised by autoclaving for 20 mins at 
120°C and 15 psi. Media were cooled to ~50°C before addition of antibiotics or other 
supplements. Agar plates were poured under sterile conditions (approximately 25 ml agar per 
Petri dish) and stored at 4°C. 
 
Nutrient agar: 23 g/l nutrient agar (Difco) 
Lactose MacConkey agar: 50 g/l
 
MacConkey lactose agar (Difco) 
 
2.3.3 Antibiotics  
All stock solutions were made up as indicated below and sterile filtered through 0.2 µm 
syringe filters. 
 
Ampicillin: 40 mg/ml in sterile distilled water (stored at -20°C) 
Tetracycline: 10 mg/ml in ethanol (stored at -20°C) 
Kanamycin: 50 mg/ml in sterile distilled water (stored at -20°C) 
Chloramphenicol: 25 mg/ml in ethanol (stored at -20°C) 
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To select for strains carrying resistance genes, antibiotics were added to liquid or solid media 
after autoclaving at the following final concentrations: 80 µg ml
-1
 ampicillin, 35 µg ml
-1 
chloramphenicol, 50 µg ml
-1 
kanamycin, and 35 µg ml
-1 
tetracycline. 
 
2.4 Bacterial strains and plasmids 
2.4.1 Bacterial strains and growth conditions 
The bacterial strains used in this study are listed in Table 2.1. The bacterial strains were 
restreaked before use onto freshly prepared agar plates and incubated at 37C overnight. The 
strains were stored at 4C for up to one month. Glycerol stocks were made from a culture and 
stored at -80°C. Overnight cultures were grown by inoculating a single fresh colony into 5-10 
ml LB medium supplemented with antibiotics as appropriate and incubating at 37°C with 
shaking for 16-18 hrs. When sub-culturing was necessary, required volume of medium was 
inoculated with 0.01-0.02 volume overnight culture. Growth of cultures was monitored by 
measuring the optical density at 650 nm using Helios Gamma Spectrophotometer (Thermo 
Fisher Scientific Inc).  
 
2.4.2 Plasmids 
Plasmids used in this study are listed in Table 2.2. Plasmid maps are shown in the Figures 2.1 
to 2.7. In brief, plasmid pRW224 carrying different fragments of LEE1 and LEE2 regulatory 
sequences as transcription fusions to lacZ was used to quantify the promoter activities by 
measuring the amount of β-galactosidase. Plasmid pJW15Δ100 was used to express genes of 
interest under the control of melR promoter. Plasmid pACYC184 was used to clone target 
genes under their own regulatory sequences. Plasmid pRW902 was used to clone DNA 
sequences of interest to facilitate in vivo identification of bound protein on it following the 
DNA sampling method. Plasmid pRW225 was used to clone the DNA sequence of interest as 
translational fusions to lacZ. Plasmid pSR was used in in vitro potassium permanganate 
analysis and transcription assays. 
 
2.5 Gel electrophoresis 
2.5.1 Agarose gel electrophoresis of DNA 
Agarose gels were used to analyse and purify DNA fragments greater than 500 bp in length. 
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Table 2.1:  E. coli strains used in this study 
 
Strains Description References 
M182 E. coli K-12 strain, lacX74 galK galU 
strA 
Casadaban and Cohen (1980) 
MG1655 Δhns E. coli K-12 MG1655 Δhns rpsL Grainger et al. (2008) 
Sakai 813 ΔStx A derivative of EHEC strain O157:H7 
Sakai, ΔStx1 and ΔStx2 
Given by Chihiro Sasakawa 
EDL933 A derivative of EHEC strain O157:H7 
EDL933, TUV93-0, ΔStx1 and ΔStx2 
Given by Arthur Donohue 
-Rolfe  
MG1655 lacI 
3xFLAG 
E. coli K-12 MG1655 3xFLAG-tagged 
lacI  
Butala et al. (2009) 
Sakai grlR A derivative of EHEC Sakai ΔStx, the 
alanine codon 37 in grlR changed to 
TAG amber stop codon 
Zhang and Pallen 
(unpublished)
1
 
Sakai grlA A derivative of EHEC Sakai ΔStx, the 
alanine codon 55 in grlA changed to 
TAG amber stop codon 
Zhang and Pallen 
(unpublished)
1
 
EDL933 Ler-KO A derivative of EHEC strain EDL933, 
Δler 
Bingle and Pallen 
(unpublished)
2
 
Sakai rpoC::4PrA A derivative of EHEC O157 Sakai 
ΔStx, rpoC::4PrA 
Lee et al. (2008) 
 
1
The Sakai strain mutants (both Sakai grlR an Sakai grlA) were constructed by Lihong Zhang 
in Mark Pallen‟s laboratory by replacing alanine codon 55 in grlA and alanine codon 37 in 
grlR with a TAG amber stop codon, using the gene gorging method (Herring et al., 2003). In 
each case, a BfaI restriction site (CTAG) was simultaneously created by mutating the 
preceding base to a C. This site was exploited to identify mutant colonies that were then 
confirmed by DNA sequencing. Both mutants were checked to contain no other gene deletion 
by genomic hybridization to a microarray.  
 
2
The EDL933 ler KO strain was constructed by Lewis Bingle in Mark Pallen‟s laboratory. An 
inframe (i.e. non-polar) deletion of the ler gene was made using the Gene Doctoring system 
(Lee et al., 2009) first by replacement of the ler coding sequence with the kanamycin 
resistance gene cassette and then removal of this cassette via flanking FLP recombination 
sites. The resultant ler-KO locus encodes the first and last 9 amino acids of Ler sandwiching a 
central "scar region" derived from the FLP recombinase sites encoding 29 (non-Ler) amino 
acids. The strain was checked for unwanted secondary deletions by microarray comparative 
genomic hybridisation. 
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Table 2.2:  Plasmids used in this study (continued on pages 65- 67)     
 
Plasmids Description References 
pRW224-U9 Derivative of pRW50, which allows cloning of 
promoter fragments as transcription or translation 
fusions to lacZ carrying pUC9 linker between the 
EcoRI and HindIII sites (Tet
R
) (Figure 2.1) 
Islam et al. 
(2011) 
 LEE10-568/pRW224 Derivative of pRW224 carrying an EcoRI-HindIII 
LEE1 regulatory region fragment (-568 to -19, 
numbered with respect to the translation start site of 
ler) as a transcription fusion to lacZ (Figure 2.10, 
2.11) 
This study 
 LEE10-315/pRW224 Derivative of LEE10-568/pRW224 carrying an 
EcoRI-HindIII fragment (-315 to -19) as a 
transcription fusion to lacZ (Figure 2.10, 2.11) 
This study 
 LEE10-275/pRW224 Derivative of LEE10-568/pRW224 carrying an 
EcoRI-HindIII fragment (-275 to -19) as a 
transcription fusion to lacZ (Figure 2.10, 2.11) 
This study 
 LEE10-235/pRW224 Derivative of LEE10-568/pRW224 carrying an 
EcoRI-HindIII fragment (-235 to -19) as a 
transcription fusion to lacZ (Figure 2.10, 2.11) 
 
 LEE10-215/pRW224 Derivative of LEE10-568/pRW224 carrying an 
EcoRI-HindIII fragment (-215 to -19) as a 
transcription fusion to lacZ (Figure 2.10, 2.11) 
This study 
 LEE10-203/pRW224 Derivative of LEE10-568/pRW224 carrying an 
EcoRI-HindIII fragment (-203 to -19) as a 
transcription fusion to lacZ (Figure 2.10, 2.11) 
This study 
 LEE10-195/pRW224 Derivative of LEE10-568/pRW224 carrying an 
EcoRI-HindIII fragment (-195 to -19) as a 
transcription fusion to lacZ (Figure 2.10, 2.11) 
This study 
 LEE10-155/pRW224 Derivative of LEE10-568/pRW224 carrying an 
EcoRI-HindIII fragment (-155 to -19) as a 
transcription fusion to lacZ (Figure 2.10, 2.11) 
This study 
 LEE10-115/pRW224 Derivative of LEE10-568/pRW224 carrying an 
EcoRI-HindIII fragment (-115 to -19) as a 
transcription fusion to lacZ (Figure 2.10, 2.11) 
This study 
 LEE10-75/pRW224 Derivative of LEE10-568/pRW224 carrying an 
EcoRI-HindIII fragment (-75 to -19) as a 
transcription fusion to lacZ (Figure 2.10, 2.11) 
This study 
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Table 2.2:  Plasmids used in this study (continued) 
 
Plasmids Description References 
 LEE20-568/pRW224 Derivative of LEE10-568/pRW224 carrying an 
EcoRI-HindIII fragment (-568 to -158) as a 
transcription fusion to lacZ (Figure 2.10, 2.11) 
This study 
 LEE20-315/pRW224 Derivative of LEE10-568/pRW224 carrying an 
EcoRI-HindIII fragment (-315 to -158) as a 
transcription fusion to lacZ (Figure 2.10, 2.11) 
This study 
 LEE20-275/pRW224 Derivative of LEE10-568/pRW224 carrying an 
EcoRI-HindIII fragment (-275 to -158) as a 
transcription fusion to lacZ (Figure 2.10, 2.11) 
This study 
 LEE20-203/pRW224 Derivative of LEE10-568/pRW224 carrying an 
EcoRI-HindIII fragment (-203 to -158) as a 
transcription fusion to lacZ (Figure 2.10, 2.11) 
This study 
 LEE30-275/pRW224 Derivative of LEE10-568/pRW224 carrying an 
EcoRI-HindIII fragment (-275 to -114) as a 
transcription fusion to lacZ (Figure 2.10, 2.11) 
This study 
 LEE2-220/pRW224 Derivative of pRW224 carrying an EcoRI-
HindIII LEE2 regulatory region fragment (-220 
to +109, numbered with respect to the transcript 
start site of the LEE2 promoter) as a 
transcription fusion to lacZ (Figure 2.12, 2.13) 
This study 
 LEE2-125/pRW224 Derivative of LEE2-220/pRW224 carrying an 
EcoRI-HindIII fragment (-125 to + 109) as a 
transcription fusion to lacZ (Figure 2.12, 2.13) 
This study 
 LEE2-100/pRW224 Derivative of LEE2-220/pRW224 carrying an 
EcoRI-HindIII fragment (-100 to +109) as a 
transcription fusion to lacZ (Figure 2.12, 2.13) 
This study 
pSR High copy number pBR322 derivative, used for 
cloning EcoRI-HindIII promoter fragments 
upstream of the λ oop terminator (AmpR) 
(Figure 2.2) 
Kolb et al., 
(1995) 
 LEE20-275/pSR Derivative of pSR containing LEE20-275 
fragment between EcoRI-HindIII sites (Figure 
2.14, 2.15) 
This study 
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Table 2.2:  Plasmids used in this study (continued) 
 
Plasmids Description References 
LEE20-275 98C/pSR Derivative of pSR containing LEE20-275 98C 
fragment between EcoRI-HindIII sites (Figure 2.14, 
2.15) 
This study 
LEE20-275 98C 
64G/pSR 
Derivative of pSR containing LEE20-275 98C 64G  
fragment between EcoRI-HindIII sites (Figure 2.14, 
2.15) 
This study 
pACYC184 Cloning vector constructed by ligating restriction 
fragments from pSC101, Tn9 and p15A. Used for 
cloning HindIII-SalI DNA fragments (Tet
R
 and 
Cm
R
) (Figure 2.3)  
Chang  
and Cohen 
(1978) 
 pACYC184ΔHN Derivative of pACYC184 in which HindIII-NruI 
fragment has been deleted, chloramphenicol 
resistance and tetracycline sensitive 
Mitchell et 
al. (2007) 
 pSI01 Derivative of pACYC184 carrying grlR+A+ genes 
cloned between HindIII and SalI sites (Figure 2.16, 
2.17) 
This study 
 pSI02 Derivative of pSI01 in which there is an in-frame 
deletion of grlR gene, carrying grlR-A+ cloned 
between HindIII and SalI sites (Figure 2.16, 2.17) 
This study 
 pSI03 Derivative of pSI01 in which grlA gene was 
removed, carrying grlR+A- between HindIII and 
SalI sites (Figure 2.16, 2.17) 
This study 
pRW902 Derivative of pRW50. DNA sequence of interest 
was cloned into the EcoRI-HindIII sites, immediate 
downstream of 5 LacI operators with two flanking 
target sites for SceI. Used to pull down the DNA 
sequences together with bound protein on it during 
DNA sampling (Tet
R
) (Figure 2.4) 
Butala et 
al. (2009) 
 
 LEE20-275/pRW902 Derivative of pRW902 carrying LEE20-275 
promoter fragment (Figure 2.18) between EcoRI 
and HindIII sites  
This study 
 LEE30-275/pRW902 Derivative of pRW902 carrying LEE30-275 
promoter fragment (Figure 2.18) between EcoRI 
and HindIII sites  
This study 
 LEE30-275 151T/ 
pRW902  
Derivative of pRW902 carrying LEE30-275 151T 
promoter fragment (Figure 2.18)  between EcoRI 
and HindIII sites  
This study 
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Table 2.2:  Plasmids used in this study (continued) 
 
  Plasmids Description References 
pJW15Δ100 Derivative of pJW15 (Williams et al., 1994) 
carrying melR promoter with truncated melR gene. 
Used to clone promoterless DNA fragments into 
NsiI-HindIII sites under the control of melR 
promoter (Amp
R
). (Figure 2.5) 
Wade et al. 
(2000) 
 pSI04 Derivative of pJW15Δ100 carrying ler gene as a 
NsiI-HindIII fragment under the control of melR 
promoter (Figure 2.19, 2.20) 
This study 
 pSI05 Derivative of pJW15Δ100 carrying pchC gene as a 
NsiI-HindIII fragment under the control of melR 
promoter (Figure 2.19, 2.20) 
This study 
 pSI06 Derivative of pJW15Δ100 carrying cesD gene as a 
NsiI-HindIII fragment under the control of melR 
promoter (Figure 2.19, 2.20) 
This study 
 pSI07 Derivative of pJW15Δ100 carrying cesT gene as a 
NsiI-HindIII fragment under the control of melR 
promoter (Figure 2.19, 2.20) 
This study 
 pSI08 Derivative of pJW15Δ100 carrying cesL as a NsiI-
HindIII fragment under the control of melR 
promoter (Figure 2.19, 2.20) 
This study 
pRW225 Derivative of pRW224, which allows cloning of 
promoter fragment in EcoRI-HindIII or EcoRI-
BamHI as translational fusion to lacZ (Tet
R
) 
(Figure 2.6) 
Kerry 
Hollands 
(unpublished) 
 LEE30-225/pRW225 Derivative of pRW225 carrying LEE30-275 
promoter fragment between EcoRI and BamHI 
sites (Figure 2.21) 
This study 
 LEE151/pRW225 Derivative of pRW225 carrying LEE151 fragment 
(Figure 2.22) between EcoRI and HindIII sites  
This study 
 LEE150/pRW225 Derivative of pRW225 carrying LEE150 fragment 
(Figure 2.22) between EcoRI and HindIII sites  
This study 
 LEE150-1/pRW225 Derivative of pRW225/LEE150 in which small 
ORF was replaced with KpnI site (Figure 2.23) 
This study 
pACBSR-DL1 Mutagenesis plasmid for use in DNA sampling 
(Cm
R
) (Figure 2.7) 
Butala et al. 
(2009) 
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Figure 2.1. Plasmid map of the lac fusion vector pRW224-U9. 
pRW224-U9 carries pUC9 linker between EcoRI and HindIII sites. It is a derivative of 
plasmid pRW50 (Lodge et al., 1992) from which trpBA has been removed and whose cloning 
site has been modified such that promoter fragments can be cloned as either transcription or 
translation fusions to lacZYA. The sequence of the cloning site is shown in the lower part. 
EcoRI-HindIII promoter fragments are cloned as transcription fusions, where translation of 
lacZ is directed by a translation initiation region (TIR), i.e., Shine-Dalgarno (SD) sequence 
and start codon. EcoRI-BamHI fragments are cloned as translation fusions to lacZ, and in this 
case, lacZ translation is initiated by the TIR on the cloned fragment.  
 
 
ATTCGCGAGAGCCTTGAGTCCACGCTAGATCTGAATTCCCGGGGATCCGTCGACCTGCAGCCAAGCTT 
 
AATGGAGCGAATTATGAGAGTTCTGGTTACCGCCAAGCTCCGGGATCCCGTCGTTTTACAACGTCGTG 
 
ACTGGGAAAACCCTGGCGTTACCCAACTTAATCGC 
EcoRI HindIII 
BamHI SD sequence lacZ 
pUC9 linker 
Translation initiation codon 
pRW224-U9 
trfB 
trfA 
tet
R
 
lacA 
lacY 
lacZ 
oriV 
EcoRI HindIII BamHI 
pRW224-U9 
15 kb 
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Figure 2.2. Plasmid map of pSR. 
pSR-TB10 carries an EcoRI-HindIII melR promoter fragment. EcoRI-HindIII promoter 
fragments are cloned upstream of the λ oop terminator. pSR is used in in vitro transcription 
reactions, in which transcription initiates at the cloned promoter and terminates at the λ 
terminator, to produce a discrete transcript of a defined length. Also shown are the RNA-I 
gene, which produces a control transcript during in vitro transcription, the ampicillin 
resistance gene (amp
R
), which produce ampicillin resistance marker (Amp
R
), and the origin of 
replication (ori). 
EcoRI (1) 
HindIII (158) 
ori 
RNA-I 
amp
R
 
pSR 
2.6 kb 
λ oop terminator 
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Figure 2.3. Plasmid map of pACYC184. 
pACYC184 is a small and low copy number E. coli plasmid. The cloning vector contains the 
replicon rep responsible for the replication of the plasmid. Also shown are tetracycline 
resistance gene (tet
R
), and chloramphenicol resistance gene (cm
R
). The plasmid contains 
single or multi-cleavage sites for a number of commonly employed site-specific 
endonucleases.  
 
 
 
 
 
 
cm
R
 
tet
R
 
rep 
HindIII    
(1524) 
  SalI  
(2146) 
NruI 
 (2467) 
pACYC184 
(4.25 Kb) 
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Figure 2.4. Plasmid map of pRW902. 
pRW902 carries an EcoRI-HindIII cka promoter region. EcoRI-HindIII promoter fragments 
are cloned immediately downstream of five lac operator sites with two flanking 18-bp target 
sites for the yeast meganuclease I-SceI. Also shown are reporter gene lacZ, the tetracycline 
resistance gene (tet
R
) and the origin of replication (oriV). 
 
 
lacZ 
lacY 
lacA 
tet
R
 
trfA 
trfB 
oriV 
pRW902 
17.6 kb 
EcoRI HindIII 
5 lacO SceI SceI 
cka promoter fragment 
trpBA 
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Figure 2.5. Plasmid map of pJW15Δ100. 
pJW15Δ100 is a pAA121 derivative multicopy plasmid carrying melR promoter. The plasmid 
contains a truncated melR gene (Δ1-100 nucleotides) between NsiI and HindIII sites. 
Promoterless genes of interest are cloned between NsiI and HindIII sites under the control of 
melR promoter. The ATG in NsiI site (5'-ATGCAT-3') is used as the translation start codon, 
therefore ATG start in the gene of interest is removed. Also shown are the ampicillin 
resistance gene (amp
R
), the galK gene and the origin of replication (ori). 
 
 
 
 
 
EcoRI 
pJW15 Δ1-100 HindIII 
galK 
melR  
(truncated) 
amp
R
 
ori 
pmelR 
NsiI 
SD  ATG start 
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ATTCGCGAGAGCCTTGAGTCCACGCTAGATCTGAATTCTGACCTGACGTACCGACCCCATATCGTGACGCCGCTG 
CTGTTGTACTAACCAAACAGGTTCCCCCTGCCATTCGCCGATTTGTAGTGCGCGCTGACCCACAAGATCGAAATT 
 
 
TGCCCGTTCGAAGCTTCCGGATCCCGTCGTTTTACAACGTCGTGACTGGGAAAACCCTGGCGTTACCCAACTTAA 
 
 
Figure 2.6. Plasmid map of the lac fusion vector pRW225. 
pRW225 is a derivative of pRW224, which allows cloning of EcoRI-HindIII promoter 
fragments as well as EcoRI-BamHI fragments as translation fusions to lacZ. The sequence of 
the cloning site is shown in the lower part. The plasmid carries a promoterless “stuffer” 
sequence between the EcoRI and HindIII sites. The plasmid was produced by cloning a 
promoterless EcoRI-BamHI fragment, derived from upstream of the rsd promoter and 
carrying a HindIII site, between the EcoRI and BamHI sites in pRW224. With the exception 
of the altered cloning site, pRW225 is identical to pRW224 (see Figure 2.1). 
 
 
 
EcoRI 
HindIII BamHI lacZ 
lacY 
trfA 
tet
R
 
lacA 
trfB 
lacZ 
oriV 
EcoRI (1) 
HindIII (128) 
 BamHI (136) 
pRW225-0 
15kb 
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Figure 2.7. Plasmid map of pACBSR-DL1. 
pACBSR-DL1 is used in DNA sampling experiment in which DNA fragment cloned between 
two SceI sites in pRW902 (Figure 2.4) are cut in vivo by I-SceI enzymes encoded by 
pACBSR-DL1. It is a derivative of pACBSR (Herring et al., 2003) in which the internal SphI-
SphI DNA fragment encoding the bacteriophage lambda Red genes (exo and bet genes) was 
replaced with a smaller SphI-SphI fragment encoding the Gam protein. It encodes I-SceI and 
the bacteriophage lambda Gam protein, under the control of an arabinose inducible araBAD 
promoter (para). The araC gene, which encodes an activator of araBAD, the chloramphenicol 
resistance gene (cm
R
) and the origin of replication (ori) are also indicated. 
araC 
para 
sceI 
gam 
cmR ori 
pACBSR-DL1 
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Molten 0.8% or 1.3% solutions of agarose in 1 x TAE buffer were cooled to approximately 
50°C and poured onto the surface of a glass plate or onto a gel-casting tray. A gel of about 2-3 
mm in thickness was made in this way. Sample wells, which could hold 10-100 µl samples, 
were created by placing a comb above the surface of the plate or the gel-casting tray. Once 
solidified, gel was immersed in 1 x TAE buffer in a horizontal electrophoresis tank. DNA 
samples for electrophoresis were mixed in a 1:1 ratio with DNA loading dye and loaded into 
the wells. The samples were run at 10 V/cm for 30 to 45 mins. Gels were stained in a solution 
of 0.5 µg/ml ethidium bromide for 20 mins, viewed and photographed under ultraviolet light 
of 300 nm using gel documentation system (Bio-Rad). However, to reduce the damage to 
DNA fragments, which were to be purified, gels were viewed under ultraviolet light of 360 
nm. 
 
2.5.2 Polyacrylamide gel electrophoresis of DNA 
Polyacrylamide gels were used to analyse DNA fragments of 50 to 1000 bp in length. 
Polyacrylamide gels contained 7.5% (w/v) stock acrylamide, 4% glycerol and 1 x TBE, and 
were polymerised by adding 0.01 volumes of 10% (w/v) ammonium persulphate (freshly 
made solution) and 0.001 volumes TEMED. Gels were cast between small glass plates (10x10 
cm) or large glass plates for fragment preparation (18x18 cm). Combs were inserted into the 
top of the gel to create sample wells. The gels were assembled into vertical electrophoresis 
apparatus. DNA samples for electrophoresis were mixed in a 1:1 ratio with DNA loading dye 
and loaded into the sample wells. Gels were run in 1 x TBE at 30-40 mA for 30 mins to 4 hrs, 
then stained in ethidium bromide solution and visualized under UV light as described in 
section 2.5.1.   
 
2.5.3 Sequencing polyacrylamide gel electrophoresis of DNA and RNA 
For analysis of DNA footprinting or in vitro transcription reactions, samples were run on thin 
denaturing 5.5-6% acrylamide sequencing gels (40 cm x 30 cm x 0.4 mm), prepared using the 
SequaGel sequencing system as described in the manufacturer‟s instructions. Gels were  
pre-run in 1 x TBE buffer at 60 W for approximately 1 hr prior to loading. DNA samples in 
loading buffer were heated to 90º for 2 mins before loading onto the gel. Gels were run in 1 x 
TBE buffer at 60 W for 2.5-3 hrs, fixed for 10 mins in a 10% methanol/ 10% acetic acid 
solution. Gels were transferred to Whatman filter paper and dried under vacuum at 80ºC for 
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30-40 mins. Dried gels were exposed to a Fuji Imaging Phosphor screen for 1 to 16 hrs, the 
phosphor screen was scanned using a Bio-Rad Molecular Imager FX and images were 
analysed using QuantityOne software (Bio-Rad). 
 
2.5.4 Denaturing gel electrophoresis of proteins  
During DNA-sampling and pull-down assays, proteins were separated and analysed using 
NuPAGE 12% Bis-Tris pre-cast gels (Invitrogen). Proteins were mixed with an equal volume 
of SDS-PAGE loading buffer. Samples were heated to 95°C for 5 mins, vortexed for 10 s, and 
centrifuged for 15 s at ~18000 x g, then loaded onto the gel.  Gels were run in 1 x MES SDS 
running buffer (Invitrogen) at 140 V for approximately 1 hr.  Gels were stained by incubating 
for 30 mins with agitation in Coomassie blue stain solution or by silver staining following 
SilverQuest™ Microwave Silver Staining Protocol (Invitrogen). 
 
2.6 Extraction and purification of DNA fragments 
2.6.1 Phenol/chloroform extraction of DNA 
In order to remove contaminating proteins, solutions of DNA were mixed with an equal 
volume of phenol/chloroform/isoamylalcohol solution, vortexed for 15 s and centrifuged for 3 
mins at ~18000 x g to separate the aqueous and organic phases. The DNA containing aqueous 
layer was transferred to a fresh eppendorf tube. An equal volume of water or TE buffer was 
then added to the remaining organic phase, which was then vortexed and centrifuged for 3 
mins at ~18000 x g. The aqueous layer was combined with that removed previously and 
concentrated by ethanol precipitation as detailed below. 
 
2.6.2 Ethanol precipitation of DNA 
Ethanol precipitation was used to concentrate DNA solutions and to allow transfer of DNA 
samples to a different buffer. 1/10 volume of 3 M sodium acetate (pH 5.2) and 2.5-3 volumes 
of ice-cold 100% ethanol were added to the DNA solution. For samples containing DNA 
fragments smaller than 500 bp, 1 µl 20 mg/ml
 
glycogen was also added. The samples were 
then incubated at -20°C for at least 30 mins and centrifuged for 15 mins at 4°C at ~18000 x g. 
The supernatant was removed; the pellet was washed with 1 ml ice-cold 70% ethanol and 
centrifuged for 10 mins at room temperature. The supernatant was removed and the pellet was 
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dried for 10-15 mins in a vacuum dryer. The dry pellet was resuspended in TE buffer, sterile 
distilled water or loading buffer, as indicated. 
 
2.6.3 Purification of DNA using QIAquick PCR purification kit  
DNA purification after PCR or restriction digestion reactions was carried out using the 
QIAquick PCR purification kit (Qiagen), following manufacturer‟s instructions. Purified 
DNA was eluted from QIAquick columns in 50 µl sterile distilled water. 
 
2.6.4. Extraction of DNA fragments from agarose gels 
DNA samples were mixed in 1:1 ratio with gel loading dye and run on 0.8%-1.3% agarose 
gels as described in section 2.5.1. DNA bands for extraction were excised from the gel and 
eluted using the QIAquick gel extraction kit (Qiagen) according to the manufacturer‟s 
instructions. Extracted DNA fragments were eluted from the QIAquick columns in 50 µl 
sterile distilled water.  
 
2.6.5 Electroelution of DNA fragments from polyacrylamide gels 
The process of electroelution (Maniatis et al., 1982) was used to purify DNA fragments after 
PCR, restriction digestion or other enzymatic modifications. DNA samples were mixed in a 
1:1 ratio with gel loading dye and run on a 7.5% polyacrylamide gel as described in section 
2.5.2. DNA bands for extraction were excised from the gel and placed into 6.3 mm dialysis 
tube (Medicell International Ltd.), sealed with clips and filled with 0.1 x TBE buffer. 
Electroelution was carried out at 30 mV for 20-30 mins. After that the buffer was removed 
from the dialysis bag and transferred to a microcentrifuge tube. The bag was rinsed out with 
100 µl sterile distilled water, which was also added to the microfuge tube. The DNA fragment 
was extracted from the buffer by phenol/chloroform extraction and ethanol precipitation 
method as described in sections 2.6.1 and 2.6.2. 
 
2.6.6 Sephadex G-50 spin columns 
Sephadex G-50 spin columns were used to remove unincorporated radioisotopes from radio 
labelled DNA fragment during in vitro footprinting or transcription assays. 5 g of Sephadex 
G-50 was autoclaved in 100 ml TE buffer and allowed to settle. Excess TE was decanted and 
a further 150 ml of fresh TE mixed with the Sephadex. The larger Sephadex particles were 
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allowed to settle for 5 mins, the TE buffer decanted and a further 150 ml added. This wash 
procedure was repeated a further two times to remove the under-sized particles of Sephadex, 
leaving a homogeneous G-50 suspension. The final TE wash was decanted and the particles 
resuspended in 100 ml fresh TE buffer (50% G-50 suspension) and stored at 4C. 
 
400 l of settled 50% G-50 suspension was added to Micro Bio-spin columns (Bio-Rad) and 
centrifuged for 2 mins at ~1300 x g to pack the column. 20 l of DNA sample (or one-tenth 
column volume) was applied to the top of the column, and the column assembly centrifuged 
for a further 2 mins at ~1300 x g. The purified DNA fragment that eluted during 
centrifugation was collected into a microcentrifuge tube. 
 
2.7 Isolation of chromosomal and plasmid DNA from bacteria 
2.7.1 Small-scale preparation of genomic DNA 
Genomic DNA was isolated in a small-scale from 1 ml overnight bacterial culture (A600 ≤ 4.0) 
using illustra bacteria genomicPrep Mini Spin Kit (GE Healthcare) following manufacturer‟s 
instruction. In brief, 1 ml overnight bacterial culture was pelleted and culture medium was 
removed. Cells were lysed by the detergent and salt in combination with Proteinase K to 
release genomic DNA into solution from bacterial cells. RNA was removed by RNase A. The 
genomic DNA was then bound onto a silica column in the presence of the chaotrope. Protein 
and other contaminants from membrane-bound genomic DNA were removed by using 
chaotropic salt. Ethanolic wash buffer was used to remove salts and other contaminants and 
dry the silica membrane at the same time. Finally, genomic DNA was eluted in 200µl low 
ionic strength buffer, collected in sterile microfuge tube and stored at -20ºC. 
 
2.7.2 Small-scale preparation of plasmid DNA (“mini-prep”)  
QIAprep Spin Miniprep kit (QIAGEN) was used to isolate plasmids from bacteria in  
small-scale following manufacturer‟s instructions. A brief outline of the protocol followed 
from the handbook provided with the kit is given below. A single bacterial colony from a 
freshly restreaked plate was used to inoculate 5 ml of LB containing appropriate antibiotic(s) 
in a 25 ml sterile flask. The culture was incubated aerobically overnight at 37C with vigorous 
shaking. Three 1.5 ml aliquots of this culture were transferred to microcentrifuge tubes and 
harvested by centrifugation at ~20000 x g for 1 min. The bacterial pellet was resuspended in 
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250 l Buffer P1 (RNase A solution was added to this solution prior to use). An aliquot of 
250 l of Buffer P2 was added and then the microfuge tube inverted 4-6 times. Immediately 
following this 350 l of Buffer N3 was added and the tubes were inverted 4-6 times as before. 
The tubes were then centrifuged at ~20000 x g for 10 mins until a white pellet had formed.  
 
The supernatant was then decanted into a QIAprep spin column. The column and collection 
tube were centrifuged for 60 s and the flow through discarded. The column was then washed 
by the addition of 0.5 ml Buffer PB and this was again centrifuged for 60 s. The QIAprep 
column was then washed by the addition of 0.75 ml Buffer PE and was centrifuged again. The 
flow through was once again discarded. The column was then centrifuged again to remove 
any final traces of PE Buffer. The QIAprep column was then placed in a clean 
microcentrifuge tube and 50 l (for high copy number plasmids) or 30 µl (for low copy 
number plasmids) of Buffer EB was added to the centre of the column. The tubes were then 
centrifuged one final time for 60 s at ~20000 x g to collect plasmid DNA. The isolated 
plasmid DNA was then stored at -20°C. 
 
2.7.3 Large-scale plasmid DNA preparation (“maxi-prep”)  
QIAfilter Plasmid Maxi Kit (QIAGEN) was used to prepare large scale plasmid DNA from 
bacterial cells according to the manufacturer‟s instruction. In brief, a single colony from a 
freshly restreaked selective plate was inoculated as a starter culture in 5 ml LB medium 
supplemented with appropriate antibiotic and incubated for approximately 8 hrs at 37°C with 
vigorous shaking. 100 ml LB medium supplemented with required antibiotic in a 500 ml flask 
was inoculated with 200 µl of starter culture (dilution 1/500) and incubated at 37°C for 16 hrs 
with vigorous shaking. 
 
Cultures were taken into two 50 ml falcon tubes and subjected to centrifugation at ~3400 x g 
for 30 mins at 4°C. Bacterial pellets were resuspended in resuspension buffer containing 
RNase A, lysed with NaOH/SDS and neutralized by potassium acetate. Cell debris, genomic 
DNA, protein and SDS were removed by filtration with QIAfilter cartridge and the lysates 
were passed through an anion-exchange resin by gravity flow under appropriate low salt and 
pH condition that helps bind the plasmid DNA to the resin. The plasmid DNA bound onto the 
resin were then washed with medium salt to remove contaminants (protein, RNA, or low 
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molecular weight impurities), eluted in a high salt buffer, concentrated and desalted by 
isopropanol and 70% ethanol precipitation and air-dried. Finally, purified plasmid DNA was 
redissolved in appropriate volume of TE buffer and stored at -20°C. 
 
2.8 Bacterial transformations 
2.8.1 Preparation of competent cells using the CaCl2 method 
50 ml LB was inoculated with 1 ml of an overnight culture of the strain to be transformed, 
and incubated at 37°C until the culture reached mid-logarithmic phase (OD650 = 0.4-0.6). The 
culture was then transferred to a sterile 50 ml Falcon tube, incubated on ice for 10 mins and 
subjected to centrifugation at ~2700 x g at 4°C. The pellet was then resuspended in 25 ml  
ice-cold 0.1 M CaCl2, incubated for 10 mins on ice, and the cells were harvested by 
centrifugation for 5 mins at ~2700 x g. Following removal of supernatant, the pellet was 
resuspended in 3.3 ml ice-cold buffer containing 0.1 M CaCl2 and 15% glycerol, and the cells 
were kept on ice for 24 hrs before use. For storage, each of 200 µl aliquots in sterile 
microfuge tube was stored at -70°C.  
 
2.8.2 Preparation of competent cells using the RbCl method 
The method was used to maximize the transformation efficiency of competent cells, needed 
for selection of hundreds of transformants during random mutagenesis. 100 ml LB in a 250 ml 
flask was inoculated with 1 ml of an overnight culture of the strain to be transformed, and 
incubated at 37°C until the culture reached mid-logarithmic phase (OD650 = 0.4-0.6). The 
culture was then transferred to 2 sterile 50 ml falcon tubes, kept on ice for 10 mins, and 
centrifuged for 5 mins at ~3400 x g at 4°C. Following removal of supernatant, contents of one 
tube was resuspended in ice-cold 40 ml (1/2.5 volume) of TFB1 (see section 2.2.3) buffer and 
transferred to the second tube and resuspended the cells. Cells were kept on ice for 10 mins 
and centrifuged ~3400 x g for 5 mins at 4°C. The pellet was resuspended in 4 ml (1/25 
volume) ice-cold TFB2 buffer (see section 2.2.3) and kept on ice for an hr. For storage, each 
of 200 µl aliquots in sterile microfuge tube was stored at -70°C. 
 
2.8.3 Transformation of competent cells with plasmid DNA  
50-100 µl competent cells were mixed with 1-3 µl plasmid DNA on ice, and incubated 45-60 
mins on ice. Cells were then heat-shocked at 42°C for 1 min and kept on ice for 2 mins. 1 ml 
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LB or SOC medium was added to the heat-shocked cells, and they were then incubated for 1 
hr at 37°C. After 1 min centrifugation at ~18000 x g, the pellet was resuspended in 
approximately 100 µl of the supernatant, plated onto nutrient agar or MacConkey agar 
supplemented with required antibiotic(s), and incubated overnight at 37°C. 
 
2.8.4 Transformation of bacterial cells using electroporation  
Cell preparation 
500 µl overnight cultures of bacterial cells were inoculated in 50 ml LB medium 
supplemented with appropriate antibiotics if necessary. When cells reach mid-exponential 
growth phase (OD650 = 0.5), they were collected in a 50 ml falcon tube and subjected to 
centrifugation at ~3400 x g at 4°C for 10 mins. Pellets were resuspended in ice-cold 25 ml of 
10% glycerol and the contents were centrifuged at ~3400 x g for 10 mins at 4°C. Pellets were 
resuspended in 1 ml of ice-cold 10% glycerol, transferred to a 1.5 ml eppendorf tube and 
centrifuged at ~18000 x g for 1 min. Following removal of supernatant, pellets were finally 
resuspended in 500 µl ice-cold 10% glycerol and kept on ice. 
 
Electroporation 
Prior to electroporation, SOC medium was preheated to 37°C, P1000 pipette was set to 1 ml 
and P100 to 40 µl, 1 mM cuvettes were placed on ice, electroporator was set to 1.8 kvolts, 
post-electroporation tubes were kept in a rack, and dry orbital shaker was turned on 37°C. 
Then 1 µl plasmid DNA to be transformed was transferred in a tube and placed on ice. 40 µl 
cells were added to the DNA on ice and mixed by pipetting up and down twice and 
immediately transferred to an electroporation cuvette and subjected to pulse in electroporator, 
immediately followed by addition of 1 ml of 37°C SOC. The content was transfer to a 1.5 ml 
tube and placed at 37°C in a heat block. When all the samples had been electroporated, the 
tubes were transferred to a rack and placed them in the dry orbital shaker with vigorous 
shaking for an hr. After 1 min centrifugation at ~18000 x g, the pellet was resuspended in 
approximately 100 µl of the supernatant, plated onto nutrient agar or MacConkey agar 
supplemented with required antibiotic(s), and incubated overnight at 37°C. 
 
2.9 Recombinant DNA techniques 
2.9.1 Routine PCR 
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Polymerase chain reaction (PCR) is used to amplify specific region of a DNA strand. It 
consists of a mixture of template DNA, two oligonucleotide primers, DNA polymerase and 
deoxynucleoside triphosphates (dNTPs). The two oligonucleotide primers are designed so that 
they anneal to complementary DNA strands, either side of the target DNA to be amplified, 
with their 3' ends facing towards each other. The PCR reaction amplifies DNA by cycling 
three different steps. The first step is denaturing step in which the double-stranded DNA 
template is denatured and separated to single stranded templates. The second step is an 
annealing step, which allows the primers to anneal to complementary sequences of the single 
-stranded DNA templates. The third step is an elongation step, which allows the DNA 
polymerase to synthesise complementary DNA strands from 3' end of each primer.  
 
PCR was carried out using Finnzymes‟ Phusion™ High-Fidelity DNA polymerase (New 
England BioLabs
®
 Inc.) or Biotaq polymerase (Bioline) in the buffer supplied with the 
relevant enzyme. Reaction conditions for different enzymes were optimised according to 
manufacturer‟s instructions. Phusion polymerase was routinely used for PCR throughout the 
study whilst Biotaq polymerase was used mainly for error-prone PCR. Phusion DNA 
polymerase enzyme possesses both 5'→3' DNA polymerase activity and 3'→5' exonuclease 
activity and thus it can clone the DNA fragment with more accuracy and speed. Optimum 
reaction conditions of this enzyme differ from standard enzyme protocols. PCR reactions 
were performed in a 50 µl reaction mix containing 10 µl of 5 x Phusion HF buffer containing 
1.5 mM MgCl2, 0.5 µM of each of the two primers , 0.8 mM dNTPs (200 µM each) (Bioline), 
10-50 ng of template DNA, 1 unit of enzyme and a suitable amount of sterile distilled water. 
DNA amplification was performed in an oil-free thermal cycler (GeneAmp
®
 PCR System, 
Applied Biosystems). PCR cycling conditions are shown in the Table 2.3.  
 
2.9.2 Colony PCR 
Colony PCR was used to amplify DNA fragments from the chromosome, to screen for 
chromosomal insertions/deletions and to check the presence of cloned inserts in plasmids.  
Template DNA was prepared by suspending one fresh colony in 100 µl sterile distilled water, 
heating the cell suspension to 100°C for 10 mins, and removing cell debris by centrifugation 
for 1 min at ~18000 × g.  10 µl template preparation was used in a 50 µl PCR as described in 
section 2.9.1. 
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Table 2.3:  PCR cycle 
 
Temperature Time Purpose 
98 °C 30 s “hot start” 
98 °C 10 s Melting 
TA °C 30 s          30-35 cycles Annealing  
72 °C X s  Extension 
72 °C 5 mins Final extension 
 
The table shows thermal profile of a PCR reaction using Phusion High Fidelity DNA 
polymerase. An annealing temperature (TA°C) of 3°C above the melting temperature (Tm) of 
the lower Tm primer was used.  The extension time (X s) was calculated based on PCR 
product length and complexity of the amplicon. For genomic DNA, X = 30 s/kb, whilst for 
plasmid DNA, X= 15 s/kb was used. 
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2.9.3 Error-prone PCR 
Error-prone PCR is a modification of a standard polymerase chain reaction method. It takes 
advantage of the inherently low fidelity of Taq DNA polymerase and thus introduces random 
mutations into a defined segment of a DNA. Taq DNA polymerase can misincorporate with a 
frequency as high as 0.02% per position (Eckert and Kunkel, 1991). The error rate can be 
further increased by skewing the relative dNTP concentrations and using a high concentration 
of Mg
2+
 in the reaction mix (Leung et al., 1989).  
 
Mutagenic or error-prone PCR reactions were performed in a 50 µl reaction mix containing 
final concentration of 1.5-5 mM MgCl2 (Bioline) , 1 µM each of the two oligos, 0.4-1.0 mM 
dNTPs (Bioline), ~ 10 ng of template DNA, 5 µl of 10 x NH4 buffer (no MgCl2), 1 unit of 
Biotaq polymerase (Bioline) and a suitable amount of sterile distilled water. DNA 
amplification was performed in an oil- free thermal cycler (GeneAmp
®
 PCR System, Applied 
Biosystems). The PCR profiles were: pre-amplification denaturation at 95°C for 5 mins, 
followed by 40 cycles of 10 s denaturation at 95°C, 1 min annealing at 60°C, and 2 mins 
extension at 74°C. After the last cycle, a final step of 5 mins at 74°C was added to allow 
complete extension of the all amplified fragments.  
 
2.9.4 Site directed mutagenic PCR 
Site directed mutagenic PCR was used to introduce point mutations in a DNA sequence of 
interest. To do this, a downstream or upstream oligonucleotide primer containing the desired 
base change together with an upstream or downstream primer were used to amplify the DNA 
fragment carrying desired mutations. A number of oligonucleotide primers used for site 
directed mutagenesis are listed in the Table 2.4. 
 
2.9.5 Megaprimer PCR 
Megaprimer PCR (Perrin and Gilliland, 1990), a polymerase chain reaction based method was 
used to introduce a desired mutation in an internal position, which was not adjacent to a 
suitable restriction site in a template DNA. This method involved two or more rounds of PCR 
that utilize two 'flanking' primers and one internal mutagenic primer containing the desired 
base substitution(s). The first PCR was performed using the mutagenic internal primer and the 
first flanking primer to amplify megaprimer with desired base change from template DNA 
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Table 2.4: DNA oligonucleotides used in this study (continued on pages 86-92) 
 
Name Sequence (5'-3') Use 
Oligonucleotides used for sequencing and PCR screening of inserts in plasmid vectors 
D10520 CCCTGCGGTGCCCCTCAA
C 
Anneals upstream of EcoRI site in pRW224 
or pRW225 or pRW902. Used for sequencing 
and amplification of inserts in these vectors 
D53463 GGGGGATGTGCTGCAAGG
CG 
Anneals within the lacZ coding sequence, 
downstream of the BamHI or HindIII site in 
pRW224, pRW225 or pRW902. Used for 
sequencing and amplification of inserts in 
these vectors 
D3407 GTAATACGACTCACTATA
GGGC 
Anneals upstream of NsiI site in pJW15Δ100. 
Used for sequencing and amplification of 
inserts in pJW15Δ100 
D4600 GTAGTCGGTGTGTTCAC Anneals downstream of HindIII site in 
pJW15Δ100. Used for sequencing of inserts 
in pJW15Δ100 
D63048 CTCTTCAAATGTAGCACC
TGAAG 
Anneals upstream of HindIII site in 
pACYC184. Used for sequencing and 
amplification of inserts in pACYC184 
D63049 GAAGACAGTCATAAGTGC
GGCGAC 
Anneals downstream of SalI site in 
pACYC184. Used for sequencing and 
amplification of inserts in pACYC184 
D5431 ACCTGACGTCTAAGAAAC
C 
Anneals upstream of EcoRI site in pSR. Used 
for sequencing and amplification of inserts in 
pSR 
D56033 AGCGTTCTG AACAAATC 
 
Anneals downstream of HindIII site in pSR. 
Used for sequencing and amplification of 
inserts in pSR 
Oligonucleotides used for deletion analysis of LEE1 operon regulatory region 
D61221 GCAGAATTCTGCACCCGT
TCCAGG 
Upstream primer for amplification of EcoRI 
-HindIII LEE10-568 fragment 
D61222 GCAAAGCTTGCTTTAATA
TTTTAAGC 
Downstream primer for amplification of 
EcoRI-HindIII LEE10-568 fragment 
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Table 2.4: DNA oligonucleotides used in this study (continued) 
 
Name Sequence (5'-3') Use 
D68822 GCAGAATTCAGAGAAACGCTTA
ACTAAAT 
Upstream primer used in PCR reaction 
with D61222 to produce EcoRI-HindIII 
LEE10-315 fragment 
D63949 GCAGAATTCCGTTTGTTAACGA
GATGATTTTCTTC 
Upstream primer used in PCR reaction 
with D61222 to produce EcoRI-HindIII 
LEE10-275 fragment 
D63948 GCAGAATTCTAAATGGATTTTA
AAAATATATG 
Upstream primer used in PCR reaction 
with D61222 to produce EcoRI-HindIII 
LEE10-235 fragment 
D64557 GCAGAATTCATGATTTTTTTGTT
GACA 
Upstream primer used in PCR reaction 
with D61222 to generate EcoRI-HindIII 
LEE10-215 fragment 
D68959 GCAGAATTCTTGACATTTAATGA
TAATGT 
Upstream primer used in PCR reaction 
with D61222 to generate EcoRI-HindIII 
LEE10-203 fragment 
D63947 GCAGAATTCTAATGATAATGTA
TTTTACACATTAG 
Upstream primer used in PCR reaction 
with D61222 to produce EcoRI-HindIII 
LEE10-195 fragment 
D63697 GCAGAATTCTAACATTTTAAGGT
GGTTGTTTGATG 
Upstream primer used in PCR reaction 
with D61222 to produce EcoRI-HindIII 
LEE10-155 fragment 
D63696 GCAGAATTCTAATTTGATAGAT
AAACGTTATCTCAC 
Upstream primer used in PCR reaction 
with D61222 to produce EcoRI-HindIII 
LEE10-115 fragment 
D63695 GCAGAATTCTTTGATTAATTGTT
GGTCCTTCCTG 
Upstream primer used in PCR reaction 
with D61222 to produce EcoRI-HindIII 
LEE10-75 fragment 
D64100 GCAAAGCTTATTCTCTTTTTTCT
AATG 
Downstream primer used in PCR 
reaction with D61221, D68822, D63949  
or D68959 to produce EcoRI-HindIII 
LEE20-568, LEE20-315, LEE20-275 or 
LEE20-203 fragments, respectively. 
Both D63949 and D64100 were also 
used in error-prone PCR reaction during 
random mutagenesis of LEE20-275 
fragment 
  
 
87 
Table 2.4: DNA oligonucleotides used in this study (continued) 
 
Name Sequence (5'-3') Use 
D64101 GCAAAGCTTTAGGACACATCT
ATTTCA 
Downstream primer used in PCR reaction 
with upstream D63949 primer to produce 
EcoRI-HindIII LEE30-275 fragment. 
Both D64101 and D63949 were also used 
in error-prone PCR reaction during 
random mutagenesis of LEE30 
-275 fragment 
Oligonucleotides used for deletion analysis of LEE2 operon regulatory region 
D62263 GCAGAATTCACGTAACAAAAA
CATTATTATC 
Upstream primer for amplification of 
EcoRI-HindIII LEE2-220 fragment. 
D62265 GCAAAGCTTTGATCTTTCTCCT
TTTGTC 
Downstream primer for amplification of 
EcoRI-HindIII LEE2-220 fragment 
D62264 GCAGAATTCCGTTTCTTTTAAC
TAAAAG 
Upstream primer used in PCR reaction 
with downstream D62265 to produce 
EcoRI-HindIII LEE2-125 fragment. 
D62865 GCAGAATTCCCCAATAATCTT
AAAAACTC 
Upstream primer used in PCR reaction 
with downstream D62265 to produce 
EcoRI-HindIII LEE2-100 fragment. 
Oligonucleotides  used for mutagenesis of LEE20-275 and LEE20-203 promoter 
fragments 
D64737 GCAAAGCTTATTCTCTTTTTTC
TAATGTGTAAAATACATTATC
ATTAAATGTDAACAAAAAAAT
C 
Downstream primer used in PCR reaction 
with D63949 to produce LEE20-275 75C 
D64736 GCAAAGCTTATTCTCTTTTTTC
TAATGTGTAAAATACATTATC
ATTAAATHTCAACAAAAAAAT
C 
Downstream primer used in PCR reaction 
with D63949 to produce LEE20-275 77A 
and LEE20-275 77G 
D65245 GCAAAGCTTATTCTCTTTTTTC
TAATGTGTAAATACATTATC 
Downstream primer used in PCR reaction 
with D63949 and D68959 to produce 
LEE20-275 Δ94T and LEE20-203 Δ94T, 
respectively 
D64735 GCAAAGCTTATTCTCTTTTTTC
TAATGTGTABAATACATTATC 
Downstream primer used in PCR reaction 
with D63949 to produce LEE20-275 96C 
or LEE20-275 96G 
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Table 2.4: DNA oligonucleotides used in this study (continued) 
 
Name Sequence (5'-3') Use 
D68520 GATAATGTATTTTCCA
CATTAGA 
Upstream primer used in PCR reaction with 
D53463 to produce megaprimer for construction of 
LEE20-275 98C and LEE20-203 98C 
D65244 GCAAAGCTTATTCTCT
TTTTTCTAATGTHTAA
AATACATTATC 
Downstream primer used in PCR reaction with 
D63949 to produce LEE20-275 99A and LEE20 
-275 99G  
D65243 GCAAAGCTTATTCTCT
TTTTTCTAATHTGTAA
AATACATTATC 
Downstream primer used in PCR reaction with 
D63949 to produce LEE20-275 101G 
D65242 GCAAAGCTTATTCTCT
TTTTTCTAAVGTGTAA
AATACATTATC 
Downstream primer used in PCR reaction with 
D63949 to produce LEE20-275 102C and LEE20 
-275 102G  
D69576 TTGACACTTAATGATA
AT 
Upstream primer used in PCR reaction with 
D64100 to produce megaprimer for construction of 
LEE20-203 79C 
D69715 TTGACATGTAATGATA
ATGTATT 
Upstream primer used in PCR reaction with 
D64100 to produce megaprimer for construction of 
LEE20-203 80G 
D68262 GACATTTAATGCTAAT
GTATTT 
Upstream primer used in PCR reaction with 
D64100 to produce megaprimer for construction of 
LEE20-203 86C 
D70042 TGACATTTAATGAAAA
TGTATTTTA 
Upstream primer used in PCR  reaction with 
D64100 to produce megaprimer for construction of 
LEE20-203 87A 
D68263 GACATTTAATGATCAT
GTATTTT 
Upstream primer used in PCR reaction with 
D64100 to produce megaprimer for construction of 
LEE20-203 88C 
D69717 TAATGATAATATATTT
TACACA 
Upstream primer used in PCR reaction with 
D53463 to produce megaprimer for construction of 
LEE20-203 91A 
D69323 TAATGATAATCTATTT
TACA 
Upstream primer used in PCR reaction with 
D64100 to produce megaprimer for construction of 
LEE20-203 91C 
D70041 TAATGATAATGAATTT
TACACA 
Upstream primer used in PCR reaction with 
D53463 to produce megaprimer for construction of 
LEE20-203 92A 
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Table 2.4: DNA oligonucleotides used in this study (continued) 
 
Name Sequence (5'-3') Use 
D69324 TGTATTTTACAGATTAG
AAAAAAGA 
Upstream primer used in PCR reaction with 
D54363 to produce megaprimer for construction 
of LEE20-203 101G 
D69325 ATTTTACACAATAGAAA
AAAGA 
Upstream primer used in PCR reaction with 
D54363 to produce megaprimer for construction 
LEE20-203 103A 
D69718 ATTTTACACATGAGAAA
AAAGAGAA 
Upstream primer used in PCR reaction with 
D53463 to produce megaprimer for construction 
of LEE20-203 104G 
D69894 TTGACATTAATGATAAT
GTATTTTACA 
Upstream primer used in PCR  reaction with 
D64100 to produce megaprimer for construction 
of LEE20-203 Δ79T 
D71441 TTGACATAATGATAATG
TATTTTACA 
Upstream primer used in PCR reaction with 
D64100 to produce megaprimer for construction 
of LEE20-203 Δ79/80 
D69893 TTGACATTTTAATGATA
ATGTATTTTACA 
Upstream primer used in PCR  reaction with 
D64100 to produce megaprimer for construction 
of LEE20-203 InsT (78-79) 
D68075 GCAAAGCTTATTCTCTT
TTTTCTAA 
Downstream primer used in PCR reaction with 
D68959 to generate LEE20-203 InsT (93-94) 
fragment with  pRW224 carrying LEE20-275 
InsT (93-94) as a template 
Oligonucleotides used for cloning grlRA and derivatives 
D62895 GCAAAGCTTTTTTACGT
TGTTACTCAATATTATT
AATCAG 
Upstream primer for amplification of HindIII-SalI 
grlR+A+ fragment 
D62897 GCAGTCGACCTAACTCT
CCTTTTTCCGCC 
Downstream primer for amplification of HindIII 
-SalI grlR+A+ fragment 
D63698 GCAGTCGACTCGACATA
AAAAACATAC 
Downstream primer used in PCR reaction with 
D62895 to generate HindIII-SalI grlR+A- 
fragment 
D63209 GCAGGATCCAATGCTAT
AGATGCCATC 
Downstream primer used in PCR reaction with 
D62895 to generate upstream BamHI DNA 
fragment for construction of an in-phase deleted 
mutant grlR-A+ 
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Table 2.4: DNA oligonucleotides used in this study (continued) 
 
Name Sequence (5'-3') Use 
D63210 
 
GCAGGATCCACAGGAATGC
CACAAGTT 
Upstream primer used in PCR reaction with 
D62897 to generate downstream BamHI 
DNA fragment for construction of in-phase 
deleted mutant grlR-A+. Both D63210 and 
D62897 were also used in error-prone PCR 
reaction to analyze GrlA-dependent 
activation by suppression genetics 
Oligonucleotides used for mutagenesis of grlA 
D71098 TCGGTATAAACGCGAGGA
GAGCATC 
Codes for LA substitution at codon 52 of grlA 
D71099 GTATAAACCTGGCGAGAG
CATCATTTA 
Codes for RA substitution at codon 53 of grlA 
D71100 GTATAAACCTGAGGGCAG
CATCATTTATTATAAC 
Codes for RA substitution at codon 54 of grlA 
D71101 GAGGAGAGCAGCATTTAT
TATAACT 
Codes for SA substitution at codon 56 of grlA 
D71102 GAGAGCATCAGCTATTAT
AACTTATATATC 
Codes for FA substitution at codon 57 of grlA 
D71103 AGCATCATTTGCTATAAC
TTATATATC 
Codes for IA substitution at codon 58 of grlA 
D71104 CATCATTTATTGCAACTT
ATATATC 
Codes for IA substitution at codon 59 of grlA 
D71105 CATTTATTATAGCTTATAT
ATCGAG 
Codes for TA substitution at codon 60 of grlA 
D71106 TATTATAACTGCTATATC
GAGAAGAAAAG 
Codes for YA substitution at codon 61 of grlA 
D71107 TATAACTTATGCATCGAG
AAGAAAAG 
Codes for IA substitution at codon 62 of grlA 
D71108 AACTTATATAGCGAGAAG
AAAAG 
Codes for SA substitution at codon 63 of grlA 
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Table 2.4: DNA oligonucleotides used in this study (continued) 
 
Name Sequence (5'-3') Use 
Oligonucleotides used for amplification of genes cloned into pJW15Δ100 
D61652 GCAATGCATCGGAGATTATTT
ATTATG 
Upstream primer containing NsiI site for 
amplification the ler gene 
D61223 GCAAAGCTTTTAAATATTTTTC
AGCGG 
Downstream primer containing HindIII 
site for amplification of the ler gene 
D61658 
 
GCAATGCATCTACATGATCAC
CTGGCAG 
Upstream primer containing NsiI site for 
amplification of pchC gene 
D61659 GCAAAGCTTTTAGCATTTTTTT
GACCG 
Downstream primer containing HindIII 
site for amplification of the pchC gene 
D64149 GCAATGCATAGCAGGAAATTT
AGCTCTC 
Upstream primer containing NsiI site for 
amplification of the cesD gene 
D64150 GCAAAGCTTTTACTCTGTATTA
CCTAAC 
Downstream primer containing HindIII 
site for amplification of the cesD gene 
D64151 GCAATGCATTCATCAAGATCT
GAACTTTTA 
Upstream primer containing NsiI site for 
cloning cesT gene 
D64152 GCAAAGCTTTTATCTTCCGGCG
TAATA 
Downstream primer containing HindIII 
site for amplification of cesT gene 
D65247 GCAATGCATAATCTTTTAGTTA
AAAGAAACG 
Upstream primer containing NsiI site for 
cloning cesL gene 
D65248 GCAAAGCTTTCATGATGTCATC
CTGCGAA 
Downstream primer containing NsiI site 
for cloning cesL gene 
Oligonucleotides used for amplification of promoter fragments cloned into pRW225 
D65474 GCAGGATCCCAAGCTTTAGGA
CACATC 
Downstream primer used in PCR 
reaction with D63949 to amplify EcoRI 
-BamHI LEE30-275 fragment 
D65812 GCAAAGCTTCATGCTTTAATAT
TTTAAGCT 
Downstream primer used in PCR 
reaction with D61221 containing 
HindIII site for amplification of LEE151 
D65811 GCAAAGCTTCATAATAAATAA
TCTCCG 
Downstream primer used in PCR 
reaction with D61221 containing 
HindIII site for amplification of LEE150 
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Table 2.4: DNA oligonucleotides used in this study (continued) 
 
Name Sequence (5'-3') Use 
Oligonucleotides  used for mutagenesis of LEE30-275 and LEE150 promoter fragments 
D65813 GGTGGTTGTTTGTTGAAA
TAGATGT 
Upstream primer used in PCR reaction with 
D53463 to produce megaprimer for 
construction of LEE30-275 144T fragment 
D65814 GTTTGATGAAATTGATGT
GTCCTAA 
Upstream primer used in PCR reaction with 
D53463 to produce megaprimer for 
construction of EE30-275 151T fragment 
D66032 GCAGGTACCAGATGTGTC
CTAATTTGATAG 
Upstream primer used in PCR reaction with 
D65811 to generate downstream KpnI fragment 
for construction of LEE150-1 fragment  
D66033 GCAGGTACCTCAAACAAC
CACCTTAAAATG 
Downstream primer used in PCR reaction with 
D61221 to generate upstream KpnI fragment 
for construction of LEE150-1 fragment 
D66176 TCTGGTACCTGAAACAAC
CAC 
Downstream primer used in PCR reaction 
together with D61221 to generate LEE150-1 
143C fragment. This oligo was also used with 
D10520 to produce megaprimer for 
construction of LEE30-275-1 143C fragment 
D66271 GTGGTTGTTTGAGGAAAT
AGATGTGT 
 
Upstream primer used in PCR reaction together 
with D65811 or D53463 to produce 
megaprimers for construction of LEE150 145G 
and LEE30-275 145G, respectively 
D66270 TAAGGTGGTTGTTTCAGG
AAATAGATGTGTC 
Upstream primer used in PCR reaction with 
D65811 or D53463 to produce megaprimers for 
construction of LEE150 143C 145G or LEE30 
-275 143C 145G, respectively 
D66870 GAAATATATGTGTCCTAA
AGCTT 
Upstream primer used in PCR reaction  with 
D53463 to produce megaprimer for 
construction of LEE30-275 152T fragment 
D67046 GTGGTTGTTTCATGAAAT
AGATG 
Upstream primer used in PCR reaction with 
D65811 or D53463 to produce megaprimers for 
construction of LEE150 143C or LEE30-275 
143C fragments, respectively 
 
Restriction sites incorporated in the oligos are underlined 
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containing the sequence of interest. The product of this first PCR, the 'megaprimer', was 
purified by electroelution from polyacrylamide gel (see section 2.6.5) and used, along with 
the second flanking primer, as a primer for a second round PCR. The  final PCR product that 
contained the desired mutation in the particular DNA sequence was purified using QIAquick 
PCR purification kit (Qiagen) or Qiagen gel extraction kit (see sections 2.6.3 and 2.6.4, 
respectively), double-digested with appropriate restriction enzymes as described below and 
cloned into the desired plasmid. The basic megaprimer procedure is shown schematically in 
Figure 2.8 and a list of mutagenic internal primers used during megaprimer PCR is shown in 
the Table 2.4. 
 
2.9.6 Restriction digestion of DNA  
50 µl DNA (purified PCR product or plasmid miniprep) was digested using 2 µl each 
restriction enzyme (all from New England BioLabs
®
 Inc.) in a final volume of 60 µl of the 
appropriate buffer, as determined using the New England Biolabs double digest finder 
(http://www.neb.com/nebecomm/DoubleDigestCalculator.asp). Restriction digests were 
incubated for 3 hrs at 37°C. Digested plasmid DNA for use in cloning was treated with 
alkaline phosphatase to remove terminal 5' phosphate groups, in order to prevent religation of 
vector DNA. Where this was required, 3µl calf alkaline phosphatase (CAP) (New England 
BioLabs
®
 Inc.) was added to the restriction digest mix after the 3 hrs incubation, and 
incubated for a further 1 hr at 37°C. Digested and CAP treated DNA was purified by PCR 
purification kit or agarose gel extraction kit or electroelution from 7.5% polyacrylamide gel 
(see sections 2.6.3- 2.6.5). 
  
2.9.7 Ligation 
Concentration of both vector and insert DNA was estimated by agarose gel electrophoresis 
along with molecular weight standards of a known concentration and tested various  
vector: insert DNA ratios in order to find the optimum ratio for a particular vector and insert. 
1:1 or 1:3 molar ratio of vector: insert DNA has been found to work well and used throughout 
the study. Ligation reactions were performed in a 20 µl reaction mix containing 1-3 µl 
restriction digested insert DNA, 3-6 µl digested and alkaline phosphate-treated vector DNA, 1 
µl T4 DNA ligase (New England BioLabs
®
 Inc.), 2 µl 10x T4 DNA ligase buffer and a 
suitable amount of sterile distilled water. Ligation mixes were incubated for 5 mins at room 
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Figure 2.8. Introduction of point mutations into EcoRI-HindIII promoter fragments by 
megaprimer PCR. 
A mutagenic primer, carrying the desired point mutation(s), was used together with the down 
stream flanking primer, to amplify a megaprimer by PCR from the plasmid carrying the 
promoter of interest. The megaprimer carrying the mutant(s) of interest was then used 
together with the upstream flanking primer, to generate a mutated EcoRI-HindIII promoter 
fragment, which was subsequently cloned into the plasmid. Note that if the position of the 
mutation(s) was closer to the EcoRI site, the megaprimer was synthesized using a mutagenic 
primer and the downstream flanking primer. The megaprimer was then used with the 
upstream primer, in a second round PCR to produce the mutated fragment. 
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temperature. 100 µl E. coli M182 competent cells were transformed with ligation mix. In 
order to select transformants, cells were plated onto nutrient agar or MacConkey agar 
supplemented with appropriate antibiotics. In order to screen candidate plasmids for the 
presence of an insert of the expected size, candidate transformants were grown overnight and 
plasmid minipreps were prepared from each. Plasmids were digested with appropriate 
restriction enzymes to excise the cloned fragment and run on 1.3% agarose gels or 7.5% 
PAGE gels (see sections 2.5.1, 2.5.2) to check for the presence of an insert of the expected 
size. As an alternative, primers which anneal to the plasmid either side of the insert site were 
used to screen candidates by colony PCR. Candidates testing positive for an insert were 
sequenced. 
 
2.9.8 Sequencing 
Plasmid-to-profile sequencing was carried out by the Functional Genomics and Proteomics 
Laboratory, University of Birmingham, UK. For sequencing of plasmid templates, 6.8 µl 
plasmid miniprep was mixed with 3.2 µl of 1 µM sequencing primer. For sequencing of PCR 
products, 3 µl purified PCR product was mixed with 3 µl of 1 µM sequencing primer and 4 µl 
of sterile distilled water. Primers used for sequencing inserts in plasmids are listed in Table 
2.4. 
 
2.10 Construction of pBAD-SG plasmid 
For DNA sampling experiment, pBAD-SG (Amp
R
) plasmid was constructed and used as an 
alternative of pACBSR-DL1 plasmid (Cm
R
) particularly when pSI02 (Cm
R
) was needed to 
co-transform in E. coli cells. The pBAD-SG was generated by introducing the sequence 
encoding both the SceI and the Gam proteins from pACBSR-DL1 to the MulI-EcoRI 
restriction sites in the pBAD plasmid (Guzman et al., 1995). The resulting plasmid  could 
encode I-SceI meganuclease and Gam protein, which are necessary to obtain discreate and 
stable DNA fragments in E. coli cells during DNA sampling experiment. 
 
The construction of pBAD-SG is shown schematically in Figure 2.9. The MluI-EcoRI insert 
fragment was derived by PCR from pACBSR-DL1 plasmid (Figure 2.7).  PCR was carried 
out using an upstream primer D70504 (5'-AAAAACGCGTAACAAAAGTGTCTATAATCA 
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Figure 2.9. Construction of plasmid pBAD-SG. 
Upstream primer D70504 that anneals upstream of sequence encoding SceI and downstream 
primer D70353 that anneals downstream of the sequence encoding Gam protein were used to 
amplify MluI-EcoRI fragment encoding SceI and Gam proteins using pACBSR-DL1 as 
template. Resulting fragment was digested with MluI-EcoRI restriction enzymes (M-E) and 
cloned into the MluI-EcoRI digested and dephosphorilated pBAD plasmid. The resulting 
plasmid is pBAD-SG containing sequences encoding SceI and Gam proteins under the control 
of an arabinose inducible araBAD promoter (para). 
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-3'), which anneals upstream of the sequence encoding SceI and a downstream primer D70353  
(5'-GACGAATTCGCCAAAACAGCCAAGCTTGC-3') that anneals downstream of the 
sequence encoding Gam protein. The PCR product was purified using the QIAquick PCR 
purification kit (see section 2.6.3), eluted in 50 µl sterile distilled water and digested using 
MluI and EcoRI. The MluI and EcoRI fragment was then purified by electroelution from a 
7.5% polyacrylamide gel (see section 2.6.5).  
 
To prepare pBAD vector DNA, pBAD/His was digested with MluI and EcoRI, treated with 
alkaline phosphatase and purified by phenol/chloroform extraction and ethanol precipitation 
(see sections 2.6.1, 2.6.2). The MluI and EcoRI insert fragment was ligated into pBAD, strain 
M182 was transformed with the ligation mix using the CaCl2 method, and transformants were 
selected on nutrient agar supplemented with ampicillin. Plasmids were isolated from 
candidate colonies, digested with both MluI and EcoRI restriction enzymes and run on 1.3% 
agarose gel to check inserts. Positive candidates were sequenced using primers D70504 and 
D70353. 
 
2.11 Cloning of promoter fragments and/or genes 
A full list of oligonucleotide primers used to amplify different DNA fragments is shown in 
Table 2.4. All the promoter fragments or target genes were amplified from the E. coli O157: 
Sakai genomic DNA by PCR. However, when nested or in-phase deletion derivatives or point 
mutations at a specific promoter fragment were made, the plasmid containing the starting 
promoter fragment was used as template. In most cases, PCR primers were designed such that 
the forward and reverse primers incorporate restriction enzyme sites upstream and 
downstream of the amplified target region, respectively. These restriction sites in the DNA 
fragments are specific to the restriction sites of plasmid DNA and facilitate the fragments to 
be cloned within the plasmid. 
 
2.11.1 Construction of pRW224 derivatives  
Vector DNA was prepared from plasmid pRW224-U9 (see plasmid detail in Figure 2.1). 
Miniprep plasmid DNA was digested with EcoRI and HindIII, treated with alkaline 
phosphatase and purified by phenol/chloroform extraction and ethanol precipitation method 
(see sections 2.6.1, 2.6.2). PCR amplified target DNA fragments were digested with the same 
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enzymes and purified using PCR purification kit or agarose gel extraction kit or electroelution 
from 7.5% polyacrylamide gel (see sections 2.6.3-2.6.5). Insert DNA was ligated into EcoRI 
-HindIII digested vector for 15 mins at room temperature. E. coli M182 competent cells were 
transformed with the ligation mix and transformants were selected for on MacConkey lactose 
agar supplemented with tetracycline. Screening of candidates for inserts was carried out by 
digesting plasmid DNA with EcoRI and HindIII. Positive candidates were sequenced using 
primers D10520 and/or D53463 which anneal to the plasmid DNA sequence flanking the 
insert site (Table 2.4). 
 
LEE1 operon regulatory region is located upstream of the ler gene. PCR was used to amplify 
the LEE10-568 fragment using the D61221 and D61222 oligos and genomic DNA from the 
O157:H7 Sakai 813 strain. This fragment carries the base sequence from position  
-568 to position -19 upstream of the functional ATG start codon of the ler gene (Yerushalmi 
et al., 2008). The DNA sequence of the LEE10-568 fragment is shown in the Figure 2.10. The 
fragment was designed with flanking EcoRI and HindIII sites respectively located upstream 
and downstream of the LEE1 regulatory region, with the HindIII site positioned such that the 
fragment excluded the ler gene SD sequence. The resulting product was restricted with EcoRI 
and HindIII and cloned into pRW224 (Figure 2.11).  
 
In order to determine the relative activity of LEE1 P1 and P2 promoters, different fragments 
in the LEE10 and LEE20 or LEE30 sets of nested deletions were made using primers listed in 
the Table 2.4. Each fragment is described by the location of its upstream end, in terms of the 
number of bases upstream from the functional ler ATG codon. DNA sequence of each of the 
nested deleted fragments is shown in Figure 2.10. All of these fragments were cloned into the 
EcoRI-HindIII sites of the pRW224 as transcription fusion to lacZ (Figure 2.11). The 
resulting plasmids are recorded in Table 2.2. 
 
To identify functional elements of the LEE1 P1 promoter or to determine the GrlA target site 
in the LEE1 promoter sequence, different mutations were introduced into the LEE20-275 and 
LEE20-203 fragments, respectively using error prone PCR (Leung et al., 1989), or by using 
megaprimer PCR (Perrin and Gilliland, 1990) as in Chismon et al. (2010). All the primers are 
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LEE10-568 
 
  
GAATTCTGCACCCGTTCCAGGTTAGTGCTGGCTGTAGCTTATGTCCGGGAAACAGCTAATAGATATATATACTCGTCATACTTCAAGTTGCATGTGCTGCGACTGCGTTCG 
 
 
CTTACCCCAATCACTTACTTATGTAAGCTCCTGGGGATTCACTCGCTTGCCGCCTTCCTGTAACTCGAATTAAGTAGAGTATAGTGAAACGGTTCAGCTTGGTTTTTATTC 
 
 
TGTTTTATTTGTTTATGCAATGAGATCTATCTTATAAAGAGAAACGCTTAACTAAATGGAAATGCAATTATTAAAGTCGTTTGTTAACGAGATGATTTTCTTCTATATCAT 
 
 
TGATTTTAAATGGATTTTAAAAATATATGATTTTTTTGTTGACATTTAATGATAATGTATTTTACACATTAGAAAAAAGAGAATAATAACATTTTAAGGTGGTTGTTTGAT 
                                       -35          P1         -10 
 
GAAATAGATGTGTCCTAATTTGATAGATAAACGTTATCTCACATAATTTATATCATTTGATTAATTGTTGGTCCTTCCTGATAAGGTCGCTAATAGCTTAAAATATTAAAG 
                                                         -35          P2          -10 
 
CAAGCTT 
 
 
LEE10-315 
 
GAATTCAGAGAAACGCTTAACTAAATGGAAATGCAATTATTAAAGTCGTTTGTTAACGAGATGATTTTCTTCTATATCATTGATTTTAAATGGATTTTAAAAATATATGAT 
 
 
TTTTTTGTTGACATTTAATGATAATGTATTTTACACATTAGAAAAAAGAGAATAATAACATTTTAAGGTGGTTGTTTGATGAAATAGATGTGTCCTAATTTGATAGATAAA 
        -35           P1        -10 
 
CGTTATCTCACATAATTTATATCATTTGATTAATTGTTGGTCCTTCCTGATAAGGTCGCTAATAGCTTAAAATATTAAAGCAAGCTT 
                          -35         P2           -10    
 
 
Figure 2.10. DNA sequences of the derivatives of LEE1 promoter regulatory region (continued on pages 100-103). 
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-19 
-315 
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LEE10-275 
 
 
GAATTCCGTTTGTTAACGAGATGATTTTCTTCTATATCATTGATTTTAAATGGATTTTAAAAATATATGATTTTTTTGTTGACATTTAATGATAATGTATTTTACACATTA 
                                                                               -35           P1        -10 
 
GAAAAAAGAGAATAATAACATTTTAAGGTGGTTGTTTGATGAAATAGATGTGTCCTAATTTGATAGATAAACGTTATCTCACATAATTTATATCATTTGATTAATTGTTGG 
                                                                                                 -35       P2 
 
TCCTTCCTGATAAGGTCGCTAATAGCTTAAAATATTAAAGCAAGCTT 
            -10                           
 
LEE10-235 
 
 
GAATTCTAAATGGATTTTAAAAATATATGATTTTTTTGTTGACATTTAATGATAATGTATTTTACACATTAGAAAAAAGAGAATAATAACATTTTAAGGTGGTTGTTTGAT 
                                       -35          P2         -10 
 
GAAATAGATGTGTCCTAATTTGATAGATAAACGTTATCTCACATAATTTATATCATTTGATTAATTGTTGGTCCTTCCTGATAAGGTCGCTAATAGCTTAAAATATTAAAG 
                                                         -35           P2         -10  
 
CAAGCTT 
 
 
LEE10-215 
 
 
GAATTCATGATTTTTTTGTTGACATTTAATGATAATGTATTTTACACATTAGAAAAAAGAGAATAATAACATTTTAAGGTGGTTGTTTGATGAAATAGATGTGTCCTAATT 
                   -35          P2         -10 
 
TGATAGATAAACGTTATCTCACATAATTTATATCATTTGATTAATTGTTGGTCCTTCCTGATAAGGTCGCTAATAGCTTAAAATATTAAAGCAAGCTT 
                                     -35          P2          -10       
 
 
Figure 2.10. DNA sequences of the derivatives of LEE1 promoter regulatory region (continued). 
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-215 
-275 
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LEE10-203 
 
        
GAATTCTTGACATTTAATGATAATGTATTTTACACATTAGAAAAAAGAGAATAATAACATTTTAAGGTGGTTGTTTGATGAAATAGATGTGTCCTAATTTGATAGATAAAC 
       -35          P1         -10 
 
GTTATCTCACATAATTTATATCATTTGATTAATTGTTGGTCCTTCCTGATAAGGTCGCTAATAGCTTAAAATATTAAAGCAAGCTT 
                         -35           P2         -10      
 
LEE10-195    
 
                                       
GAATTCTAATGATAATGTATTTTACACATTAGAAAAAAGAGAATAATAACATTTTAAGGTGGTTGTTTGATGAAATAGATGTGTCCTAATTTGATAGATAAACGTTATCTC 
 
 
ACATAATTTATATCATTTGATTAATTGTTGGTCCTTCCTGATAAGGTCGCTAATAGCTTAAAATATTAAAGCAAGCTT 
                 -35         P2           -10                           
 
LEE10-155    
 
                                                                               
GAATTCTAACATTTTAAGGTGGTTGTTTGATGAAATAGATGTGTCCTAATTTGATAGATAAACGTTATCTCACATAATTTATATCATTTGATTAATTGTTGGTCCTTCCTG 
                                                                                        -35          P2 
 
ATAAGGTCGCTAATAGCTTAAAATATTAAAGCAAGCTT 
  -10                            
 
 
LEE10-115 
 
 
GAATTCTAATTTGATAGATAAACGTTATCTCACATAATTTATATCATTTGATTAATTGTTGGTCCTTCCTGATAAGGTCGCTAATAGCTTAAAATATTAAAGCAAGCTT 
 
 
Figure 2.10. DNA sequences of the derivatives of LEE1 promoter regulatory region (continued). 
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LEE10-75 
 
 
GAATTCTTTGATTAATTGTTGGTCCTTCCTGATAAGGTCGCTAATAGCTTAAAATATTAAAGCAAGCTT 
        -35        P2            -10                           
 
 
LEE20-568 
 
 
GAATTCTGCACCCGTTCCAGGTTAGTGCTGGCTGTAGCTTATGTCCGGGAAACAGCTAATAGATATATATACTCGTCATACTTCAAGTTGCATGTGCTGCGACTGCGTTCG 
 
 
CTTACCCCAATCACTTACTTATGTAAGCTCCTGGGGATTCACTCGCTTGCCGCCTTCCTGTAACTCGAATTAAGTAGAGTATAGTGAAACGGTTCAGCTTGGTTTTTATTC 
 
 
TGTTTTATTTGTTTATGCAATGAGATCTATCTTATAAAGAGAAACGCTTAACTAAATGGAAATGCAATTATTAAAGTCGTTTGTTAACGAGATGATTTTCTTCTATATCAT 
 
 
TGATTTTAAATGGATTTTAAAAATATATGATTTTTTTGTTGACATTTAATGATAATGTATTTTACACATTAGAAAAAAGAGAATAAGCTT 
                                       -35         P1          -10 
 
LEE20-315 
 
 
GAATTCAGAGAAACGCTTAACTAAATGGAAATGCAATTATTAAAGTCGTTTGTTAACGAGATGATTTTCTTCTATATCATTGATTTTAAATGGATTTTAAAAATATATGAT 
 
 
TTTTTTGTTGACATTTAATGATAATGTATTTTACACATTAGAAAAAAGAGAATAAGCTT 
        -35        P2           -10         
 
 
Figure 2.10. DNA sequences of the derivatives of LEE1 promoter regulatory region (continued). 
-19 -75 
-315 
-158 
-158 
-568 
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LEE20-275 
 
 
GAATTCCGTTTGTTAACGAGATGATTTTCTTCTATATCATTGATTTTAAATGGATTTTAAAAATATATGATTTTTTTGTTGACATTTAATGATAATGTATTTTACACATTA 
                                                                               -35           P1        -10 
                                                                                
GAAAAAAGAGAATAAGCTT 
 
LEE20-203 
 
 
GAATTCTTGACATTTAATGATAATGTATTTTACACATTAGAAAAAAGAGAATAAGCTT 
       -35          P2         -10 
 
LEE30-275 
 
 
GAATTCCGTTTGTTAACGAGATGATTTTCTTCTATATCATTGATTTTAAATGGATTTTAAAAATATATGATTTTTTTGTTGACATTTAATGATAATGTATTTTACACATTA 
                                                                               -35         P1          -10 
 
GAAAAAAGAGAATAATAACATTTTAAGGTGGTTGTTTGATGAAATAGATGTGTCCTAAAGCTT   
 
 
 
Figure 2.10. DNA sequences of the derivatives of LEE1 promoter regulatory region (continued). 
The figure shows the DNA sequences of different nested deleted fragments of LEE1 regulatory region. EcoRI and HindIII sites are red 
coloured. Predicted P1 promoter -35 and -10 elements are boxed and predicted P2 promoter -35 and -10 elements are underlined 
(Sperandio et al., 2002). The coordinates of the upstream and downstream end of each fragment refer to the number of base pairs upstream 
from the functional ATG start codon of the ler gene reported by Yerushalmi et al. (2008). 
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Figure 2.11. Nested deletions of the LEE1 promoter regulatory region.  
The upper line shows the organisation of the different LEE transcription units. The lower part shows 
an expanded sketch of the LEE1 regulatory region and illustrates the LEE10-568 fragment and nested 
deleted derivatives cloned into the EcoRI-HindIII sites (E-H) of pRW224 lac expression vector (see 
plasmid detail in Figure 2.1). The locations of the two LEE1 regulatory region promoters P1 and P2 
are indicated. The coordinates of the upstream and downstream end of each fragment refer to the 
number of base pairs upstream from the functional ATG start codon of the ler gene reported by 
Yerushalmi et al. (2008). 
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listed in Table 2.4. The different bases at the LEE1 P1 promoter in the LEE20-275 fragment 
are numbered 1-118, as shown in Figure 3.3. This numbering system was used to describe 
different P1 promoter mutations, in both the LEE20-275 and LEE20-203 fragments (Figure 
3.3, 3.11). Note that the customary convention of numbering bases with respect to the 
transcript start point was not followed because of uncertainty about its location. 
 
In order to understand regulation of expression from LEE2 promoter, different LEE2 operon 
regulatory region fragments were cloned into pRW224. Each fragment is described by the 
location of its upstream end, in terms of the number of bases upstream from the transcription 
start site reported by Mellies et al. (1999) (Figure 2.12). Primers used for amplification of the 
LEE2 operon regulatory region are listed in the Table 2.4. LEE2-220 (-220 to +109) fragment 
was PCR amplified using primers D62263 and D62265 and genomic DNA of Sakai: O157 as 
template. The resulting product was restricted with EcoRI and HindIII, and cloned into 
pRW224. Two nested deletions were made of starting fragment LEE2-220. LEE2-125 (-125 
to +109) was amplified using LEE2-220/pRW224 as template and primers D62865 and 
D62265. The resulting product was EcoRI-HindIII digested and cloned into pRW224 to give 
LEE2-125/pRW224. LEE2-100 (-100 to +109) fragment was made using LEE2-125/pRW224 
as template and primers D62264 and D62265 (Figure 2.13, Table 2.2). 
 
2.11.2 Construction of pSR derivatives 
The cloning vector pSR was used to clone promoter fragments for in vitro KMnO4 
footprinting and transcription assays. Plasmid miniprep DNA was digested with EcoRI and 
HindIII, treated with alkaline phosphatase and purified by gel extraction from a 0.8% agarose 
gel. PCR amplified target promoter fragments were digested with the same enzymes and 
extracted from 1.3% agarose gel. EcoRI-HindIII promoter fragments were then ligated into 
the EcoRI-HindIII digested pSR vectors for 15 mins at room temperature and E. coli M182 
competent cells were transformed with the ligation mix. Cells were plated onto nutrient agar 
supplemented with ampicillin and incubated overnight at 37°C to select for transformants. 
Candidates were screened for the presence of an insert of the expected size by restriction 
digestion with EcoRI and HindIII, and candidate plasmids testing positive for an insert were 
sequenced using primers D5431 and/or D56033, which anneal up or downstream of the insert 
site, respectively (Table 2.4). 
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LEE2-220 
 
 
GAATTCACGTAACAAAAACATTATTATCAATTATTTCAATAAAAAAAGAAAACCCATTAAAATCAATTTCAACACGGTTATCAAATAAATAAAAATCATTTCCCAATAATC 
 
 
TTAAAAACTCTTCAACGTTTCTTTTAACTAAAAGATTCATCTGCAGGCTCTGAAGTAAGTATACGTGTGAATATTATTGCTTGAAAAAGCGTATTGGATAATATATACAGT 
 
 
ATATGTACTTTATGTACATTGCAACTATTTAAATAATATAATAGTTGCCTATGGGATAATTTGGTTATTTATAACCAGGTAAATGTCTAAATTAGACAAAAGGAGAAAGAT 
 
 
CAAAGCTT 
 
 
LEE2-125 
 
 
GAATTCCCCAATAATCTTAAAAACTCTTCAACGTTTCTTTTAACTAAAAGATTCATCTGCAGGCTCTGAAGTAAGTATACGTGTGAATATTATTGCTTGAAAAAGCGTATT 
 
 
GGATAATATATACAGTATATGTACTTTATGTACATTGCAACTATTTAAATAATATAATAGTTGCCTATGGGATAATTTGGTTATTTATAACCAGGTAAATGTCTAAATTAG 
 
 
ACAAAAGGAGAAAGATCAAAGCTT                                                                                                        
                                                                                                            
LEE2-100 
 
 
GAATTCCGTTTCTTTTAACTAAAAGATTCATCTGCAGGCTCTGAAGTAAGTATACGTGTGAATATTATTGCTTGAAAAAGCGTATTGGATAATATATACAGTATATGTACT 
 
 
TTATGTACATTGCAACTATTTAAATAATATAATAGTTGCCTATGGGATAATTTGGTTATTTATAACCAGGTAAATGTCTAAATTAGACAAAAGGAGAAAGATCAAAGCTT 
 
Figure 2.12. DNA sequences of the LEE2 promoter regulatory region. 
EcoRI and HindIII sites are coloured red. Predicted -35 and -10 promoter elements are boxed and transcription start site is indicated by bent arrow 
(Mellies et al., 1999). Nucleotide positions are numbered with respect to the transcription start site. Starting with LEE2-220 fragment, LEE2-125 and 
LEE2-100 were generated by deletion of upstream sequences from positions -125 and -100, respectively.   
-220 
+109 
+109 
+100 
+109 
+125 
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Figure 2.13. Nested deletions of the LEE2 promoter regulatory region. 
The upper line shows the organisation of the different LEE transcription units. The lower part 
shows an expanded sketch of the LEE2 regulatory region and illustrates the LEE2-220 
fragment and nested deleted derivatives cloned into the EcoRI-HindIII sites (E-H) of pRW224 
lac expression vector (see plasmid detail in Figure 2.1). The coordinates of the upstream and 
downstream end of each fragment refer to the number of base pairs upstream and downstream 
from the transcription start point (Mellies et al., 1999). Predicted promoter -35 and -10 
elements are shown by black boxes and transcription star site are indicated by bent arrow. 
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For both in vitro KMnO4 footprinting analysis and in vitro transcription assays, LEE20-275 
and two derivatives such as LEE20-275 98C and LEE20-275 98C 64G (Figure 2.14) were 
cloned into EcoRI-HindIII sites of pSR. Fragments were amplified from pRW224 containing 
LEE20-275 or LEE20-275 98C or LEE20-275 98C 64G using primers D63949 and D64100 
and cloned into EcoRI-HindIII sites of pSR resulting in plasmids LEE20-275/pSR, LEE20 
-275 98C/pSR and LEE20-275 98C 64G/pSR, respectively (Table 2.2). Linear fragments 
were produced following PstI and BamHI restriction digestion during performing both in vitro 
KMnO4 footprinting analysis and in vitro transcription assays (Figure 2.15). 
 
2.11.3 Construction of pACYC184 derivatives 
Vector DNA was prepared from pACYC184 plasmid (see plasmid detail in Figure 2.3). 
Plasmid miniprep DNA was digested sequentially using HindIII and SalI restriction enzymes, 
treated with alkaline phosphatase and purified by phenol/chloroform extraction and ethanol 
precipitation method (see section 2.6). PCR amplified target DNA fragments were digested 
with the same enzymes and extracted from 1.3% agarose gel. Insert DNA was ligated into 
HindIII-SalI digested pACYC184 vector for 15 mins at room temperature. E. coli M182 
competent cells were transformed with the ligation mix and transformants were selected for 
on nutrient agar supplemented with chloramphenicol. Screening of candidates for an insert 
was carried out by digesting plasmid DNA with HindIII and SalI. Positive candidates were 
sequenced using primers D63048 and D63049, which anneal up- and downstream of the insert 
site, respectively (Table 2.4).  
 
In order to determine the effect of GrlR/GrlA on the activity of the LEE1 promoter, the grlRA 
operon and derivatives were cloned into pACYC184. The DNA sequence of grlRA operon is 
shown in Figure 2.16. Maps of grlRA operon and the derivatives generated upon it by deletion 
mutation are shown in Figure 2.17. PCR was used to amplify a HindIII-SalI fragment carrying 
the grlRA operon using the D62895 and D62897 oligos (Table 2.4) and genomic DNA from 
the O157:H7 Sakai 813 strain. The resulting product was restricted with HindIII and SalI and 
cloned into pACYC184 to give pSI01 (Table 2.2). To construct pSI02, which is a derivative 
of pSI01 carrying a large in-frame deletion in grlR, PCR amplification was done using 
primers D63209 and D63210 (Table 2.4) and pSI01 as a template. The resulting product was 
cut with BamHI and circularised by ligation to give pSI02 (Table 2.2). To construct pSI03, 
  
 
109 
LEE20-275 
 
 
GAATTCCGTTTGTTAACGAGATGATTTTCTTCTATATCATTGATTTTAAATGGATTTTAAAAATATATGATTTTTTTGTTGACATTTAATGATAATGTATTTTACACATTA 
                                                                               -35           P1        -10 
                                                                                
GAAAAAAGAGAATAAGCTT 
 
LEE20-275 98C 
 
 
GAATTCCGTTTGTTAACGAGATGATTTTCTTCTATATCATTGATTTTAAATGGATTTTAAAAATATATGATTTTTTTGTTGACATTTAATGATAATGTATTTTACACATTA 
                                                                               -35           P1          -10 
                                                                                
GAAAAAAGAGAATAAGCTT 
 
 
LEE20-275 98C 64G  
 
 
GAATTCCGTTTGTTAACGAGATGATTTTCTTCTATATCATTGATTTTAAATGGATTTTAAAAATATATGATTTTTTTGTTGACATTTAATGATAATGTATTTTACACATTA 
                                                                               -35           P1          -10 
                                                                                
GAAAAAAGAGAATAAGCTT 
 
Figure 2.14. DNA sequences of the LEE20-275 promoter fragment and derivatives.  
EcoRI and HindIII sites are red coloured. Nucleotide positions are numbered, 1-120, starting with the first cloned LEE1 regulatory region 
base (that is 275 base pairs upstream from the ler translation start codon). Base substitution at 98 position in LEE20-275 98C fragment and 
substitutions at 64 and 98 positions in LEE20-275 98C 64G are indicated by the arrows. 
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Figure 2.15. Construction of pSR derivatives and preparation of PstI-BamHI fragments. 
EcoRI-HindIII promoter fragments such as LEE20-275, LEE20-275 98C and LEE20-275 98C 
64G were cloned into upstream of the λ oop terminator site of a multicopy plasmid pSR. 
Plasmids containing the promoter fragments were digested with BamHI, dephosphorylated, 
purified and digested with PstI to get PstI-BamHI fragments. The fragments contain a λ oop 
terminator downstream of the cloned promoters. These fragments were used for in vitro 
KMnO4 footprinting and transcription assays. Transcription initiates at the cloned promoter 
and terminates at the λ oop terminator, and thus produces transcripts of defined lengths. 
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AAGCTTTTTTACGTTGTTACTCAATATTATTAATCAGAAATTACATATGTTAACCAGGGAAACAGCAGGTTGAAACATGAGTATATTTAATGATATATTACATTGCAATCT 
 
                                                                                          grlR 
GGAGAAAAAGAAAGGTCTCCATTATTCTTGATATTGCTTATGGATAGAACAAATTGAAAGGAGTGAGGTTAGTATGAAACTGAGTGAGTTATGATTATGAAGGATGGCATC 
 
 
TATAGCATTATATTTATTAGCAATGAAGACTCCTGTGGGGAAGGTATACTGATTAAAAATGGAAATATGATCACTGGCGGCGATATTGCTTCTGTGTATCAGGGGGTCCTC 
 
 
TCTGAAGATGAGGACATCATACTTCATGTCCATCGATATAATTACGAAATTCCCTCGGTGCTAAACATTGAACAAGATTATCAATTAGTTATCCCTAAAAAAGTACTGAGT 
 
 
AATGATAATAATCTCACATTACATTGCCATGTAAGAGGAAATGAAAAATTGTTTGTTGATGTTTATGCCAAATTTATAGAACCATTAGTTATTAAAAACACAGGAATGCCA 
  
            grlR/stop                                                  grlA 
CAAGTTTATTTAAAATAATTTTATGTATGTTTTTTATGTCGATTTATTTATCAAATAAAAAGAATATGGAAAATGGAATCTAAAAATAAAAATGGCGACTATGTAATTCCT 
 
 
GACTCAGTAAAGAATTACGATGGTGAACCTCTGTATATCTTGGTTTCTCTTTGGTGTAAATTGCAGGAGAAATGGATTTCTCGCAATGATATTGCCGAAGCATTCGGTATA 
 
 
AACCTGAGGAGAGCATCATTTATTATAACTTATATATCGAGAAGAAAAGAAAAAATTTCATTTCGTGTCAGATATGTTAGTTATGGTAATTTGCATTATAAGCGCCTTGAG 
 
 
ATTTTCATTTATGATGTTAACCTTGAGGCGGTTCCGATAGAAAGTCCTGGAACAACCGGACCAAAAAGAAAAACCTACCGAGTTGGTAATGGTATTGTGGGACAGTCTAAT 
 
                                      grlA/stop 
ATCTGGAACGAAATGATCATGAGGCGGAAAAAGGAGAGTTAGGTCGAC 
 
 
Figure 2.16. DNA sequence of the grlRA operon.  
HindIII-SalI restriction sites are underlined. Predicted promoter -35 and -10 elements are boxed and transcription start site is indicated by a 
bent arrow (Mellies et al., 1999). Shown that grlR (red coloured sequence) and grlA (grey shaded sequence) genes are separated by a short 
intergenic DNA sequence (blue coloured sequence). Predicted start and stop codons of grlR and grlA genes are indicated. The grlR base 
sequence that is shaded yellow was deleted to give grlR-A+ derivative (see Figure 2.17). 
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Figure 2.17. Schematic representation of construction of recombinant plasmids pSI01, pSI02 
and pSI03. 
(A) grlRA operon was amplified from E. coli 0157: Sakai chromosome digested and cloned into 
pACYC184 resulting in pSI01 (GrlR+A+).  
(B) An in-phase deletion in the grlR gene of grlRA operon leads to the excision of most part of the 
gene (BamHI deletion of 312 bp), which results in pSI02 (GrlR-A+).  
(C) Amplification of grlR gene with its regulatory sequence and cloning it into the pACYC184 
resulting in pSI03 (GrlR+A-). H, S and B represent HindIII, SalI and BamHI, respectively. 
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which is a derivative of pSI01 deleted for grlA, primers D62895 and D63698 (Table 2.4) and 
pSI01 as a template were used for amplification. The resulting product was restricted with 
HindIII and SalI and cloned into pACYC184 to give pSI03 (Table 2.2). 
 
2.11.4 Construction of pRW902 derivatives 
Vector DNA was prepared from pRW902 plasmid. Plasmid miniprep DNA was double 
digested using EcoRI and HindIII restriction enzymes, treated with alkaline phosphatase and 
purified by phenol/chloroform extraction and ethanol precipitation method (see section 2.6).  
PCR amplified target DNA fragments were digested with the same enzymes and extracted 
from 1.3% agarose gel.  Insert DNA was ligated into EcoRI-HindIII digested pRW902 vector 
for 15 mins at room temperature. E. coli M182 competent cells were transformed with the 
ligation mix and transformants were selected for on MacConkey lactose indicator plate 
supplemented with tetracycline. Screening of candidates for an insert was carried out by 
digesting plasmid DNA with EcoRI-HindIII. Positive candidates were sequenced using 
primers D10520, which anneal to the plasmid DNA sequence flanking the insert site (Table 
2.4). 
 
For DNA-sampling experiments, three fragments for example, LEE20-275, LEE30-275 and 
LEE30-275 151T (Figure 2.18) were cloned into pRW902. LEE20-275 fragment was PCR 
amplified using D63949 and D64100 primer pair (Table 2.4) from LEE20-275/pRW224 
plasmid DNA. LEE30-275 and LEE30-275 151T fragments were PCR amplified from  
LEE30-275/pRW224 and LEE30-275 151T/pRW224 plasmid DNA, respectively using 
D63949 and D64101 or D63949 and D53463 primer pairs, respectively (Table 2.4). The 
fragments were double digested with EcoRI-HindIII and cloned into the EcoRI-HindIII sites 
of the vector pRW902 (Figure 2.4, Table 2.2). 
 
2.11.5 Construction of pJW15Δ100 derivatives 
Vector DNA was prepared from pJW15Δ100 plasmid (see plasmid detail in Figure 2.5). 
Plasmid miniprep DNA was digested with NsiI and HindIII restriction enzymes, treated with 
alkaline phosphatase and purified by phenol/chloroform extraction and ethanol precipitation 
method (see section 2.6). PCR amplified target DNA fragments were digested with the same 
enzymes and extracted from 1.3% agarose gel. Insert DNA was ligated into NsiI-HindIII  
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LEE20-275 
 
 
GAATTCCGTTTGTTAACGAGATGATTTTCTTCTATATCATTGATTTTAAATGGATTTTAAAAATATATGATTTTTTTGTTGACATTTAATGATAATGTATTTTACACATTA 
                                                                               -35           P1        -10 
                                                                                
GAAAAAAGAGAATAAGCTT 
 
LEE30-275 
 
 
GAATTCCGTTTGTTAACGAGATGATTTTCTTCTATATCATTGATTTTAAATGGATTTTAAAAATATATGATTTTTTTGTTGACATTTAATGATAATGTATTTTACACATTA 
                                                                               -35           P1        -10 
                                                                                
GAAAAAAGAGAATAATAACATTTTAAGGTGGTTGTTTGATGAAATAGATGTGTCCTAAAGCTT 
 
LEE30-275 151T 
 
 
GAATTCCGTTTGTTAACGAGATGATTTTCTTCTATATCATTGATTTTAAATGGATTTTAAAAATATATGATTTTTTTGTTGACATTTAATGATAATGTATTTTACACATTA 
                                                                               -35           P1        -10 
                                                                                
GAAAAAAGAGAATAATAACATTTTAAGGTGGTTGTTTGATGAAATAGATGTGTCCTAAAGCTT 
 
 
Figure 2.18. DNA sequences of LEE20-275, LEE30-275 and LEE30-275 151T promoter fragments. 
EcoRI and HindIII sites are coloured red. Nucleotide sequences are numbered starting with the first cloned LEE1 regulatory region base. 
Predicted promoter elements are boxed. Yellow shaded sequence corresponds to the predicted small ORF both in LEE30-275 and LEE30-
275 151T fragments and a single base change at position 151 in LEE30-275 151T fragment is indicated by arrow. 
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digested pJW15Δ100 vector for 15 mins at room temperature. E. coli M182 competent cells 
were transformed with the ligation mix and transformants were selected for on nutrient agar 
plates supplemented with ampicillin. Screening of candidates for an insert was carried out by  
digesting plasmid DNA with NsiI and HindIII. Positive candidates were sequenced using 
primers D3407 and/or D4600 which anneal to the plasmid DNA sequence flanking the insert 
site (Table 2.4). 
 
DNA sequences of different genes cloned into pJW15Δ1-100 are shown in Figure 2.19. To 
construct pSI04, the ler gene (390 bp) was PCR amplified using genomic DNA of EHEC 
Sakai as template and primers D61652 and D61223 (Table 2.4). The resulting product was 
digested with NsiI and HindIII cloned into pJW15Δ100 (Figure 2.20). The pchC gene (315 
bp) was PCR amplified using genomic DNA of EHEC Sakai strain as template and primers 
D61658 and D61659 (Table 2.4). The resulting product was digested with NsiI and HindIII 
and cloned into pJW15Δ100 to give pSI05 (Figure 2.20). The cesD (456 bp) was amplified 
using genomic DNA of EHEC Sakai strain as template and primers D64149 and D64150 
(Table 2.4). The PCR product was then cloned into the NsiI-HindIII sites of the vector 
pJW15Δ100 to give pSI06 (Figure 2.20). Plasmid pSI07 was constructed by amplifying the 
cesT (471 bp) gene using genomic DNA of EHEC Sakai strain as template and primers 
D64151 and D64152 (Table 2.4) and cloning the product after NsiI-HindIII restriction 
digestion into the pJW15Δ100 vector (Figure 2.20). To construct pSI08, cesL gene (354 bp) 
(Younis et al., 2010) was amplified using EHEC Sakai genomic DNA as template and 
primers D64149 and D64150 (Table 2.4). The resulting product was cloned into the NsiI-
HindIII sites of the vector pJW15Δ100 (Figure 2.20). 
 
2.11.6 Construction of pRW225 derivatives 
Vector  DNA was prepared  from  pRW225. Plasmid miniprep DNA was digested with EcoRI 
and HindIII or EcoRI and BamHI, treated with alkaline phosphatase and purified by 
phenol/chloroform extraction and ethanol precipitation method (see section 2.6). Insert DNA 
was ligated into EcoRI-HindIII or EcoRI-BamHI digested vector for 15 mins at room 
temperature. E. coli M182 competent cells were transformed with ligation mix and 
transformants were selected on MacConkey lactose indicator plates supplemented with 
tetracycline. Screening of candidates for an insert was carried out by digesting plasmid DNA  
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ler(390bp) 
 
       Δ 
ATGCATATGCGGAGATTATTTATTATGAATATGGAAAATAATTCACATACAACAAGTCCATACATTCAGCTTATAGAGCAAATTGCAGTTCTACAGCAGGAAGCAAAGCGA 
 
CTGCGAGAGCAGGAAGTTCAAAGTGTAATTGAGTCGATTCAGAAGCAGATTACTTATTACAATATAACCTTACAAGAGCTGGGATATACTAATGTGCCTGATGATGGACTC 
 
GCTCGCCGGAACTCATCGAAAGGTGTTTACTACCGCAATGAAGAAGGGCAGACCTGGTCGGGCGTAGGCCGACAGCCACGCTGGCTTAAAGAAGCACTGTTGAATGGAATG 
 
AAGAAAGAAGATTTTCTTGTGAAGGACACTGAAGAAGAAATAATACCGCTGAAAAATATTTAAAAGCTT 
                                                                                  
pchC(315bp) 
 
       Δ 
ATGCATATGCTACATGATCACCTGGCAGAATGTCTGGAGAAAAAAGGACTGTACCGGAGAGCAGCTGAACGATGGGCAAAAGTGATGGTACAGCTAAGTGATGACCAGAAA 
 
AGAAAAGTGGCGGCACAGAAACGAGCAGAGTGTTTGCGTAAGGCGCGCCGGACTCCGGTTTCACCGATGAACCTGACAGAAATAAAACAAGCGGTCAACAGACTACATTCT 
 
GAGTTGGGAATGGGATTTGAAGAGCGGCGGGTATTCCGACGATATAAAGGGACAGGAGAACAGAATACGTCCGGAAACGCGCGGTCAAAAAAATGCTAAAAGCTT 
 
cesD(456bp) 
 
       Δ 
ATGCATATGAGCAGGAAATTTAGCTCTCTAGAGGATATTTATGATTTCTACCAGGATGGTGGCACATTAGCGTCATTAACAAATCTGACACAACAAGATCTCAATGACCTT 
 
CATTCTTATGCCTATACAGCATATCAATCTGGTGATGTTATAACCGCAAGAAATCTATTCCATTTGCTCACATATCTGGAACACTGGAATTATGACTACACCTTATCTCTG 
 
GGCTTATGTCATCAGCGTTTATCAAATCATGAAGATGCACAACTGTGTTTCGCACGCTGTGCAACTTTAGTTATGCAAGATCCCAGGGCATCTTATTATTCTGGAATTAGC 
 
TACTTACTCGTCGGAAATAAGAAAATGGCCAAGAAAGCCTTTAAGGCTTGTTTAATGTGGTGTAATGAAAAAGAAAAATACACTACATATAAAGAAAATATTAAAAAATTG 
 
TTAGGTAATACAGAGTAAAAGCTT 
 
Figure 2.19. DNA sequences of ler, pchC, cesD, cesT and cesL  genes (continued on page 117). 
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cesT(471bp) 
 
NsiI   Δ 
ATGCATATGTCATCAAGATCTGAACTTTTATTAGAAAAATTTGCAGAAAAAATTGGTATTGGATCTATTTCATTTAATGAAAACAGATTGTGTTCTTTTGCTATTGATGAA 
 
ATTTATTATATTTCGTTATCTGATGCCAATGACGAATATATGATGATTTATGGTGTCTGTGGGAAATTCCCGACAGATAACTCTAACTTCGCTCTTGAGATTTTGAATGCA 
 
AACTTATGGTTTGCAGAGAATGGTGGGCCATATCTGTGCTATGAGGCTGGAGCACAATCGCTGTTGTTAGCGTTACGTTTCCCTCTCGATGATGCTACCCCTGAAAAACTC 
 
GAGAATGAAATAGAAGTCGTTGTTAAGTCAATGGAAAACCTGTATTTGGTATTACATAATCAGGGAATAACATTAGAAAACGAACATATGAAAATAGAGGAAATCAGTTCA 
 
AGCGACAATAAACATTATTACGCCGGAAGATAAAAGCTT 
                                                         
cesL (354bp) 
 
NsiI   Δ 
ATGCATATGCATAATCTTTTAGTTAAAAGAAACGTTGAAGAGTTTTTAAGATTATTGGGAAATGATTTTTATTTATTTGATAACCGTGTTGAAATTGATTTTAATGGGTTT 
 
TCTTTTTTTATTGAAATAATTGATAATAATGTTTTTGTTACGTTTGCTTTAGAGTATAACGAAAACGCATTTTTCTCTTTCTTTAGTGCCCTTGCTCCTGAGCGTACGCAG 
 
GGAGTGATTGAACATATTTTTGTCTACGATAATAAATTGTGCTTAAGTTGTTTGTTAACCAATATCGATGTTTTTTTTCTAATGAATACTTTTCAACAGCATGTGCAGATT 
 
ATTGAGCGCGTTCGCAGGATGACATCATGAAAGCTTAAGCTT 
 
 
Figure 2.19. DNA sequences of ler, pchC, cesD, cesT and cesL genes (continued).  
The figure shows the base sequences together with restriction maps of ler, pchC, cesD, cesT, and cesL genes.  NsiI and HindIII restriction 
sites are coloured red. Translation start codon (ATG) of each gene, indicated by yellow colour was deleted (Δ) since NsiI restriction site 
contains ATG. 
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Figure 2.20. Cloning of genes into plasmid pJW15Δ100. 
Promoterless ler, pchC, esD, cesT and cesL genes were amplified from E. coli O157: Sakai 
chromosome with NsiI-HindIII sites. Amplified fragments were digested and cloned into the 
NsiI-HindIII sites of the cloning vector pJW15Δ100 that contains melR promoter (see plasmid 
detail in Figure 2.5) resulting in plasmids pSI04, pSI05, pSI06, pSI07 and pSI08, respectively. 
N and H represent NsiI and HindIII restriction sites, respectively. 
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with EcoRI and HindIII or EcoRI and BamHI. Positive candidates were sequenced using 
primers D10520 or D53463 (Table 2.4), which anneal to the plasmid DNA sequence flanking 
the insert site. 
 
To determine experimentally whether the upstream mini-ORF located in the downstream site 
of LEE30-275 fragment (Figure 2.18) is translated, the LEE30-275 fragment was cloned into 
the EcoRI-BamHI sites of plasmid pRW225 as translation fusion to lacZ. In order to 
incorporate the BamHI restriction site in the downstream end of the EcoRI-HindIII  
LEE30-275 fragment and to make sure that the predicted translation start codon in the 
LEE30-275 fragment could be in frame with lacZ gene in the plasmid, the downstream primer 
D65474 containing BamHI site together with the upstream primer D63949 was used to 
amplify the EcoRI-BamHI LEE30-275 fragment from plasmid LEE30-275/pRW224. The 
resulting LEE30-275 fragment was then cloned into EcoRI-BamHI sites of pRW225 to give 
LEE30-275/pRW225 (Figure 2.21).  
 
To experimentally determine the ler functional translation start site, LEE151 (553 bp) 
containing the predicted translation start codon that is assigned in coliBASE (Chaudhuri et al., 
2004) (Figure 2.22) was PCR amplified using primers D61221 and D65812 (Table 2.4) and 
cloned into the EcoRI-HindIII sites of pRW225, which results in the plasmid 
LEE151/pRW225 (Table 2.2). The regulatory region LEE150 (571 bp) containing the second 
predicted translation start codon located 15 bp downstream of the first one (Figure 2.22) was 
also PCR amplified using primers D61221 and D65811 and cloned into the EcoRI-HindIII 
sites of pRW225 to give LEE150/pRW225 (Table 2.2).  
 
The predicted ORF in the LEE150 fragment (Figure 2.22) was replaced with KpnI site, which 
results in LEE150-1 fragment. This fragment was cloned into the EcoRI-HindIII sites 
pRW225 to give LEE150-1/pRW225 (Figure 2.23). 
 
2.12 β-galactosidase assays 
β-galactosidase assays (Miller, 1972) were used to measure the lacZ activity in cells 
containing plasmid- encoded promoter:: lacZ fusions in a range of genetic backgrounds and 
under different growth conditions. 
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Figure 2.21. Cloning of the LEE30-275 fragment into pRW225 as translational fusion to 
lacZ. 
LEE30-275 promoter fragment was amplified from LEE30-275/pRW224 using a primer pair 
D65474 and D63949 and cloned into EcoRI-BamHI sites of pRW225. The D65474 was designed 
in such a way that the start codon (ATG, position 44-46) (Figure 2.18) in the promoter fragment 
was in frame with the start codon of lacZ. Therefore, translation initiated on the cloned promoter 
fragment would be in-frame with the lacZ coding sequence in pRW225. E, H and B represent 
EcoR1, HindIII and BamHI restriction sites, respectively. 
Donor Plasmid 
Recipient Plasmid 
E HLEE30-275
lacZ
LEE30-275/pRW224
GAATTC------TAGATGTGTCCTAAAGCTTGGGATCC
BHE
C
G
T
C
G
T
T
T
T
A
lacZ
lacZ
GAATTC--------TAGATGTGTCCTAAAGCTTAATGGAG
CTACACAGGATTTCGAA C CCTAG
G
ACG
Primer
.150E SD
B
H
GAATTC--------TAGATGTGTCCTAAAGCTTGGGATCCTGC
PCR product
E BH
PCR
Dig
esti
on
GAATTC-----AAGCTTCCGGATCCCGTCGTTTTA
lacZBHE
lacZ
pRW225
Digestion LEE30-275/pRW225
E B
pRW225
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LEE151(553bp) 
 
 
GAATTCTGCACCCGTTCCAGGTTAGTGCTGGCTGTAGCTTATGTCCGGGAAACAGCTAATAGATATATATACTCGTCATACTTCAAGTTGCATGTGCTGCGACTGC 
 
GTTCGCTTACCCCAATCACTTACTTATGTAAGCTCCTGGGGATTCACTCGCTTGCCGCCTTCCTGTAACTCGAATTAAGTAGAGTATAGTGAAACGGTTCAGCTTG 
 
GTTTTTATTCTGTTTTATTTGTTTATGCAATGAGATCTATCTTATAAAGAGAAACGCTTAACTAAATGGAAATGCAATTATTAAAGTCGTTTGTTAACGAGATGAT 
 
TTTCTTCTATATCATTGATTTTAAATGGATTTTAAAAATATATGATTTTTTTGTTGACATTTAATGATAATGTATTTTACACATTAGAAAAAAGAGAATAATAACA 
                                                         -35           P1         -10 
 
TTTTAAGGTGGTTGTTTGATGAAATAGATGTGTCCTAATTTGATAGATAAACGTTATCTCACATAATTTATATCATTTGATTAATTGTTGGTCCTTCCTGATAAGG 
                                                                                 -35           P2          -10 
 
TCGCTAATAGCTTAAAATATTAAAGCATGAAGCTT 
 
LEE150(571bp) 
 
 
GAATTCTGCACCCGTTCCAGGTTAGTGCTGGCTGTAGCTTATGTCCGGGAAACAGCTAATAGATATATATACTCGTCATACTTCAAGTTGCATGTGCTGCGACTGC 
 
GTTCGCTTACCCCAATCACTTACTTATGTAAGCTCCTGGGGATTCACTCGCTTGCCGCCTTCCTGTAACTCGAATTAAGTAGAGTATAGTGAAACGGTTCAGCTTG 
 
GTTTTTATTCTGTTTTATTTGTTTATGCAATGAGATCTATCTTATAAAGAGAAACGCTTAACTAAATGGAAATGCAATTATTAAAGTCGTTTGTTAACGAGATGAT 
 
TTTCTTCTATATCATTGATTTTAAATGGATTTTAAAAATATATGATTTTTTTGTTGACATTTAATGATAATGTATTTTACACATTAGAAAAAAGAGAATAATAACA 
                                                         -35           P1         -10 
 
TTTTAAGGTGGTTGTTTGATGAAATAGATGTGTCCTAATTTGATAGATAAACGTTATCTCACATAATTTATATCATTTGATTAATTGTTGGTCCTTCCTGATAAGG 
                                                                                 -35           P2          -10  
 
TCGCTAATAGCTTAAAATATTAAAGCATGCGGAGATTATTTATTATGAAGCTT 
 
 
Figure 2.22. DNA sequences of LEE151 and LEE150 fragments of the LEE1 regulatory region.  
 
EcoRI and HindIII sites are coloured red. Predicted P1 and P2 promoters (Sperandio et al., 2002) are boxed and underlined, respectively. The 
coordinates of the upstream and downstream end of each fragment refer to the number of base pairs upstream from the functional ATG start codon of 
the ler gene reported by Yerushalmi et al. (2008). Dotted boxes both in LEE151 and LEE150 fragments correspond to a database assigned translation 
start point (TSP) of the ler gene. Closed grey shaded box in LEE150 corresponds to an additional predicted TSP that has a SD sequence (blue coloured) 
in front of it. Yellow colour in both fragments represents the predicted mini-ORF that has a SD sequence (blue coloured) in front of it.  
-568 
+1
-568 
-19
-19 
  
 
122 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.23. Construction of the LEE150-1/pRW225.  
The predicted ORF in the LEE150 fragment was replaced with the KpnI (K) site. Plasmid 
LEE150/pRW225 was used as template. Primer D66033 (containing the KpnI site) together 
with D61221, and D66032 (containing the KpnI site) together with D65811 were used to 
amplify two fragments containing a KpnI site in each. Both fragment were digested, purified 
and cloned into pRW225 as translation fusion to lacZ through three way ligation, resulting in 
plasmid LEE150-1/pRW225. E, H and K represent EcoRI, HindIII and KpnI restriction sites, 
respectively. 
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2.12.1 β-galactosidase assays during exponential growth phase  
5 ml LB supplemented with approximate antibiotic(s) was inoculated with a fresh colony of 
each strain carrying the plasmid-encoded promoter::lacZ fusion to be assayed. The strains 
were grown overnight at 37°C with shaking, and the following morning, 100 µl overnight 
culture was sub-cultured into 5 ml of the same medium for each strain. These cultures were 
incubated at 37°C until they reached an OD650 of 0.3-0.6 (exponential phase). Each culture 
was lysed using 2 drops each of toluene and 1% sodium deoxycholate, vortexed for 15 s, and 
shaken for 20 mins at 37°C with the bung removed from the flask, to allow the toluene to 
evaporate off. 100 µl of each lysate was assayed for β- galactosidase activity by adding 2.5 ml 
13 mM 2-Nitrophenyl β-D-galactopyranoside (ONPG) solution and incubating at 37°C until a 
yellow colour developed. At this point, the reaction was stopped by adding 1 ml of 1M 
sodium carbonate and the optical density at 420 nm was read. β-galactosidase activity was 
calculated using the formula: 
 
 
 
Where, 
2.5 = factor for conversion of OD650 into bacterial mass, based on OD650 of 1 being 
equivalent to 0.4 mg/ml bacteria (dry weight). 
3.6 = final assay volume (ml) 
  100/4.5 = factor for conversion of OD420 into nmol o-nitrophenyl (ONP), based on 1 nmol  
ml
-1
 ONP having an OD420 of 0.0045 
t = incubation time (min) 
v = volume of lysate added (ml) 
 
Each set of conditions was assayed in triplicate with at least two separate experiments, and the 
mean β-galactosidase activity and standard deviation calculated under each condition. In all 
plasmid fusion assays, cells containing only the plasmid were used as control. 
 
2.12.2 β-galactosidase assays during stationary growth phase  
β-galactosidase assays of cultures grown to stationary phase were carried out as detailed in 
section 2.12.1, but the assays were carried out on the overnight culture directly. Overnight 
1000 X 2.5 X 3.6 X OD420nm 
OD650nm x 4.5 x t x v 
β-galactosidase activity = nmol/min/mg bacterial mass 
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cultures were diluted 1 in 10 in the appropriate medium, the OD650 calculated, and the diluted 
culture was lysed and assayed. Again, each strain/set of conditions was assayed in triplicate in 
each of at least two separate experiments.  
 
2.13 DNA sampling 
An out line of DNA sampling is shown in the Figure 2.24. 
2.13.1 Sample preparation 
 
LEE20-275, LEE30-275 and LEE30-275 151T promoter fragments (Figure 2.18) were cloned 
into the EcoRI-HindIII sites of pRW902 (Table 2.2). Resulting plasmids together with 
pACBSR were introduced into E. coli strain MG1655 encoding 3xFLAG-tagged LacI. A 
single fresh colony was inoculated in a 5 ml LB medium supplemented with appropriate 
antibiotics and grown overnight at 37°C. The 2.5 ml overnight cultures were inoculated in 500 
ml LB (1:200 dilutions) supplemented with required antibiotics and grown with aeration at 
37°C. When cells reached mid-exponential growth phase (OD650 = 0.5), 0.4% l-arabinose 
was added to induce the expression of the I-SceI meganuclease and the bacteriophage lambda 
Gam protein from plasmid pACBSR. After 20 mins, bacteria were harvested by centrifugation 
for 15 mins at ~11300 x g at room temperature. Cell pellets were resuspended in 20 ml of 
extraction buffer (see section 2.2.4) and a Roche Diagnostics protease inhibitor cocktail tablet 
was added. RNase A (300 μg/ml) and lysozyme (400 μg/ml) were than added and, after 
incubation at room temperature for 10 mins, mixture was cooled on ice and sonicated for 
three periods of 30 s. Samples were then centrifuged at ~40000 x g for 20 mins at 4°C to get  
clear lysates. 
 
2.13.2 Confirmation of discrete promoter fragments in cells 
To check the discrete promoter fragment in the cells, 7 ml of cultures before addition of 
arabinose and after 20 mins induction by arabinose were collected and crude DNA was 
extracted using Qiagen Mini prep kit and PCR purification kit and run on 7.5% 
polyacrylamide gel. 
 
2.13.3 Isolation and analysis of protein-DNA complexes 
The 20 ml of clear lysate was transferred to a 50 ml centrifuge tube and mixed with 25 mg of 
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Figure 2.24. Outline of DNA sampling (Butala et al., 2009). 
pRW902 plasmid derivative 
I-SceI-5xLacI site-test DNA 
fragment-I-SceI 
 
pACBSR-DL1 plasmid 
Arabinose-inducible-endonuclease I-SceI 
bacteriophase λ-Gam protein 
 
Cotransformation 
 
MG1655 E. coli strain 
encoding 3xFLAG- tagged LacI 
Arabinose-induced expression of endonuclease I-SceI to liberate DNA 
fragment cloned into pRW902  
Cell lysis 
 
Affinity isolation of protein-DNAcomplex using anti-FLAG 
tagged LacI 
DNA 
 
Protein 
 
Protein-DNA complexes vacuumed down, 
resolved on the SDS-PAGE, proteins identified 
by mass spectrometry 
Phenol chloroform extraction, ethanol 
precipitation, electrophoretic analysis of the 
DNA from the complex 
Bacterial growth in 200 ml culture 
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Dynabeads (M270-epoxy; Invitrogen) cross-linked to mouse anti-FLAG antibody (F3165, 
Sigma) and incubated on ice for 10 mins with gentle agitation. Dynabeads were collected to 
the side of the tube with a magnet and the lysate removed. The isolated beads were transferred 
to a 2 ml protein Lo-Bind tube (Eppendorf) and washed five times with 1 ml of wash buffer 
(See section 2.2.4). The protein-DNA complexes were eluted from the anti-FLAG antibody 
by addition of 500 μl of elution buffer (see section 2.2.4), and mixing on a rotating wheel for 
5 mins. The supernatant was removed from the beads and transferred to a fresh tube. DNA in 
the supernatant was purified by phenol-chloroform extraction and ethanol precipitated and 
analyzed by electrophoresis in 1.3% agarose gels. Proteins in the supernatant were vacuum 
dried and dissolved in SDS-PAGE loading buffer containing 10 mM tris (2-carboxymethyl) 
phosphine-HCl (Sigma), which reduced any disulphide bonds. The samples were heated at 
95°C for 5 mins. Samples were then alkylated by addition of 50 mM iodoacetamide (Sigma) 
for 30 mins at room temperature, resolved by SDS-PAGE in 4-12% gradient gels (Invitrogen), 
and visualized by Coomassie blue staining. Quantities and relative stoichiometries of DNA 
and proteins in the complexes were determined after scanning agarose gels and SDS-PAGE 
gels, that had been calibrated with the NEB 100-bp DNA ladder and Invitrogen SeeBlue Plus 
2 protein markers, respectively.  
 
To identify different proteins in SDS-PAGE gels, 1 mm gel slices were excised. The gel slices 
were placed in protein Lo-Bind tubes and destained for 1 hour, with agitation, by the addition 
of a 1 ml mixture of 50 % (v/v) acetonitrile and 50 mM ammonium bicarbonate. After 1 hr, 
the destaining solution was removed and the gel slices were dehydrated by the addition of 100 
µl of acetonitrile. When the gel slices became opaque, the acetonitrile was removed, and the 
gel slices allowed to air dry for 5 minutes. Finally, proteins in each gel slice were digested 
with 8 ng of trypsin (Promega), in 100 µl of 50 mM ammonium bicarbonate solution, at 37°C 
for 4 hrs. Peptides from each slice were analyzed on a Thermo-Finnigan FT-ICR mass 
spectrometer using a NanoMate chip-based electrospray system operated by the University of 
Birmingham Functional Genomics and Proteomics Unit.  
 
The experimental masses of peptides in each gel slice, as determined by mass spectrometry, 
were then compared to an in silico derived E. coli protein digestion database, using the 
Thermo-Finnigan Proteome Discoverer Software. Proteins whose expectation values were 
  
 
127 
lower than the 0.01 cut-off, and that were identified by the presence of more than 1 individual 
peptide, were considered to be positive identifications. Proteins whose expectation values 
were higher than the 0.01 cut-off, or that were identified by the presence of only one 
individual peptide were considered to be false-positives, and were therefore discarded from 
the identification list.   
 
2.14 Pull down assays 
In order to determine whether GrlA can associate with RNAP before interacting with the 
target site at the LEE1 P1 promoter, pull down assays were used (Lee et al., 2008) in which 
protein A affinity tagged RNAP with associated proteins from Sakai rpoC::4PrA strain 
containing plasmid encoded GrlA was analyze. 
 
Plasmids, pACYC184ΔHN (R-A-), pSI01 (R+A+) or pSI02 (R-A+) were introduced into 
Sakai rpoC::4PrA strain. In each case, a single fresh colony was inoculated in a 5 ml LB 
medium supplemented with chloramphenicol and grown overnight at 37°C. 2.5 ml overnight 
cultures were inoculated in 500 ml LB (1:200 dilutions) supplemented with chloramphenicol 
and grown with aeration at 37°C. When cells reached mid-exponential growth phase  
(OD650 = 0.7), they were harvested by centrifugation for 15 mins at ~11300 x g at 4°C and cell 
pellet was stored at -80°C. The cell pellet was then resuspended in 20 ml of extraction buffer 
(see section 2.2.5). DNase I (20 μg/ml), RNase A (300 μg/ml), and lysozyme (200 μg/ml) 
were then added. After incubation at room temperature for 10 mins, the mixture was cooled 
on ice and sonicated three times for 1 min. Sample was then centrifuged at ~40000 x g for 20 
mins at 4°C to get  clear lysates. 
 
The supernatant was removed and incubated with 20 mg of Dynabeads (M270-epoxy; Dynal) 
coated with rabbit immunoglobulin G for 3 mins. The beads were collected with a magnet and 
washed with buffer (see section 2.2.5). The proteins were then eluted from the beads by 
incubation for 5 mins with elution buffer (see section 2.2.5). Coeluted proteins were vacuum 
dried and reduced and alkylated by resuspension in SDS-PAGE loading buffer containing 10 
mM tris (2-carboxyethyl) phosphine-HCl (Sigma) and 50 mM iodoacetamide (Sigma). The 
proteins were resolved by SDS-PAGE in 4% to 12% gradient gels (Invitrogen) and visualized 
with Coomassie blue staining and/or silver staining following SilverQuest™ Microwave 
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Silver Staining Protocol (Invitrogen). Target protein bands were sliced and digested with 
trypsin for 8 hrs at 37°C. The peptides from each gel slice were purified and analyzed by mass 
spectrometry. 
 
2.15 In vitro DNA footprinting analysis 
2.15.1 Preparation of fragments for DNA footprinting 
DNA footprinting experiments were performed using PstI-BamHI fragments, excised from 
pSR carrying the EcoRI-HindIII promoter fragment of interest (Figure 2.15). Approximately 
200 µl pSR maxiprep DNA was digested with 16µl BamHI in a final volume of 240 µl 1 x 
NEBuffer 3 supplemented with 100 µg/ml BSA, then treated with 8 µl alkaline phosphatase to 
remove the 5' phosphate. After phenol/chloroform extraction and ethanol precipitation, the 
DNA was digested with 8 µl PstI in 80 µl 1 x NEBuffer 3 supplemented with 100 µg/ml BSA. 
PstI-BamHI fragments were purified by electroelution from a 7.5% polyacrylamide gel, 
extracted using phenol/chloroform and ethanol precipitation (see section 2.6), and then 
resuspended in 50 µl TE buffer. 
 
2.15.2 Radio-labeling of DNA fragments 
PstI-BamHI DNA fragments were end-labeled with [γ-32P] on the BamHI end using T4 
polynucleotide kinase (New England Biolabs), which catalyses the transfer of the γ phosphate 
from ATP to 5' terminal hydroxyl groups in DNA. 8-16 µl DNA was mixed with 1 µl T4 
polynucleotide kinase and 1 µl [γ-32P]-ATP in a final volume of 20 µl T4 polynucleotide 
kinase buffer, and incubated for 30 mins at 37°C. Unincorporated [γ 32P]-ATP was then 
removed by passing the labelling mix down a Sephadex G-50 column: 400 µl 50% Sephadex 
-G50 suspension was loaded onto a Micro Bio-Spin column (Bio-Rad) and centrifuged for 2 
mins at ~1300 x g. The column was then placed into a fresh collection tube, and the 20 µl 
labeling reaction was loaded onto the column and centrifuged for a further 2 mins at ~1300 x 
g. 
 
2.15.3 Preparation of G+A ladder 
Radio-labeled PstI-BamHI promoter fragments were treated with formic acid and piperidine 
to generate Maxam-Gilbert G+A sequence ladders, used to calibrate DNA footprinting gels. 
3-4 µl labeled promoter fragment was made up to a final volume of 12 µl using sterile 
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distilled water, mixed with 50 µl formic acid, and incubated for 90 s at room temperature. The 
reaction was stopped by adding 200 µl 0.3 M sodium acetate (pH 7) and 700 µl ice-cold 
100% ethanol, and the DNA sample ethanol precipitated as described in section 2.6. The 
DNA pellet was resuspended in 100 µl 1 M piperidine, and incubated for 30 mins at 90ºC. 
Samples were then ethanol precipitated, resuspended in 20 µl denaturing gel loading buffer, 
and heated to 90ºC before loading 0.5-2 µl onto footprinting gels. 
 
2.15.4 In vitro potassium permanganate footprinting 
Potassium permanganate footprinting was used to detect open complex formation at 
promoters in vitro. Potassium permanganate oxidizes unpaired thymine residues in single 
stranded regions of DNA, and subsequent treatment with piperidine results in cleavage of the 
DNA backbone on the 3' side of the modified nucleotide. Permanganate footprints were 
performed following the protocol of Savery et al. (1996). In each reaction, 0.1-0.5 µl  
PstI-BamHI promoter fragment, labeled with [γ-32P] on the BamHI end, was mixed with a 
final concentration of 50 nM RNAP holoenzyme in a final volume of 20 µl 1 x 
HEPES/glutamate binding buffer containing 0.5 mg/ml BSA. After incubation for 20 mins at 
37º C, reactions were treated with 1 µl 100 mM KMnO4 solution for 4 mins at 37ºC, then 
stopped with 50 µl potassium permanganate stop solution. After phenol/chloroform extraction 
and ethanol precipitation, samples were resuspended in 40 µl 1 M piperidine and incubated at 
90ºC for 30 mins. Samples were purified by phenol/chloroform extraction and ethanol 
precipitation, resuspended in denaturing gel loading buffer, and analysed by electrophoresis 
on a denaturing 6% polyacrylamide sequencing gel as described in the section 2.5.3. 
 
2. 16 In vitro transcription assays 
Multi round in vitro transcription analysis was performed using PstI-BamHI fragments as 
template excised from pSR containing promoter of interest (Figure 2.15), using purified 
RNAP holoenzyme, following the method as described by Browning et al. (2009). RNAP 
holoenzyme was diluted to 25 x the required final concentration in 1x transcription buffer. For 
each transcription reaction, 40 ng linear DNA fragment carrying the promoter of interest was 
mixed with 1 µl 25 x concentrated RNAP holoenzyme in a final volume of 25 µl 1 x Tris 
acetate transcription buffer containing 100 µg/ml BSA, 200 µM GTP, 200 µM ATP, 200 µM 
CTP, 10 µM UTP and 5µCi [α32P]-UTP. Reactions were started by adding the RNAP, 
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incubated for exactly 15 mins, and stopped by adding 25 µl transcription stop solution. 6 µl 
each reaction was run on a denaturing 5.5% polyacrylamide sequencing gel and analyzed as 
described in the section 2.5.3. 
 
2.17 Fluorescent actin staining (FAS) tests 
To confirm whether the Ler protein encoded from the plasmid pSI04 plasmid is functional, 
Robert Shaw, Research Fellow, School of Biosciences, University of Birmingham performed 
a Ler complementation test.  
 
2.17.1 HeLa cell culture 
HeLa cell culture was done by Robert Shaw. Cells were maintained in bicarbonate buffered 
Minimum Essential Medium (MEM) (Sigma) supplemented with 10% foetal calf serum (PAA 
laboratories) at 37°C in a Sanyo CO2 incubator at a ratio of 5% CO2 in air. Cells were 
removed from 75 cm flasks with 1:1 trypsin/EDTA (Sigma) and seeded onto ethanol 
sterilized 13 mm circular glass coverslips in 24 well plates, at a split ratio of 1:20. Cells were 
grown for a further 48 hrs for cell attachment and spreading. 
 
2.17.2 FAS tests  
The assay was done by Robert Shaw. Adhesion of EHEC to HeLa cells was tested as 
described by Knutton et al. (1989). Tissue culture cells on 13-mm-diameter glass cover slips 
were placed in the wells of a multiwell tissue culture plate with 1 ml of HEPES-buffered 
essential medium containing 2% serum and 0.5% D-mannose. A sample (10 l) of overnight 
bacterial broth culture was added to each well, and the cells were incubated for 6 hrs at 37°C. 
In 6 hrs assays, cells were washed and fresh medium was added after 3 hrs. After three 
washes to remove nonadhering bacteria, cells were fixed for 20 mins in 3% Formalin. 
 
Formalin fixed coverslips were washed with phosphate-buffered saline (PBS) three times to 
remove formalin. Cells were permeabilised with 0.1% Triton X100 in (PBS) for 4 mins. After 
three washes in PBS, cover slips were stained with a mixture of 5 g/ml solution of 
fluorescein isothiocyanate-phalloidin (Sigma) and 2 μg/ml propidium iodide (Invitrogen) in 
PBS for ~30 mins to specifically stain filamentous actin and the adherent bacteria. Cover slips 
were washed three times in PBS and mounted in citifluor mountant (Agar Scientific). The 
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slides were viewed on a Leica SP2 confocal microscope with spectral detection and XYZ 
maximum projections of full cell thickness were obtained. 
 
2.18 Helix-turn-helix predictions for GrlA 
Lewis Bingle, Research Fellow, School of Biosciences, University of Birmingham performed 
helix-turn-helix prediction for GrlA. The DNA-binding helix-turn-helix of GrlA, suggested by 
Deng et al. (2004), was confirmed computationally by the Dodd and Egan (1990) method, 
http://npsa-pbil.ibcp.fr/cgi-bin/npsa_automat.pl?page=/NPSA/npsa_hth.html, the GYM2.0 
method, http://users.cis.fiu.edu/~giri/bioinf/GYM2/prog.html (Narasimhan et al., 2002), and 
the Jpred structure prediction tool, http://www.compbio.dundee.ac.uk/www-jpred/index.html 
(Cole et al., 2008). 
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Chapter 3 
 
Organisation of the LEE1 operon regulatory  
region and activation by GrlA 
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3.1 Introduction 
Ler is the key activator for expression of most of the LEE genes (Mellies et al., 1999; 
Bustamante et al., 2001; Umanski et al., 2002; Haack et al., 2003). The regulatory region of 
the ler gene is the target for a range of regulatory factors including GrlR and GrlA (Mellies et 
al., 2007; Hansen and Kaper, 2009; Tree et al., 2009; Kendall et al., 2010; Deng et al., 2004; 
Barba et al., 2005; Jimenez et al., 2010). GrlA acts as a transcription activator, whereas GrlR 
interacts with the GrlA and prevents its activity (Jobichen et al., 2007).  
 
GrlA-mediated regulation of the ler gene expression is not fully understood. Both Huang and 
Syu (2008) and Jimenez et al. (2010) reported that purified GrlA fusion proteins could bind to 
the EHEC LEE1 regulatory region but did not find its binding target, whilst Russell et al. 
(2007) suggested that GrlA might need another factor to modulate the LEE1 expression. The 
work described in this chapter was aimed to get a better understanding of the action of GrlA at 
the EHEC LEE1 regulatory region. Individual regulatory components can function in isolation 
(Barnard et al., 2004) and, thus, in this work a laboratory strain of E. coli K-12 was used to 
reproduce GrlA-dependent activation at LEE1 and to determine the functional determinants in 
both GrlA and in the LEE1 promoter.  
 
3.2 Activity of the LEE1 promoters and nested deletion analysis 
The LEE1 operon regulatory region is located upstream from the ler gene. Thus, a construct 
was made in which lacZ expression is controlled by the LEE10-568 fragment. The fragment 
contains the base sequence from position -568 to position -19 upstream of the functional ATG 
start codon of the ler gene (Figures 2.10, 2.11, 3.1). A series of eight nested deletions of this 
fragment were constructed. The upstream end of each of the nested deleted fragments is 
shown with respect to the reported LEE1 P1 and P2 promoters (Sperandio et al., 2002). 
Fragments were cloned into the vector, pRW224, and the resulting recombinants were 
transformed into both M182, and EHEC strains (both Sakai and EDL933). Effects of the 
deletions on the LEE1 promoter activity were assessed by the level of the measured 
β-galactosidase expression (Figure 3.1B). The patterns of activity from different promoter 
fragments seem to be invariable in all three strains backgrounds and in both LB medium 
(Figure 3.1) and DMEM medium (Figure 3.2). Removal of upstream sequences causes ~2-4 
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Figure 3.1. Nested deletions of the LEE1 regulatory region.  
A. Schematic representation of a set of EcoRI-HindIII DNA fragments covering the LEE1 
regulatory region. The coordinates of the upstream and downstream end of each fragment 
refer to the number of base pairs upstream from the functional ATG start codon of the ler 
gene reported by Yerushalmi et al. (2008). The P1 and P2 promoters are indicated by bent 
arrows and the shaded black boxes represent the cognate -10 and -35 hexamer elements.   
B. Bar chart to illustrate measured β-galactosidase activities in E. coli K-12, EHEC Sakai and 
EHEC EDL933 cells carrying pRW224 with each of the different fragments. Vector refers to 
empty pRW224 with a short linker between the EcoRI and HindIII sites. Activities were 
measured after growing the cells in LB medium to an optical density at 650 nm of ~0.5 at 
37°C. The values are the average of three independent assays and standard deviations are 
shown with bars. 
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Figure 3.2. Nested deletion analysis of the LEE1 regulatory region. 
A. Schematic representation of a series of nested deleted derivatives of LEE1 operon regulatory 
region. The coordinates of upstream and downstream end of each derivative refer to the number of 
base pairs upstream from the functional ATG start codon of the ler gene.  
B. Bar chart to illustrate the β-galactosidase activities in EHEC EDL933 carrying pRW224 with 
each of the different fragments. Vector refers to empty pRW224 with a short linker between the 
EcoRI and HindIII sites. Activities were measured after growing the cells either in LB (open bars) 
or DMEM (shaded bars) media at 37ºC to an optical density of ~0.5 at 650 nm. Values are the 
average of at least three independent assays, and standard deviations are shown with bars. 
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fold increase in lac expression and the expression was found to be optimal with the LE10-275 
and LEE10-215 fragments, which carry DNA sequence up to positions -275 and -215 
upstream from the ler start codon, respectively. Deletions to positions -203, -195 and -155 
result in a large decrease in expression. The region from positions -215 to -155 contains the 
proposed sequence elements for the P1 promoter (Sperandio et al., 2002). Hence, I conclude 
that, at least in my experimental conditions, P1 must be the major functional promoter for the 
LEE1 operon. Absence of the P1 promoter elements in both LEE10-155 and LEE10-115 
fragments reduces the expression to 10-15%. This expression is most likely due to the P2 
promoter because deletion to the LEE10-275 fragment, which carries P2 only, reduces the 
expression to basal levels. In a complementary experiment, the effect of the deletions of the 
downstream sequences containing the P2 promoter elements was checked. To do this, the 
LEE10-568, LEE10-315, LEE10-275 and LEE10-203 fragments were shortened to move the 
downstream HindIII site to position -158, rather than position -19, thereby deleting the 
downstream P2 promoter, and generating the LEE20-568, LEE20-315, LEE20-275 and 
LEE20-203 fragments (Figure 3.1A). Fragments were cloned into pRW224 and lacZ 
expression was measured. The observed patterns of β-galactosidase expression in both the 
O157:H7 and M182 strains were similar to with the LEE10 fragment series (Figure 3.1B). 
The data are consistent with the conclusion that the P2 promoter makes but a minor 
contribution to the activity measured here. However, the increased expression seen with the 
LEE20 fragments is probably due to the shorter untranslated leader sequence upstream of the 
reporter lacZ gene.  
 
3.3 Identification of functional elements at the LEE1 regulatory region P1 
promoter 
The experiment illustrated in Figure 3.1 shows that the shortest fragment, which shows 
maximum promoter activity is the LEE20-275 fragment. This fragment carries the DNA 
sequence from positions -275 to -158 upstream of the ler start codon and contains the P1 
promoter. The base sequence of this fragment is shown in Figure 3.3, where the sequence has 
been renumbered 1-120, starting immediately downstream of the EcoRI linker. This 
numbering system was adopted to describe the ensuing mutational analysis of the LEE20-275 
fragment and the shorter LEE20-203 fragment.  
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Figure 3.3. Mutational analysis of the LEE20-275 fragment.  
The figure shows the nucleotide sequence of the upper strand of LEE20-275 fragment. The 
base sequences are numbered 1-120, starting with the first cloned LEE1 regulatory region 
base (that is 275 base pairs upstream from the ler translation start codon). The positions of 
randomly generated single mutations that reduced expression from this fragment are 
illustrated by showing the substituted base and, in each case, the adjacent number records the 
number of times that the particular substitution was obtained. The locations of the P1 
promoter -35 and -10 hexamer elements, deduced from this study, are shown by grey shading 
and the transcript start, at position 107A, determined from data in Figure 3.4B is indicated. 
The upstream end of the smaller LEE20-203 fragment is indicated by a bent solid/dotted line. 
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In order to define elements essential for promoter activity, error-prone PCR was performed, 
which generated ten independent preparations of the LEE20-275 fragment carrying random 
point mutations. The fragments were then cloned into pRW224, recombinant plasmids were 
transformed into E. coli strain M182, and transformants were grown on MacConkey lactose 
indicator plates. As expected, the majority of colonies were found as Lac
+
 (red). However, 
after screening over 100,000 transformants, ~100 Lac
-
 (pale pink) colonies were identified. 
Sequence analysis showed that 43 of these carried single mutations in the LEE20-275 
fragment cloned in pRW224. The locations of the different single point mutations that 
reduced lac expression from the LEE20-275 promoter fragment are illustrated in Figure 3.3.  
 
Surprisingly, 25 of the 43 point mutations fall in the TTGACA motif at positions 73-77. The 
motif matches perfectly the consensus hexamer -35 element for E. coli promoters (Rosenberg 
and Court, 1979; McClure, 1985) and it was predicted to be the P1 promoter -35 element by 
Sperandio et al. (2002). The effects of the different substitutions in this element were 
quantified (Table 3.1). The results are consistent with this being the functional -35 element 
controlling expression from the LEE20-275 fragment. Another of the point mutations (71A) 
falls just upstream of the -35 element, and its effects are consistent with the lower promoter 
activity of the LEE20-203 fragment compared to the LEE20-275 fragment (Figure 3.1B). 
 
A further 15 of the 43 point mutations form a second cluster that appears to fall in the 
promoter -10 hexamer (Figure 3.3). It is well understood that base pairs at positions 1 and 2 of 
promoter -10 hexamers in E. coli are most crucial for promoter activity (Rosenberg and Court, 
1979; McClure, 1985). This suggests that the motif TACACA at positions 97-102 is likely to 
be the functional -10 hexamer element of the P1 promoter. Since the consensus -10 element 
for E. coli promoters is TATAAT, I performed site-directed mutagenesis to generate 
complementary mutations to check this suggestion. Effects of different mutations are 
presented in Table 3.1. The base substitutions 97C, 98C, 98G, 98T and 100G cause >90% 
reductions in expression, whilst the 99A, 99G, 101G, 102C and 102G substitutions have 
lesser effects. These results support my prediction and confirm the TACACA hexamer as the  
-10 element. However, this suggests that the spacer between the proposed -35 and -10 
hexamer elements is 18 base pairs rather than the optimal 17 base pairs. To check the effect of 
the spacer length on the promoter activity, a LEE20-275 fragment derivative in which a T in 
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Table 3.1: Mutational analysis of the LEE1 P1 promoter 
 
The table shows measured β-galactosidase activities in cultures of E. coli strain M182 
carrying pRW224 containing the LEE20-275 fragment and different mutations. Cultures were 
grown aerobically at 37°C in LB medium to an optical density of ~0.5 at 650 nm. Activities 
were measured in triplicate, giving a mean and standard deviation (sd). Activities expressed as 
a percentage of activity with the starting LEE20-275 fragment are shown in parentheses. The 
central part of the table shows the fragment base sequence from position 71 to position 102, 
with the P1 promoter -10 and -35 hexamer elements underlined. Base substitutions and 
insertions in the different fragments are highlighted in boldface type and coloured red whilst 
the 94 deletion is shown by a dash. Mutations made by site directed mutagenesis are 
indicated by asterisks, whilst the other mutations came from the random PCR mutagenesis 
experiment illustrated in Figure 3.3. 
Fragment 
 
Promoter sequence from positions 71-102 β-galactosidase activity 
(Miller units ± sd) 
Starting fragment   
LEE20-275  5’-TGTTGACATTTAATGATAATGTATTTTACACA-3’ 5477 ± 300 
Point mutation upstream of the -35 element 
LEE20-275 71A
 5’-AGTTGACATTTAATGATAATGTATTTTACACA-3’ 1034 ± 123 (18.9) 
Point mutations in the  -35 element  (TTGACA) 
LEE20-275  73A 5’-TGATGACATTTAATGATAATGTATTTTACACA-3’ 1103 ± 20 (20.1) 
LEE20-275  73C 5’-TGCTGACATTTAATGATAATGTATTTTACACA-3’ 1128 ± 28 (20.6) 
LEE20-275  74C 5’-TGTCGACATTTAATGATAATGTATTTTACACA-3’ 991 ± 90 (18.1) 
LEE20-275  75A 5’-TGTTAACATTTAATGATAATGTATTTTACACA-3’ 690 ± 27 (12.6) 
LEE20-275 75C
*
 5’-TGTTCACATTTAATGATAATGTATTTTACACA-3’ 962 ± 141 (17.6) 
LEE20-275  76G 5’-TGTTGGCATTTAATGATAATGTATTTTACACA-3’ 1478 ± 120 (27.0)  
LEE20-275  77A
*
 5’-TGTTGAAATTTAATGATAATGTATTTTACACA-3’ 1532 ± 40 (28.0) 
LEE20-275  77G
*
 5’-TGTTGAGATTTAATGATAATGTATTTTACACA-3’ 1136 ± 80 (20.7) 
LEE20-275  77T 5’-TGTTGATATTTAATGATAATGTATTTTACACA-3’ 1185 ± 60 (21.6) 
Point mutations in the spacer region 
LEE20-275  93T 5’-TGTTGACATTTAATGATAATGTTTTTTACACA-3’ 812 ± 86 (14.8) 
LEE20-275 InsT (93-94) 5’-TGTTGACATTTAATGATAATGTATTTTTACACA-3’ 205 ± 26 (3.7) 
LEE20-275 Δ94T
*
 5’-TGTTGACATTTAATGATAATGTA─TTTACACA-3’ 11622 ± 291 (212.2) 
Point mutations in the  -10 element  (TACACA) 
LEE20-275  97C 5’-TGTTGACATTTAATGATAATGTATTTCACACA-3’ 318 ± 12 (5.8) 
LEE20-275  98C
*
 5’-TGTTGACATTTAATGATAATGTATTTTCCACA-3’ 233 ± 4 (4.3) 
LEE20-275  98G 5’-TGTTGACATTTAATGATAATGTATTTTGCACA-3’ 202 ± 15 (3.7) 
LEE20-275  98T 5’-TGTTGACATTTAATGATAATGTATTTTTCACA-3’ 234 ± 9 (4.3) 
LEE20-275  99A
*
 5’-TGTTGACATTTAATGATAATGTATTTTAAACA-3’ 10169 ± 298 (185.7) 
LEE20-275  99G
*
 5’-TGTTGACATTTAATGATAATGTATTTTAGACA-3’ 2721 ± 16 (50.0) 
LEE20-275  100G 5’-TGTTGACATTTAATGATAATGTATTTTACGCA-3’ 305 ± 9 (5.6) 
LEE20-275  101G
*
 5’-TGTTGACATTTAATGATAATGTATTTTACAGA-3’ 2493 ± 132 (45.5) 
LEE20-275  102C
*
 5’-TGTTGACATTTAATGATAATGTATTTTACACC-3’ 4375 ± 105 (80.0) 
LEE20-275  102G
*
 5’-TGTTGACATTTAATGATAATGTATTTTACACG-3’ 1843 ± 72 (33.6) 
71 80 90 100 
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the spacer was deleted (Δ94T), thus reducing the spacer length from 18 to the optimal 17 base 
pairs was constructed. The mutation Δ94T causes ~2 fold increase in the promoter activity 
(Table 3.1). Note that one of the Lac
-
 mutants carrying the LEE20-275 fragment with an extra 
T between position 93 and 94 (Figure 3.3) was found during random mutagenesis of the 
LEE20-275 fragment. This insertion increased the spacer length from 18 to 19 base pairs, and 
caused a sharp reduction in lac expression (Table 3.1). These results suggest that an increase 
in the spacer length further away from the optimal 17 base pairs causes a reduction in the 
promoter activity. 
 
3.4. Biochemical analyses 
In a complementary experiment, complexes between purified DNA fragments and purified E. 
coli RNAP holoenzyme were studied to confirm the location of the functional promoter in the 
LEE20-275 fragment. In these experiments, the starting „wild-type‟ DNA fragment and a 
corresponding fragment carrying the 98C substitution at position 2 of the -10 hexamer 
element were compared. To monitor the effect of the 98C base substitution on the open 
complex formation, an in vitro potassium permanganate foot-printing analysis (Savery et al. 
1996) was performed. In this analysis, interaction between purified RNAP and purified DNA 
fragment results in single stranded „bubble‟ produced after local unwinding of promoter DNA 
around the transcription start site. Potassium permanganate modifies single stranded thymine 
residues and subsequent treatment with the piperidine of the modified DNA causes cleavage 
of the DNA backbone on the 3' side of the modified nucleotide. Results of the potassium 
permanganate foot-printing analysis shown in Figure 3.4A reveal an extensive unwinding just 
downstream of the promoter -10 hexamer and, crucially, this unwinding is greatly reduced 
with the 98C mutant. 
 
In a complementary experiment, multi round in vitro transcription assays following the 
protocol used by Browning et al. (2009) were performed in which RNAP runs to a terminator 
in the DNA fragment synthesising labelled RNA molecules that are detected by gel 
electrophoresis. The labelled transcripts that formed after labelled nucleoside triphosphates 
were added to the binary RNAP-DNA complexes were analyzed (Figure 3.4B). The major 
transcript starting in the LEE20-275 fragment is ~102 bases and this corresponds to a  
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Figure 3.4. In vitro permanganate footprinting and transcription assays (continued on 
page 142). 
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Figure 3.4. In vitro permanganate footprinting and transcription assays (continued). 
A. The figure shows an autoradiogram that identifies the potassium permanganate sensitive 
sites in complexes of holo RNA polymerase with a DNA fragment that includes the 
LEE20-275 sequence (WT) or a derivative carrying the 98C mutation (98C). Lanes 1 and 3 
show the result after control incubations without RNA polymerase, whilst lanes 2 and 4 show 
the analysis of samples with 50 nM RNA polymerase. The gel was calibrated using a  
Maxam-Gilbert sequence reaction (GA) and relevant positions are indicated. The location of 
the LEE1 P1 promoter -10 and -35 elements are indicated by black boxes and the asterisks 
identify 6 consecutive residues just downstream of the -10 element that display RNA 
polymerase-dependent reactivity to permanganate.  
B. Autoradiogram of an analysis by gel electrophoresis of 
32
P-labelled RNA transcripts made 
by RNA polymerase holoenzyme from PstI-BamHI fragments carrying wild type LEE20-275 
sequences (lanes 1-3) and the 98C derivative (lanes 4-6). The RNA polymerase concentration 
was: lanes 1 and 4, no enzyme; lanes 2 and 5, 200 nM; lane 3 and 6, 400 nM. The gel was 
calibrated with the pSR plasmid-encoded 108 base RNA-I transcript (lane 7) and a Maxam 
-Gilbert sequence reaction (GA). The proposed LEE1 P1 transcript is indicated by an asterisk. 
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transcript starting at position 107A, 5 bases downstream from the proposed -10 element 
(Figure 3.3). This RNA species is completely absent when the DNA fragment carrying the 
98C substitution is used (Figure 3.4B). 
 
3.5 Contribution of P1 and P2 promoters to the expression of the LEE1 
operon 
Sperandio et al (2002) showed that the LEE1 P2 promoter plays a major role in the expression 
of the LEE1 operon. The P2 promoter has an extended -10 element with a TG motif. The P2 
promoter carries TTGATT and TAAGGT as the -35 and -10 elements, respectively, with a 19 
base pairs promoter spacer (Sperandio et al., 2002). Transcription initiates from this promoter 
at a site located 35 base pairs upstream of the translation start site of ler gene. The nested 
deletion analysis presented (Figure 3.1) shows that the P1 promoter is the principal promoter, 
whilst the P2 promoter plays a minor role. In a complementary experiment, mutational 
analysis of the LEE10-275 promoter fragment that contains both P1 and P2 promoters was 
carried out to confirm further the contribution of two promoters in lac expression. The 
nucleotide sequence of this fragment is numbered 1-257 following the numbering system of 
LEE20-275 fragment (Figure 3.3). Site directed mutagenesis using megaprimer PCR was 
used to introduce a base substitution either at the second position of the P1 -10 element (98C) 
or at the second position of the P2 -10 element (228C) and at both positions (98C 228C) in the 
LEE10-275 fragment. Derivatives were then cloned into pRW224 and lac expression was 
quantified (Figure 3.5). Mutation of the P1 promoter (LEE10-275 98C) reduced the promoter 
activity sharply (~95%) whilst mutation of the P2 promoter (LEE10-275 228C) caused a 
~40% decrease in lac expression. However, mutations in both P1 and P2 (LEE10-275 98C 
228C) reduced the promoter activity to a low level similar to that found with the mutation in 
P1 alone (LEE10-275 98C). These results support the conclusion, based on nested deletion 
analysis that the LEE1 P1 promoter plays the major role in LEE1 expression. 
 
3.6 Activation by GrlA 
In order to carry out a thorough investigation of the role of GrlA at the LEE1 operon 
regulatory region, a series of pACYC184 derivatives carrying the grlRA operon (pSI01), grlA 
alone (pSI02) and grlR alone (pSI03) were constructed (Figure 2.17). Each of recombinant  
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GAATTCCGTTTGTTAACGAGATGATTTTCTTCTATATCATTGATTTTAAATGGATTTTAA 
 
AAATATATGATTTTTTTGTTGACATTTAATGATAATGTATTTTACACATTAGAAAAAAGA 
 
GAATAATAACATTTTAAGGTGGTTGTTTGATGAAATAGATGTGTCCTAATTTGATAGATA 
 
AACGTTATCTCACATAATTTATATCATTTGATTAATTGTTGGTCCTTCCTGATAAGGTCG 
 
CTAATAGCTTAAAATATTAAAGCAAGCTT 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5. Mutational analysis of the LEE10-275 fragment. 
A. The figure shows the nucleotide sequence of the upper strand of LEE10-275 fragment. The 
base sequences are numbered 1-257 following numbering system at Figure 3.3. P1 and P2 
promoter elements are shaded grey and underlined, respectively. Transcription initiation site 
from both promoters are indicated by bent arrows. Vertical arrows indicate the location of the 
mutations. EcoRI and HindIII sites are coloured red. 
B. The bar chart illustrates the measured β-galactosidase activity in M182 cells containing lac 
expression vector pRW224 with LEE10-275 fragment (WT) or mutant derivatives. 
Measurements were made after growing the cells in LB at 37°C to an optical density of ~0.5 
at 650 nm. Values are the average of at least three independent assays, and standard 
deviations are shown with bars. 
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plasmids or empty vector was transformed into the E. coli K-12 M182 Δlac strain carrying 
pRW224 derivatives with different LEE1 regulatory region fragments (Figure 3.1). Initially, 
M182 was co-transformed with pRW224 carrying the LEE10-568 fragment and the different 
pACYC184 derivatives, and lac expression was quantified. The results illustrated in Figure 
3.6 show that GrlA causes ~6-fold activation of expression from the promoter fragment and as 
expected, this activation was found to be suppressed by the presence of GrlR (Jobichen et al., 
2007).  
 
In order to map a minimal region of LEE1 operon regulatory region necessary for GrlA-
dependent activation, the GrlA-dependent activation was measured at the LEE1 regulatory 
region carried by fragments with the two series of nested deletions described earlier (Figure 
3.1). Interestingly, activation is observed with the LEE20 series of fragments that lack the P2 
promoter (Figure 3.7). Moreover, the activation is lost with the LEE10-195, LEE10-155, 
LEE10-115 and LEE10-75 fragments in which segments of the P1 promoter are deleted 
(Figure 3.7). These results suggest that the LEE1 P1 promoter is the target for activation by 
GrlA, and this can be measured even with the short LEE20-203 fragment that carries only 52 
base pairs P1 sequence.  
 
GrlA-dependent activation was also measured in the Sakai EHEC serotype O157:H7 strain 
using the LEE1 P1 promoter carried by the LEE20-203 fragment. Results illustrated in Figure 
3.8 show that activation level in Sakai is similar to that seen in M182 (Figure 3.8). The 
expression from the LEE20-203 promoter fragment cloned into pRW224 in E. coli Sakai wild 
type background was also measured in the absence of plasmid encoded GrlA and that activity 
was compared with those measured in either grlA or grlR mutant strains. Results illustrated in 
Figure 3.8 show that no significant differences appear in the β-galactosidase activity between 
different strains. However, the promoter activity was found to be decreased slightly in grlA 
mutant strain and increased in grlR mutant strain compared with the activity observed in wild-
type Sakai background. The reduced trend of the promoter activity in grlA mutant background 
suggests that the GrlA might play a positive role in the expression from the LEE1 P1 
promoter. The slight increase in the level of promoter activity in the grlR mutant background 
compared with that in the wild-type Sakai background again suggests that the free GrlA might  
positively regulate expression from the LEE1 P1 promoter. Moreover, this supports the fact
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Figure 3.6. Activation of expression from the LEE1 regulatory region by GrlA. 
The bar chart illustrates measured β-galactosidase expression in M182 cells containing 
pRW224 with the LEE10-568 promoter fragment together with plasmid pACYC184ΔHN 
(R-A-), pSI01 (R+A+), pSI03 (R+A-) or pSI02 (R-A+). Measurements were made after 
growing the cells in LB medium at 37ºC to an optical density of ~0.5 at 650 nm. Each bar 
represents the mean of three independent experiments together with the standard deviation.  
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Figure 3.7. GrlA-dependent activation at different LEE1 regulatory region fragments.   
The left part of the figure illustrates different fragments covering the LEE1 regulatory region that were cloned into pRW224, using the 
same conventions as in Figure 3.1. The right part of the figure presents β-galactosidase activities measured in M182 cells carrying pRW224 
containing each of the fragments. Cells also contained either pSI02 (+GrlA) or empty vector, pACYC184ΔHN (-GrlA). Measurements 
were made after growth in LB at 37ºC to an optical density of ~0.5 at 650 nm. Standard deviations (sd) were obtained from at least three 
independent experiments. The fold activation by GrlA for each fragment is shown in third column. 
 
Expression from different promoters 
β-galactosidase activity 
(Miller Units ± sd ) 
-GrlA +GrlA Fold  
activation 
584 ± 21 3831 ± 72 6.6 
1120±93 5325±81 4.8 
1838±273 6178±162 3.4 
1821±28 5848±231 3.2 
381±5 2278±260 6 
354±5 356±3 1.0 
49±1 49±1 1.0 
146±17 153±17 1.0 
26±0 24±1 1.0 
3721±130 7645±67 2.1 
5012±297 10772±616 2.1 
5477±300 9125±237 1.7 
1353±16 4448 ± 169 3.3 
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Figure 3.8. GrlA-dependent activation in an EHEC strain. 
The figure illustrates β-galactosidase activities measured in E. coli Sakai 813 strain (Wild 
type: WT), and grlA and grlR mutant derivatives carrying pRW224 with the LEE20-203 
promoter fragment. Cells also contained either empty vector, pACYC184ΔHN (-GrlA: open 
bars), or pSI02 (+GrlA: shaded bars). Measurements were made after growth in LB at 37ºC to 
an optical density of ~0.5 at 650nm. Standard deviations were obtained from three 
independent experiments. 
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that GrlR interacts with the GrlA and prevents the GrlA from activating the LEE1 P1 
promoter (Jobichen et al., 2007). 
 
Both Barba et al. (2005) and Jimenez et al. (2010) reported that GrlA activates LEE1 
promoter mainly by counteracting H-NS-mediated repression. They also reported GrlA 
-dependent activation of LEE1 in the absence of H-NS. To address this issue further, lac 
expression from four different nested derivatives of the LEE1 regulatory region was measured 
in E. coli K-12 strain MG1655 and its isogenic hns derivative. Data shown in Figure 3.9 
illustrate that activity from the full-length LEE10-568 is clearly repressed by H-NS, but 
expression from the short LEE20-203 fragment is not. It also shows that both upstream 
(LEE20-568) and downstream (LEE10-203) sequences of the P1 promoter are needed for 
repression by H-NS, which might support the DNA bridging property of H-NS (Dame et al., 
2005; Stoebel et al., 2008; Browning et al., 2010). GrlA-dependent activation was also 
measured in MG1655 and its isogenic hns derivative (Figure 3.10). With the full-length 
LEE10-568 fragment, repression of the LEE1 promoter by H-NS is overcome by GrlA, which 
activates to higher levels in both the hns
+
 and hns backgrounds. With the short LEE20-203 
fragment, the LEE1 promoter activity that is not repressed by H-NS is activated similarly by 
GrlA in both genetic backgrounds. These results suggest that GrlA can activate the LEE1 P1 
promoter independently of H-NS as well as counteract repression by H-NS. 
 
3.7 Evidence that GrlA binds to the spacer region at the LEE1 P1 promoter 
GrlA activates expression from both LEE10-203 and LEE20-203 promoter sequences, which 
begin immediately upstream of the -35 TTGACA hexamer element (Figure 3.11A). These 
data suggest that GrlA interacts with the promoter DNA sequence located downstream of its  
-35 element. To identify essential promoter determinants for activation, a series of derivatives 
of the LEE20-203 fragment containing different point mutations throughout the fragment 
were constructed and GrlA-dependent activation was measured. The effects of 23 point 
mutations throughout this fragment, which carries only 46 base pairs of the LEE1 regulatory 
region sequence, were measured. Results illustrated in Figure 3.11 show that GrlA-dependent 
activation is completely suppressed by the 89G, 90C, 91C, 92A and 98C substitutions. 
Mutation 98C corresponds to the base change at the second position of the promoter -10  
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Figure 3.9. Repression by H-NS at the LEE1 regulatory region. 
A. Schematic representation of four nested deleted derivatives of LEE1 operon regulatory 
region.  
B. The bar chart illustrates measured β-galactosidase activities in E. coli K-12 strain MG1655 
(WT) and a Δhns derivative carrying pRW224 with LEE10-568, LEE10-203, LEE20-568 or 
LEE20-203 fragments. Measurements were made after growth of the cells in LB at 37ºC to an 
optical density of ~0.5 at 650 nm. Values are the average of at least three independent assays, 
and standard deviations are shown with bars. 
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Figure 3.10. Repression by H-NS and activation by GrlA at the LEE1 regulatory region. 
A. Schematic representation of the LEE10-568 and LEE20-203 fragments of LEE1 operon 
regulatory region.  
B. The bar chart illustrates measured β-galactosidase activities in E. coli K-12 strain MG1655 
(WT) and a Δhns derivative carrying pRW224 with either the LEE10-568 or LEE20-203 
fragments. Cells also contain either empty vector pACYC184ΔHN (-GrlA: open bars) or 
pSI02 (+GrlA: shaded bars). Measurements were made after growth of the cells in LB at 37ºC 
to an optical density of ~0.5 at 650 nm. Values are the average of at least three independent 
assays, and standard deviations are shown with bars. 
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Figure 3.11. Mutational analysis of the LEE20-203 fragment. 
A. Base sequence of the LEE20-203 fragment numbered and annotated as in Figure 3.3. The asterisks and shading indicate bases where 
substitutions suppress GrlA-dependent. 
B. The figure illustrates β-galactosidase activities measured in M182 cells carrying pRW224 containing the starting LEE20-203 fragment 
(WT) or derivatives with different single base substitutions, indicated on the x-axis. Measurements were made in cells containing either 
pSI02 (+GrlA: shaded bars) or empty vector, pACYC184ΔHN (-GrlA: open bars). Standard deviations were obtained from three 
independent experiments. 
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element and as described earlier, it completely inactivates the P1 (Figure 3.4). In contrast, 
positions 89-92 fall within the 18 base pair promoter spacer region. The effects of changes at 
these positions could be explained by a simple way that they fall within the binding site for 
GrlA and hence, suppress GrlA binding and prevent activation. Since the LEE1 P1 promoter 
carries 18 base pairs non-optimal spacer sequence between its -10 and -35 elements (Figure 
3.3) and GrlA binds the spacer sequence (Figure 3.11), it was speculated that the spacer 
length might play a role in the GrlA-dependent activation of this promoter. To check this, a 
number of derivatives of the LEE20-203 fragment containing insertions or deletions in the 
spacer region were constructed. In order to ensure that either base deletions or insertions are 
not interfering with the GrlA binding site, changes were made either upstream or downstream 
of, but not within, positions 89-92. The effects of altering the length of the spacer length on 
GrlA-dependent activation at the LEE1 P1 promoter were then measured and recorded in 
Table 3.2. The results show that basal promoter activity is increased by single base deletions 
at positions 79 or 94, but decreased by two-base deletions at positions 79 and 80, or by single 
base insertions between positions 78 and 79 or between positions 93 and 94. Therefore, as 
expected, the optimal LEE1 P1 activity is found with a 17 base pair spacer. On the other hand, 
GrlA-dependent activation of the LEE1 P1 promoter is found only with the starting 18 base 
pair non-optimal spacer. Interestingly, the activation is suppressed by all of the deletions and 
insertions that I tested. These results unambiguously suggest that the spacer length between 
the P1 promoter -35 and -10 elements is crucial for the GrlA-dependent activation of the 
promoter. 
 
A complementary experiment was performed to check that results concerning the GrlA target 
in the P1 spacer obtained from experiments with the short LEE20-203 fragment are applicable 
for the full-length LEE10-568 fragment. Hence, LEE10-568 derivatives containing few 
different altered bases at P1 were constructed by megaprimer PCR and cloned to pRW224. 
The effects of the changes on GrlA-dependent activation were measured. Like at the short 
LEE20-203 fragment, base alterations in the P1 promoter spacer affect GrlA binding at full 
-length LEE10-568 regulatory region (Figure 3.12). 
 
3.8. Biochemical and genetic analyses of GrlA binding to its target 
As part of this research, efforts to show direct interaction between purified GrlA and the  
 
  
 
154 
Table 3.2: Effects of spacer length on activation by GrlA at the LEE1 P1 promoter 
 
 
The table shows measured β-galactosidase activities in cultures of E. coli strain M182 carrying pRW224 containing the LEE20-203 
fragment and different derivatives with insertions or deletions in the P1 promoter spacer. Cells also contained either plasmid 
pACYC184ΔHN (-GrlA) or pSI02 (+GrlA). Cultures were grown aerobically at 37°C in LB medium to an optical density of ~0.5 at 650 
nm. Activities were measured in triplicate, giving a mean and standard deviation (sd). The second column of the table shows the fragment 
base sequence from position 73 to position 102, with the P1 promoter -10 and -35 hexamer elements underlined. Base deletions in the 
different fragments are indicated by dashes whilst insertions are shown in boldface type and coloured red. The fold activation by GrlA for 
each fragment is shown in sixth column. 
 
Derivative Promoter sequence from positions 73-102 Spacer 
length 
(bp) 
β-galactosidase activity 
(Miller units ± sd) 
- GrlA +GrlA Fold 
activation 
      
LEE20-203 (WT) 5'-TTGACATTTAATGATAATGTATTTTACACA-3' 18 1479 ± 36 4797 ± 140  3.2 
Δ79T 5'-TTGACA─TTAATGATAATGTATTTTACACA-3' 17 6255 ± 87 7213 ± 149  1.2 
Δ94T 5'-TTGACATTTAATGATAATGTA─TTTACACA-3' 17 3918 ± 79  4097 ± 55  1.0 
Δ79/80T 5'-TTGACA──TAATGATAATGTATTTTACACA-3' 16 473 ± 21 491 ± 29  1.0 
InsT (78-79) 5'-TTGACATTTTAATGATAATGTATTTTACACA-3' 19 1054 ± 123 947 ± 12  1.0 
InsT (93-94) 5'-TTGACATTTAATGATAATGTATTTTTACACA-3' 19 588 ± 6 621 ± 13  1.0 
73 80 90 100 
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Figure 3.12. Mutational analysis of the LEE10-568 fragment. 
A. Base sequence from positions 73 to 118 of the LEE10-568 fragment numbered and 
annotated as in Figure 3.5. The shading indicates bases where substitutions suppress  
GrlA-dependent activation. 
B. The figure illustrates β-galactosidase activities measured in M182 cells carrying pRW224 
containing the starting LEE10-568 fragment (WT) or derivatives with different single base 
alterations, indicated on the x-axis. Measurements were made in cells containing either pSI02 
(+GrlA: shaded bars) or empty vector, pACYC184ΔHN (-GrlA: open bars). Base alterations 
that suppress GrlA-dependent activation are indicated by asterisks. 
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LEE1 P1 promoter as well as to identify the GrlA target at the promoter spacer using the well-
known in vitro band shift and footprinting techniques, respectively (Minchin and Busby, 2009) 
were made. However, all efforts were unsuccessful as it proved impossible to purify  
soluble functional GrlA. To solve the problem, different genetic approaches were used. Firstly, 
suppression genetic analysis was considered. In this experiment, advange was taken of having 
the LEE20-203 derivative containing 92A mutation that reduces the expression from the 
fragment in either the presence or absence of wild type GrlA (Figure 3.11). Using suppression 
genetic approach, it was attempted to show whether any mutation in the GrlA could improve 
the expression level from the derivative of LEE20-203 containing 92A mutation. To do this, 
error-prone PCR was used to create 10 independent preparations of random mutations in the 
grlA coding sequence within pSI02. Mutated plasmids were then transformed into E. coli 
strain M182 containing pRW224 carrying the LEE20-203 fragment with the 92A substitution. 
Note that, reduced expression due to the 92A mutation results in Lac
-
 colonies on MacConkey 
lactose indicator plates. However, after screening over 75,000 transformants, 11 Lac
+
 colonies 
containing pSI02 with single-base substitutions leading to the RK53, IT59 or IV59 
substitutions in GrlA were found. Interestingly, all of these these substitutions fall in the 
predicted DNA recognition helix of the helix-turn-helix DNA binding motif of GrlA (Figure 
3.13A). Results illustrated in Figure 3.13B show that the RK53, IT59 and IV59 substitutions 
partially restore GrlA-dependent activation with the LEE20-203 fragment carrying the 92A 
mutation.  
 
In order to check whether the restoration of GrlA-dependent activation is specific for 92A 
base substitution, the effects of RK53, IT59 and IV59 substitutions on the expression from the 
LEE20-203 derivatives carrying either 89G, 90C or 91C substitutions were measured. Results 
illustrated in Figure 3.13B show that none of the substitutions (RK53, IT59 or IV59) 
improves the expression from LEE20-203 derivatives containing either 89G, 90C or 91C 
mutations. This suggests that the GrlA-dependent activation can only be restored by the RK53, 
IT59 or IV59 substitutions if the LEE20-203 derivative carries 92A mutation. A possible 
explanation of these results is that when bound at the LEE1 P1 promoter, residues 53 and 59 
may contact with the base pair at position 92. This suggests that the predicted helix-turn-helix 
in GrlA is functional in binding the target site at the LEE1 P1.  
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Figure 3.13. Analysis of GrlA-dependent activation using suppression genetics. 
A. The figure shows the GrlA amino acid sequence. The helix-turn-helix DNA binding motif predicted by Deng et al. (2004), and confirmed by the 
Dodd & Egan, GYM2.0 and Jpred prediction tools (see section 2.18) is indicated by grey shading. Substitutions at R53 and I59, identified after random 
mutagenesis and selection for suppressors of the 92A mutation in the LEE1 P1 promoter, are indicated. The number adjacent to each substitution is 
number of times that it was isolated. 
B. The figure shows the effect of GrlA substitutions on the activity of LEE1 P1 promoter mutants. The bar charts illustrate β-galactosidase activities in 
M182 cells carrying pRW224 containing the LEE20-203 fragment with single base substitutions, indicated on the x-axis. Measurements were made in 
cells containing either pSI02 encoding wild type GrlA (WT, open bars) or GrlA with the RK53, IT59 or IV59 substitutions, as indicated (grey bars). 
Standard deviations were obtained from three independent experiments. 
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In a complementary experiment, a set of pSI02 derivatives encoding GrlA with alanine 
substitutions at sequential residues from L52 to S63 were constructed and the GrlA-dependent 
activation of expression from the starting LEE20-203 fragment was measured. Results 
illustrated in Figure 3.14A show that RA54 substitution reduces the activation most (Figure 
3.14A). These results together with the suppression genetic data suggest that the side chain of 
residue R54 in GrlA makes a contact with the GrlA target at any of four positions 89-92 in the 
LEE20-203 fragment and that the RA54 substitution causes a loss of the side chain and thus, 
ensuing the activation and that the RK53 substitution in the neighbouring side chain makes a 
contact that compensates for the 92A substitution.  
 
In order to determine whether any of the alanine substitutions could restore the activity lost 
due to specific base substitutions in the putative GrlA operator target in the LEE20-203 
promoter fragment, the expression from the LEE203 promoter derivatives containing either 
89G, 90C or 91C was measured in the presence of alanine substitutions or the wild type GrlA. 
Among different alanine substitutions, the FA57 substitution partially restores the effects of 
the 89G and 90C substitutions (Figure 3.14B and C). The results suggest a direct interaction 
between the substitution FA57 and base pairs at positions 89-90 in the mutated LEE20-203 
89G or 90C fragments. In other words, F57 collides with the base pairs at positions 89-90 in 
the mutated LEE20-203 89G or 90C fragments, probably because when bound, residue F57 
comes closer to positions 89 and 90. Likewise, the residue R53 contacts with the position 
91(Figure 3.14D). 
 
As an alternative approach to see the direct binding of GrlA protein to the LEE1 P1 promoter, 
DNA-sampling protocol was used, originally reported by Butala et al., (2009). It is a method 
of rapid isolation of a specific segment of DNA and accompanying proteins from E. coli K-12 
strain. The DNA fragment to be sampled is produced as a discrete fragment within cells by 
the yeast I-SceI meganuclease, and is purified using FLAG-tagged LacI repressor and beads 
carrying anti-FLAG antibody. 
 
LEE20-275 promoter fragment (Figure 3.3) was cloned into pRW902 EcoRI-HindIII sites 
adjacent to the 5 LacI operators with two flanking 18 base pairs target sites for the yeast 
meganuclease I-SceI (see plasmid detail in Figure 2.4). The resulting plasmids were 
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Figure 3.14. Epistasis analysis of GrlA interactions. 
The figure shows bar charts that illustrate measured β-galactosidase activities in M182 cells 
carrying pRW224 containing the LEE20-203 fragment with the starting LEE1 P1 promoter 
sequence (panel A), and with the 89G (panel B), 90C (panel C) or 91C (panel D) mutations. 
Measurements were made as in Figure 3.6 with cells carrying pSI02 encoding wild type GrlA 
(WT) or the different alanine substitutions indicated on the x-axis. For each promoter, the data 
are expressed as a percentage of the activity with wild type, the values are the average of three 
independent assays, and standard deviations are shown with bars. 
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transformed into E. coli K-12 MG1655 3xFLAG-tagged lacI (Table 2.1). Plasmid pBAD-SG 
(Figure 2.9) that encodes SceI and the bacteriophage lambda Gam protein, under the control 
of an arabinose inducible promoter was co-transformed. The strain was also co-transformed 
either with pACYC184ΔHN (GrlR-A-), pSI01 (GrlR+A+) or pSI02 (GrlR-A+). After 
induction by arabinose, a discrete DNA fragment carrying the promoter of interest with five 
LacI repressor targets was generated and the fragment was stable due to inhibition of 
RecBCD by the Gam protein. Immunoaffinity methods using magnetic beads carrying  
anti-FLAG antibodies were then used to isolate the DNA fragment together with 
accompanying proteins, which were finally identified using gel electrophoresis and mass 
spectroscopy. Proteins that were accompanied with the LEE20-275 fragment are shown in 
Figure 3.15. Proteins that were confirmed by the mass spectroscopy are indicated by asterisks 
in the Figure 3.15. These are 50S ribosomal protein L15, RNAP ω-subunit, Hfq and HU. 
Other protein bands are labelled according to their sizes (Lee et al., 2008; Butala et al., 2009). 
On basis of sizes, the analysis reveals a major band corresponding to the FLAG-tagged LacI 
and bands for RNAP subunits in the complex. However, no GrlA protein (~16 kDa) was 
detected in the lane 4. The intensity of the bands of the RNAP subunits in the lane 4 seems to 
be high compared with those in land 2 and 3 suggesting that the level of RNAP is high in the 
lane 4 compared with those in lane 2 or 3. This suggests that the presence of GrlA in the cell 
possibly causes increased recruitment of the RNAP to the LEE1 P1 promoter.  
 
In order to determine whether GrlA can bind RNAP prior to interacting with its target at the 
spacer between P1 promoter -10 and -35 elements, a pull down experiment was conducted 
essentially following Lee et al. (2008). The experiment was designed to analyze protein A 
affinity tagged RNAP (β':4PrA) with associated proteins from E. coli Sakai cells. In this 
experiment, plasmids pACYC184ΔHN (GrlR-A-), pSI01 (GrlR+A+) or pSI02 (GrlR-A+) 
were transformed in an E. coli O157:H7 Sakai strain containing chromosomal fusion of 
protein A affinity tag with the RNAP β'-subunit (see detail in section 2.14). RNAP was 
affinity isolated from the cells grown to mid-exponential growth phase in LB and the protein 
complexes were analyzed by SDS-PAGE (Figure 3.16). However, the experiment fails to 
detect GrlA protein (~16 kDa) on the gel. As expected β':4PrA fusion protein (RpoC) and the 
other three components of core RNA polymerase β (RpoB), α (RpoA), and ω (RpoZ) were 
found. These protein bands are labelled according to their sizes (Lee et al., 2008). 
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Figure 3.15. SDS-PAGE analysis of proteins bound on the LEE20-275 promoter 
fragment.  
The figure shows the affinity-isolated proteins from E. coli K12 strain MG1655 grown in LB 
medium. Lane1 represents the calibration of the gel using Invitrogen SeeBlue Plus 2 protein 
markers (M). The lane 2 represents proteins from cells containing plasmid pACYC184ΔHN 
(GrlR-A-, as control). Lane 3 shows proteins from the cells containing plasmid pSI01 
(GrlR+A+). Lane 4 shows proteins from the cells carrying plasmid pSI02 (GrlR-A+). Proteins 
that were confirmed by mass spectrometry are indicated by asterisks, whilst other proteins are 
labelled according to their sizes (Lee et al., 2008; Butala et al., 2009).  
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Figure 3.16. Affinity isolation of RNA polymerase binding proteins. 
SDS-PAGE analysis of pulled out RNA polymerase associated proteins from E. coli O157:H7 
Sakai carrying chromosomal rpoC:PrA fusion. Cells also contain plasmids pACYC184ΔHN 
(R-A-), pSI01 (R+A+) or pSI02 (R-A+). Analyses were made after growth to mid-exponential 
growth phase in LB medium. The gel was stained with Coomassie blue and calibrated with 
Invitrogen SeeBlue Plus 2 protein markers (M). Bands are labelled according to their sizes 
(Lee et al., 2008; Butala et al., 2009). 
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3.9 Discussion 
The LEE pathogenicity island is one of the major determinants playing a leading role during 
infection in pathogenic E. coli and other related bacteria. The expression of the different LEE 
genes must be carefully controlled in time and space. Different regulatory inputs explore the 
LEE1 operon regulatory region to control overall expression from the LEE. Here, I have 
investigated GrlA-dependent activation from the LEE1 operon regulatory region using a 
simplified system where non-pathogenic E. coli K-12 strain was used as a „test tube‟.   
 
Firstly, the relative contribution of the two promoters, P1 and P2 was determined, in the 
expression from the LEE1 operon regulatory region and it was concluded that P1 is the major 
promoter in the LEE1 expression. This conclusion is in agreement with Porter et al. (2005). In 
contrast, Sperandio et al., (2002) as well as Sharp and Sperandio (2007) reported a bigger role 
for P2.  However, possible reasons for the differences could be the precise fusions, strains and 
conditions used for the experiments. Experimental conditions of this work allowed for the 
detailed mutational analysis of the key P1 promoter (Figure 3.3 and Table 3.1) and TTGACA 
and TACACA were identified as the functional -35 and -10 hexamer elements, respectively. 
The -35 element, which matches perfectly the consensus for E. coli promoters (Rosenberg and 
Court, 1979; McClure, 1985) was predicted by Sperandio et al. (2002) and other groups. In 
the case of the -10 element, Sperandio et al. (2002) originally assigned TACACA as -10 
element whilst other groups marked a hexamer sequence located 2 base pairs upstream, 
TTTACA as -10 element (Porter et al., 2005; Russell et al., 2007; Sharp and Sperandio, 2007). 
Differences in tracing the -10 element are probably due to the uncertainty in the location of 
the P1 transcript start. It is likely that both -35 and -10 elements were identified on the basis 
of their relative distance from the transcript start site and by comparison to E. coli promoter 
consensus -10 and -35 hexamers. However, mutational analysis presented here argues 
unambiguously that the TACACA is the -10 element of the P1 promoter. This means that the 
P1 promoter has a non-optimal 18 base pairs spacer sequence, which is just one above the 
optimal 17 base pairs for promoter activity (McClure, 1985). It is important to mention that 
the location of the 5‟ end of transcripts with respect to -10 hexamer regions at bacterial 
promoters is not fixed (Darst, 2009). Moreover, highly AT-rich sequence downstream of 
the -10 element might cause a greater than usual unwinding (>20 base pairs) seen in the open 
complex probed by permanganate (Figure 3.4A; compare with Browning et al., 2009). This 
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may be the reason for the greater flexibility at the LEE1 P1 promoter. Therefore, the different 
transcription start points reported by different groups in different experiments could all be 
correct. Moreover, Sclavi (2009) reported that in many cases, the upstream end of the -10 
hexamer provides the major anchoring point for RNAP and the location of the first templated 
base is not fixed. For this reason, instead of following the customary convention of numbering 
base sequences with respect to the transcript start point, an arbitrary numbering system was 
used considering the first cloned base as a start point to describe the experiments (Figure 3.3). 
 
Though most summaries of transcriptional regulation in the LEE (e.g. Kendall et al., 2010) 
show GrlA as an activator for expression from the LEE1 regulatory region, the current 
literature is not completely unambiguous. The K-12 system reconstitutes a significant 
activation at LEE1 by GrlA (Figure 3.6) and shows that the activation was suppressed by 
GrlR. This suggests that the experimental conditions presented here provide physiologically 
relevant effects. Intriguingly, it was found that GrlA could activate expression from a very 
short promoter fragment (LEE20-203) that contains only 52 base pairs sequence and lacks 
upstream sequence of promoter -35 element. More strikingly, interacting site for GrlA was 
found at the spacer between promoter -35 and -10 elements. The observation that GrlA 
exhibits dual functions in regulation of the LEE1 regulatory region is in line with Jimenez et 
al. (2010). In one hand, GrlA counteracts H-NS-mediated repression of the expression from 
the LEE1 promoter regulatory region and on the other hand, it activates the promoter in H-NS 
independent fashion (Figure 3.10). However, expression from the short 52 base pairs LEE20-
203 fragment is not repressed by H-NS but activated by GrlA. This observation 
unambiguously suggests that GrlA can function as a true transcription activator.  
 
To date, no one is able to define GrlA target at the LEE1 promoter in vitro. This is most 
probably due to the difficulty in obtaining purified functional GrlA. Attempts were made to 
reproduce the in vitro binding of purified GrlA, reported by Huang and Syu (2008) and 
Jimenez et al. (2010) but they were unsuccessful. However, different genetic approaches were 
used to show that the predicted DNA-binding helix-turn-helix motif in GrlA is functional, and 
to define its target in the promoter. Most bacterial transcription activators bind sites upstream 
of or overlapping the promoter -35 element (Browning and Busby, 2004). Surprisingly, it was 
found that GrlA binds the spacer region between the LEE1 P1 promoter -35 and -10 elements. 
It is important to recall that many members of the MerR family transcription regulators bind 
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to sites located between the -10 and -35 hexamers at target promoters (reviewed by Brown et 
al., 2003). Moreover, they act on their target promoters where the length of the spacer 
sequence between the -10 and -35 hexamers is higher than the optimum 17 base pairs. Models 
for activation by MerR family members show that their tight binding to the spacer between 
target promoters -35 and -10 elements causes physical bending or twisting the DNA resulting 
in reorientation of the  promoter -35 and -10 elements. Thus, the rearranged promoter -35 and 
-10 elements could bind the RNAP effectively to initiate transcription (Ansari et al, 1995; 
Brown et al., 2003). The observation that shortening of the LEE1 promoter spacer from 18 to 
17 base pairs increases the promoter activity and ceases GrlA-dependent activation suggests 
that activation mechanism of GrlA is similar to many of the MerR family activators (Figure 
3.17), even though there is no significant sequence similarity between GrlA and any of the 
member of the MerR family. However, association of free GrlA with holo RNAP prior to 
binding at target promoter cannot be ruled out. But a preliminary study using the materials 
and pull-down protocols described by Lee et al. (2008) did not find any evidence for direct 
association of GrlA with free RNAP (Figure 3.16). 
 
GrlA increases the ler transcription but in combination with GrlR, it does not have the effect 
on ler expression suggesting that GrlR modulates the GrlA-dependent activation of ler gene 
expression. However, to make sure GrlA-dependent activation of LEE1 promoter, bacterial 
cells might sense a signal(s) that may modulate anti-GrlA action of GrlR. In order to address 
whether any factor(s) is involved to overcome the GrlR mediated repression in GrlRA action, 
expression from LEE1 promoter regulatory region were quantified in the presence of plasmid 
encoded GrlRA together with in trans supply of different small proteins (PchC, CesD, CesT, 
CesL or Ler) in E. coli K12 cells or the activity was measured in the presence of different 
low-molecular-weight ligands or signaling molecules such as sodium bicarbonate, small fatty 
acids etc. None of the substances that were tried was found to be involved in releasing the 
GrlR-mediated repression of GrlRA (data not shown).  
 
To sum up, GrlA activates the LEE1 promoter by a novel mechanism that underscores the 
complex regulatory system at the LEE1 operon regulatory region. However, to get precise 
knowledge on the action of GrlA, other targets of GrlA need to be analysed. It has been 
reported that GrlA positively regulates the expression of the Ehx enterohaemolysin (Saitoh et 
al., 2008) and repress genes responsible for the formation of flagella (Iyoda et al., 2006). 
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Figure 3.17. Model for activation of LEE1 P1 promoter by GrlA. 
A. Weak recognition of the promoter by RNA polymerase due to sub-optimal spacer length.  
B. Efficient recognition of the promoter by RNA polymerase due to optimised spacer length.  
C. GrlA interacts with the spacer sequence and facilitates RNA polymerase activity. 
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A cryptic promoter in the LEE1 regulatory  
region: promoter specificity in AT-rich  
gene regulatory regions  
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4.1 Introduction 
Bacterial gene regulatory regions contain promoters that have evolved to set the level of 
expression of downstream genes, and the different promoter elements that are recognised by 
the multi-subunit bacterial RNAP are now well understood. Exhaustive analyses of E. coli 
promoters have shown that the principal promoter elements are the -35 and -10 hexamer 
elements, and consensus sequences of TTGACA and TATAAT respectively have been 
derived. Thus, to a first approximation, the strength of an E. coli promoter will depend on the 
degree to which the base sequence of the functional -10 and -35 elements correspond to the 
consensus (reviewed in Busby et al., 2009). 
 
Computational analysis of E. coli sequences has revealed the existence of potential -10 
and -35 elements at higher than expected frequencies in intergenic regulatory regions (Huerta 
and Collado-Vides, 2003; Huerta et al., 2006). Whilst this is probably a by-product of the 
evolution of gene regulatory regions, it raises the issue of the specificity of promoter 
recognition by RNAP, and the role played by cryptic promoter elements. This is especially 
relevant for regulatory regions within horizontally acquired pathogenicity islands that are 
generally characterised by a high proportion of AT base pairs (Hacker et al., 1997).  
 
Experimental evidence that supports the existence and function of promoter-like sequences or 
cryptic promoters within the regions upstream of genes is limited. Woody et al (1993) found 
that mutation at the PR promoter in the OR region of bacteriophage λ unmasks the Pα cryptic 
promoter. Pα competes with both PR and PRM promoters since it is only active when PR is 
mutated and can be suppressed by mutations that increase PRM activity. 
 
The E. coli lactose operon regulatory region has a principal promoter, lac P1 that is 
overlapped by at least five promoter-like elements or cryptic promoters (Reznikoff, 1992). 
One well-studied cryptic promoter is lac P2. Transcription initiates from this promoter at a 
site that is located 22 base pairs upstream of the P1 promoter transcript start. P2 promoter 
interferes with RNAP binding at the P1 promoter (Malan and McClure, 1984). In the E. coli 
galactose operon regulatory region, there are three overlapping promoters P1, P2 and P3 that 
specify transcription initiation from sites S1, S2 and S3, respectively. Musso et al. (1977) first 
found that mutational analysis of gal P1 promoter abolished transcription initiation from S1 
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site but that initiation could occur from the S2 site of P2 promoter located 5 base pairs 
upstream of S1. In contrast to lac P1 and P2 promoters, gal P1 and P2 promoters are distinct 
each other since mutation in P1 eliminates transcription initiation from S1 site without 
affecting the transcription initiation from S2 site of P2 promoter and vice-versa (Busby et al., 
1982; Bingham et al., 1986). Ponnambalam et al. (1987) further reported that a point mutation 
that simultaneously stops transcription initiation from sites S1 and S2, unmasks a third 
promoter, P3 that initiates transcription from the S3 site, which is located 14 base pairs 
upstream of S1. 
 
Transcription initiation from overlapping promoters both in lac and gal operons are co-
ordinately regulated by the cAMP and its receptor protein, CRP (Musso et al., 1977; Aiba et 
al., 1981; Malan and McClure, 1984; Kuhnke et al., 1986). In both operons, cAMP-CRP 
causes shifting of transcription initiation from the upstream promoter P2 to the downstream 
promoter P1. Generally, CRP-independent transcription comes from the P2 promoter. The 
presence of CRP plus cAMP causes repression of transcription from P2 promoter and initiates 
transcription from P1 promoter. Thus, CRP-cAMP can exert both positive and negative 
control at overlapping promoters. 
 
In Chapter 3, mutational analysis of the LEE20-275 promoter fragment was performed to 
identify functional elements of the LEE1 P1 promoter. During this work, a number of double 
mutations provided interesting observation. Subsequent biochemical- and mutational analyses 
of the mutated fragments unveiled a cryptic promoter designated, P1A, which overlaps with 
the principal P1 promoter and initiates transcription from a site located 10 base pairs upstream 
of the transcription initiation site of the P1 promoter. Surprisingly, mutations in the LEE1 P1 
promoter -10 and -35 hexamer elements unmask the cryptic promoter to different extents. 
This chapter describes experiments aimed to investigate the cryptic promoter. 
 
4.2 Unexpected promoter activity unmasked by double mutations in the 
LEE20-275 fragment 
In Chapter 3, error-prone PCR was exploited to generate a library of random mutations in the 
LEE20-275 fragment cloned in pRW224. MacConkey lactose indicator plates were then used 
to screen the Lac phenotype of colonies of M182 cells carrying the pRW224 library and 
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single base substitutions that reduced promoter activity were selected. Strikingly, over 90% of 
the selected base changes fell in two hexamer elements, TTGACA and TACACA, that were 
identified as the P1 promoter -35 and -10 hexamers respectively (Figure 3.3). Assays with the 
different mutated LEE20-275 fragments cloned in pRW224 showed that single mutations in 
the P1 -10 element reduced measured lac expression to 3-6% of the level with the starting 
fragment, whilst mutations in the -35 element reduced expression to 12-27% of the starting 
level.  
 
Since random mutagenesis is an inefficient way to produce a full repertoire of promoter 
„down‟ mutations, site-directed mutagenesis was used to introduce some mutations at specific 
positions in the P1 promoter. During the screening of Lac
-
 M182 colonies (white or pale pink 
colonies) that carried mutations at position 2 of the -10 hexamer (98C or 98G or 98T) of the 
P1 promoter in the LEE20-275 fragment cloned in pRW224, a number of anomalous Lac
+
 
colonies (Pink or Red colonies) were isolated. Sequence analysis showed that, in these 
colonies, the LEE20-275 fragments carrying mutation at position 98, contained an additional 
base alteration that resulted in LEE20-275 98C 64G, LEE 98C 35C, LEE20-275 98T 75C or 
LEE20-275 98G 76G derivatives (Figure 4.1). 
 
In addition, to determine functional importance of different base species substations at 
position 96 (one base upstream of the P1 -10 hexamer sequence) in P1 promoter activity, the 
nucleotide T in 96 position was replaced with G or C in LEE20-275 fragment and cloned into 
pRW224. M182 cells containing recombinant plasmids were then screened for their Lac 
phenotype in MacConkey lactose indicator plate. Most of the colonies screened were Lac
+
 
(red colonies) and some were Lac
-
 (white or pink colonies). Sequence analysis confirmed that 
C for T change at position 96 (LEE20-275 96C) caused a red phenotype, G for T (LEE20-275 
96G) caused a white phenotype. Amongst the colonies, I isolated G for T at position 96 
together with G for A at position 100 (LEE20-275 96G 100G) that gave a pink phenotype. 
 
The lacZ expression from each of the derivatives containing double mutations was compared 
with that of wild type LEE20-275 fragment or the derivatives with single mutations. 
Expression from the derivatives appears to be interesting as β-galactosidase activities from 
these derivatives significantly differ from those containing single mutations (Figure 4.1). 
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GAATTCCGTTTGTTAACGAGATGATTTTCTTCTATATCATTGATTTTAAATGGATTTTAAAAATA 
 
 
TATGATTTTTTTGTTGACATTTAATGATAATGTATTTTACACATTAGAAAAAAGAGAATAAGCTT 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1. Effects of different double mutations in the expression from the LEE20-275 
promoter fragment.  
(A) Nucleotide sequence of LEE20-275 promoter fragment numbered and annotated as in 
Figure 3.3. EcoRI and HindIII restriction sites are underlined. Positions of the mutations are 
indicated by arrows and double base substitutions are indicated by the same colour.  
(B) The figure illustrates β-galactosidase activities measured in M182 cells carrying pRW224 
containing the starting LEE20-275 fragment (WT) or derivatives with different base 
substitutions. Measurements were made after growth of the cells in LB at 37ºC to an optical 
density of ~0.5 at 650 nm. Values are the average of at least three independent assays, and 
standard deviations are shown with bars. 
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Most interestingly, the base substitution 98C (LEE20-275 98C) at the second position of the 
P1 promoter -10 element almost inactivates the promoter as expected, but this mutation 
together with  64G (LEE20-275 98C 64G), located 34 base pairs upstream of the 98C base 
change, restores the wild type promoter activity. Table 4.1 shows measurements of the 
promoter activity of this fragment, together with controls. As expected, the 98C substitution 
reduces expression to 4% of the starting level, whilst the measured promoter activity of the 
LEE20-275 fragment with both the 98C and 64G substitutions is 20-fold higher, which is 
nearly 80% of the starting level. Results in Table 4.1 also show that, in isolation, the 64G 
mutation causes but a modest 14% increase in promoter activity. 
 
The effect of each of the other double mutations is not as large as that of 98C 64G but they 
also gave interesting observations (Figure 4.1). Double base substitutions 98C 35C caused ~3 
fold increase of the promoter activity compared with that of single base substitution 98C, 
whereas in isolation, the 35C causes 20% increase in promoter activity. The reason for the 
increased promoter activity due to 98C 35C mutations compared with 98C is not clear. Also 
given that base substitutions at the second position of -10 element (98T or 98G) reduced the 
promoter activity to ~3-4% and changes at third or fourth positions of the consensus -35 
element (75C or 76G, respectively) reduces the promoter activity to 18-27%., as expected. 
Unexpectedly, base changes at -10 element together with changes at -35 element (98T 75C or 
98G 76G) increased the promoter activity 6-8 fold compared with that of single mutations at 
position 98 (98T or 98G) and the activity covers 28-32% of the starting level. Results 
illustrated in Figure 4.1 also show that base substitution G for T at position 96 reduced the 
promoter activity drastically. The reason for the reduction of the promoter activity due to 96G 
mutation is not known. The change G for A at position 100 reduced the promoter activity to 
~5%. The reduced level of promoter activity due to 100G is expected since the base change at 
the fourth position of the -10 element results in a weak -10 element (consensus 
1
TATAAT
6
).  
Unexpectedly, the double base substitutions 96G 100G increased the promoter activity 
dramatically compared with the single mutations (96G or 100G) and the activity is nearly 
40% of the starting level. However, since 98C 64G double mutation restored the promoter 
activity largely compared with other double mutations, the promoter derivative containing 
98C 64G double mutations was considered mainly for further study, aimed to address the 
reason for the restoration of the promoter activity. 
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Table 4.1: Mutational analysis of LEE20-275 promoter fragment 
 
Promoter fragments Promoter sequences from positions  62 to 102 β-galactosidase activity 
(Miller units ± sd) 
   
   
LEE20-275 (WT) 5'-TGATTTTTTTGTTGACATTTAATGATAATGTATTTTACACA-3' 5513 ± 261 
LEE20-275 98C  5'-TGATTTTTTTGTTGACATTTAATGATAATGTATTTTCCACA-3' 233 ± 4 (4.2) 
LEE20-275 98C 64G  5'-TGGTTTTTTTGTTGACATTTAATGATAATGTATTTTCCACA-3' 4375 ± 133 (79.4) 
LEE20-275 64G 5'-TGGTTTTTTTGTTGACATTTAATGATAATGTATTTTACACA-3' 6276 ± 20 (114) 
 
The table shows measured β-galactosidase activities in cultures of E. coli strain M182 carrying pRW224 containing the LEE20-275 (WT) 
fragment and different derivatives. Cultures were grown aerobically at 37°C in LB medium to an optical density of ~0.5 at 650 nm. 
Activities were measured in triplicate, giving a mean and standard deviation (sd). Activities expressed as a percentage of activity with the 
starting LEE20-275 fragment are shown in parentheses. The central part of the table shows the fragment base sequence from position 62 to 
position 102, with the P1 promoter -10 and -35 hexamer elements shaded grey. Base substitutions in the different fragments are underlined, 
highlighted in boldface type and coloured red. 
 
 
 
 
62 70 80 90 102 
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4.3 Characterisation of the cryptic LEE1 P1A promoter 
Since it is known that many E. coli promoters are completely inactivated by base changes at 
position 2 of the -10 hexamer (Rosenberg and Court, 1979; Miroslavova and Busby, 2006), 
the simplest explanation for the effect of the 64G mutation is that it unmasks a cryptic 
promoter in the LEE20-275 fragment. To investigate this, transcripts formed, after labelled 
nucleoside triphosphates were added to binary complexes of purified RNAP and the 
LEE20-275 fragment, were analysed. In this experiment, RNAP runs to a downstream 
transcription terminator, and the RNA transcripts are labelled by using 
32
P-labelled UTP and 
analysed by gel electrophoresis (Figure 4.2). With the starting LEE20-275 fragment, the 
major transcript is ~102 bases, which corresponds to the LEE1 P1 transcript that starts at 
position 107A. As expected, this transcript is completely absent when the DNA fragment 
carries the 98C substitution. However, with the LEE20-275 fragment carrying both the 98C 
and 64G substitutions, a new ~112 base transcript is observed. This corresponds to a 
transcript starting at position 97T, suggesting that the 64G substitution has unmasked a 
cryptic promoter (Figure 4.2). To confirm this, I used potassium permanganate footprinting to 
compare regions of DNA duplex unwinding in binary complexes of purified RNAP and the 
LEE20-275 fragment either without or with the 98C and 64G substitutions. Recall that 
potassium permanganate modifies T residues in the single stranded „bubble‟ produced after 
local unwinding of promoter DNA around the transcription start at promoters (Savery et al., 
1996). Results in Figure 4.3 show that, without the substitutions, there is extensive unwinding 
that starts just downstream of the P1 promoter -10 hexamer, and that this unwinding is 
suppressed by the 98C substitution. In contrast, with the fragment carrying both the 98C and 
64G substitutions, clear duplex opening is seen at positions 86, 88, 89 and 93, just upstream 
from the transcript start at 97T. This argues that 98C and 64G substitutions cause RNAP to 
recognise a new promoter (P1A), with a transcript start that is 10 base pairs upstream from the 
P1 promoter start (Figure 4.2). 
 
In order to identify sequence elements essential for the P1A promoter, error prone PCR was 
used to generate 3 independent preparations of the LEE20-275 fragment with the 98C and 
64G substitutions. They were cloned into pRW224 and the mixture of resulting recombinant 
plasmids was transformed into E. coli strain M182, and transformants were grown on 
MacConkey lactose indicator plates. As expected, the majority of colonies scored as Lac
+
, 
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Figure 4.2. In vitro run off transcription assay. 
The figure shows an autoradiogram of an analysis by gel electrophoresis of 
32
P-labelled RNA 
transcripts made by RNA polymerase holoenzyme from PstI-BamHI fragments carrying 
LEE20-275 sequences (lanes 1-3) and derivatives carrying either 98C (lanes 4-6) or 98C 64G 
(lanes 7-9) substitutions. The RNA polymerase concentration was: lanes 1, 4 and 7, no 
enzyme; lanes 2, 5 and 8, 200 nM; lanes 3, 6 and 9, 400 nM. The gel was calibrated with the 
pSR plasmid-encoded 108 nucleotides RNA-I transcript (lane 10) and Maxam-Gilbert 
sequence reaction (GA). Proposed transcripts are indicated by asterisks and transcription 
initiation sites are shown by bent arrows in partial nucleotide sequences of LEE20-275 (WT) 
and LEE20-275 98C 64G fragments. 
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Figure 4.3. In vitro potassium permanganate footprinting analysis. 
An autoradiogram that identifies the potassium permanganate sensitive sites in complexes of 
holo RNA polymerase with a DNA fragment that includes the LEE20-275 sequence (WT) or  
derivatives containing either 98C mutation (98C) or  98C 64G mutations (98C 64G). Lanes 1, 
3 and 5 show the results after control incubations without RNA polymerase, while lanes 2, 4 
and 6 show the analysis of samples with 50 nM RNA polymerase. The gel was calibrated 
using Maxam-Gilbert sequence reaction (GA) and relevant positions are indicated. Asterisks 
identify the residues that display RNA polymerase-dependent reactivity to permanganate. 
Partial sequences of LEE20-275 and LEE20-275 98C 64G with reactive sites (asterisks) are 
shown in left and right sites of the gel, respectively. 
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but, after screening over 15,000 transformants, I identified 4 Lac
-
 colonies that each carried a 
supplementary base change. These were an A for C change at position 88 (88C), A for G 
substitution at position 89 (89G), a T for C substitution at position 90 (90C) and the insertion 
of a single T between positions 71 and 72 (Figure 4.4).  
 
The effects of the different substitutions were quantified and the data are shown in Table 4.2. 
The results show that the 88C substitution reduces promoter activity by over 20 fold, whilst 
the other three substitutions have smaller effects. These data, together with the in vitro results 
in Figures 4.2 and 4.3, identify the hexamer, TAATGT, from position 87 to position 92 as the 
P1A -10 hexamer, upstream of the transcript start at position 97. Hence, the 88C mutation at 
position 2 of the hexamer has the biggest effects on P1A activity and is within the region of 
duplex unwinding following RNA. I tentatively assign TGGTTT from position 62 to position 
67 as the P1A -35 hexamer (Figure 4.4). Although this corresponds to the consensus 
TTGACA at only 2 out of 6 positions, the concordant G at position 64 is the G that was 
created by the 64G substitution that unmasked the P1A promoter. Thus, the high promoter 
activity of the LEE20-275 fragment carrying the 98C and 64G substitutions is likely due to 
improvement of the -35 element from TGATTT to TGGTTT. This data also suggest that the 
spacer length between -10 and -35 elements is 19 base pairs. Note that one of the Lac
-
 mutants 
selected after random mutagenesis carried LEE20-275 98C 64G fragment with an extra T 
between positions 71 and 72 (Table 4.2). This extra base changes the promoter spacer length 
to 20 base pairs and that reduced the promoter activity sharply. In order to determine the 
effect of shorter spacer length on the promoter activity, derivative LEE20-275 98C 64G with 
Δ71T deletion was constructed by site directed mutagenesis and lac expression from the 
derivative was measured. Data presented in the Table 4.2 shows that deletion of the base at 
position 71, that brings spacer length 19 to 18, closure to optimal spacer (17 base pairs) 
caused a significant increase in the lac expression. 
 
4.4 Activity of LEE1 P1A without the 64G substitution 
The chance isolation of the 64G substitution in the LEE20-275 fragment, in combination with 
the 98C substitution, unmasked the P1A promoter. To address the issue of whether P1A is 
functional without the 64G substitution, I have exploited the 88C substitution that I had found 
to inactivate P1A activity (Table 4.2). Results in Table 4.3 show that the 88C substitution has 
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GAATTCCGTTTGTTAACGAGATGATTTTCTTCTATATCATTGATTTTAAATGGATTTTAAAAATA 
 
 
TATGGTTTTTTTGTTGACATTTAATGATAATGTATTTTCCACATTAGAAAAAAGAGAATAAGCTT 
 
 
Figure 4.4. Mutational analysis of the LEE20-275 98C 64G fragment.  
The figure shows the nucleotide sequence of the upper strand of the LEE20-275 98C 64G 
fragment. The base sequences are numbered 1-120 as Figure 4.1. The positions of randomly 
generated single mutations that reduced expression from this fragment are illustrated by 
showing the substituted base. The P1A promoter -35 and -10 hexamer elements, deduced 
from this study, are solid boxed and the transcript start, at position 97T, determined from the 
results in Figure 4.2 is indicated by a bent arrow. Dotted boxes represent the location of 
mutated P1 promoter elements. 
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Table 4.2: Identification of the functional elements of the P1A promoter 
 
Promoter fragments Promoter sequences from positions  62 to 102 β-galactosidase activity 
(Miller units ± sd) 
   
   
LEE20-275 98C 64G  5'-TGGTTTTTTTGTTGACATTTAATGATAATGTATTTTCCACA-3' 4375 ± 133 
LEE20-275 98C 64G 88C 5'-TGGTTTTTTTGTTGACATTTAATGATCATGTATTTTCCACA-3' 190 ± 45 (4.3) 
LEE20-275 98C 64G 89G 5'-TGGTTTTTTTGTTGACATTTAATGATAGTGTATTTTCCACA-3' 517 ± 28 (11.8) 
LEE20-275 98C 64G 90C 5'-TGGTTTTTTTGTTGACATTTAATGATAACGTATTTTCCACA-3' 263 ± 15 (6.0) 
LEE20-275 98C 64G InsT (71-72) 5'-TGGTTTTTTTTGTTGACATTTAATGATAACGTATTTTCCACA-3' 939 ± 8 (21.5) 
LEE20-275 98C 64G Δ71T* 5'-TGGTTTTTT─GTTGACATTTAATGATAACGTATTTTCCACA-3' 7109 ±107 (162.5) 
 
The table shows measured β-galactosidase activities in cultures of E. coli strain M182 carrying pRW224 containing the LEE20-275 98C 
64G fragment and different mutations. Cultures were grown aerobically at 37°C in LB medium to an optical density of ~0.5 at 650 nm. 
Activities were measured in triplicate, giving a mean and standard deviation (sd). Activities expressed as a percentage of activity with the 
starting LEE20-275 98C 64G fragment are shown in parentheses. The central part of the table shows the fragment base sequence from 
position 62 to position 102, with the location of P1 promoter -10 and -35 hexamer elements shaded grey and P1A promoter -10 and -35 
elements are underlined. Base substitutions and insertion in the different fragments are highlighted in boldface type and coloured red whilst 
Δ71T is indicated by a dash. Mutation made by site directed mutagenesis is indicated by asterisk, whilst the other mutations came from the 
random PCR mutagenesis experiment illustrated in Figure 4.4. 
 
 
 
 
62 70 80 90 102 
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very little effect on the measured promoter activity of the starting LEE20-275 fragment. In 
contrast, the activity of the fragment carrying the 98C substitution is reduced by over 95% by 
the 88C substitution. Recall that the 98C substitution completely prevents LEE1 P1 promoter 
activity (Figure 4.2, 4.3). Thus, I deduce that reduced expression from the LEE20-275 
fragment carrying the 98C substitution is due to P1A activity, and, hence, is suppressed by the 
88C change. Similarly, expression from the LEE20-275 fragment carrying the 76G 
substitution, in the P1 -35 element, is also greatly reduced by the 88C substitution. From these 
results, I deduce that P1A activity increases as P1 becomes less active, due to substitutions in 
either the -10 or -35 element. 
 
Table 4.3 also shows the results from the LEE20-275 derivative carrying a substitution in the 
P1 -35 hexamer (76G) combined with a substitution in the P1 -10 hexamer (98G). The 
introduction of 76G substantially increased the activity of the LEE20-275 fragment carrying 
the 98G substitution, which was also described in Figure 4.1. This increased expression is 
completely suppressed by the 88C substitution, and, hence, must be due to the P1A promoter. 
From this, I conclude that, even though the P1 promoter is completely inactivated by the 98G 
substitution, the activity of P1A remains low because RNAP still makes abortive contacts 
with the P1 consensus TTGACA -35 hexamer element. However, P1A activity increases as 
these interactions are weakened, due to substitutions such as 76G. These observations also 
suggest that the activity of the promoter fragments containing either 75C or 75C 98T 
mutations described in the Figure 4.1 could possibly come from the P1A promoter.  
 
In a related experiment, I strengthened P1A by deletion of one of the 7 consecutive T residues 
immediately upstream of the P1 promoter -35 hexamer element (71T) which alters the 
length of the spacer between the P1A promoter -10 and -35 hexamer closer to the optimal 17 
base pairs (Rosenberg and Court, 1979). Results in Table 4.3 show that the promoter activity  
of the resulting LEE20-275 fragment carrying the 71T change is reduced ~3 fold by the 88C 
substitution. 
 
Results described in Table 4.3 also show that Δ71 caused ~45% reduction of the overall 
promoter activity. These results suggest that shortening the P1A promoter spacer length 
from19 to 18 base pairs strengthens the P1A (Table 4.2) and this might increase the 
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Table 4.3: Effect of mutations in unmasking P1A promoter 
 
The table shows measured β-galactosidase activities in cultures of E. coli strain M182 carrying pRW224 containing the LEE20-275 
fragment and different mutations. Cultures were grown aerobically at 37°C in LB medium to an optical density of ~0.5 at 650 nm. 
Activities were measured in triplicate, giving a mean and standard deviation (sd). Activities with the fragments containing P1A -10 mutants 
expressed as a percentage of activities with the starting fragments are shown in parentheses. The central part of the table shows the 
fragment base sequence from position 62 to position 102, with the P1 promoter -10 and -35 hexamer elements shaded grey and P1A 
promoter -10 and -35 elements are underlined. Base substitutions in the different fragments are highlighted in boldface type and red 
coloured whereas Δ71 deletions are shown by dashes. 
 
Promoter fragments Promoter sequences from positions  62 to 102 β-galactosidase activity 
(Miller units ± sd) 
   
   
LEE20-275  (WT) 5'-TGATTTTTTTGTTGACATTTAATGATAATGTATTTTACACA-3' 5513 ± 261 
LEE20-275  88C 5'-TGATTTTTTTGTTGACATTTAATGATCATGTATTTTACACA-3' 4596 ± 30 (83.4) 
   
LEE20-275  98C  5'-TGATTTTTTTGTTGACATTTAATGATAATGTATTTTCCACA-3' 233 ± 4 
LEE20-275  98C 88C 5'-TGATTTTTTTGTTGACATTTAATGATCATGTATTTTCCACA-3' 10 ± 1 (4.3) 
   
LEE20-275  76G 5'-TGATTTTTTTGTTGGCATTTAATGATAATGTATTTTACACA-3' 1568 ± 24 
LEE20-275  76G  88C 5'-TGATTTTTTTGTTGGCATTTAATGATCATGTATTTTACACA-3' 220 ± 13 (14.0) 
   
LEE20-275  98G 5'-TGATTTTTTTGTTGACATTTAATGATAATGTATTTTGCACA-3' 202 ± 15 
LEE20-275  98G 76G  5'-TGATTTTTTTGTTGGCATTTAATGATAATGTATTTTGCACA-3' 1289 ± 3 
LEE20-275  98G 76G 88C 5'-TGATTTTTTTGTTGGCATTTAATGATCATGTATTTTGCACA-3' 11 ± 1 (1.0) 
   
LEE20-275  Δ71 5'-TGATTTTTT─GTTGACATTTAATGATAATGTATTTTACACA-3' 3107 ± 115 
LEE20-275  Δ71 88C 5'-TGATTTTTT─GTTGACATTTAATGATCATGTATTTTACACA-3' 1103 ± 24 (35.5) 
62 70 80 90 102 
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competition between two promoters for RNAP, and result in low level of activity. However, 
an insertion of T between 71-72 positions in the LEE20-275 fragment increased the lacZ 
expression from 5513 Miller units to 7898 Miller units. This suggests that increasing the P1A 
spacer length from 19 to 20 base pairs weakens the P1A promoter as seen in Table 4.2 and 
this might reduce the competition between two promoters for RNAP and result in high level 
of activity. 
 
4.5 Discussion 
Many bacterial gene regulatory regions, especially those that are AT-rich, contain multiple 
promoters, and it is generally assumed that they are a by-product of evolution. Here I have 
identified a cryptic promoter, P1A, which overlaps the LEE1 P1 promoter of EHEC serotype 
O157:H7. In vivo reporter gene assays and subsequent in vitro footprinting and transcription 
analyses revealed that base substitutions in the key elements of the P1 promoter unmask P1A 
promoter that specifies transcription initiation from a site that is located 10 base pairs 
upstream of the P1 transcription start site (Figure 4.2). 
 
Mutational analysis revealed that DNA sequence upstream of the P1A promoter transcription 
initiation site contains a -10 region showing 3 of 6 base pairs homology with the consensus 
-10 element sequence (TAATGT vs consensus TATAAT) (McClure, 1985). There is a very 
weak -35 element having only 1 of 6 base pairs homology with the consensus sequence for 
the other promoters (TGATTT vs TTGACA) (McClure, 1985). These two key elements are 
separated by a non-optimal 19 base pairs spacer sequence. Moreover, there is an extended -10 
element or a TG motif located one base pair upstream of the -10 element and also short runs 
of T residues in the spacer. These results are in agreement with previous studies supporting 
the fact that extended -10 element or TG motif-dependent promoters have longer spacer 
sequence, contain short runs of T residues in the spacer region and render the -35 hexamer 
sequences dispensable compared with those of  non-TG promoters (Burr et al., 2000; Mitchell 
et al., 2003). 
 
The P1A promoter was discovered following the chance isolation of the 64G substitution that 
improves its -35 element. Here, however, I have presented evidence that the P1A promoter 
can function even without the 64G substitution. The P1A promoter overlaps with P1 and the 
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two promoters compete and are mutually exclusive. In the present condition, with the starting 
LEE20-275 fragment, the P1 promoter clearly wins the competition. However, as P1 is 
weakened, or P1A is strengthened, the scale tips towards P1A (Figure 4.5). A common 
phenomenon is found in the OR region of bacteriophage λ. Inactivation of PR promoter in that 
region uncovered Pα cryptic promoter (Woody et al., 1993). Likewise, mutation(s) that 
weakens the principal lac P1 promoter favours unmasking a weak upstream P2 promoter in 
lac regulatory region (Malan and McClure, 1984).  
 
Most important observation of this work is that mutations in P1 promoter -10 and -35 
elements unmask the P1A promoter in different extents. Interestingly, even when P1 is 
completely inactivated by a substitution at position 2 of its -10 hexamer, measured P1A 
activity remains low due to the P1 -35 element, which corresponds exactly to the consensus. 
Thus the P1 promoter, even when inactive, can retain the ability to sequester RNAP, thereby 
blocking access to the P1A promoter. Specific contact of RNAP with inactivated gal P2 
promoter has been reported (Johnston et al., 1987). Mutation in extended -10 element of gal 
P2 promoter reduced the promoter activity but RNAP could still make a specific contact with 
the inactivated promoter. In contrast with a mutation in the gal P2 -10 hexamer sequence, 
RNAP could not make this contact. 
 
The presence of the P1A promoter may result from high evolutionary rate in the LEE1 
regulatory region that may alter the functional promoter‟s activity significantly or to some an 
extent as mutation(s) occurs nearby the functional promoter. Alignment of the base sequence 
of the LEE1 regulatory region of EHEC O157:H7 Sakai and EPEC E2348/69 finds a single 
base deletion (ΔT) located one base upstream of the EHEC LEE1 P1 promoter -35 element 
(Porter et al., 2005). Insertion of a T base in that position in EHEC LEE1 sequence reduces 
the P1A promoter activity sharply (Table 4.2). This suggests that the influence of P1A 
promoter in the expression from EHEC LEE1 regulatory region is high compared with that of 
EPEC. Moreover, addition of an extra T that makes the EHEC LEE1 P1 promoter sequences 
more likely to EPEC LEE1 promoter significantly increases the promoter activity. This 
suggests that EHEC LEE1 P1A promoter might compete with the main P1 promoter for 
RNAP binding and thus reduces the overall promoter activity whereas competition between 
the two promoters in EPEC LEE1 is less since P1A is weak, which might favor increased
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Figure 4.5. Schematic representation of the unmasking P1A promoter. 
(A) RNA polymerase holoenzyme recognizes P1 promoter -35 and -10 elements (shaded grey) and 
initiates transcription. (B) Mutation in the second position of the -10 element causes poor -10 element 
that results in sharp reduction of the transcription initiation from P1 promoter. RNA polymerase 
holoenzyme moves towards P1A promoter -10 and -35 elements (underlined). Consensus -35 element 
of the inactivated P1 promoter sequestered RNA polymerase and blocked recruitment by P1A that 
results in very weak transcription initiation from P1A promoter. (C) Mutation in the P1 -35 hexamer 
causes sharp reduction of transcription initiation from the P1 promoter that facilitates initiation from 
the P1A promoter. (D) Mutations both in P1 promoter -35 and -10 elements cause complete 
destruction of the P1 promoter, which favors efficient transcription initiation from the P1A promoter. 
(E) Improvement of P1A -35 hexamer sequence together with weakening P1 -10 element cause 
complete shifting of the RNA polymerase from P1 to the P1A promoter, ensuring efficient 
transcription initiation from P1A. Arrows below the nucleotide sequences indicate mutations and bent 
arrows show the transcription start sites of the promoters. 
TGATTTTTTTGTTGACATTTAATGATAATGTATTTTCCACATTAGAAA
Holo RNA polymerase 
TGATTTTTTTGTTGGCATTTAATGATAATGTATTTTACACATTAGAAA
TGATTTTTTTGTTGGCATTTAATGATAATGTATTTTCCACATTAGAAA
Holo RNA polymerase 
TGGTTTTTTTGTTGACATTTAATGATAATGTATTTTCCACATTAGAAA
Holo RNA polymerase 
TGATTTTTTTGTTGACATTTAATGATAATGTATTTTACACATTAGAAA
Holo RNA polymerase 
 
(A) 
(B) 
(C) 
(D) 
(E) 
P1 promoter 
P1A promoter 
P1A promoter 
P1A promoter 
P1A promoter 
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expression from EPEC LEE1 promoter.  
 
Among the double mutations, described in Figure 4.1, 98C 64G or 98T 75C or 98G 76G 
double mutation unmasks the P1A. Though other two double mutations e.g., 98C 35C or 96G 
100G were not investigated, I assume that the increased lac expression from the promoter 
derivatives containing either 98C 35C or 96G 100G double mutation could be the 
consequence of the presence of other promoter-like signals in the LEE1 promoter regulatory 
region.  
 
Potentially, clusters of potential promoter elements in regulatory regions can have many 
different consequences. For example, they may quite simply give rise to multiple transcription 
starts and recent high-resolution analysis of the E. coli transcriptome has identified many 
cases of this (Mendoza-Vargas et al., 2009). This can lead to complex patterns of regulation. 
Alternatively, these elements could be the remains of now defunct regulatory systems, or be 
awaiting future adoption. My observation that the P1 -35 element retains function even when 
P1 is inactive, together with data with the E. coli gal operon regulatory region (Johnston et al., 
1987) underscores that residual promoter elements at non-functional promoters can affect the 
distribution of RNAP. At present, the role of the LEE1 P1A is unclear. However, I note that 
consensus -35 hexamer elements are very rare at E. coli promoters (Mitchell et al., 2003). I 
speculate that the rationale for retaining TTGACA as the LEE1 P1 -35 element is to focus 
RNAP at P1 and to reduce the use of neighbouring promoters such as P1A.  
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Chapter 5 
 
A small translated open reading frame in the leader 
sequence of LEE1 regulatory region: role in the 
expression of downstream genes 
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5.1 Introduction 
The leader sequence of a messenger RNA (mRNA) can modulate the translation process of a 
gene. The leader sequence is the sequence at the 5' end of a mRNA molecule that is not 
translated into protein. It starts at the +1 position (transcription start site) of the gene and ends 
just before the start codon (AUG) of the coding region. This region often contains a SD 
sequence, which is a 4-6 base sequence that is complementary to a sequence at the 3' end of 
one of the ribosomal RNAs (Shine and Dalgarno, 1975; Steitz and Jakes, 1975).  
 
Most of the 5' end sequences of E. coli messenger RNAs have 40-80 untranslated bases, but 
some are much longer (Shultzaberger et al., 2007). Genes that contain unusual long leader 
sequences are often subjected to complex regulation mechanisms. Long leader region may 
contain regulatory sequence, including binding sites for proteins that can affect the stability of 
the mRNA. Upstream ORF found in a leader region can couple with the downstream gene and 
can regulate its expression. This is the case for the tap (translation activator peptide) and repA 
(encoding replicase) genes in the regulation of plasmid R1 replication. The leader peptide tap 
is located in the region between the copA and repA genes. The CopA regulatory RNA binds to 
the RBS of tap and this results in translational inhibition, transmitted to the repA gene by 
translational coupling (Blomberg et al., 1992).  
 
In some cases, 5' untranslated long leader regions encode short peptides, which influence 
expression of neighbouring downstream genes (Vitreschak et al., 2004). Some of the bacterial 
operons involved in biosynthesis of amino acids including threonine, leucine, histidine, 
tryptophan and phenylalanine are subject to this kind of post-transcriptional regulation 
(Gardner, 1979; Gemmill et al., 1979; Johnston et. al., 1980; Yanofsky, 1981; Gavini and 
Pulakat, 1991; Gurvich et al., 2010). In many cases, riboswitches in 5' untranslated regions of 
mRNA molecules can serve as receptors for specific metabolites. These metabolites bind to 
the targets and affect the downstream gene expression positively or negatively (Mironov et al., 
2002; Nahvi et al., 2002; Winkler et al., 2002a,b; Sudarsan et al., 2003; Mandal and Breaker., 
2004; Nudler and Mironov, 2004; Lemay and Lafontaine, 2007). Additionally, recently 
Artsimovitch (2010) reported that cis-acting RNA elements, termed as EAR, located between 
the epsB and epsC genes, increase the expression of exopolysaccharide genes in Bacillus 
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subtilis at the level of transcription termination. The EAR shares the complexity of 
riboswitches but uniquely function as a processive, long-range antiterminator.  
 
During work with the ~170 nucleotides-long LEE1 leader sequence, which contains mostly 
adenines and uracils, a mini-gene was identified. The translation of this mini-gene is 
necessary for optimal expression of the downstream ler gene. 
 
5.2 Identification of the functional Ler translation start site 
The 5' untranslated leader sequence of a gene is defined by a section of an mRNA molecule 
that starts at the +1 (where transcription begins) and ends one nucleotide before the translation 
start codon. Thus, the start point of this work was to determine the translation start site of the 
ler gene. According to coliBASE (ECs4588) (Chaudhuri et al., 2004) and other databases, ler 
translation starts from ATG located one base pair upstream of a potential SD sequence 
(Figure 2.22). However, there is a potential translation start codon (ATG), located 10 base 
pairs downstream of the SD site. Generally, translation initiation codons of genes are located 
5-9 nucleotides downstream of the SD sequence (Gualerzi and Pon, 1990). Therefore, the 
database information about ler translation start site is ambiguous. In order to experimentally 
determine the ler translation start site, the LEE151 fragment containing the assigned 
translation start codon in the database (550 base pairs), or the LEE150 fragment carrying the 
second predicted translation initiation codon (571 base pairs) (Figure 2.22) were cloned into 
pRW225 as translation fusions to lacZ. The resulting plasmids were transformed into M182 
cells and measured lacZ expression was taken as a measurement of translation activity. 
Results illustrated in Figure 5.1 shows no expression from the LEE151 fragment cloned as 
translation fusion to lacZ, whilst the level of lac expression from the LEE150 is 3597 Miller 
units. These results suggest that the ler translation starts at a site (ATG), located 10 base pairs 
downstream of the ribosomal binding site. However, this would mean that the ler regulatory 
region contains a ~170 nucleotides long leader sequence, which corresponds to a LEE1 
mRNA section located between the site of LEE1 P1 promoter transcription start and the 
nucleotide before the ler translation start site. 
 
5.3 Downstream elements affect expression from the LEE1 P1 promoter  
In an attempt to understand the role of the long leader sequence in the EHEC LEE1 regulatory 
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Figure 5.1. Translational activities from LEE151 and LEE150 fragments. 
(A) Schematic representation of the LEE151 and LEE150 fragments showing the differences 
between them (nucleotide sequence details in Figure 2.22). LEE151 fragment carries the 
predicted translation start site of the ler assigned in coliBASE whereas LEE150 fragments 
carries second predicted translation start site assigned by Yerushalmi et al., (2008) that 
contains a ribosomal binding sequence (SD) in front of it. Bent arrows indicate the LEE1 P1 
promoter. Both fragments were cloned as translation fusions to lacZ in pRW225.  
(B) Bar graph shows the measured β-galactosidase activities in E. coli K-12 strain M182 
containing plasmid pRW225 with LEE151 or LEE150 fragments. Vector represents the 
plasmid pRW225 that contains promoterless 122 base pairs “stuffer” sequence. Measurements 
were made after growth of the cells in LB medium at 37°C to an optical density of ~0.5 at 650 
nm. Values are the average of at least three independent assays, and standard deviations are 
shown with bars. 
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region, a nested deleted derivative, LEE30-275 was constructed. This contains extra 44 base 
pairs downstream LEE1 leader sequence compared with the sequence of the LEE20-275 
derivative (Figure 2.10). After cloning the derivative into pRW224, lacZ expression was 
measured in M182 cells. Figure 5.2 shows the level of lacZ expression from LEE30-275 
fragment and compares the activity with those from LEE10-275 and LEE20-275 promoter 
fragments. As seen in Figure 3.1, the highest level of lacZ expression was quantified from 
LEE20-275 fragment whilst the level of lacZ expression from LEE10-275 was found to be 
~2.5-fold lower than that from LEE20-275. Decreased expression seen from the LEE10-275 
fragment compared with that from LEE20-275 fragment is probably due to the longer 
untranslated leader sequence upstream of the reporter lacZ gene. Surprisingly, inclusion of 44 
base pairs downstream leader sequence caused a sharp reduction in expression from LEE30-
275 promoter fragment compared with that from LEE20-275 promoter fragment. This results 
suggest that cis- and/or trans- acting elements in untranslated long leader sequence upstream 
of the reporter gene may play a role in the differential level of expressions from these three 
derivatives. 
 
The complete sequence of the LEE30-275 fragment that showed decreased lac expression 
compared with that of LEE20-275 is shown in Figure 5.3, where the sequence has been 
numbered 1-162 following the numbering system adopted for the LEE20-275 fragment in 
Figure 3.3. Sequence analysis suggests that the DNA sequence of the LEE30-275 fragment 
has a potential SD sequence located downstream, between positions 129-137, and a potential 
translation start (ATG) and stop sites (TAG) located at the positions 144 and 150, respectively 
(Figure 5.4). Moreover, the program “RBS calculator version 1.0” (Salis et al., 2009) 
predicted two adjacent translation start codons located at positions 141 (TTG) and 144 (ATG), 
respectively and the predicted translation initiation rate was 5-fold higher at ATG compared 
with TTG. Therefore, bioinformatics data suggest that the LEE30-275 promoter fragment 
might contain a small translated ORF, which may interfere with the translation of downstream 
reporter gene, hence cause a low level of expression from the fragment. 
 
5.4 Analysis of up-mutants of the LEE30-275 fragment 
In order to identify the determinant(s) responsible for the low level of lac expression from the 
LEE30-275, an experiment with error-prone PCR was conducted to generate 6 independent 
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Figure 5.2. Expression from different LEE1 promoter fragments.  
(A) Schematic representation of three nested deleted derivatives of LEE10-568 promoter 
fragments. The coordinates of the upstream and downstream end of each fragment refer to the 
number of base pairs upstream from the functional ATG start codon of the ler gene. The P1 
and P2 promoters are indicated by bent arrows and the shaded black boxes represent the 
cognate -10 and -35 hexamer elements.   
(B) The bar graph shows the measured β-galactosidase activities in E. coli K-12 strain M182 
carrying the plasmid pRW224 with LEE10-275 and two derivatives LEE20-275 and LEE30 
-275 as transcriptional fusion to lacZ. Measurements were made after growth of the cells in 
LB medium at 37°C to an optical density at 650 nm of ~0.5. Values are the average of at least 
three independent assays, and standard deviations are shown with bars. 
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GAATTCCGTTTGTTAACGAGATGATTTTCTTCTATATCATTGATTTTAAATGGATTTTAAAAATATATGATTTTTTTGTTGACATTTAATGAT 
 
AATGTATTTTACACATTAGAAAAAAGAGAATAATAACATTTTAAGGTGGTTGTTTGATGAAATAGATGTGTCCTAAAGCTT                                                                                                                                                                                                                                                                                                    
 
 
 
 
 
Figure 5.3. Mutational analysis of the LEE30-275 fragment.  
The figure shows the nucleotide sequence of the upper strand of LEE30-275 fragment with restriction sites EcoRI and HindIII. The base 
sequences are numbered 1-162, starting with the first cloned LEE1 regulatory region base following the numbering system in Figure 3.3. 
The positions of randomly generated single and double mutations that increased expression from this fragment are illustrated by showing 
the substituted base(s) and, in each case, the adjacent number records the number of times that the particular substitution was obtained. 
Single mutations are indicated by black letters whilst double base substitutions are indicated by the yellow or grey colours. The locations of 
the P1 promoter -35 and -10 hexamer elements are shaded grey and the transcript start is indicated by bent arrow. Predicted small ORF and 
associated SD sequence are indicated by solid and dotted boxes, respectively. 
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Figure 5.4. Sequence similarity between the predicted translational initiation region in 
LEE30-275 and some bacterial and viral mRNAs. 
The figure shows the alignment of translational initiation region of some bacteria, viral and 
LEE30-275 mRNA molecules. Sequence of LEE30-275 corresponds to the partial sequence 
of LEE30-275 promoter fragment (positions 126 to 155 in Figure 5.3). Potential SD sequence 
marked by red colour, and translational initiation codons are shaded yellow. Translation stop 
codon in LEE30-275 is underlined. 
E. coli trpA 5'-AGCACGAGGGGAAAUCUGAUGGAACGCUAC-3' 
E. coli lacI 5'-CAAUUCAGGGUGGUGAAUGUGAAACCAGUA-3' 
E. coli araB 5'-UUUGGAUGGAGUGAAACGAUGGCGAUUGCA-3' 
E. coli thrA 5'-GGUAACGAGGUAACAACCAUGCGAGUGUUG-3' 
E. coli gale 5'-AGCCUAAUGGAGCGAAUUAUGAGAGUUCUG-3' 
λ phage cro 5'-AUGUACUAAGGAGGUUGUAUGGAACAACGC-3'  
 
LEE30-275  5'-UUUUAAGGUGGUUGUUUGAUGAAATAGATG-3' 
 
Pairs with  
16S rRNA 
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preparations of the LEE30-275 fragment carrying random mutations. The fragments were 
then cloned into the lac reporter plasmid pRW224, the resulting recombinant plasmids were 
transformed into E. coli strain M182, and transformants were grown on MacConkey lactose 
indicator plates. As expected, the majority of colonies scored as Lac
-
 (white) colonies, but 
after screening over 10000 transformants, 36 Lac
+
 (pink) colonies were identified. Sequence 
analysis showed that 12 of these carried single mutations whilst 5 carried double mutations. 
Most of the double mutations were not informative and thus not included in the further study. 
Four of the single mutations were found more than once (up to 8 times for LEE30-275 116T).  
 
The location of mutations that increased lac expression from the LEE30-275 promoter 
fragment is illustrated in Figure 5.3. Of the 12 single mutations, 3 fall in the P1 promoter -10 
element. These were a T for C substitution at position 99 (99T) and an A or a T for C at 
position 101 (101A or 101T).  Also included a double base substitution that was a T for A at 
position 102 together with a change at position 15 (15C 102T). The effects of the base 
substitutions were quantified and data are recorded in the Table 5.1. Mutations at the -10 
element increased the promoter activity 3-8 fold. The high promoter activity of theLEE30-275 
fragment carrying the 99T, 101A, 101T or 15C 102T substitutions is due to the improvement 
of the P1 promoter -10 element from TACACA to a close proximity of the consensus 
TATAAT for E. coli promoters (McClure, 1985). 
 
Other 3 point mutations were found at the predicted ribosomal binding site. Theses are an A 
or a T for G at position 132, an A for G at position 133 and an A for G at position 135. They 
also included a double mutation that was a C for A at position 137 together with a C for A at 
position 123. Presumably, these reduce SD activity to promote translation. 
 
Three other single mutations fall in the coding region of predicted small ORF. These are a T 
for A at position 144 that changed the predicted translation start point from ATG to TTG, a 
base deletion at position 150 (Δ150T) or a T for A at position 151. These latter two changes 
disrupted the predicted translation stop site of the small ORF. Results illustrated in Table 5.1 
show that base changes in the predicted SD sequence or in small ORF increased the lac 
expression 3-10 fold compared with that of starting LEE30-275 fragment. The reason for this 
remains unclear. My speculation is that translation of the mini-ORF might interfere with the 
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 Table 5.1: Mutational analysis of LEE30-275 promoter fragment 
 
 
The table shows measured β-galactosidase activities in cultures of E. coli strain M182 
carrying pRW224 with the LEE30-275 fragment and different mutant derivatives. 
Measurements were made after growing the cells in LB medium at 37°C to an optical density 
of ~0.5 at 650 nm and are listed in the central column. Activities were measured in triplicate, 
giving a mean and standard deviation (sd). Activities expressed as fold increase compared to 
the starting LEE30-275 fragment are given in the third column.  
 Promoter fragments β-galactosidase activity  
(Miller units ± sd) 
Fold 
increase 
Starting fragment 
 LEE30-275  124 ± 9 - 
Mutations at P1 promoter -10 element 
 LEE30-275 99T 554 ± 18 4.5 
 LEE30-275 101A 565  ± 18 4.6 
 LEE30-275 101T 412 ± 9 3.3 
 LEE30-275 102T 15C 928 ± 31 7.5 
Mutations at predicted SD sequence 
 LEE30-275 132A 551 ± 28  4.5 
 LEE30-275 132T 498 ± 130 4.0 
 LEE30-275 133A 460 ± 9  3.7 
 LEE30-275 135T 401 ± 33 3.2 
 LEE30-275 123T 137C 751 ± 33 6.0 
Mutations at predicted mini-ORF 
 LEE30-275 144T 288 ± 11  2.3 
 LEE30-275 Δ150 357 ± 13 2.9 
 LEE30-275 151T 1270 ± 109 10.2 
Mutations at other positions 
 LEE30-275 116T 765 ± 53 6.2 
 LEE30-275 122C 948 ± 126  7.6 
LEE20-275 fragment (wild type) 5247 ± 242 42 
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translation of the reporter lac gene and thus reduced the lac expression from the LEE30-275 
promoter. Base change either in SD or in mini-ORF might reduce the interference and thus 
increase lac expression to some an extent. 
 
Increased activity from the LEE30-275 containing a change A to C at position 122 might be 
due to the similar reasons. A single base change A to T at position 116 increased the lac 
expression 6 fold. The increased transcriptional activity might be due to the creation of a new 
strong promoter because the base change makes a consensus -10 element around the position. 
However, though a number of up-mutations generated in the LEE30-275 fragment through 
error-prone PCR, none of the mutations brought the level of lac expression from the LEE30-
275 fragment closure to that from LEE20-275 promoter fragment (Table 5.1). This might be 
due to the residual effect of strong ribosomal binding site of mini-ORF on the translation of 
reporter lac. 
 
5.5 RNA secondary structure predictions 
To investigate whether secondary structure in the LEE message could affect the 
transcriptional activity of the LEE30-275 promoter, the RNA structure for LEE30-275 
fragment was predicted using the mfold program (version 3.2) (Zuker, 2003). To see whether 
all the mutations generated during random mutagenesis of the LEE30-275 could fit with the 
predicted secondary structure, the base substitutions were plotted on the structure at respective 
positions (Figure 5.5). Most of the up-mutations such as 132A/T, 144T, Δ150T or 151T fall 
outside of the hairpin like structure. Only two changes such as 116T and 133A could affect 
the hairpin like structure and thus the increased LEE30-275 promoter activity due to these two 
base substitutions could be explained by the secondary structure. But increased transcriptional 
activity due to the base substitution at positions 122 and 135 or other up-mutations that fall 
outside of the hairpin like structure cannot be explained by the secondary structure of RNA. 
From this analysis, I conclude that the low level of lac expression from the LEE30-275 
fragment is difficult to explain by the secondary RNA structure. 
 
5.6 DNA sampling 
To identify possible negative regulatory proteins that might play a role in lowering lac 
expression from the LEE30-275 promoter fragment, the DNA sampling method (Butala et. al., 
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Figure 5.5. Secondary RNA structure of mRNA molecule of LEE30-275 fragment. 
The figure shows the predicted secondary RNA structure of LEE30-275 fragment produced 
by using a program mfold (version 3.2) (Zuker, 2003). Up-mutations generated during 
random mutagenesis of the fragment, were plotted in the respective sites. Fold-increases in 
lacZ expressions compared to the starting LEE30-275 fragment were shown in the 
parentheses. 
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2009) was applied. The method allows rapid isolation of specific segments of DNA, together 
with bound proteins, from E. coli K-12. The DNA fragment to be sampled is produced as a 
discrete fragment within cells by the yeast I-SceI meganuclease, and is purified using FLAG-
tagged LacI repressor and beads carrying anti-FLAG antibody. 
 
Three DNA fragments, LEE20-275, LEE30-275 and LEE30- 275 151T were taken for DNA 
-sampling aiming to obtain the protein(s) specifically bound with LEE30-275 fragment. 
Fragments were cloned in pRW902 EcoRI-HindIII sites adjacent to the 5 LacI operators with 
two flanking 18 base pairs target sites for the yeast meganuclease I-SceI (plasmid detail in 
Figure 2.4). The resulting plasmids were transformed into E. coli K-12 strain MG1655 in 
which the lacI gene had been modified to encode a 3× FLAG-tagged LacI repressor. Plasmid 
pACBSR-DL1 that encodes SceI and the bacteriophage lambda Gam protein, under the 
control of an arabinose inducible promoter was co-transformed. After induction by arabinose, 
a discrete DNA fragment carrying the promoter of interest with five LacI repressor targets 
was generated and the fragment was stable due to inhibition of RecBCD by the Gam protein. 
Immunoaffinity methods using magnetic beads carrying anti-FLAG antibodies were then used 
to isolate the DNA fragment together with accompanying proteins, which were finally 
identified using gel electrophoresis and mass spectroscopy. Proteins bound on the LEE20-275, 
LEE30-275 and LEE30-275 151T fragments are shown in Figure 5.6. As expected, protein 
complexes contain a major band corresponding to the FLAG-tagged LacI, which is labelled 
by its molecular size (Butala et al., 2009). The intensity of these bands reflects the relative 
level of each protein bound on the different promoter fragments. Two protein bands such as 
50S ribosomal protein L15 and HU were confirmed by mass spectrometry. The bands for 
RNAP β' and β sub units are also detected in the gel and labelled by their respective sizes 
(Lee et al., 2008; Butala et al., 2009). However, no protein bound specifically on the LEE30-
275 promoter fragment was detected. 
 
5.7 Study of a small translated ORF in LEE30-275 fragment 
Random mutation analysis of the LEE30-275 fragments suggested that the LEE30-275 
fragment contains a small ORF. To determine experimentally whether the predicted small 
ORF is translated; starting LEE30-275 fragment and a derivative containing a mutation at 
predicted stop codon in the small ORF (151T) were cloned into pRW225 as translation fusion 
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Figure 5.6. SDS-PAGE analysis of proteins that were bound on LEE20-275, LEE30-275 
and LEE30-275 151T promoter fragments.  
The figure shows the affinity-isolated proteins from E. coli K12 strain MG1655 grown in LB 
medium. Proteins that were identified by mass spectrometry analysis are indicated by 
asterisks, whilst other proteins are labelled according to their sizes (Lee et al., 2008; Butala et 
al., 2009). The gel was calibrated with Invitrogen SeeBlue Plus 2 protein markers (M). 
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to lacZ in a manner so that predicted translation start point of the small ORF could be  
in-frame with the lacZ initiation codon (Figure 2.21). Results illustrated in Figure 5.7 show no 
lac expression from the starting LEE30-275 fragment whereas the mutation (151T) at the 
predicted stop codon in small ORF results in a high level of lac expression. This result 
suggests that the LEE30-275 leader sequence contains a translated small ORF and its 
translation stop codon, TAG, is located at position 150 (Figure 5.3).  
 
Some of the LEE30-275 derivatives containing mutations at the stop codon in the small ORF 
were generated spontaneously. M182 cells carrying pRW225 with the LEE30-275 fragment 
produced white colonies on MacConkey lactose indicator plates after overnight incubation at 
37°C. However, when plates were incubated for two more days at 37°C, a number of small 
red colonies on the white colonies appeared. Sequence analysis confirmed spontaneous base 
substitutions at the TAG codon. These were a C (151C) or G (151G) or T (151T) for A at 
position 151 (Table 5.2). lacZ expression from these derivatives was quantified and reported 
in the Table 5.2. In each case, mutation at the stop codon caused a high level of lac 
expression and the expression is codon specific. The highest level of lac expression was 
found when the third nucleotide of the stop codon, G at position 152 changed to T. From this 
result, it appears that possibly ribosome starts the translation of the ORF from ATG at 
position 144 and stops at TAG codon at position 150. Single base(s) changes either at 151 or 
at 152 positions disrupt the stop codon that helps pass the message to the reporter gene. 
 
In order to confirm the translation start site in the mini-gene, a number of derivatives of the 
LEE30-275 152T fragment were constructed. These derivatives contain base substitutions at 
two predicted translation start sites of the ORF. The changes were a C for G at position 143 
(143C), a T for A at position 144 (144T), or G for T at position 145 (145G) and a double base 
change at positions 143 and 145 (143C 145G). The derivatives were cloned in pRW225 lac 
reporter plasmid and expressions were recorded (Table 5.2). Data presented in Table 5.2 show 
that introduction of 143C mutation that changes the second predicted start codon from TTG to 
TTC did not have any effect on the lac expression from LEE30-375 152 fragment. But 
mutation 144T that changed the first predicted start codon from ATG to TTG caused 4.5-fold 
reduction of the lac expression from LEE30-275 152T and 145G mutation that changed ATG 
to AGG caused 9-fold decrease in the expression. Recall that TTG is used as an alternative 
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Figure 5. 7. Translation activity in the LEE30-275 fragment. 
Measured β-galactosidase activity in M182 cells carrying plasmid pRW225 with starting 
LEE30-275 fragment or derivative cloned in pRW225 as translation fusion to lacZ. 
Measurements were made after growth of the cells in LB at 37°C to an optical density of ~0.5 
at 650 nM. Values are the average of at least three independent assays, and standard 
deviations are shown with bars. 
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Table 5.2: Effects of mutations on the translation of mini-ORF (continued on page 203) 
 
Derivatives Sequences of cloned LEE30-275 fragment from 129 to 162::lacZ 
 
β-galactosidase activity 
(Miller units ±sd) 
Starting LEE30-275 fragment 
   
 TAAGGTGGTTGTTTGATGAAATAGATGTGTCCTAAAGCTTGGGATCCCGTCGTTTTA 16 ± 0 
 
Mutations in the translation stop codon 
151C TAAGGTGGTTGTTTGATGAAATCGATGTGTCCTAAAGCTTGGGATCCCGTCGTTTTA 8281 ± 168 
151G  TAAGGTGGTTGTTTGATGAAATGGATGTGTCCTAAAGCTTGGGATCCCGTCGTTTTA 3751 ± 205 
151T TAAGGTGGTTGTTTGATGAAATTGATGTGTCCTAAAGCTTGGGATCCCGTCGTTTTA 16035 ± 353 
152T TAAGGTGGTTGTTTGATGAAATATATGTGTCCTAAAGCTTGGGATCCCGTCGTTTTA 22995 ± 561 
Mutations in the translation star sites 
144T 152T TAAGGTGGTTGTTTGTTGAAATATATGTGTCCTAAAGCTTGGGATCCCGTCGTTTTA 5083 ± 178 
145G 152T TAAGGTGGTTGTTTGAGGAAATATATGTGTCCTAAAGCTTGGGATCCCGTCGTTTTA 2503 ± 17 
143C 152T TAAGGTGGTTGTTTCATGAAATATATGTGTCCTAAAGCTTGGGATCCCGTCGTTTTA 23375 ± 801 
143C 145G 152T TAAGGTGGTTGTTTCAGGAAATATATGTGTCCTAAAGCTTGGGATCCCGTCGTTTTA 52 ± 2 
129 140 150 162 
lacZ 
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Table 5.2: Effects of mutations on the translation of mini-ORF (continued) 
 
Derivatives Sequences of cloned LEE30-275 fragment from 129 to 162::lacZ 
 
β-galactosidase activity 
(Miller units ±sd) 
Replacement of mini-ORF by KpnI site 
   
LEE30-275-1 TAAGGTGGTTGTTTGAGGTACCAGATGTGTCCTAAAGCTTGGGATCCCGTCGTTTTA 542 ± 7 
LEE30-275-1 143C TAAGGTGGTTGTTTCAGGTACCAGATGTGTCCTAAAGCTTGGGATCCCGTCGTTTTA 22 ± 2 
Mutations in the SD sequence 
132T 152T TAATGTGGTTGTTTGATGAAATATATGTGTCCTAAAGCTTGGGATCCCGTCGTTTTA 8582 ± 188 
132T 150C TAATGTGGTTGTTTGATGAAACAGATGTGTCCTAAAGCTTGGGATCCCGTCGTTTTA 3083 ± 7 
 
 
The table shows measured β-galactosidase activities in cultures of E. coli strain M182 carrying pRW225 containing the LEE30-275 
fragment and different mutant derivatives. Cultures were grown aerobically at 37°C in LB medium to an optical density of ~0.5 at 650 nm. 
Activities were measured in triplicate, giving a mean and standard deviation (sd). The central part of the table shows the base sequence 
from position 129 to position 162 of LEE30-275 fragment cloned in pRW225 as translation fusion to lacZ in a manner so that predicted 
translation start site of the mini-ORF is in-frame with the lacZ gene. Shine-Dalgarno sequence and mini-ORF deduced from mutational 
analysis are grey- and yellow respectively. In LEE30-275-1, mini-ORF was replaced with a KpnI site. Base substitutions are coloured red 
and underlined. 
 
 
 
129 140 150 162 
lacZ 
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translation start codon in E. coli (Blattner et al., 1997; O'Donnell and Janssen, 2001). 
Therefore, a change from ATG to AGG affects the translation of the mini-gene severely 
compared with the change from ATG to TTG. Double mutations (143C 145G) that alter both 
start codons reduced the lac expression from the LEE30-275 152T derivative to the basal 
level. This argues that the mini-gene contains two adjacent alternative translation start points, 
TTG and ATG, located at positions 141 and 144 respectively and ribosome preferentially 
used ATG as the major translation start point during translation of the mini-gene.  
 
In a complementary experiment, a new derivative LEE30-275-1, where the coding sequence 
of the mini-gene was altered by the introduction of a KpnI restriction site was constructed. 
This alteration leads to the disruption of the major translation start point (ATG to AGG), 
sense codon (AAA to TAC) and stop codon (TAG to CAG) of the mini-gene (Figure 2.23, 
Table 5.2). The LEE30-275-1 derivative was cloned into pRW225 and the lac expression 
from the derivative was quantified. Data recorded in Table 5.2 show that alteration of the 
mini-gene by KpnI site reduced the lac expression to ~2%, compared with the expression 
from the LEE30-275 152T fragment. Data presented in the Table 5.2 also show that lac 
expression from the LEE30-275-1 is 5-fold lower that that from LEE30-275 145G 152T. This 
might be due to the codon-specific effect on the lac expression as reported for E. coli galE 
gene by Dreyfus et al. (1985). Moreover, derivative of LEE30-275-1 containing a base 
substitution at the second translation start site (143C) reduced the lac expression to a barely 
detectable level. These results also confirms that ler leader sequence contain a translated 
mini-gene, which has two alternative translation start sites and a single sense codon. 
 
Mutation(s) in the SD sequence can affect the translation efficiency of a gene. Recall that a 
number of up-mutations clustering in the predicted SD sequence were obtained during 
random mutagenesis of LEE30-275 cloned in pRW224 as transcription fusions to lacZ 
(Figure 5.3). In a complementary experiment, to determine the effect of the mutation at the 
SD sequence on the translation efficiency of the small ORF, derivatives of LEE30-275 
containing mutations both at the stop codon and the SD sequence (132T 150C or 132T 152T) 
were constructed and cloned in pRW225 as translation fusions. The Lac expressions from the 
derivatives were quantified. Data presented in the Table 5.2 show that single base 
  205 
substitutions at the SD sequence caused a sharp reduction in the translation of the mini-gene. 
The reduction might be due to a reduced mRNA-ribosome pairing efficiency. 
 
5.8 Role of the mini-ORF in the context of the downstream gene expression  
The LEE150 fragment that ends with ler translation start codon ATG, cloned in pRW225 as a 
translation fusion to lacZ (Figure 5.1), was used to investigate downstream effects of the 
small LEE1 leader ORF. Mutations that appeared to alter the mini-gene translation (Table 5.2) 
were introduced in the LEE150 fragment using megaprimer PCR. The name of each of the 
derivatives of LEE150 was based on the position of base substitution and base species 
substitution(s) adopted from LEE30-275 derivatives (Table 5.2). All the derivatives including 
LEE150 145G, LEE150 143C, LEE150 143C 145G, LEE 150-1 or LEE150-1 143C were 
cloned in pRW225 as translation fusions to the lacZ reporter gene. Lac expression from each 
of the derivatives was measured in M182 cells after growth in LB (Figure 5.8A). Results 
illustrated in Figure 5.8 show that mutation in the second alternative start codon (143C) of the 
mini-gene has no effect; mutation in the first start codon (145G) reduced the lac expression 
~30% whilst mutations at both start sites caused ~55% reduction in lac expression compared 
with the starting LEE150 fragment. This suggests that translation of the upstream mini-gene 
has positive effect on the expression of the downstream ler gene.  Similarly, the alteration of 
the mini-gene by KpnI site that results in the derivative LEE150-1 (Figure 2.23) and an 
additional change in the second translation start site that results in LEE150-1 143C reduced 
the expression of the downstream ler gene.  
 
Many studies have showed that environmental signals can alter the LEE gene expression and 
this differs from strain to strain (Russell et al., 2007). In order to check whether the effect of 
the upstream mini-gene on ler gene expression varies with bacterial strains and environment, the 
effects were measured in EHEC Sakai cells after growth in both LB and DMEM. Results 
illustrated in Figure 5.8C show that translation of the upstream mini-gene reduced the 
downstream ler gene expression in EHEC Sakai cells in agreement with the results obtained 
in M182 cells, and the effect does not vary with different culture conditions.  
 
The mini-gene located in the leader sequence of LEE1 operon is conserved among other 
attaching and effacing bacteria including EPEC and C. rodentium (Figure 5.9). The sequence 
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Figure 5.8. Effects of the upstream mini-ORF on the expression of downstream gene.  
(A) Schematic representation of the ler regulatory region of LEE150, and derivatives carrying 
mutations in the mini-ORF. LEE150 145G carries a point mutation in the first translation start 
site of the mini-ORF. LEE150 143C carries a point mutation in the second predicted 
translation start site.  LEE150 143 145G carries mutations that altered both translation start 
sites. In LEE150-1, the predicted mini-ORF was replaced with a KpnI site. LEE150-1 143C 
carries a mutation in the second predicted translation start site. Derivatives were cloned as 
translation fusions to lacZ in pRW225.  
(B) Measured β-galactosidase activities in E. coli K-12 strain M182 containing pRW225 with 
LEE150 or derivatives. Measurements were made after growing the cells in LB at 37°C to an 
optical density of ~0.5 at 650 nM. 
(C) Measurements were also made in EHEC Sakai cells after growth both in LB (grey shaded 
bars) and DMEM media (dashed bars). Values are the average of at least three independent 
assays, and standard deviations are shown with bars. 
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                                    P1          
E_coli_O157:H7_Sakai   TTGACATTTAATGATAATGTATTTTACACATTAGAAAAAAGAGAATAATAACATTT-TAAGGTGGTTGT 
E_coli_E2348/69        TTGACATTTAATGATAATGTATTTTACACATTAGAAAACAGAGAATAATAACATTT-TAAGGTGGTTGT 
C_rodentium_DBS100     TTGACATTTAAGGATAATATATTTTACACATTATGTATCAGGGGTTAATAGCTTTTATAGGGGTTTTGT 
                       *********** ****** **************   *  ** *  ***** * *** ** **   ****  
 
                                                                                       
E_coli_O157:H7_Sakai   TTGATGAAATAGATGTGTCCTAATTTGATAGATAA-ACGTTATCTCACATAATTTATATCATTTGATTA 
E_coli_E2348/69        TTGATGAAATAGATGTGTCCTAATTTGATAGATAA-ACGTTATCTCACATAATTTATATCATTTGATTA 
C_rodentium_DBS100     ATGATGAAGTAGAT-TTTTCTAATGTGATAGATAAGACGTTATCTTACATAATTTATAACATTCTATTA 
                        ******* ***** * * ***** ********** ********* ************ ****  **** 
 
                            P2                
E_coli_O157:H7_Sakai   ATTGTTGGTCCTTCCTGATAAGG------TCGCTAATAGCTTAAAATATTAAAGCATGCGGAGATTATT 
E_coli_E2348/69        ATTGTTG-TCCTTCCTGATAAGGATAAGGTCGCTAATAGCTTAAAATATTAAAGCATGCGGAGATTATT 
C_rodentium_DBS100     ATTGTTGACCCATCCATGTAAGGATGAGCTTGTTAATATCTTAATATATAAAAGTATGAGGAGATTATT 
                       *******  ** ***   *****      * * ***** ***** **** **** *** ********** 
 
E_coli_O157:H7_Sakai   TATTATG 
E_coli_E2348/69        TATTATG 
C_rodentium_DBS100     TATTATG 
                       ******* 
 
Figure 5.9. Alignment of the DNA sequences of the LEE1 operon regulatory region of EHEC, EPEC and C. rodentium.  
Solid white boxes correspond to two promoters: P1, which is present in EHEC (Sakai), EPEC (E2348/69) and C. rodentium (DBS100) and 
P2 promoter that is specific to EHEC (Sakai). Bent arrows indicate the predicted transcription start sites. Dotted box corresponds to the 
mini-ORF. Yellow regions correspond to the SD sequences. The grey shaded box represents the translation start site of the ler gene.  
  208 
covering the SD sequence and coding sequence of the mini-gene in both EHEC and EPEC is 
identical. In each case, the mini-gene has a good SD sequence, two adjacent translation start 
sites (TTG and ATG), only one sense codon specific for lysine (AAA) and translation stop 
codon (TAG). In the case of C. rodentium, the mini-gene has a relatively weak SD sequence, 
two  adjacent start sites (two ATG codons), one sense codon specific for lysine (AAG) and 
translation stop codon (TAG). However, in C. rodentium, both translation start sites are strong 
(two ATG codons compared with TTG and ATG in both EPEC and EHEC) and this perhaps 
compensates the weak SD sequence compared with EHEC and EPEC.  However, in all three 
strains, the mini-gene has a lysine specific last sense codon.  
 
In an attempt to determine whether lysine can modulate expression from the LEE30-275 
promoter fragment, EHEC EDL933 cells containing pRW224 with the LEE30-275 fragment 
or derivatives carrying base substitutions at translation start sites (143C 145G) or a base 
substitution (147T) that changed the lysine specific sense-codon (AAA) to non-sense codon 
(TAA), were grown in minimal medium with or without L-lysine supplementation at 37°C. 
The Lac expression was measured after growing the cells to an optical density of ~0.4 at 650 
nm. Results illustrated in Figure 5.10A show that lysine does not affect the lac expression 
from each of the derivatives. In another experiment, EHEC EDL933 cells containing pRW225 
lac expression plasmid with the LEE150 or derivatives where translation of mini-gene was  
altered by base substitutions at translation start sites (LEE150 143C 145G) were grown in  
minimal medium with or without supplementation of L-lysine and lac expressions were  
quantified. Results illustrated in Figure 5.10B show that lysine does not influence the 
expression from the LEE150 or derivatives. 
 
The small ORF located in the leader sequence of the LEE1 is translated and it encodes a 
dipeptide (Met-Lys) (Table 5.2). In order to determine whether in-trans supply of mini-gene 
encoded dipeptide can modulate the expression of downstream gene, the LEE30-275 fragment 
containing the mini-gene was cloned in a multicopy plasmid pSR, and the resulting plasmid 
was transformed into EHEC EDL933 cells containing plasmid pRW225 with the LEE150 or 
derivatives where mini-genes were knocked out. Results in Figure 5.11 show that, as expected, 
knocking out the mini-gene reduced the downstream gene expression but there is no effect of 
the plasmid-encoded dipeptide on the expression of the downstream gene. 
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Figure 5.10. Effects of lysine on the expression from derivatives of both LEE30-275 and 
LEE150 fragments. 
(A) Measured β-galactosidase activity in EHEC EDL933 cells containing pRW224 with 
LEE30-275 or derivatives cloned as transcription fusion to lacZ. Measurements were made 
after growing the cells to an optical density at 650 nM of 0.3-0.4 in minimal medium with or 
without supplementation of L-lysine at 37°C. Values are the average of at least three 
independent assays, and standard errors are shown with error bars. 
(B) Measured β-galactosidase activity in EHEC EDL933 cells containing pRW225 with 
LEE150 or derivatives cloned as translation fusion to lacZ. Measurements were made after 
growing the cells to an optical density at 650 nM of 0.3-0.4 in minimal medium with or 
without supplementation of L-lysine at 37°C. Values are the average of at least three 
independent assays, and standard deviations are shown with bars. 
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Figure 5.11. In-trans effect of mini-ORF on the expression from LEE150 derivatives. 
The bar chart shows the measured β-galactosidase activity in EHEC EDL933 cells containing 
pRW225 with LEE150 or derivatives cloned as translation fusions to lacZ. Cells also contain 
multicopy plasmid pSR (vector alone: open bars) or pSR with the LEE30-275 fragment 
(shaded bars). Measurements were made after growing the cells in LB at 37° to an optical 
density of ~0.5 at 650 nm. Values are the average of at least three independent assays, and 
standard deviations are shown with bars. 
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5.9 Discussion 
The cis-acting elements in untranslated leader sequences such as small ORFs can take part in 
gene expression regulation (Yanofsky, 1981; Vitreschak et al., 2004). Reports on the 
identification of short translated upstream ORFs are limited and the possibility of alternative 
initiation codons complicate the recognition of associated ORFs (Morris and Geballe, 2000). 
Mutational analysis and subsequent reporter gene assays suggested that the LEE1 leader 
sequence contains a potential ribosomal binding site followed by a small ORF, which has two 
adjacent alternative translation initiation codons, a sense codon specific for lysine and a stop 
codon located just six nucleotides downstream of the first predicted start codon (Figure 
5.12A). Base change at the first predicted translation initiation codon (ATG) reduced the 
translational activity ~9 fold but did not completely abolish the activity. Base change at a 
second possible initiator codon (TTG) had no effect on the translational activity. However, 
base changes at both initiators reduced the translational activity to a barely detectable level. 
This suggests that, though the predicted ORF contains two adjacent initiator codons, 
translation initiation mostly takes place at the first predicted initiation codon (ATG) with a 
trace from the second (TTG). Similar minigenes were reported to be present at the bar loci in 
the bacteriophage λ chromosome. Expression of mini-genes containing rare codons at the end 
results in accumulation of peptidyl-tRNAs, which inhibit protein syntheis and thus cause 
lethal effects in bacteria (Ontiveros et al., 1997; Oviedo et al., 2004). However, role of the 
LEE1 operon leader mini-gene seems to be different. 
 
An interesting finding from my work concerned the role of the upstream mini-gene in the 
expression of downstream genes. Knocking out the mini-gene reduces the expression of the 
down stream ler gene significantly, suggesting that efficient translation of down stream gene(s) 
requires prior translation of upstream mini-gene (Figure 5.12B). How the mini-gene increases 
downstream gene expression is unclear. There is a wide range of sequence variations in the 
LEE1 regulatory region among EHEC, EPEC and C. rodentium. However, the mini-gene 
region is fairly conserved and in each case, it possesses a triplicate (AAA or AAG) that is 
specific for lysine. However, my work did not find involvement of lysine in the mini-gene-
dependent regulation of the downstream gene. One possible mode of action would be that the 
upstream mini-gene might function as processive, long-range antiterminator for the LEE1 
operon. The mRNA transcript of the mini-gene may directly, or associated with other factors, 
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Figure 5.12. Schematic representation of the role of the mini-gene located in the LEE1 
operon leader region. 
(A) Partial sequence of mRNA molecules representing leader sequence of LEE1 operon. 
Ribosome recognizes the SD sequence, located upstream of the mini-ORF and initiate 
translation at the immediate downstream ATG start site and a dipeptide is synthesized.  
(B)  Translation of upstream mini-ORF increases the expression of the downstream ler gene. 
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interact with the RNA and that may allow RNAP to bypass termination signals of the genes in 
the LEE1 operon. Recently Irnov and Winkler (2010) reported that a cis-acting RNA element, 
coined „EAR‟, located between the second and third genes of the eps (exopolysaccharide)  
operon associates with RNAP to readthrough of distally located termination signals. The 
observation that knocking out the mini-gene reduced ~55% of the expression of the first 
cistron (ler) suggests that possibly the mRNA transcript acts as an EAR sequence and 
expression of the distal cistrons of the LEE1 operon might be more dependent on the mini-
gene transcript. To address this possibility, I made an isogenic derivative of EHEC EDL933 
using the gene gorging method (Herring et al., 2003). In this strain, mini-gene has been 
replaced with the KpnI site and also the second translation start point TTG has been changed 
to TTC (data not shown). Quantification of mRNA molecules for different genes in LEE1 
operon both from the wild type strain and the derivative will give an idea whether the LEE1 
leader mini-gene transcript functions as a processive, long range antiterminator. 
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Chapter 6 
 
Regulation of the LEE1 and LEE2 operons 
 by Ler 
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6.1 Introduction 
The LEE1 operon is considered the master operon in the LEE region because the first cistron 
of this operon encodes the Ler protein, which positively regulates most of the LEE genes. 
Nucleoid associated protein, H-NS, plays a suppressive role in LEE gene expression. Ler is 
supposed to negate the H-NS mediated repression ensuring the LEE gene expression (Mellies 
et al., 1999; Elliott et al., 2000; Sperandio et al., 2000; Bustamante et al., 2001; Sanchez-
SanMartin et al., 2001; Umanski et al., 2002; Haack et al., 2003). However, the role of Ler in 
the expression of genes from the LEE1 operon is open to question. Most of the previous 
studies reported that Ler does not play any role in the expression of the LEE1 operon (Mellies 
et al., 1999; Elliott et al., 2000; Haack et al., 2003). However, Berdichevsky et al. (2005) and 
Yerushalmi et al. (2008) reported that Ler negatively regulates LEE1 transcription in EPEC.  
 
Ler positively regulates the expression of the LEE2 operon. In an effort to know whether Ler 
can activate expression from the LEE2 promoter in EPEC, Sperandio et al. (2000) performed 
deletion analysis of the LEE2 operon regulatory region and found that the expression from the 
LEE2 regulatory region covering nucleotide sequence from -247 to +149 is activated by Ler, 
whereas expression from a fragment of -126 to +149 sequence is not activated. Moreover, 
DNA- binding assays showed that Ler bound to a DNA fragment containing -300 to +1 region 
of LEE2 and DNase I footprinting revealed that Ler protected a region of 121 base pairs 
upstream of LEE2. This extended region protected by Ler suggests that Ler binds in a 
multimerized form. Bustamante et al. (2001) suggested that Ler activates the LEE2 operon by 
counteracting H-NS mediated repression. To date, the role of Ler in expression of LEE1 and 
LEE2 operons has been investigated in EPEC. This study was aimed to determine the effects 
of Ler on expression from both LEE1 and LEE2 operon regulatory regions in EHEC.  
 
6.2 The role of Ler in the expression from the LEE1 operon regulatory 
region 
In an attempt to study the role of Ler in expression of LEE1, the ler gene was cloned into a 
multicopy plasmid pJW15Δ100 under the control of the melR promoter to give plasmid pSI04. 
(Figure 2.20). Functional Ler encoded from the plasmid was confirmed by the pathogenicity 
test commonly known as FAS test (Knutton et al., 1989, 1991).  
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EHEC produce a type three secretion mediated characteristic A/E lesion when they adhere to 
intestinal mucosa in vivo and to tissue culture cells in vitro. The A/E lesion is associated with 
the dense concentration of microfilamentous actin that accumulates in the apical cytoplasm 
beneath attached bacteria. This actin can be detected by fluorescence staining in the FAS test.  
To test this, HeLa cells were infected with wild type EHEC EDL933 cells and infected cells 
were fluorescence stained with fluorescein isothyocyana-phalloidin, a phallotoxin that binds 
specifically to polymerized actin that results in fluorescence. Since Ler plays a positive role in 
the regulation of the LEE genes that are involved in the formation of A/E lesion, an EHEC 
EDL933 ler mutant bacterium should not be adherent to HeLa cells and thus should be the 
negative control for the FAS test as seen by Friedberg et al. (1999) and Elliott et al. (2000). 
However, if the Ler expressed from pSI04 plasmid is functional, EDL933 ler mutant cells 
transformed with pSI04 should be capable of adhering to HeLa cells and give a positive FAS 
test.  Figure 6.1 clearly illustrates that deletion of ler gene from the EHEC Sakai strain altered 
the wild type adherence-phenotype (loss of actin formation) (D-F), complementation of the 
Δler mutation with the plasmid encoded Ler (pSI04) restored the wild type adherence-
phenotype (A-C), and positive FAS staining (G-I). These results suggested that pSI04 encodes 
Ler, which is functional. 
 
To investigate the action of Ler at the LEE1 operon regulatory region, plasmids pSI04 
containing ler or empty vector pJW15Δ100 were introduced in E. coli K-12 strain M182 Δlac 
carrying pRW224 derivatives with different LEE1 regulatory region fragments (Figure 2.11). 
In a preliminary experiment, M182 was co-transformed with pRW224 carrying the 
LEE10-568 fragment and the plasmid pSI04 or empty vector pJW15Δ100, and 
β-galactosidase expression was measured. The results show ~30% repression of the promoter 
activity in the presence of Ler (Figure 6.2).  
 
Ler-mediated repression at the LEE1 operon regulatory region carried by fragments with the 
two series of nested deletions described earlier (Figure 3.1) was measured. Moreover, Ler 
-mediated repression was also quantified for one new nested deleted derivatives namely 
LEE10-235, which was cloned into pRW224. With the LEE10 series of nested fragments, 
repression is observed with the LEE10-568, LEE10-275, LEE10-235, LEE10-215,  
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Figure 6.1. Ler complementation assay. 
The figure illustrates the actin fluorescence (A, D, and G), corresponding bacterial 
fluorescence (B, E, and H) and merge of fluorescence and phage-contrast (C, F, and I) 
micrographs showing EHEC EDL933 infected HELA cells. Micrographs A-C: wild type 
EDL933 cells, D-F: EDL933Δler with pJW15Δ100 (no ler) and G-I: EDL933Δler with 
pJW15 containing ler. Bar = 20μm; 0.5μm (inset). The assay was done by Robert Shaw. 
 
   
   
   
Actin EHEC Merge 
A B C 
D E 
G H I 
F 
  218 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2. Repression of expression from the LEE1 regulatory region by Ler. 
The bar chart illustrates measured β-galactosidase expression in M182 cells containing 
pRW224 with the LEE10-568 promoter fragment together with plasmid pJW15Δ100 (-Ler), 
or pSI04 (+Ler). Measurements were made after growing the cells in LB medium at 37ºC to 
stationary growth phase. Each bar represents the mean of three independent experiments 
together with the standard deviations.  
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and LEE10-203 fragments containing both the P1 and P2 promoters but lost with the LEE10-
155, LEE10-115 and LEE10-75 fragments, which contain only the P2 promoter (Figure 6.3), 
suggesting that Ler might target the LEE1 promoter. Interestingly, the level of repression was 
found to be higher with LEE10-235 and LEE10-215 fragments and decreased with LEE10 
-203 and LEE10-195. These suggest that possibly Ler nucleates immediately upstream of the 
P1 promoter and overlaps with the promoter -35 element.  
 
6.3 Regulation of expression from the LEE2 promoter by Ler  
The regulatory region of the LEE2 operon is located upstream of espZ gene. Therefore, the 
start point of this work is to create a construct in which lacZ expression is controlled by the 
fragment LEE2-220, which carries base sequence from position -220 to +109 with respect to 
the transcription start point reported by Mellies et al. (1999) (Figure 2.12, 2.13). Figure 6.4A 
illustrates three nested deletion derivatives of this fragment showing the location of the 
upstream end of each fragment with respect to the proposed LEE2 promoter. Each fragment 
was cloned into the lac expression vector, pRW224, and the resulting recombinants were 
transformed into the Δlac E. coli K-12 laboratory strain, M182. Measurements of 
β-galactosidase expression at 37°C and 25°C illustrated in Figure 6.4 show the effects of the 
deletions on the activity of the LEE2 promoters. Expression increases as upstream sequences 
are removed and increased expression is found both with the LEE2-125 and LEE2-100 
fragments that carry DNA upstream sequence up to positions -125 and -100, respectively. 
These results suggest that sequence upstream of position -125 might contain negative 
elements that could reduce the LEE2 promoter activity.  
 
Nucleoid associated protein H-NS plays a negative role in the expression of the A/T rich LEE 
genes and it represses the expression better at lower temperature (Umanski et al., 2002). In 
order to determine whether the lower level of expression from the LEE2-220 fragment 
compared with two other fragments is associated with H-NS, lac expression from all these 
three fragments were measured at 25°C. Results illustrated in Figure 6.4 show that the 
removal of upstream sequence caused a ~3.5 fold increase in expression at 37°C whilst at 
25°C, the expression increased ~6.5-fold suggesting that H-NS might be associated with the 
low level of activity of the LEE2-220 fragment. 
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Figure 6.3. Ler-mediated repression at different LEE1 regulatory region fragments. 
A. Schematic representation of a series of nested deleted derivatives of LEE1 operon 
regulatory region. The coordinates of the upstream and downstream end of each derivative 
refer to the number of base pairs upstream from the functional ATG start codon of the ler 
gene.  
B. Bar charts illustrate the measured β-galactosidase activities in M182 carrying pRW224 
with each of the different fragments together with plasmid pJW15Δ100 (-Ler: open bars) or 
pSI04 (+Ler: shaded bars). Measurements were made after growing the cells in LB at 37ºC to 
stationary growth phase.Standard deviations were obtained from three independent 
experiments. 
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Figure 6.4. Nested deletions of the LEE2 regulatory region.  
A. Schematic representation of three EcoRI-HindIII DNA fragments of LEE2 regulatory 
region. The coordinates of the upstream and downstream end of each fragment refer to the 
number of base pairs upstream and down stream from the transcription start point of espZ 
gene reported by Mellies et al. (1999). The transcription start site is indicated by bent arrow 
and the shaded black boxes represent the cognate -10 and -35 hexamer elements.   
B. The bar chart to illustrate measured β-galactosidase activities in E. coli K-12 cells carrying 
pRW224 with each of the different fragments. Activities were measured after growing the 
cells in LB medium to stationary growth phase at 37°C (open bars) or at 25°C (shaded bars). 
The values are the average of three independent assays. Standard deviations are shown with 
bars. 
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In order to investigate the action of Ler at the LEE2 operon regulatory region, plasmid pSI04 
(Ler) or empty vector were introduced with the E. coli K-12 M182 Δlac strain carrying 
pRW224 derivatives with three different LEE2 regulatory region fragments (Figure 6.4A). In 
a preliminary experiment, M182 was co-transformed with pRW224 carrying the LEE2-220 
fragment and the plasmid pSI04 (Ler) or empty vector, and β-galactosidase expression was 
measured both at 37°C and 25°C. Results illustrated in Figure 6.5 show that Ler activates the 
lac expression from the LEE2-220 promoter fragment and the activation was higher at 25°C 
(~4 fold) than that at 37°C (~2 fold). Ler-dependent activation was also checked for the 
nested derivatives, LEE2-125 and LEE2-100 after growing the cells at 25°C. Results 
illustrated in Figure 6.6 show that there is no influence of Ler in the expression from both 
LEE2-125 and LEE2-100. This suggests that LEE2 promoter no longer needs Ler for 
transcription activation if the negative elements located between positions -125 and -220 are 
removed.  
 
6.4 Discussion 
Whilst most of the previous studies reported that Ler does not have any influence in 
expression of its own operon, the conclusion of my work that over-expression of the Ler 
represses expression from the LEE1 promoter is interesting and is in agreement with the 
findings of Berdichevsky et al. (2005) and Yerushalmi et al. (2008). In E. coli, many central 
regulators are negatively autoregulated. This mechanism enables rapid promoter activation 
upon stimulation while maintaining a relatively low steady-state level of the regulator 
(Rosenfeld et al., 2002). In addition, cell-to-cell variability in the levels of promoter activity is 
reduced by an autorepression mechanism (Becskei and Serrano, 2000). This study made a 
detailed nested deletion analysis of Ler regulatory region and checked the effects of Ler on 
the expression from each of the promoter fragment. Deletion analysis revealed that Ler does 
not have any effect on the LEE1 P2 promoter but it represses expression from the LEE1 P1 
promoter. Ler-mediated repression was found with upstream (LEE20-568) and down stream 
sequences (LEE10-203) but not with short fragment LEE20-203 of the LEE1 promoter. The 
action of Ler in the LEE1 regulatory region resembles the action of H-NS, as H-NS needs 
both upstream and downstream sequences for repression of the expression from the LEE1 
promoter regulatory region (Figure 3.9). 
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Figure 6.5. Activation of expression from the LEE2 operon regulatory sequence by Ler. 
The bar chart illustrates measured β-galactosidase activity in M182 cells containing pRW224 
with the LEE2-220 promoter fragment together with plasmid pJW15Δ100 (-Ler), and pSI04 
(+Ler). Measurements were made after growth of the cells in LB medium to stationary growth 
phase at 37°C (open bars) or at 25°C (shaded bars). The values are the average of three 
independent assays. Standard deviations are shown with bars. 
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Figure 6.6. Ler-dependent activation at different LEE2 regulatory region fragments.   
The left part of the figure illustrates three different fragments covering the LEE2 regulatory region. The fragments were cloned into 
pRW224, using the same conventions as in Figure 6.4. The right part of the figure presents β-galactosidase activities measured in M182 
cells carrying pRW224 containing each of the fragments. Cells also contained either empty vector pJW15Δ100 (-Ler) or pSI04 (+Ler). 
Measurements were made after growth in LB at 25ºC to stationary growth phase. Standard deviations (sd) were obtained from at least three 
independent experiments. The fold activation by Ler is shown in fourth column. 
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β-galactosidase activity 
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LEE2-220 552 ± 11 1993 ± 20 3.6 
LEE2-125 3960 ± 295 3972 ± 219 1.0 
LEE2-100 3537 ± 82 3521 ± 50 1.0 
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Ler plays an opposite role in the case of expression from the LEE2 promoter. It activates the 
LEE2 promoter. Expression from the nested deleted derivatives of the LEE2 promoter 
suggests that upstream region of the promoter located between -125 and -220 contains a 
negative element that represses the expression from the promoter. Nucleoid associated protein 
H-NS plays major negative role in LEE gene expression. The sequences to which it binds are 
usually A+T-rich and are often associated with regions of intrinsic curvature (Stoebel et al., 
2008; Browning et al., 2010). Increase in temperature reduces the degree of curvature and 
thus H-NS cannot function effectively. A negative element located between positions -125 
and -220 of the LEE2 regulatory region represses the promoter activity higher at 25°C than at 
37°C. This suggests that possibly H-NS binds to the upstream sequence and conveys the 
negative effect to the promoter. Deletion of the upstream sequence important for H-NS 
mediated repression thus results in increase in promoter activity. The conclusion that H-NS is 
the player that represses the expression from the LEE2 promoter is in line with Sperandio et 
al. (2000) and Bustamante et al. (2001). 
 
The role of Ler in the expression from the LEE2 seems to be interesting. Ler only increases 
the expression from the fragment that is repressed by H-NS. This suggests that the role of Ler 
is to displace H-NS (Stoebel et al., 2008). However, Ler increases the activity from the 
repressed fragment but the activation did not reach the level of activity of the fragments that 
lack the negative elements. This implies that Ler partially antagonises the H-NS repression. In 
other words, Ler is not needed for maximal expression from the LEE2 promoter.  
 
In conclusion, this preliminary work finds that overexpression of Ler represses the LEE1 
promoter activity by interacting with an extended region of P1 promoter and activates the 
LEE2 promoter possibly by displacing H-NS from a region located between positions -125 
and -220 with respect to the transcription start site.  
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In EHEC or related pathogenic bacteria, horizontally acquired LEE genes play vital roles 
during infection. Upon the completion of full genome sequencing of pathogenic bacteria, 
researchers are investing their efforts to understand the functional mechanisms of the 
expression of the LEE genes. In over a decade and a half, there has been remarkable progress 
in understanding the regulation of LEE genes. Genetic and biochemical studies revealed that 
both LEE and non-LEE-encoded regulatory proteins regulate LEE gene expression. Among 
them, Ler, encoded by the first gene of LEE1 operon, functions as the central receiver of 
regulatory inputs. Most of the both negative and positive regulatory proteins and signals 
associated with the LEE genes convey their regulatory role to the LEE genes via modulating 
ler gene expression (Figure 1.9). Knowledge on regulation of the ler gene is therefore, crucial 
for understanding of the regulation of other LEE genes. Hence, to upgrade the present 
understanding of the LEE gene regulation, I put my efforts to determine the organization of 
the LEE1 operon regulatory region and to know how LEE-encoded GrlA exploits the complex 
structure of LEE1 operon regulatory region to activate ler expression. Study of the LEE1 
operon regulatory region has enabled me to identify the P1A cryptic promoter that overlaps 
the main promoter, and a mini-gene in the leader region, further suggesting that ler is subject 
to very complex regulations. Moreover, it was found that overexpression of Ler regulates its 
own transcription and activates the expression from the LEE2 promoter by negating H-NS 
repression. 
 
Until recently, there is a big debate whether there are one or two functional promoters in the 
EHEC LEE1 operon regulatory sequence (Sperandio et al., 1999, 2002; Porter et al., 2005). 
To advance understanding of the issue, I performed a deletion analysis of the LEE1 regulatory 
region. The deletion analysis described in Chapter 3 finds several clues concerning LEE1 
promoter structure: (i) P1 is the major functional promoter, (ii) P2 plays but a minor role, (iii) 
the immediate upstream sequence from the P1 promoter contains up-elements, (iv) further 
upstream as well as downstream sequences from the P1 promoter contain negative elements, 
which are thought to be the sites for interacting sites for H-NS that needs both upstream and 
downstream sequences for repression. To date, the LEE1 promoter functional -10 and -35 
elements had been predicted based on their relative positions from the transcription start site 
and sequence homology with the consensus E. coli σ70-dependent promoter. This results in 
different sets of -10 and -35 elements suggested by different groups (Mellies et al., 1999; 
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Sperandio et al., 2002; Deng et al., 2004; Russell et al., 2007; Sharp and Sperandio, 2007; 
Kendall et al., 2010). Using both genetic and biochemical assays, the precise location of the 
P1 promoter -35 and -10 hexamers was determined. These are TTGACA and TACACA 
respectively and they are separated from each other by a non-optimal 18 base pairs spacer 
sequence. 
 
The major aim of my project was to investigate GrlA-dependent activation of the LEE1 
promoter. This is one of the big issues among the researchers dealing with LEE gene 
regulation since the LEE-encoded GrlA was reported to play a positive role in LEE gene 
expression (Deng et al., 2004). Many of the reports published to date, concerning the action of 
GrlA at the LEE1 promoter are confusing and contradictory. Whilst some groups (Barba et al. 
2005; Huang and Syu, 2008) suggested that GrlA activates expression from the LEE1 
promoter independently, Russell et al (2007) assumed that GrlA might need other factor(s) to 
activate expression of the ler. In view of these reports, and to obtain advance understanding of 
the action of GrlA, a systematic study of the LEE1 promoter and its activation by GrlA in 
both EHEC and K-12 backgrounds was performed.  
 
GrlA activates the LEE1 promoter in both E. coli K12 and EHEC backgrounds suggesting 
that GrlA can activate the LEE1 promoter independently. GrlA-dependent activation from a 
series of nested deleted LEE1 regulatory region fragments located the GrlA targets at the 
LEE1 P1 promoter. Mutational analysis of a 52 base pair-long P1 promoter fragment, 
containing the functional promoter elements, activated by GrlA defined that GrlA activates 
LEE1 promoter by targeting the non-optimal spacer sequence between P1 -35 and -10 
elements. It is important to recall that both Barba et al  (2005) and Jimenez et al. (2010) found 
GrlA-dependent LEE1 activation from a promoter fragment that lacks upstream sequence of 
the promoter -35 element but, amazingly, they never tested a fragment that lacks both 
upstream and downstream sequences. 
 
Concerning the point, raised by Jimenez et al. (2010), that GrlA mainly acts to counteract 
repression by H-NS, my work revealed that both upstream and downstream sequences are 
necessary for H-NS-mediated repression of the P1 promoter, and interestingly, the short 52 
base pairs promoter fragment that is activated by GrlA, is not repressed by H-NS (Figure 3.9).  
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This strongly argues that GrlA is a bona fide transcription activator, likely acting directly. 
 
Attempts were made to perform DNA electrophoresis mobility-shifting assay for providing 
evidence that GrlA-dependent activation occurs via a direct binding at the promoter region, 
and to perform footprinting assay to map GrlA binding site. To do these, GrlA protein fused 
either to His tag, a maltose binding protein (MBP) tag, or a glutathione-S-transferase (GST) 
tag, were used to purify the protein, but no functional GrlA protein was obtained. Purified 
functional GrlA protein is difficult to obtain (Barba et al., 2005). However, Huang and Syu 
(2008) reported GrlA binding to the LEE1 promoter using purified GrlA-GST but their results 
are unconvincing since there were no controls to establish specificity. Recently, Jimenez et al, 
(2010) reported convincing GrlA band shifts, together with controls and showed that it bound 
to a target downstream of position -54 at the LEE1 P1. However, they did not present 
footprints to show a GrlA binding site. In view of these problems, a genetic suppression 
approach was used to solve the problem. This classical approach revealed that GrlA interacts 
with the LEE1 P1 spacer region and provided the first experimental evidence that the 
proposed GrlA helix-turn-helix is functional. 
 
Based on the mutational analysis described in chapter 3, I argue that GrlA compensates the 
abnormal spacing of the LEE1 P1 promoter. If the spacer, which is 18 bp between the -10 and 
-35 region is changed to the optimum 17 bp, GrlA regulation is no longer necessary. This 
suggests that GrlA activates transcription in a manner similar to members of the  MerR family 
regulators, which activate transcription by binding to the spacer of target promoters at which 
the distance between the -10 and-35 elements is greater than normal (O‟Halloran et al., 1989; 
Parkhill and Brown, 1990). Models for activation mechanism of MerR family members 
suggest that the binding of MerR family members to their target promoter spacers causes 
deformation, which is defined by a local unwinding of the spacer DNA by 33°, causing 
realignment of the -10 and -35 elements and thus facilitating RNAP binding (O‟Halloran et 
al., 1989; Frantz and O‟Halloran, 1990; Ansari et al., 1992). Evidence that GrlA targets the 
LEE1 P1 promoter spacer and compensates abnormal spacer length suggests that, like MerR 
family members, GrlA possibly activate transcription by provoking a change in the 
conformation of the target DNA that makes the promoter more attractive to RNAP. However, 
an alternative mechanism cannot be ruled out. One possibility is that GrlA directly interacts 
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with RNAP before interacting with its DNA target. However, pull down assays in which 
proteins bound to RNAP are resolved failed to find evidence for any “off-DNA” direct 
interaction between GrlA and RNAP.  
 
Although further investigations are necessary, the available evidence suggests that the 
function of the GrlA is unusual. Whilst previous studies suggest that GrlA activates the LEE1 
promoter mainly by negating H-NS mediated repression, my work shows that GrlA can 
directly interact with a target promoter and its mode of action is unusual. Instead of following 
the usual role of an activator, by recruiting RNAP by binding upstream or overlapping the 
promoter -35 element, GrlA activates the LEE1 promoter by interacting with its non-optimal 
spacer sequence, possibly following the role of many of the MerR family activators. However, 
it is worth mentioning that there is no sequence similarity between GrlA and any of the MerR 
family activators. Whole genome analysis to identify GrlA targets and investigation of those 
regulons might provide more precise knowledge on the mode of action of GrlA.  
 
The LEE1 promoter regulatory region is very complex. This is the target for many regulators 
that switch on and off LEE gene expression via ler gene expression. Identification of the 
cryptic promoter P1A overlapped with the LEE1 P1 described in the Chapter 4 underscores its 
complexity. Weakening or inactivating the functional P1 promoter unmasks the P1A promoter 
suggesting that two promoters compete each other for RNAP and the P1 promoter wins in 
competition over P1A since it does contain a consensus -35 element. Though the regulatory 
role of the P1A promoter in ler gene expression is still unknown, investigation of this 
promoter gives some observations of general interest, presumably applicable for other 
promoters. My most important observation is that sequestration of RNAP by inactivated P1 
promoter consensus -35 element prevents the cryptic promoter from functioning. This 
suggests that a consensus -35 elements make the P1 promoter more attractive to RNAP 
compared with the P1A ensuring the dominancy of the P1 over the P1A. Residual effects of 
an inactivated promoter have been reported for the gal P2 promoter (Johnston et al., 1987), 
where an inactivated gal P2 promoter created by an alteration of a base at the extended -10 
element can make contact with RNAP.  
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A regulatory role for the P1A promoter cannot be ruled out. It may sense different 
environmental signal(s). Note that both the E. coli gal and lac promoters contain upstream 
overlapping promoters. Expression from the gal or lac P1 promoters is up-regulated by CRP 
(Musso et al., 1977; Malan and McClure, 1984). In each case, a weak overlapping promoter 
overlaps the target site for CRP and the cryptic promoter activity is suppressed by the 
activator. In the case of LEE, the P1A cryptic promoter -10 element region overlaps the 
recognition site for GrlA. However, GrlA does not have any influence in the expression from 
the cryptic promoter (data not shown). Possibly other transcription factors particularly EHEC 
specific transcription factor(s) act on this promoter in response to environmental signals. 
 
Another important finding of my work is the identification of a short ORF in the ~170 bases 
long leader sequence of the LEE1 operon described in Chapter 5. Interestingly, translation of 
this mini-gene is important for the optimal expression of the downstream ler gene. However, 
the precise functional mechanism needs to be addressed. The positive role of the mini-gene on 
the expression of the ler gene implies that translation of the mini-gene could stabilize the 
mRNA. It is well known that the bound ribosome can affect the mRNA stability by 
functioning as a barrier for mRNA decay (Cole and Nomura, 1986; Nilsson et al., 1987; 
Petersen, 1992; Rauhut and Klug, 1999; Arraiano et al., 2010). Alternatively, transcription of 
the mini-gene could help RNAP to bypass termination sites ensuring full length transcript as 
described by Artsimovitch (2010).  
 
It is thought that Ler acts as an anti-silencer by negating H-NS mediated repression of most of 
the LEE operons. It overcomes H-NS repression as it has higher affinity for DNA than H-NS 
and functions in multimerized form (Yerushalmi et al., 2008; Mellies et al., 2011). The 
repressive role of overexpressed Ler in the expression from LEE1 operon regulatory described 
in Chapter 6 is unusual. However, autorepression of the Ler may maintain a steady-state 
concentration of the Ler, which is sufficient to activate other LEE genes. In contrast, Ler 
functions as an activator in LEE2 expression and  it can only function indirectly by negating 
repressing elements since it can not activate the expression from a LEE2 promoter fragment 
that contains an upstream sequence up to position -125 with respect to the transcription start 
site. In order to know the role of Ler in the expression from both LEE1 and LEE2 operon 
regulatory region effectively, more study is necessary. Moreover, study of its other targets 
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need to be considered. Genome wide analysis found that Ler regulates a number of non-LEE 
genes. Some of these are are associated with attaching and effacing phenotype whereas many 
are found in the non-pathogenic E. coli K-12 strain (Abe et al., 2008).  
 
In summary, the studies communicated here, indicate that the expression of ler is subject to 
complex regulatory systems. The presence of an overlapping cryptic promoter and a translated 
mini-ORF in the leader region indicate that the ler regulatory system is much more complex 
than was thought before. GrlA is part of this regulatory system and plays an important role in 
the induction of the expression from the LEE1 promoter by an unusual mechanism. Moreover, 
over-expression of Ler autorepresses its own transcription. On the other hand, H-NS mediated 
repression of the LEE2 promoter is overcome partially by Ler (Figure 7.1). However, though 
my laboratory-based in vitro system has produced several interesting observations concerning 
the LEE gene regulation, much more research considering the consequences of in vivo 
conditions needs to be done to get precise knowledge on these aspects.  
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Figure 7.1. Model for the regulation of the LEE1 and LEE2 operons by Ler and 
GrlR/GrlA.  
GrlA activates expression from the LEE1 operon regulatory region ensuring induction of the 
ler expression. Ler then increases the expression from the LEE2 promoter by negating the H-
NS mediated repression whilst overexpressed Ler autorepresses its own expression. GrlR 
interacts with GrlA and negates the capability of the GrlA to activate expression from the 
LEE1 promoter.  
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